"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type"
"CHEMBL3318761";"";"None";"579.55";"2";"5.39";"9";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)NC2CC2)C2CC2)C1=O";"IC50";"'='";"0.059";"nM";"10.23";"";"";"UO_0000065";"17.65";"0.37";"4.84";"9.86";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318777";"";"None";"609.62";"2";"6.37";"28";"CN(C1CC1)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"15.45";"0.32";"3.05";"9.92";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318779";"";"None";"623.64";"2";"6.76";"30";"C[C@@H]1CCCN1S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"15.75";"0.33";"3.06";"10.34";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318780";"";"None";"623.64";"2";"6.76";"31";"C[C@H]1CCCN1S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"14.37";"0.30";"2.20";"9.43";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318781";"";"None";"638.66";"2";"5.52";"32";"CN1CCN(S(=O)(=O)C[C@@H](N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C(C)(C)C)CC1";"IC50";"'='";"0.074";"nM";"10.13";"";"";"UO_0000065";"15.86";"0.33";"4.61";"10.31";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318784";"";"None";"659.62";"2";"7.01";"35";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCC(F)(F)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"14.30";"0.30";"2.42";"9.93";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318787";"";"None";"675.65";"2";"7.48";"38";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCc2cc(F)ccc21)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"14.29";"0.29";"2.18";"10.17";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL405395";"";"None";"1209.76";"None";"None";"Page No 2481, R4C1";"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"6.86";"None";"None";"None";"1";"CHEMBL2383516";"Antagonist activity at human GST-tagged MDM2 assessed as inhibition of binding to full length p53";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2398474";"";"None";"534.46";"1";"4.52";"4";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"15.13";"0.31";"3.57";"8.94";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2398472";"";"None";"552.47";"1";"3.74";"2";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"14.50";"0.30";"4.27";"7.24";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL380399";"";"None";"692.43";"2";"5.55";"30";"CN1CCN(CCCN2C(=O)[C@H](c3ccc(Cl)cc3)N(Cc3ccc(Cl)cc3N)C(=O)c3cc(I)ccc32)CC1";"IC50";"'='";"5410.0";"nM";"5.27";"";"";"UO_0000065";"7.61";"0.18";"-0.28";"7.20";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3355431";"";"None";"480.37";"0";"3.70";"20";"N[C@@H](C(=O)N[C@H]1CC[C@H](O)CC1)[C@H](c1cccc(Cl)c1F)C1C(=O)Nc2cc(Cl)ccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL207541";"";"None";"678.35";"2";"5.75";"12l";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(C(=O)CN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"7.77";"0.18";"-0.48";"7.51";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL378851";"";"None";"664.37";"2";"6.22";"12d";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6250.0";"nM";"5.20";"";"";"UO_0000065";"7.83";"0.19";"-1.02";"9.80";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210151";"";"None";"651.33";"2";"7.14";"19";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"856.0";"nM";"6.07";"";"";"UO_0000065";"9.32";"0.22";"-1.07";"7.79";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210151";"";"None";"651.33";"2";"7.14";"19";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"9.45";"0.23";"-0.99";"7.90";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL382389";"";"None";"736.43";"2";"6.99";"16";"CCN(CC)C(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"37000.0";"nM";"4.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"8, MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866342";"Antiproliferative activity against human PC3 cell line with deleted p53";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PC-3";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148527";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307570";"";""
"CHEMBL1688169";"";"None";"369.44";"0";"3.82";"48";"CCCN1C(=O)c2ccccc2C1(OC1CCC(O)C1)c1ccc(F)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688252";"";"None";"478.93";"1";"5.04";"52";"O=C1c2ccccc2C(O[C@H]2CC[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.36";"0.26";"1.36";"6.89";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688258";"";"None";"464.91";"0";"4.67";"58";"O=C1c2ccccc2C(OC/C=C\CO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.76";"0.26";"1.73";"6.89";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688275";"";"None";"492.96";"1";"5.43";"75";"O=C1c2ccccc2C(O[C@H]2CC[C@H](O)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"13.00";"0.25";"0.98";"6.90";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688279";"";"None";"468.38";"1";"5.64";"80";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.04";"0.24";"0.00";"11.33";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688281";"";"None";"559.83";"2";"5.59";"82";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(I)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.40";"0.25";"0.23";"11.70";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3291219";"";"None";"300.36";"1";"5.31";"8";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccon1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"20.07";"0.36";"0.72";"14.41";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3125703";"";"None";"492.44";"1";"6.08";"3";"CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"15.22";"0.31";"1.41";"9.63";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3683127";"";"None";"502.01";"2";"6.59";"BDBM161841";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(-c3cn[nH]c3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"1383.0";"nM";"5.86";"";"304973";"UO_0000065";"11.67";"0.22";"-0.73";"8.69";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657004";"";"None";"577.51";"2";"7.21";"BDBM129908";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"70.5";"nM";"7.15";"";"261639";"UO_0000065";"12.38";"0.24";"-0.06";"10.57";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3318764";"";"None";"595.59";"2";"6.03";"12";"CC(C)(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.091";"nM";"10.04";"";"";"UO_0000065";"16.86";"0.35";"4.01";"9.68";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318770";"";"None";"616.57";"2";"6.15";"21";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)Nc2ccccn2)C2CC2)C1=O";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"15.89";"0.33";"3.65";"8.40";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318774";"";"None";"609.62";"2";"6.37";"25";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"15.60";"0.32";"3.14";"10.01";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3657113";"";"None";"557.41";"2";"5.33";"BDBM130031";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.371";"nM";"9.43";"";"261752";"UO_0000065";"16.92";"0.34";"4.10";"8.70";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691770";"";"None";"545.00";"1";"3.81";"BDBM143661";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.663";"nM";"9.18";"";"279811";"UO_0000065";"16.84";"0.32";"5.37";"7.01";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687312";"";"None";"596.49";"2";"7.31";"BDBM143441";"COC(=O)CCC1(c2ccc(Cl)cc2)c2c(nn(-c3ccccc3OC)c2C(C)C)C(=O)N1c1ccc(F)c(Cl)c1";"IC50";"'='";"0.499";"nM";"9.30";"";"279751";"UO_0000065";"15.59";"0.31";"1.99";"12.63";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL407632";"NUTLIN-2";"None";"686.45";"2";"5.89";"2";"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.98";"0.23";"0.96";"8.81";"0";"CHEMBL3413423";"Binding affinity to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407475";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3657092";"";"None";"573.41";"1";"4.83";"BDBM130009";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.252";"nM";"9.60";"";"261730";"UO_0000065";"16.74";"0.34";"4.77";"9.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683103";"";"None";"522.09";"2";"6.34";"BDBM161688";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1N(C)C";"IC50";"'='";"5505.0";"nM";"5.26";"";"304948";"UO_0000065";"10.07";"0.19";"-1.08";"11.62";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220086";"";"None";"359.84";"0";"2.66";"4a";"Cc1cc(C=C2C(=O)NC(=S)NC2=O)c(C)n1-c1ccc(Cl)cc1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"17.07";"0.35";"3.48";"9.73";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220087";"";"None";"435.94";"0";"4.58";"4b";"Cc1cc(/C=C2\C(=O)NC(=S)N(c3ccccc3)C2=O)c(C)n1-c1ccc(Cl)cc1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"12.57";"0.25";"0.90";"10.09";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3653169";"";"None";"605.57";"2";"7.95";"BDBM129733";"COc1ccc(C(=O)NC(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261464";"UO_0000065";"16.22";"0.32";"1.87";"12.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657038";"";"None";"605.57";"2";"7.95";"BDBM129945";"COc1ccc(C(=O)NC(C)C)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.08";"nM";"10.10";"";"261675";"UO_0000065";"16.67";"0.33";"2.15";"13.21";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3260821";"";"None";"629.54";"2";"7.80";"16";"Nc1nnc(-c2nc(C3CCCCC3)n(-c3c(CC(=O)NC4CCCCC4)ccc(Cl)c3F)c2-c2ccc(F)c(Cl)c2)o1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.82";"0.28";"0.90";"7.78";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260814";"";"None";"451.30";"1";"6.87";"9";"O=C(O)c1nc(C2CCCCC2)n(-c2cccc(Cl)c2F)c1-c1ccc(F)c(Cl)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"18.61";"0.38";"1.53";"15.24";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL462089";"ISOLISSOCLINOTOXIN B";"None";"353.58";"0";"4.56";"1";"COc1cc(CCN(C)C)c2c(c1O)SSSSS2";"IC50";"'='";"58600.0";"nM";"4.23";"";"";"UO_0000065";"11.97";"0.30";"-0.33";"12.94";"0";"CHEMBL988050";"Inhibition of GST fused human Hdm2 assessed as polyubiquitylation by electrochemiluminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151701";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";""
"CHEMBL3665594";"";"None";"550.02";"1";"4.54";"BDBM119730";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"121.9";"nM";"6.91";"";"246794";"UO_0000065";"12.57";"0.25";"2.37";"7.64";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665595";"";"None";"566.48";"2";"5.05";"BDBM119731";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"89.59";"nM";"7.05";"";"246795";"UO_0000065";"12.44";"0.25";"2.00";"7.79";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665585";"";"None";"532.03";"1";"4.40";"BDBM119717";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'='";"2742.86";"nM";"5.56";"";"246796";"UO_0000065";"10.45";"0.21";"1.16";"6.15";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3929636";"";"None";"546.06";"1";"4.79";"BDBM119721";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"175.0";"nM";"6.76";"";"246804";"UO_0000065";"12.37";"0.24";"1.97";"7.47";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649851";"";"None";"575.08";"2";"4.79";"BDBM135187";"Cn1ncnc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"268696";"UO_0000065";"13.35";"0.26";"2.89";"5.63";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4169540";"";"None";"516.56";"2";"1.59";"9";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NC(c2ccccc2)c2ccccc2)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"13.83";"0.26";"5.55";"3.83";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL593074";"";"None";"1068.95";"None";"None";"9";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"4.71";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3683163";"";"None";"659.27";"2";"6.63";"BDBM162077";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCCNC(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.4";"nM";"8.85";"";"305016";"UO_0000065";"13.43";"0.26";"2.22";"11.91";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653210";"";"None";"531.98";"2";"6.06";"BDBM129775";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(NC)nc4OC)n3C(C)C)C(=O)N2c2cccc(Cl)c2F)cc1";"IC50";"'='";"0.31";"nM";"9.51";"";"261506";"UO_0000065";"17.87";"0.34";"3.45";"10.62";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687229";"";"None";"488.43";"1";"7.56";"BDBM143336";"Cc1cc(Cl)ccc1C1c2c(nn(CCC(C)C)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.8";"nM";"8.06";"";"279496";"UO_0000065";"16.49";"0.33";"0.50";"21.13";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653191";"";"None";"565.51";"2";"6.67";"BDBM129756";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.16";"nM";"9.80";"";"261487";"UO_0000065";"17.32";"0.34";"3.13";"12.83";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657051";"";"None";"540.99";"2";"6.01";"BDBM129959";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"1.2";"nM";"8.92";"";"261688";"UO_0000065";"16.49";"0.31";"2.91";"8.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2347396";"";"None";"510.23";"2";"5.36";"4";"CC(C)(C)OC(=O)N1CC(=O)N[C@H](c2ccc(Br)cc2)[C@@H]1c1ccc(Br)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3601320";"";"None";"576.18";"2";"7.16";"BDBM161880";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"3.7";"nM";"8.43";"";"304986";"UO_0000065";"14.63";"0.28";"1.27";"12.39";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687295";"";"None";"511.50";"2";"6.95";"BDBM143423";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCN(C)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"3.0";"nM";"8.52";"";"279563";"UO_0000065";"16.66";"0.33";"1.57";"20.60";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2347383";"";"None";"530.42";"2";"6.64";"16";"CCC[C@H](C(=O)O)N1C(=O)[C@H](Cc2ccc(F)cc2)O[C@@H](c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20700.0";"nM";"4.68";"";"";"UO_0000065";"8.83";"0.18";"-1.96";"7.01";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347377";"";"None";"434.32";"0";"4.89";"30";"O=C(O)C[C@@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.78";"0.32";"1.96";"10.25";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347403";"";"None";"594.14";"2";"6.86";"12";"CN1C(=O)[C@H](Cc2ccc(Br)cc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"9.80";"0.27";"-1.04";"19.72";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3683138";"";"None";"604.24";"2";"7.81";"BDBM161882";"CCN[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(O[C@H](C)CC)cc4C3c3ccc(Cl)cc3)cc2)CC1";"IC50";"'='";"5.8";"nM";"8.24";"";"304987";"UO_0000065";"13.63";"0.26";"0.43";"15.24";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683124";"";"None";"596.18";"2";"6.40";"BDBM161817";"CC(=O)NCCN(c1ccc2c(c1)C(c1ccc(Cl)cc1)N(c1ccc(N(C)Cc3ccncc3)cc1)C(=O)C2)C(C)C";"IC50";"'='";"120.1";"nM";"6.92";"";"304970";"UO_0000065";"11.61";"0.22";"0.52";"10.06";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691739";"";"None";"593.55";"2";"7.31";"BDBM143548";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"0.5";"nM";"9.30";"";"279623";"UO_0000065";"15.67";"0.31";"1.99";"15.55";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3402515";"";"None";"666.72";"2";"6.92";"2";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)C3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"11.52";"0.23";"0.76";"12.91";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3402519";"";"None";"685.70";"2";"6.50";"6";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CC3(CC3)NC[C@@H]2C)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"11.61";"0.24";"1.46";"9.81";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL2440443";"";"None";"391.74";"0";"3.85";"15";"O=c1nc2n(-c3cccc(Cl)c3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.87";"0.29";"1.97";"8.60";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440444";"";"None";"391.74";"0";"3.85";"14";"O=c1nc2n(-c3ccc(Cl)cc3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"11900.0";"nM";"4.92";"";"";"UO_0000065";"12.57";"0.25";"1.07";"7.27";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3687226";"";"None";"509.41";"2";"6.95";"BDBM143333";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"7.8";"nM";"8.11";"Potential transcription error";"279493";"UO_0000065";"";"";"";"";"1";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691704";"";"None";"523.42";"2";"5.76";"BDBM143467";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.425";"nM";"9.37";"";"279755";"UO_0000065";"17.90";"0.36";"3.61";"13.51";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653278";"";"None";"555.04";"1";"4.37";"BDBM129846";"COC(=O)N1CCC(N2C(=O)c3nc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"4.99";"nM";"8.30";"";"261575";"UO_0000065";"14.96";"0.29";"3.93";"7.42";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4206176";"";"None";"1899.88";"None";"None";"D-MIPC-e5a";"CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C";"IC50";"'='";"13700.0";"nM";"4.86";"";"";"UO_0000065";"2.56";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268897";"UO_0000065";"16.19";"0.31";"2.98";"7.20";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650023";"";"None";"597.99";"2";"5.31";"BDBM135426";"O=c1[nH]c(-c2cc3nc(N4CCO[C@@H]5CCC[C@H]54)n(Cc4ccc(C(F)(F)F)cc4)c3c(-c3cncc(Cl)c3)n2)no1";"IC50";"'='";"39.0";"nM";"7.41";"";"268935";"UO_0000065";"12.39";"0.24";"2.10";"6.44";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653333";"";"None";"527.09";"2";"6.17";"BDBM135452";"CCC(CSC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268961";"UO_0000065";"16.50";"0.33";"2.53";"8.49";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653334";"";"None";"559.09";"1";"4.85";"BDBM135453";"CCC(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268962";"UO_0000065";"14.59";"0.29";"3.30";"5.97";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650008";"";"None";"559.11";"2";"5.91";"BDBM135408";"CNC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"268917";"UO_0000065";"12.15";"0.23";"0.89";"7.98";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"268928";"UO_0000065";"14.68";"0.28";"1.53";"7.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650021";"";"None";"542.04";"2";"5.24";"BDBM135424";"CCON(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268933";"UO_0000065";"15.72";"0.31";"3.28";"6.86";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691766";"";"None";"559.03";"1";"3.83";"BDBM143651";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"86.64";"nM";"7.06";"";"279807";"UO_0000065";"12.63";"0.24";"3.23";"5.78";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2152320";"";"None";"515.47";"2";"5.02";"9c, (+/-)-9c";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"12.77";"0.26";"1.57";"10.13";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152331";"";"None";"515.47";"2";"5.02";"(+)-9c";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"13.18";"0.27";"1.78";"10.45";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4094076";"";"None";"531.48";"2";"6.66";"25";"Cc1nnc([C@H]2[C@H](c3cccc(Cl)c3F)[C@]3(C(=O)Nc4cc(Cl)ccc43)C3(CCCCC3)N2C)s1";"IC50";"'='";"38.6";"nM";"7.41";"";"";"UO_0000065";"13.95";"0.29";"0.75";"12.76";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4100348";"";"None";"418.45";"0";"3.93";"8";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O";"IC50";"'='";"13.8";"nM";"7.86";"";"";"UO_0000065";"18.78";"0.35";"3.93";"7.18";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3703679";"";"None";"545.84";"2";"7.00";"BDBM47310";"Cc1cc(Cl)cnc1NC(c1ccc2cccnc2c1O)c1c(F)c(F)c(OCC(F)(F)F)c(F)c1F";"IC50";"'='";"8500.0";"nM";"5.07";"";"198818";"UO_0000065";"9.29";"0.19";"-1.93";"7.54";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL427042";"";"None";"691.40";"2";"5.73";"24";"Nc1cc(C2(N3C(=O)c4cc(I)ccc4N(CCN4CCOCC4)C(=O)[C@@H]3c3ccc(Cl)cc3)CC2)ccc1Cl";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"6.66";"0.16";"-1.13";"5.82";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL2386167";"";"None";"713.77";"2";"7.58";"2m";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"232.0";"nM";"6.63";"";"";"UO_0000065";"9.30";"0.19";"-0.95";"8.04";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3657089";"";"None";"586.46";"1";"4.89";"BDBM130006";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.117";"nM";"9.93";"";"261727";"UO_0000065";"16.94";"0.34";"5.04";"10.10";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL425780";"";"None";"201.61";"0";"2.30";"2";"CC(O)c1ccc(Cl)cc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"1, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"17.53";"0.36";"2.70";"10.77";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125697";"";"None";"566.55";"2";"6.13";"39";"CC(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.12";"0.36";"3.57";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125536";"";"None";"596.62";"2";"7.16";"34";"CC(C)(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"15.59";"0.33";"2.14";"10.14";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125516";"";"None";"581.56";"2";"5.73";"14";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"15.55";"0.33";"3.32";"9.52";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125517";"";"None";"593.57";"2";"5.73";"15";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"16.34";"0.34";"3.97";"10.21";"1";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"1, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"18.73";"0.38";"3.27";"11.51";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3109038";"";"None";"620.53";"2";"6.29";"18";"COc1cc(C(=O)O)ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)sc32)[C@@H]1c1cccc(Cl)c1F";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"11.67";"0.24";"0.95";"6.20";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109039";"";"None";"614.51";"2";"5.02";"17";"COc1cc(C(N)=O)ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)ncc32)[C@@H]1c1cccc(Cl)c1F";"IC50";"'='";"5764.0";"nM";"5.24";"";"";"UO_0000065";"8.53";"0.17";"0.22";"3.87";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109040";"";"None";"619.55";"2";"5.69";"16, RO5353";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)sc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.16";"0.27";"2.46";"6.65";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109054";"";"None";"581.04";"1";"4.97";"1";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3ccncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"12.54";"0.24";"2.31";"5.62";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2386170";"";"None";"606.64";"2";"9.19";"2c";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCCCC1";"IC50";"'='";"209.0";"nM";"6.68";"";"";"UO_0000065";"11.01";"0.22";"-2.51";"14.80";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL1689396";"";"None";"1946.26";"None";"None";"1b";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"3.49";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3236360";"";"None";"699.64";"2";"6.40";"8";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)NS(=O)(=O)C(F)(F)F)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"12.16";"0.26";"2.11";"7.23";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236650";"";"None";"656.67";"2";"7.99";"30";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"12.98";"0.26";"0.53";"9.29";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236663";"";"None";"661.65";"2";"6.04";"44";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nnc(CC(=O)O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.11";"0.31";"3.96";"7.50";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236356";"";"None";"657.66";"2";"7.38";"3, AM-1900";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"13.83";"0.28";"1.72";"8.69";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236641";"";"None";"657.66";"2";"7.38";"21";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cccc(C(=O)O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"11.59";"0.24";"0.24";"7.28";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2386345";"";"None";"651.68";"2";"7.31";"2f";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"11.64";"0.23";"0.28";"11.06";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3291221";"";"None";"351.41";"0";"4.76";"12";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnc2ncnn12";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"17.22";"0.31";"1.29";"10.28";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3291217";"";"None";"299.38";"1";"5.05";"6";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccn[nH]1";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"20.06";"0.36";"0.95";"13.50";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3653219";"";"None";"535.48";"2";"6.96";"BDBM129784";"COc1cc(CN)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261515";"UO_0000065";"18.24";"0.36";"2.81";"13.31";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683148";"";"None";"618.26";"2";"8.07";"BDBM161955";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(C)[C@H]3CC[C@@H](N(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"202.6";"nM";"6.69";"";"304997";"UO_0000065";"10.83";"0.21";"-1.38";"14.79";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220096";"";"None";"521.60";"1";"4.90";"4k";"CCOC(=O)c1ccc(-n2c(-c3ccccc3)cc(C=C3C(=O)NC(=S)NC3=O)c2-c2ccccc2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"11.80";"0.22";"1.25";"6.88";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220097";"";"None";"467.91";"1";"5.21";"4m";"O=C1NC(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Cl)cc3)c2-c2ccccc2)C(=O)N1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"13.94";"0.26";"1.31";"8.13";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3288450";"";"None";"791.19";"1";"4.66";"11b, Diastereomer 2";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)[C@@H]2CC(O)CO)CC1.Cl";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"10.33";"0.20";"3.14";"6.24";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3402517";"";"None";"670.68";"2";"6.72";"4";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCNC3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"12.11";"0.25";"1.40";"11.90";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3691760";"";"None";"555.42";"1";"4.56";"BDBM143635";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.453";"nM";"9.34";"";"279801";"UO_0000065";"16.82";"0.34";"4.78";"8.95";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687308";"";"None";"460.34";"1";"5.26";"BDBM143437";"Cc1cc(Cl)ccc1C1c2c(nn(CCO)c2C2CC2)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"23.2";"nM";"7.63";"";"279576";"UO_0000065";"16.58";"0.34";"2.37";"13.08";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3402520";"";"None";"689.66";"2";"6.06";"7";"CC(C)C1=C(C(=O)N2C[C@H](F)C[C@H]2C(=O)N2CC3(CC3)NC[C@@H]2C)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"12.55";"0.26";"2.60";"10.67";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3236362";"";"None";"582.59";"2";"6.00";"11";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"15.83";"0.33";"3.22";"10.05";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236365";"";"None";"615.64";"2";"5.34";"14";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CS(N)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"12.76";"0.28";"2.51";"6.85";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236662";"";"None";"679.64";"2";"7.05";"43";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)o2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"13.07";"0.27";"1.84";"7.54";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233129";"";"None";"542.48";"2";"5.08";"15";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"16.38";"0.35";"3.81";"8.80";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233121";"";"None";"569.51";"1";"4.68";"7";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"13.97";"0.29";"3.28";"7.64";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233122";"";"None";"631.58";"2";"6.26";"8";"CC[C@@H](CN(c1ccccc1)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"13.35";"0.27";"2.17";"8.09";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3402516";"";"None";"652.69";"2";"6.58";"3";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCNC3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"12.29";"0.25";"1.44";"11.75";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3800127";"";"None";"707.67";"2";"5.91";"20o";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(C(N)=O)cn2)CC1";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"9.67";"0.19";"0.93";"5.35";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800561";"";"None";"678.67";"2";"7.12";"20a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C)n2)CC1";"IC50";"'='";"5027.0";"nM";"5.30";"";"";"UO_0000065";"7.81";"0.15";"-1.82";"6.24";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798706";"";"None";"665.63";"2";"6.20";"16";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ncccn2)CC1";"IC50";"'='";"334.0";"nM";"6.48";"";"";"UO_0000065";"9.73";"0.19";"0.28";"6.63";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798260";"";"None";"664.65";"2";"6.81";"15b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccnc2)CC1";"IC50";"'='";"267.0";"nM";"6.57";"";"";"UO_0000065";"9.89";"0.19";"-0.24";"7.75";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3799970";"";"None";"698.10";"2";"8.07";"13c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(Cl)cc2)CC1";"IC50";"'='";"4112.0";"nM";"5.39";"";"";"UO_0000065";"7.72";"0.15";"-2.68";"7.48";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800543";"";"None";"663.66";"2";"7.41";"10a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccccc2)CC1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"8.47";"0.16";"-1.79";"7.81";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3665587";"";"None";"532.03";"1";"4.40";"BDBM119719";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"246817";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665612";"";"None";"562.51";"2";"5.25";"BDBM119750";"CN1[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2F)[C@@H]1C(=O)N[C@H]1C[C@@](C)(O)C1";"IC50";"'<'";"100.0";"nM";"";"";"246826";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3890230";"";"None";"576.54";"2";"5.69";"BDBM119743";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(C)(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"11.0";"nM";"7.96";"";"246840";"UO_0000065";"13.80";"0.28";"2.27";"8.80";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647049";"";"None";"585.11";"2";"6.50";"BDBM135109";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268618";"UO_0000065";"14.57";"0.28";"2.02";"8.35";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"1.0";"nM";"9.00";"";"268676";"UO_0000065";"15.00";"0.29";"2.72";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268705";"UO_0000065";"14.63";"0.28";"2.98";"7.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3220093";"";"None";"556.49";"2";"6.60";"4h";"Cc1cc(C=C2C(=O)N(c3ccccc3)C(=S)N(c3ccccc3)C2=O)c(C)n1-c1ccc(Br)cc1";"IC50";"'='";"199.0";"nM";"6.70";"";"";"UO_0000065";"12.04";"0.25";"0.10";"14.71";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3407564";"";"None";"700.69";"2";"7.17";"14";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"13.81";"0.28";"2.51";"7.24";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407563";"";"None";"680.70";"2";"7.95";"13";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccc(C#N)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"12.66";"0.26";"0.67";"8.03";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407562";"";"None";"728.74";"2";"7.19";"12";"COc1cc(NC(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(N)=O";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"12.78";"0.26";"2.12";"6.85";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407558";"";"None";"729.72";"2";"7.78";"8";"COc1cc(NC(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"13.55";"0.28";"2.11";"7.60";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407576";"";"None";"747.71";"2";"7.92";"26";"COc1cc(NC(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3F)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"12.44";"0.25";"1.38";"7.15";"0";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3657096";"";"None";"591.40";"2";"5.55";"BDBM130013";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C(F)F)c2)C3=O)c(OC)n1";"IC50";"'='";"0.396";"nM";"9.40";"";"261734";"UO_0000065";"15.90";"0.32";"3.85";"9.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683149";"";"None";"646.27";"2";"7.99";"BDBM161958";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(C(C)=O)[C@H]3CC[C@@H](N(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"69.3";"nM";"7.16";"";"304998";"UO_0000065";"11.08";"0.21";"-0.83";"11.49";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653170";"";"None";"633.58";"2";"7.29";"BDBM129734";"COc1ccc(C(=O)N2CCOCC2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261465";"UO_0000065";"15.38";"0.30";"2.45";"12.67";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3604661";"";"None";"479.02";"1";"6.27";"BDBM161648";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"115.9";"nM";"6.94";"";"304944";"UO_0000065";"14.48";"0.28";"0.67";"16.51";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691790";"";"None";"586.46";"1";"4.75";"BDBM143719";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.128";"nM";"9.89";"";"279832";"UO_0000065";"16.87";"0.34";"5.14";"10.06";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687255";"";"None";"489.42";"1";"6.07";"BDBM143378";"Cc1cc(Cl)ccc1C1c2c(nn(CCN(C)C)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.1";"nM";"8.09";"";"279523";"UO_0000065";"16.53";"0.33";"2.02";"19.56";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656976";"";"None";"554.44";"2";"5.15";"BDBM129878";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cnc1O)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"261608";"UO_0000065";"17.77";"0.35";"4.70";"9.00";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3220106";"";"None";"584.54";"2";"6.95";"4w";"CCN1C(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Br)cc3)c2-c2ccccc2)C(=O)N(CC)C1=S";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"11.27";"0.24";"-0.36";"14.46";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL611623";"";"None";"1132.99";"None";"None";"15";"COc1ccc(CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc2ccc(Br)cc2)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc2ccc(Br)cc2)cc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"4.34";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL4446816";"";"None";"705.83";"1";"4.76";"MC-217";"O=C1CCC(N2Cc3c(CCCCCNC(=O)[C@@H]4NC5(CCCCC5)[C@@]5(C(=O)Nc6ccccc65)[C@H]4c4ccccc4F)cccc3C2=O)C(=O)N1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3653182";"";"None";"531.44";"2";"7.38";"BDBM129747";"COc1cc(C#N)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.29";"nM";"9.54";"";"261665";"UO_0000065";"17.95";"0.35";"2.16";"13.40";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683153";"";"None";"604.19";"2";"6.87";"BDBM161965";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCC(NC(C)=O)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"111.9";"nM";"6.95";"";"305002";"UO_0000065";"11.50";"0.22";"0.08";"9.78";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683129";"";"None";"606.12";"1";"4.53";"BDBM161849";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(=O)N3C[C@H](O)C[C@H]3C(=O)NC)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"16203.0";"nM";"4.79";"";"304975";"UO_0000065";"7.90";"0.15";"0.26";"4.42";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691713";"";"None";"516.44";"2";"6.99";"BDBM143479";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCC(O)CC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"22.5";"nM";"7.65";"";"279609";"UO_0000065";"14.81";"0.30";"0.66";"13.10";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650068";"";"None";"556.14";"2";"6.35";"BDBM135938";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(C1CCC([C@@](C)(O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"12.5";"nM";"7.90";"";"269516";"UO_0000065";"14.21";"0.28";"1.55";"11.58";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653270";"";"None";"624.53";"2";"6.33";"BDBM129837";"CCOC(=O)C1(c2ccc(Cl)cc2C)c2c(nc(-c3cnc(OC)nc3OC)n2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.3";"nM";"8.64";"";"261566";"UO_0000065";"13.83";"0.27";"2.31";"7.95";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL382422";"";"None";"624.26";"1";"4.58";"3";"O=C(NCCO)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2120.0";"nM";"5.67";"";"";"UO_0000065";"9.09";"0.22";"1.09";"5.75";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL207505";"";"None";"651.33";"2";"7.14";"18";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL381185";"";"None";"537.18";"2";"5.93";"7";"O=C1Nc2ccc(I)cc2C(=O)N(Cc2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL3656996";"";"None";"536.42";"2";"6.06";"BDBM129900";"COc1ncc(-c2nc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"1.32";"nM";"8.88";"";"261631";"UO_0000065";"16.55";"0.33";"2.82";"10.78";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687294";"";"None";"552.46";"2";"5.07";"BDBM143422";"Cc1cc(Cl)ccc1C1c2c(nn(-c3cc(=O)n(C)c(=O)n3C)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"24.4";"nM";"7.61";"";"279562";"UO_0000065";"13.78";"0.27";"2.54";"9.27";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683117";"";"None";"451.95";"1";"5.82";"BDBM161752";"CCCOc1cc2c(cc1OC)CC(=O)N(c1ccc(OC)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"424.2";"nM";"6.37";"";"304963";"UO_0000065";"14.10";"0.27";"0.55";"13.28";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657079";"";"None";"577.02";"1";"4.11";"BDBM129996";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.35";"nM";"9.46";"";"261717";"UO_0000065";"16.39";"0.31";"5.35";"7.74";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683173";"";"None";"673.30";"2";"6.97";"BDBM162130";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.4";"nM";"8.85";"";"305028";"UO_0000065";"13.15";"0.25";"1.88";"13.50";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2398475";"";"None";"548.49";"1";"4.91";"5";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"14.69";"0.30";"3.15";"8.91";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL4102664";"";"None";"561.49";"1";"4.60";"17";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"52.6";"nM";"7.28";"";"";"UO_0000065";"12.96";"0.26";"2.68";"7.04";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4099868";"";"None";"594.54";"1";"4.47";"36";"O=C(NC1CCS(=O)(=O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"20.7";"nM";"7.68";"";"";"UO_0000065";"12.92";"0.27";"3.21";"7.36";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4072993";"";"None";"602.53";"2";"5.79";"35";"O=C(NC[C@H]1CC[C@H](C(=O)O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"17.3";"nM";"7.76";"";"";"UO_0000065";"12.88";"0.26";"1.97";"7.22";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3627748";"";"None";"512.57";"1";"4.73";"22";"COc1ccc(-c2cn(CCC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)nn2)cc1";"IC50";"'='";"5660.0";"nM";"5.25";"";"";"UO_0000065";"10.24";"0.19";"0.52";"4.54";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3260818";"";"None";"490.34";"1";"6.80";"13";"Nc1nnc(-c2nc(C3CCCCC3)n(-c3cccc(Cl)c3F)c2-c2ccc(F)c(Cl)c2)o1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"16.77";"0.34";"1.42";"9.93";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3691732";"";"None";"522.01";"2";"7.14";"BDBM143533";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cc(C#N)ccc4OC)c3C(C)C)C(=O)N2c2cc(Cl)ccc2C)cc1";"IC50";"'='";"0.242";"nM";"9.62";"";"279777";"UO_0000065";"18.42";"0.35";"2.48";"12.73";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657116";"";"None";"558.40";"2";"5.11";"BDBM130034";"COc1ncc(-c2nc3c(n2[C@H](C)CO)[C@H](c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.107";"nM";"9.97";"";"261755";"UO_0000065";"17.86";"0.36";"4.86";"9.72";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657042";"";"None";"581.50";"2";"6.31";"BDBM129949";"COCCn1cc(N2C(=O)c3nc(-c4ccccc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"0.56";"nM";"9.25";"";"261679";"UO_0000065";"15.91";"0.32";"2.94";"11.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687259";"";"None";"509.41";"2";"6.95";"BDBM143382";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccncc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"6.2";"nM";"8.21";"";"279527";"UO_0000065";"16.11";"0.32";"1.26";"16.09";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653287";"";"None";"540.99";"2";"6.01";"BDBM129855";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.69";"nM";"9.16";"";"261584";"UO_0000065";"16.93";"0.32";"3.15";"8.50";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657059";"";"None";"550.42";"2";"6.80";"BDBM129969";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261696";"UO_0000065";"17.96";"0.36";"3.09";"11.76";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691718";"";"None";"521.45";"2";"7.07";"BDBM143496";"COc1ccncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"2.5";"nM";"8.60";"";"279614";"UO_0000065";"16.50";"0.33";"1.53";"14.28";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657000";"";"None";"555.44";"2";"6.19";"BDBM129904";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.36";"nM";"9.44";"";"261635";"UO_0000065";"17.00";"0.34";"3.25";"12.36";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653281";"";"None";"525.01";"1";"3.08";"BDBM129849";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CN(C)C(=O)N(C)C1)C2=O";"IC50";"'='";"3.79";"nM";"8.42";"";"261578";"UO_0000065";"16.04";"0.31";"5.34";"6.86";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657056";"";"None";"552.47";"2";"5.76";"BDBM129964";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cn1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.122";"nM";"9.91";"";"261715";"UO_0000065";"17.94";"0.36";"4.15";"11.11";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657106";"";"None";"539.02";"1";"4.58";"BDBM130024";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O";"IC50";"'='";"0.204";"nM";"9.69";"";"261745";"UO_0000065";"17.98";"0.35";"5.11";"10.29";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653187";"";"None";"537.45";"2";"6.34";"BDBM129752";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.19";"nM";"9.72";"";"261483";"UO_0000065";"18.09";"0.36";"3.38";"11.41";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691720";"";"None";"590.47";"2";"6.15";"BDBM143499";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1OCc1nn[nH]n1)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"279765";"UO_0000065";"16.50";"0.32";"3.59";"8.78";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2440450";"";"None";"352.28";"0";"2.23";"5";"O=c1nc2n(-c3ccccc3F)c3c([N+](=O)[O-])cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3683168";"";"None";"604.19";"2";"6.90";"BDBM162104";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C(=O)[C@H]3CC[C@H](N(C)C)CC3)cc1)C(=O)C2";"IC50";"'='";"719.1";"nM";"6.14";"";"305021";"UO_0000065";"10.17";"0.20";"-0.76";"9.86";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657063";"";"None";"540.99";"2";"6.01";"BDBM129973";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261700";"UO_0000065";"17.69";"0.34";"3.56";"8.87";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653280";"";"None";"554.44";"2";"5.15";"BDBM129848";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cnc(O)c(Cl)c1)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"261577";"UO_0000065";"17.77";"0.35";"4.70";"9.00";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2396674";"";"None";"548.49";"1";"4.91";"9, MI-888";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"14.89";"0.30";"3.26";"9.03";"1";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3657121";"";"None";"598.49";"1";"4.38";"BDBM130039";"COC[C@@H](C)n1c(-c2cnc(N(C)C)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.144";"nM";"9.84";"";"261760";"UO_0000065";"16.44";"0.33";"5.46";"9.15";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4215860";"";"None";"1913.91";"None";"None";"D-MIPC-d9a";"CC(C)C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"2.75";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3653266";"";"None";"585.47";"2";"5.55";"BDBM129833";"COc1cnc(N(C)CCO)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.56";"nM";"9.25";"";"261562";"UO_0000065";"15.80";"0.32";"3.70";"9.58";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657124";"";"None";"598.49";"1";"4.38";"BDBM130042";"COC[C@@H](C)n1c(-c2cnc(N(C)C)nc2OC)nc2c1[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.059";"nM";"10.23";"";"261763";"UO_0000065";"17.09";"0.34";"5.85";"9.51";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657109";"";"None";"552.01";"2";"5.09";"BDBM130027";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2c(F)c(C4CC4)nn2C)C3=O)c(OC)n1";"IC50";"'='";"1.77";"nM";"8.75";"";"261748";"UO_0000065";"15.85";"0.31";"3.66";"8.74";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL208999";"";"None";"695.38";"2";"5.51";"28";"C[C@H](c1cc(O)c(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"8.01";"0.19";"0.06";"5.61";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3656993";"";"None";"540.41";"1";"4.72";"BDBM129896";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.19";"nM";"9.72";"";"261628";"UO_0000065";"17.99";"0.36";"5.00";"8.24";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656997";"";"None";"546.99";"2";"5.66";"BDBM129901";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2C)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.18";"nM";"9.74";"";"261632";"UO_0000065";"17.82";"0.34";"4.08";"9.18";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687264";"";"None";"486.42";"1";"7.31";"BDBM143389";"Cc1cc(Cl)ccc1C1c2c(nn(CCC(C)C)c2C2CC2)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"12.0";"nM";"7.92";"";"279532";"UO_0000065";"16.28";"0.33";"0.61";"20.77";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657031";"";"None";"607.54";"2";"6.54";"BDBM129937";"COc1ccc(C(=O)NCCO)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.05";"nM";"10.30";"";"261667";"UO_0000065";"16.96";"0.33";"3.76";"10.65";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3797962";"";"None";"698.10";"2";"8.07";"13b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(Cl)c2)CC1";"IC50";"'='";"2095.0";"nM";"5.68";"";"";"UO_0000065";"8.13";"0.16";"-2.39";"7.89";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3657009";"";"None";"535.41";"2";"7.21";"BDBM129913";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261644";"UO_0000065";"18.25";"0.36";"2.56";"13.73";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653230";"";"None";"591.54";"2";"7.51";"BDBM129795";"COc1cc(C(=O)N(C)C)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.34";"nM";"9.47";"";"261525";"UO_0000065";"16.01";"0.32";"1.96";"13.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657052";"";"None";"550.42";"2";"6.80";"BDBM129960";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.41";"nM";"9.39";"";"261689";"UO_0000065";"17.05";"0.34";"2.59";"11.17";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687236";"";"None";"475.94";"1";"6.87";"BDBM143344";"CC(C)CCn1nc2c(c1C(C)C)C(c1ccc(F)c(F)c1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"16.6";"nM";"7.78";"";"279504";"UO_0000065";"16.35";"0.32";"0.91";"20.40";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683160";"";"None";"632.25";"2";"7.14";"BDBM162073";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCOCC4)CC3)cc1)C(=O)C2";"IC50";"'='";"3.3";"nM";"8.48";"";"305013";"UO_0000065";"13.41";"0.26";"1.34";"15.57";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657107";"";"None";"555.42";"1";"4.69";"BDBM130025";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.124";"nM";"9.91";"";"261746";"UO_0000065";"17.84";"0.36";"5.22";"9.49";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691697";"";"None";"577.51";"2";"7.04";"BDBM143457";"CNC(=O)c1ccc(OC)c(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"279592";"UO_0000065";"15.06";"0.30";"1.66";"11.38";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657055";"";"None";"542.40";"2";"5.43";"BDBM129963";"COc1nn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"21.5";"nM";"7.67";"";"261692";"UO_0000065";"14.14";"0.28";"2.24";"9.32";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687228";"";"None";"512.42";"2";"6.48";"BDBM143335";"Cc1cc(Cl)ccc1C1c2c(nn(CCc3c[nH]cn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"4.0";"nM";"8.40";"";"279495";"UO_0000065";"16.39";"0.33";"1.92";"12.57";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657101";"";"None";"555.42";"2";"5.40";"BDBM130019";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cnc2OC)C3=O)c(OC)n1";"IC50";"'='";"0.243";"nM";"9.61";"";"261740";"UO_0000065";"17.31";"0.35";"4.21";"9.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657108";"";"None";"555.42";"1";"4.69";"BDBM130026";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"125.33";"nM";"6.90";"";"261747";"UO_0000065";"12.43";"0.25";"2.21";"6.61";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3318768";"";"None";"615.58";"2";"6.75";"19";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)Nc2ccccc2)C2CC2)C1=O";"IC50";"'='";"0.071";"nM";"10.15";"";"";"UO_0000065";"16.49";"0.34";"3.40";"9.78";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL1688256";"";"None";"445.95";"1";"5.21";"BDBM50339351";"Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2C=C[C@@H](O)C2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"232300";"UO_0000065";"13.13";"0.25";"0.64";"11.76";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834381";"";"None";"547.82";"2";"6.20";"BDBM111535";"O=C1c2cc(Cl)c(Cl)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3670.0";"nM";"5.43";"";"232332";"UO_0000065";"9.92";"0.21";"-0.76";"5.85";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834288";"";"None";"493.39";"1";"5.51";"BDBM111539";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"185.0";"nM";"6.73";"";"232336";"UO_0000065";"13.65";"0.27";"1.22";"9.15";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834376";"";"None";"535.04";"2";"6.19";"BDBM111544";"CC(C)(C)c1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"733.0";"nM";"6.13";"";"232341";"UO_0000065";"11.47";"0.22";"-0.06";"6.60";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"BDBM111547";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"143.0";"nM";"6.84";"";"232344";"UO_0000065";"13.33";"0.27";"1.29";"7.37";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675218";"";"None";"473.71";"0";"4.86";"BDBM111549";"O=C1c2cc(Br)ccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"5370.0";"nM";"5.27";"";"232346";"UO_0000065";"11.13";"0.25";"0.41";"6.30";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"BDBM111547";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"232357";"UO_0000065";"14.41";"0.29";"1.85";"7.96";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688293";"";"None";"475.97";"1";"5.19";"BDBM111560";"CC(=O)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"232362";"UO_0000065";"10.02";"0.19";"-0.42";"7.14";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675224";"";"None";"593.46";"2";"5.93";"BDBM111569";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(COC(=O)CCC(=O)O)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"102.0";"nM";"6.99";"";"232370";"UO_0000065";"11.78";"0.23";"1.06";"5.98";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688282";"";"None";"447.96";"1";"5.29";"BDBM111571";"Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"232372";"UO_0000065";"12.59";"0.24";"0.35";"11.33";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688283";"";"None";"463.96";"0";"4.99";"BDBM111572";"COc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"232373";"UO_0000065";"11.97";"0.23";"0.56";"9.41";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268871";"UO_0000065";"15.06";"0.30";"2.62";"6.84";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691714";"";"None";"507.42";"2";"6.76";"BDBM143480";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1ccnc(Cl)c1)C2=O";"IC50";"'='";"7.2";"nM";"8.14";"";"279610";"UO_0000065";"16.05";"0.32";"1.38";"13.51";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650073";"";"None";"580.14";"2";"7.61";"BDBM135943";"CCC(O)(c1cccc(F)c1)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"266.0";"nM";"6.58";"";"269521";"UO_0000065";"11.33";"0.22";"-1.03";"11.14";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3601397";"";"None";"645.24";"2";"6.24";"BDBM162069";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.6";"nM";"8.80";"";"305011";"UO_0000065";"13.63";"0.26";"2.56";"11.83";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236357";"";"None";"695.71";"2";"7.51";"4, AM-6761";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"10.40";"0.22";"-0.27";"6.92";"0";"CHEMBL3241329";"Binding affinity to MDM2 in human HCT116 cells expressing p53 assessed as upregulation of p21 mRNA expression after 7 hrs by quantitative RT-PCR analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308372";"";""
"CHEMBL3653209";"";"None";"517.95";"2";"5.60";"BDBM129774";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N)nc4OC)n3C(C)C)C(=O)N2c2cccc(Cl)c2F)cc1";"IC50";"'='";"1.03";"nM";"8.99";"";"261505";"UO_0000065";"17.35";"0.33";"3.39";"8.68";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653185";"";"None";"551.47";"2";"7.22";"13";"COc1ccc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.22";"nM";"9.66";"";"";"UO_0000065";"17.51";"0.35";"2.44";"13.90";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3687256";"";"None";"502.95";"2";"6.61";"BDBM143379";"CC(C)c1c2c(nn1Cc1ccccc1C#N)C(=O)N(c1ccc(F)c(F)c1)C2c1ccc(Cl)cc1";"IC50";"'='";"19.3";"nM";"7.71";"";"279524";"UO_0000065";"15.34";"0.29";"1.10";"12.46";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4460980";"";"None";"1973.94";"None";"None";"PS9";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC1CCCCC1)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'='";"3220.0";"nM";"5.49";"";"";"UO_0000065";"2.78";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3653324";"";"None";"529.65";"1";"4.73";"BDBM135442";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"268951";"UO_0000065";"16.42";"0.30";"3.97";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649970";"";"None";"559.07";"2";"6.44";"BDBM135351";"CCOC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268860";"UO_0000065";"16.10";"0.31";"2.56";"8.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268855";"UO_0000065";"14.64";"0.28";"2.48";"6.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2152324";"";"None";"543.52";"2";"5.75";"13";"CC(=O)N1CCN(C(=O)C2=C(C(C)C)N3C(=N[C@@H](c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CC1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"11.18";"0.23";"0.33";"10.81";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3355421";"";"None";"575.51";"1";"4.23";"23D";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"13.34";"0.27";"3.45";"9.28";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355424";"";"None";"522.40";"1";"2.86";"25D";"O=C(NCC[C@H](O)CO)[C@@H]1NC2(CCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"494.0";"nM";"6.31";"";"";"UO_0000065";"12.07";"0.25";"3.45";"5.70";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3653308";"";"None";"568.46";"2";"5.93";"BDBM129876";"COC[C@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.27";"nM";"8.90";"";"261606";"UO_0000065";"15.65";"0.31";"2.97";"9.71";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657056";"";"None";"552.47";"2";"5.76";"BDBM129964";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cn1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.12";"nM";"9.92";"";"261693";"UO_0000065";"17.96";"0.36";"4.16";"11.11";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691791";"";"None";"572.43";"1";"4.74";"BDBM143723";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.165";"nM";"9.78";"";"279833";"UO_0000065";"17.09";"0.34";"5.04";"8.96";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657057";"";"None";"549.97";"2";"5.52";"BDBM129965";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.15";"nM";"9.82";"";"261694";"UO_0000065";"17.86";"0.34";"4.30";"9.02";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653188";"";"None";"537.45";"2";"6.91";"BDBM129753";"COc1ccc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.19";"nM";"9.72";"";"261484";"UO_0000065";"18.09";"0.36";"2.81";"13.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687242";"";"None";"555.51";"2";"5.66";"BDBM143353";"Cc1cc(Cl)ccc1C1c2c(nn(CC(=O)N3CCC(O)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"6.1";"nM";"8.21";"";"279510";"UO_0000065";"14.79";"0.30";"2.55";"10.44";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653185";"";"None";"551.47";"2";"7.22";"BDBM129750";"COc1ccc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.22";"nM";"9.66";"";"261481";"UO_0000065";"17.51";"0.35";"2.44";"13.90";"1";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653164";"";"None";"552.46";"2";"6.61";"BDBM129728";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.17";"nM";"9.77";"";"261459";"UO_0000065";"17.68";"0.35";"3.16";"11.86";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657006";"";"None";"511.03";"2";"7.03";"BDBM129910";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261641";"UO_0000065";"18.72";"0.35";"2.54";"13.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683159";"";"None";"648.24";"2";"6.91";"BDBM162072";"COC(=O)CN(C)[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(OC(C)C)cc4[C@@H]3c3ccc(Cl)cc3)cc2)CC1";"IC50";"'='";"2.9";"nM";"8.54";"";"305012";"UO_0000065";"13.17";"0.25";"1.63";"11.93";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687298";"";"None";"528.84";"2";"8.15";"BDBM143426";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccccc3Cl)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"10.4";"nM";"7.98";"";"279566";"UO_0000065";"15.10";"0.31";"-0.17";"20.94";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683151";"";"None";"590.21";"2";"7.29";"BDBM161961";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCC(N(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"15.2";"nM";"7.82";"";"305000";"UO_0000065";"13.25";"0.25";"0.53";"17.28";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691757";"";"None";"545.99";"1";"3.78";"BDBM143619";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"1.302";"nM";"8.88";"";"279798";"UO_0000065";"16.27";"0.31";"5.11";"6.93";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656988";"";"None";"555.44";"2";"6.19";"BDBM129890";"COc1cnc(N(C)C)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"261624";"UO_0000065";"17.93";"0.36";"3.77";"13.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683104";"";"None";"522.05";"2";"5.37";"BDBM161689";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1C(N)=O";"IC50";"'='";"70257.7";"nM";"4.15";"";"304949";"UO_0000065";"7.96";"0.15";"-1.22";"4.88";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687234";"";"None";"591.47";"2";"6.81";"BDBM143342";"Cc1cc(Cl)ccc1C1c2c(nn(CCN3C(=O)c4ccccc4C3=O)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.9";"nM";"8.05";"";"279502";"UO_0000065";"13.61";"0.27";"1.24";"10.66";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653251";"";"None";"547.02";"1";"4.75";"BDBM129816";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(C(N)=O)cc2C)C3=O)c(OC)n1";"IC50";"'='";"1.31";"nM";"8.88";"";"261546";"UO_0000065";"16.24";"0.31";"4.13";"7.08";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653294";"";"None";"517.95";"1";"4.93";"BDBM129862";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.36";"nM";"9.44";"";"261592";"UO_0000065";"18.23";"0.35";"4.51";"7.68";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687241";"";"None";"486.34";"0";"4.76";"BDBM143350";"CC(C)c1c2c(nn1Cc1nnn[nH]1)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)cc1";"IC50";"'='";"16.2";"nM";"7.79";"";"279509";"UO_0000065";"16.02";"0.32";"3.03";"8.41";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653174";"";"None";"550.49";"2";"7.31";"BDBM129739";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"261470";"UO_0000065";"17.90";"0.35";"2.54";"14.58";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3957470";"";"None";"616.19";"1";"4.27";"BDBM135407";"CN(C)S(=O)(=O)NC(=O)c1cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"268916";"UO_0000065";"14.12";"0.28";"4.43";"7.10";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653193";"";"None";"523.42";"2";"5.88";"BDBM129758";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261489";"UO_0000065";"18.28";"0.36";"3.69";"9.65";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657054";"";"None";"519.01";"1";"4.65";"BDBM129962";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nc(C)n1)C2=O";"IC50";"'='";"142.5";"nM";"6.85";"";"261738";"UO_0000065";"13.19";"0.25";"2.20";"7.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3291434";"";"None";"366.46";"1";"6.23";"20a";"CC(=O)c1ccc(-c2c(C)[nH]c(-c3ccccc3)c2-c2ccccc2)nc1C";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"16.62";"0.30";"-0.14";"13.31";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3291435";"";"None";"396.49";"1";"6.20";"20b";"CCOC(=O)c1ccc(-c2c(C)[nH]c(-c3ccccc3)c2-c2ccccc2)nc1C";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"15.40";"0.28";"-0.09";"11.11";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3653201";"";"None";"530.98";"1";"4.16";"BDBM129766";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)c(=O)n(C)c2)cc1";"IC50";"'='";"2.95";"nM";"8.53";"";"261497";"UO_0000065";"16.06";"0.31";"4.37";"6.80";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3236359";"";"None";"608.59";"2";"5.97";"7";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"15.94";"0.33";"3.73";"8.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236642";"";"None";"675.65";"2";"7.52";"22";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.80";"0.30";"2.48";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236645";"";"None";"671.69";"2";"7.69";"25";"Cc1nc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"13.99";"0.29";"1.71";"8.98";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236654";"";"None";"677.72";"2";"6.92";"34";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)CO)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.76";"0.31";"3.08";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236660";"";"None";"713.70";"2";"7.98";"41";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(F)C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.01";"0.30";"2.02";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236637";"";"None";"613.65";"2";"7.69";"17";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccccn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"13.32";"0.27";"0.48";"12.14";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236638";"";"None";"612.66";"2";"8.29";"18";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccccc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"13.25";"0.27";"-0.17";"14.91";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236642";"";"None";"675.65";"2";"7.52";"22";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"13.77";"0.28";"1.78";"8.89";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236648";"";"None";"676.64";"2";"6.92";"28";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"13.37";"0.27";"2.13";"7.70";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236651";"";"None";"646.64";"2";"6.64";"31";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cn2cc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"13.92";"0.29";"2.36";"8.21";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236653";"";"None";"663.69";"2";"7.45";"33";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"13.79";"0.29";"1.70";"8.75";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236656";"";"None";"637.67";"2";"7.89";"36";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nccs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"12.95";"0.28";"0.37";"12.27";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236661";"";"None";"731.69";"2";"8.06";"42";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(F)(F)C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"12.14";"0.26";"0.83";"8.49";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236665";"";"None";"659.63";"2";"6.72";"47";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@](C)(Cc2ccc(C(=O)O)cn2)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"13.64";"0.28";"2.28";"7.90";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3653240";"";"None";"525.01";"1";"3.76";"BDBM129805";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCC(=O)N(C)C2)C3=O)c(OC)n1";"IC50";"'='";"1.54";"nM";"8.81";"";"261535";"UO_0000065";"16.79";"0.33";"5.05";"8.58";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3233121";"";"None";"569.51";"1";"4.68";"7";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.73";"0.33";"4.28";"8.60";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233133";"";"None";"576.50";"2";"5.73";"18";"CC[C@@H](CS(=O)(=O)c1ccccc1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"15.69";"0.33";"3.32";"8.96";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233137";"";"None";"610.48";"2";"6.01";"22";"CC(C)(C)S(=O)(=O)C[C@H](CC(F)(F)F)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"15.39";"0.33";"3.39";"9.31";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233130";"";"None";"556.51";"2";"5.47";"5";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.63";"0.33";"3.23";"8.61";"1";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3657103";"";"None";"573.43";"2";"6.33";"BDBM130021";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1F)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.352";"nM";"9.45";"";"261742";"UO_0000065";"16.49";"0.33";"3.12";"12.38";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687289";"";"None";"493.94";"1";"6.69";"BDBM143417";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(F)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"6.7";"nM";"8.17";"";"279557";"UO_0000065";"16.55";"0.32";"1.48";"17.26";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4101295";"";"None";"611.50";"2";"5.53";"53";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"12.84";"0.26";"2.32";"6.41";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4084366";"";"None";"560.45";"1";"4.76";"32";"O=C(N[C@H]1C[C@H](C(=O)O)C1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.55";"0.29";"3.39";"7.58";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693975";"";"None";"540.44";"1";"3.86";"30";"CS(=O)(=O)NC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"13.30";"0.28";"3.33";"6.89";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4081906";"";"None";"559.49";"2";"6.05";"28";"CN1[C@@H](c2nc(C(N)=O)cs2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"156.0";"nM";"6.81";"";"";"UO_0000065";"12.17";"0.25";"0.76";"7.71";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693969";"";"None";"476.38";"0";"4.53";"7";"CNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"21.2";"nM";"7.67";"";"";"UO_0000065";"16.11";"0.33";"3.14";"10.93";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3657070";"";"None";"534.02";"2";"5.66";"BDBM129980";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)ccc2OC)C3=O)c(OC)n1";"IC50";"'='";"0.63";"nM";"9.20";"";"261707";"UO_0000065";"17.23";"0.33";"3.54";"10.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656984";"";"None";"532.96";"2";"5.35";"BDBM129886";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"214.3";"nM";"6.67";"";"261616";"UO_0000065";"12.51";"0.24";"1.32";"6.28";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3924221";"";"None";"546.06";"1";"4.79";"BDBM60494";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"5000.0";"nM";"";"";"221945";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650078";"";"None";"514.11";"2";"6.72";"BDBM30628";"CCCC(C)(O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"7.7";"nM";"8.11";"";"187086";"UO_0000065";"15.78";"0.31";"1.39";"13.75";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653218";"";"None";"593.52";"2";"5.78";"BDBM129783";"COc1nc(N2CC(O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.21";"nM";"9.68";"";"261514";"UO_0000065";"16.31";"0.32";"3.90";"10.02";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683133";"";"None";"562.15";"2";"6.64";"BDBM161874";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCCNC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"4.7";"nM";"8.33";"";"304980";"UO_0000065";"14.81";"0.28";"1.69";"15.41";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683179";"";"None";"647.22";"2";"5.33";"BDBM162166";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1cnc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"4.3";"nM";"8.37";"";"305037";"UO_0000065";"12.93";"0.25";"3.04";"9.16";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"31";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"18900.0";"nM";"4.72";"";"";"UO_0000065";"10.93";"0.22";"-0.83";"8.20";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347392";"";"None";"434.32";"0";"4.89";"26, enantiomer 1";"O=C(O)C[C@H]1O[C@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"27, enantiomer 2";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.12";"0.33";"2.11";"10.47";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"31";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL3601322";"";"None";"604.24";"2";"7.76";"BDBM162023";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)[C@H]2c1ccc(Cl)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"305005";"UO_0000065";"14.43";"0.28";"0.96";"19.27";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647054";"";"None";"550.06";"2";"5.07";"BDBM135114";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268623";"UO_0000065";"15.81";"0.30";"3.63";"7.57";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647056";"";"None";"550.06";"2";"5.07";"BDBM135116";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268625";"UO_0000065";"15.27";"0.29";"3.33";"7.31";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649816";"";"None";"522.01";"1";"4.29";"BDBM135141";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"268650";"UO_0000065";"14.11";"0.27";"3.08";"6.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649827";"";"None";"534.06";"2";"5.84";"BDBM135156";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268665";"UO_0000065";"15.16";"0.29";"2.26";"7.66";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649831";"";"None";"524.03";"1";"4.28";"BDBM135160";"C[C@@H]1C[C@@H](O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268669";"UO_0000065";"15.69";"0.30";"3.94";"6.53";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"25.0";"nM";"7.60";"";"268692";"UO_0000065";"14.13";"0.27";"2.67";"6.61";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649848";"";"None";"564.09";"2";"5.32";"BDBM135184";"C[C@H]1CC[C@H](Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"268693";"UO_0000065";"14.18";"0.27";"2.68";"6.96";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3979460";"";"None";"607.16";"2";"5.40";"BDBM135314";"CC(C)C(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268823";"UO_0000065";"14.04";"0.27";"3.12";"6.76";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3958237";"";"None";"608.15";"1";"4.90";"BDBM135319";"C[C@H]1CN(C(=O)N(C)C)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268828";"UO_0000065";"14.80";"0.29";"4.10";"6.96";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649956";"";"None";"619.17";"2";"5.54";"BDBM135325";"C[C@@H]1CN(C(=O)C2(C)CC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"268834";"UO_0000065";"12.92";"0.25";"2.46";"6.35";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3355415";"";"None";"546.47";"1";"4.81";"16D";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"13.64";"0.28";"2.65";"8.24";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355416";"";"None";"560.50";"2";"5.20";"17D";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"17.2";"nM";"7.76";"";"";"UO_0000065";"13.85";"0.28";"2.56";"8.58";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL575121";"";"None";"589.58";"2";"5.73";"3, MI-122";"CN1CCC(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'='";"32.4";"nM";"7.49";"";"";"UO_0000065";"12.70";"0.26";"1.76";"10.19";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3220111";"";"None";"441.92";"0";"4.82";"10c";"NC(=O)C(=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1)C(N)=O";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.68";"0.24";"0.78";"6.15";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2371818";"";"None";"1476.69";"None";"None";"p53-peptide";"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"3.74";"None";"None";"None";"0";"CHEMBL3390997";"Inhibition of human full length GST-tagged MDM2 expressed in Escherichia coli TG1 after 15 mins by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3390840";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3895325";"";"None";"546.47";"1";"4.81";"BDBM112736";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"41.8";"nM";"7.38";"";"234011";"UO_0000065";"13.50";"0.27";"2.57";"8.16";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3818951";"";"None";"505.62";"1";"4.25";"6";"CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)[C@@H](C)CC";"IC50";"'='";"11.7";"nM";"7.93";"";"";"UO_0000065";"15.69";"0.29";"3.68";"6.76";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3657018";"";"None";"540.41";"1";"4.27";"BDBM129922";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.68";"nM";"9.17";"";"261653";"UO_0000065";"16.96";"0.34";"4.90";"7.57";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657053";"";"None";"551.05";"2";"6.49";"BDBM129961";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261690";"UO_0000065";"17.36";"0.33";"3.08";"8.87";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683143";"";"None";"660.26";"2";"7.37";"BDBM161948";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(CC)C(=O)C3CCN(C(C)=O)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"51.2";"nM";"7.29";"";"304992";"UO_0000065";"11.04";"0.21";"-0.08";"9.18";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683132";"";"None";"575.15";"2";"7.75";"BDBM161872";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(CC3CCCC3)C(C)=O)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"1468.1";"nM";"5.83";"";"304979";"UO_0000065";"10.14";"0.19";"-1.92";"9.87";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3109036";"";"None";"613.52";"2";"5.63";"RO8994";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.53";"0.27";"2.67";"6.77";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109037";"";"None";"619.55";"2";"5.69";"19";"COc1cc(C(N)=O)ccc1NC(=O)[C@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)sc32)[C@@H]1c1cccc(Cl)c1F";"IC50";"'='";"177.0";"nM";"6.75";"";"";"UO_0000065";"10.90";"0.22";"1.06";"5.51";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109042";"";"None";"614.51";"2";"5.02";"14, RO2468";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.38";"0.27";"3.20";"6.07";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109046";"";"None";"616.48";"2";"5.02";"10";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3nc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.33";"0.25";"2.58";"5.33";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3125513";"";"None";"583.58";"2";"6.03";"11";"CC[C@@H](CNS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"15.23";"0.32";"2.86";"8.56";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL378030";"";"None";"668.33";"2";"5.80";"26";"O=C1[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2F)C(=O)c2cc(I)ccc2N1CCN1CCOCC1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"7.58";"0.18";"-0.73";"9.54";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL515487";"";"None";"455.38";"1";"6.62";"nutlin-3, enantiomer 2";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"15.47";"0.31";"0.43";"16.44";"0";"CHEMBL965739";"Binding affinity to MDM2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153888";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";""
"CHEMBL377203";"";"None";"679.39";"2";"5.80";"12e";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL3687275";"";"None";"555.51";"2";"6.91";"BDBM143401";"COC(=O)N1CCCC1Cn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.1";"nM";"8.96";"";"279543";"UO_0000065";"16.13";"0.32";"2.05";"13.24";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703676";"";"None";"333.42";"0";"4.60";"BDBM156655";"Oc1c(C(Nc2cccnc2)c2cccs2)ccc2cccnc12";"IC50";"'='";"1500.0";"nM";"5.82";"";"298923";"UO_0000065";"17.47";"0.33";"1.22";"10.03";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663832";"";"None";"580.53";"1";"4.52";"BDBM170349";"CCCC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314320";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663846";"";"None";"532.06";"1";"3.16";"BDBM170364";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](Cc2ccccc2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"314334";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663867";"";"None";"532.06";"1";"3.43";"BDBM170388";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(F)ccc32)[C@H]1CC(C)(C)C";"IC50";"'<'";"5000.0";"nM";"";"";"314357";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704528";"";"None";"589.54";"2";"5.01";"BDBM170291";"CC(=O)N1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"500.0";"nM";"";"";"314239";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704530";"";"None";"619.61";"2";"5.23";"BDBM170293";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(CC(C)(C)O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"500.0";"nM";"";"";"314241";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704532";"";"None";"679.56";"2";"5.31";"BDBM170295";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(S(=O)(=O)C(F)(F)F)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314244";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4112640";"";"None";"566.50";"1";"4.13";"BDBM170297";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@@](C)(O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314255";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665594";"";"None";"550.02";"1";"4.54";"BDBM119730";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"314277";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647059";"";"None";"550.06";"2";"5.07";"BDBM135119";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"59.0";"nM";"7.23";"";"286138";"UO_0000065";"13.14";"0.25";"2.16";"6.29";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649823";"";"None";"552.08";"2";"5.32";"BDBM135149";"COC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"961.0";"nM";"6.02";"";"286168";"UO_0000065";"10.90";"0.21";"0.70";"5.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286171";"UO_0000065";"13.40";"0.26";"2.07";"7.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3947091";"";"None";"604.03";"2";"5.62";"BDBM135431";"O=c1nc(-c2cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(C[C@H]4CC[C@H](C(F)(F)F)CC4)c3c(-c3cncc(Cl)c3)n2)[nH]o1";"IC50";"'='";"38.0";"nM";"7.42";"";"268940";"UO_0000065";"12.28";"0.24";"1.80";"6.45";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135367";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286385";"UO_0000065";"15.40";"0.30";"2.01";"8.49";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649984";"";"None";"562.05";"2";"6.25";"BDBM135374";"Cc1cccnc1C(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286394";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649989";"";"None";"559.07";"2";"6.09";"BDBM135381";"COCC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286400";"UO_0000065";"15.56";"0.30";"2.61";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649992";"";"None";"464.96";"1";"5.35";"BDBM135386";"C=C(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286405";"UO_0000065";"17.54";"0.34";"2.80";"7.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649995";"";"None";"525.05";"2";"5.84";"BDBM135391";"CC(C)OCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286410";"UO_0000065";"15.42";"0.30";"2.26";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3959078";"";"None";"584.51";"2";"5.73";"BDBM135397";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3c(Cl)c(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286416";"UO_0000065";"15.40";"0.31";"3.27";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653177";"";"None";"536.46";"2";"7.00";"BDBM129742";"COc1cc(CO)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.12";"nM";"9.92";"";"261473";"UO_0000065";"18.49";"0.37";"2.92";"14.68";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657060";"";"None";"550.42";"2";"6.80";"BDBM129970";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"4.4";"nM";"8.36";"";"261697";"UO_0000065";"15.18";"0.30";"1.56";"9.94";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650048";"";"None";"499.05";"1";"5.40";"BDBM135918";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(C)C(C)=O)CC1)C(=O)C2";"IC50";"'='";"386.0";"nM";"6.41";"";"269496";"UO_0000065";"12.85";"0.25";"1.01";"10.86";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653277";"";"None";"545.99";"1";"3.91";"BDBM129845";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"2.33";"nM";"8.63";"";"261574";"UO_0000065";"15.81";"0.30";"4.72";"6.74";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691729";"";"None";"552.46";"2";"6.48";"BDBM143523";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.22";"nM";"9.66";"";"279774";"UO_0000065";"17.48";"0.35";"3.18";"11.72";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653305";"";"None";"566.49";"2";"6.79";"BDBM129873";"COc1ncc(-c2nc3c(n2C(C)C)C(C)(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.38";"nM";"9.42";"";"261603";"UO_0000065";"16.63";"0.33";"2.63";"11.44";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691728";"";"None";"569.45";"1";"4.87";"BDBM143519";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.45";"nM";"9.35";"";"279773";"UO_0000065";"16.41";"0.33";"4.48";"8.96";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691755";"";"None";"531.96";"1";"3.77";"BDBM143610";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.772";"nM";"9.11";"";"279796";"UO_0000065";"17.13";"0.33";"5.34";"6.55";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691778";"";"None";"545.00";"1";"3.82";"BDBM143675";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"86.07";"nM";"7.07";"";"279819";"UO_0000065";"12.96";"0.25";"3.25";"5.31";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657015";"";"None";"594.50";"2";"5.60";"BDBM129919";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.29";"nM";"9.54";"";"261650";"UO_0000065";"16.04";"0.32";"3.94";"10.64";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657001";"";"None";"582.10";"2";"6.73";"BDBM129905";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261636";"UO_0000065";"16.44";"0.31";"2.84";"10.46";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2347375";"";"None";"577.53";"1";"4.33";"17";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"13.90";"0.28";"3.70";"9.71";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3691705";"";"None";"537.45";"2";"6.24";"BDBM143468";"CCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2)cc(Cl)c1=O";"IC50";"'='";"0.377";"nM";"9.42";"";"279756";"UO_0000065";"17.53";"0.35";"3.18";"13.59";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683141";"";"None";"549.11";"2";"6.60";"BDBM161944";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCOCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"47.1";"nM";"7.33";"";"304990";"UO_0000065";"13.34";"0.26";"0.73";"14.30";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3693963";"";"None";"477.37";"0";"2.95";"BDBM112747";"CNC(=O)[C@@H]1NC2(CCNCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"234022";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704514";"";"None";"618.58";"2";"5.19";"BDBM170276";"CCNC(=O)N1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"314225";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653323";"";"None";"529.65";"1";"4.73";"BDBM135442";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCO[C@@H]5CCC[C@H]54)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"286461";"UO_0000065";"16.42";"0.30";"3.97";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653332";"";"None";"545.07";"1";"4.46";"BDBM135451";"CC(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"268960";"UO_0000065";"13.63";"0.27";"2.97";"5.44";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135366";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268875";"UO_0000065";"15.40";"0.30";"2.01";"8.49";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649882";"";"None";"552.08";"2";"5.32";"BDBM135221";"CO[C@@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"286240";"UO_0000065";"14.12";"0.27";"2.48";"6.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649890";"";"None";"536.04";"1";"4.42";"BDBM135236";"C[C@H]1CC[C@H](Cn2c(N3C4CCC3C(O)C4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"286255";"UO_0000065";"14.65";"0.28";"3.43";"6.24";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649904";"";"None";"586.04";"2";"5.32";"BDBM135255";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286274";"UO_0000065";"14.84";"0.29";"3.38";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649915";"";"None";"564.09";"2";"5.46";"BDBM135274";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCC2O1";"IC50";"'='";"8.0";"nM";"8.10";"";"286293";"UO_0000065";"14.35";"0.28";"2.64";"7.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650004";"";"None";"564.09";"2";"5.38";"BDBM135400";"Cc1c(-c2noc(=O)[nH]2)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@@H]3CCC[C@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286419";"UO_0000065";"15.42";"0.30";"3.32";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650019";"";"None";"511.03";"2";"5.97";"BDBM135421";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286440";"UO_0000065";"16.43";"0.32";"2.43";"7.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653313";"";"None";"550.06";"2";"5.07";"BDBM135432";"CCC1CCC(Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"286451";"UO_0000065";"14.17";"0.27";"2.73";"6.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL212747";"";"None";"637.35";"2";"5.86";"31";"CN(C)CCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"7.71";"0.19";"-0.95";"7.03";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL212568";"";"None";"664.37";"2";"5.97";"25";"Cc1cc(Cl)ccc1CN1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"7.11";"0.17";"-1.25";"8.89";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3929802";"";"None";"562.51";"2";"5.30";"BDBM119745";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"246821";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665601";"";"None";"548.49";"1";"4.91";"BDBM119737";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cc(F)cc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"12.0";"nM";"7.92";"";"246838";"UO_0000065";"14.44";"0.29";"3.01";"8.76";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"1";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"128000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3649982";"";"None";"566.01";"2";"6.08";"BDBM135370";"CC(F)(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268880";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3934510";"";"None";"553.11";"2";"5.49";"BDBM135401";"CN(C)c1c(C(=O)O)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@H]3CCC[C@@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"268910";"UO_0000065";"13.78";"0.27";"2.13";"7.89";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3627747";"";"None";"608.44";"2";"5.32";"21";"O=C(N[C@@H](CCCn1cc(-c2ccc(I)cc2)nn1)C(=O)O)OCC1c2ccccc2-c2ccccc21";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"9.10";"0.20";"0.22";"5.21";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3653212";"";"None";"517.95";"2";"5.60";"BDBM129777";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N)nc4OC)n3C(C)C)C(=O)N2c2ccc(F)c(Cl)c2)cc1";"IC50";"'='";"1.21";"nM";"8.92";"";"261508";"UO_0000065";"17.22";"0.33";"3.32";"8.61";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683183";"";"None";"688.27";"2";"5.71";"BDBM162222";"COc1cc2c(cc1OCC1CCCO1)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)nc1)C(=O)C2";"IC50";"'='";"3.8";"nM";"8.42";"";"305041";"UO_0000065";"12.23";"0.23";"2.71";"9.60";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653302";"";"None";"588.04";"2";"6.05";"BDBM129870";"CCOC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"2.18";"nM";"8.66";"";"261600";"UO_0000065";"14.73";"0.28";"2.61";"7.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691710";"";"None";"594.50";"2";"5.43";"BDBM143474";"CNC(=O)c1ccc(OC)c(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1";"IC50";"'='";"1.1";"nM";"8.96";"";"279605";"UO_0000065";"15.07";"0.30";"3.53";"9.10";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657128";"";"None";"551.99";"2";"2.74";"BDBM6852";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cn(C)c(=O)n(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"43.4";"nM";"7.36";"";"13371";"UO_0000065";"13.34";"0.26";"4.62";"5.83";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656977";"";"None";"540.41";"1";"4.27";"BDBM129879";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"1.35";"nM";"8.87";"";"261609";"UO_0000065";"16.41";"0.33";"4.60";"7.32";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687299";"";"None";"524.42";"2";"7.51";"BDBM143427";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"3.2";"nM";"8.49";"";"279567";"UO_0000065";"16.20";"0.32";"0.98";"17.94";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653233";"";"None";"497.00";"1";"6.72";"BDBM129798";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.19";"nM";"9.72";"";"261528";"UO_0000065";"19.56";"0.37";"3.00";"13.66";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656995";"";"None";"536.98";"2";"2.31";"BDBM129899";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)c(=O)n(C)c1=O)C2=O";"IC50";"'='";"102.7";"nM";"6.99";"";"261630";"UO_0000065";"13.01";"0.25";"4.68";"4.88";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691774";"";"None";"559.03";"1";"3.83";"BDBM143671";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.12";"nM";"9.92";"";"279815";"UO_0000065";"17.75";"0.34";"6.09";"8.12";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691707";"";"None";"553.45";"2";"5.21";"BDBM143470";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(CCO)c1)C2=O";"IC50";"'='";"10.7";"nM";"7.97";"";"279602";"UO_0000065";"14.40";"0.29";"2.76";"8.90";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653244";"";"None";"540.38";"2";"5.89";"BDBM129809";"COc1ncc(-c2nc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"3.6";"nM";"8.44";"";"261539";"UO_0000065";"15.63";"0.31";"2.55";"10.25";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687231";"";"None";"486.42";"1";"7.48";"BDBM143339";"CC(C)=CCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"4.8";"nM";"8.32";"";"279499";"UO_0000065";"17.10";"0.34";"0.84";"21.82";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4524095";"";"None";"1164.14";"None";"None";"23";"CC(C)CCC(=O)NC(CCC(=O)O)CN(C(=O)NCCCC1CCCCC1)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"4.77";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL4524093";"";"None";"1163.11";"None";"None";"22";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(=O)[C@@H]1CCCN1)C(=O)NCCCC1CCCCC1";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"4.37";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL577393";"";"None";"590.57";"1";"4.25";"2, MI-126";"CN1CCN(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'='";"25.7";"nM";"7.59";"";"";"UO_0000065";"12.85";"0.26";"3.34";"9.89";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3650049";"";"None";"513.08";"2";"5.79";"BDBM135919";"CCN(C(C)=O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"183.0";"nM";"6.74";"";"269497";"UO_0000065";"13.13";"0.26";"0.95";"11.40";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639520";"";"None";"591.54";"2";"7.45";"BDBM129738";"COc1ccc(CNC(C)=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.07";"nM";"10.15";"";"261469";"UO_0000065";"17.17";"0.34";"2.70";"13.28";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653165";"";"None";"521.45";"2";"7.21";"BDBM129729";"COc1ncccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"2.27";"nM";"8.64";"";"261460";"UO_0000065";"16.58";"0.33";"1.43";"14.35";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691771";"";"None";"530.98";"1";"3.80";"BDBM143665";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.367";"nM";"9.44";"";"279812";"UO_0000065";"17.77";"0.34";"5.64";"6.65";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125522";"";"None";"526.48";"2";"5.35";"20";"CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"18.09";"0.38";"4.17";"10.38";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3687286";"";"None";"528.84";"2";"8.15";"BDBM143414";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccc(Cl)cc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"14.7";"nM";"7.83";"";"279554";"UO_0000065";"14.81";"0.31";"-0.32";"20.54";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687244";"";"None";"596.56";"2";"5.81";"BDBM143357";"CC(=O)N1CCC(NC(=O)Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)CC1";"IC50";"'='";"2.8";"nM";"8.55";"";"279512";"UO_0000065";"14.34";"0.28";"2.74";"9.77";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3693972";"";"None";"548.44";"1";"4.76";"31";"O=C(O)CCCNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"14.64";"0.30";"3.27";"7.46";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"25";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.76";"0.33";"2.44";"9.76";"1";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125523";"";"None";"540.51";"2";"5.74";"21";"CC[C@@H](CCS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"15.67";"0.33";"2.73";"9.23";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125707";"";"None";"492.44";"1";"6.08";"7";"CC[C@@H](C[C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"16.63";"0.34";"2.11";"10.52";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125701";"";"None";"538.49";"2";"5.35";"43";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.57";"0.39";"4.65";"10.90";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125698";"";"None";"580.57";"2";"6.52";"40";"CC(C)S(=O)(=O)C[C@H](C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125534";"";"None";"554.54";"2";"6.13";"32";"C[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"18.03";"0.38";"3.87";"10.90";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"25";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.59";"0.37";"3.48";"10.90";"1";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"2, AMG 232";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.22";"0.34";"2.84";"10.05";"1";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125540";"";"None";"582.59";"2";"6.77";"38";"CC(C)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.13";"0.34";"2.63";"10.24";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125539";"";"None";"540.51";"2";"5.74";"37";"CC(C)S(=O)(=O)C[C@H](C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.94";"0.38";"3.96";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125530";"";"None";"580.57";"2";"6.67";"28";"CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.40";"0.34";"2.85";"10.38";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125529";"";"None";"566.55";"2";"6.28";"27";"CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.81";"0.33";"2.68";"9.76";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL208007";"";"None";"677.37";"2";"7.53";"20";"O=C(O)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(C(c2ccc(Cl)cc2)C2CC2)C(=O)c2cc(I)ccc21";"IC50";"'='";"2150.0";"nM";"5.67";"";"";"UO_0000065";"8.37";"0.20";"-1.86";"7.27";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL208020";"";"None";"672.31";"2";"6.55";"10";"O=C(O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(Cc2ccncc2)C(=O)C1c1ccc(Cl)cc1";"IC50";"'='";"4350.0";"nM";"5.36";"";"";"UO_0000065";"7.97";"0.19";"-1.19";"5.90";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3653164";"";"None";"552.46";"2";"6.61";"15";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"17.73";"0.35";"3.19";"11.89";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3109045";"";"None";"615.49";"1";"4.42";"11";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3nc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"11.94";"0.24";"2.93";"4.95";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL377203";"";"None";"679.39";"2";"5.80";"22";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"8.98";"0.21";"0.30";"7.71";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL2386169";"";"None";"607.63";"2";"7.61";"2b";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCNCC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.38";"0.24";"-0.09";"13.16";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3653217";"";"None";"579.49";"2";"5.48";"BDBM129782";"COc1nc(N2CC(O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261513";"UO_0000065";"17.06";"0.34";"4.41";"10.23";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3291433";"";"None";"410.50";"1";"5.62";"18";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnc2[nH]c(=S)[nH]c(=O)c12";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"15.48";"0.29";"0.74";"8.22";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"88, Nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'>'";"60000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3222409";"Inhibition of Mdm2 in p53-deficient human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL4292264";"MILADEMETAN";"1.0";"618.54";"1";"3.96";"DS-3032b";"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21";"IC50";"'='";"5.57";"nM";"8.25";"";"";"UO_0000065";"13.34";"0.27";"4.29";"6.09";"0";"CHEMBL4268705";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265957";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL3798021";"";"None";"688.67";"2";"7.28";"14c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(C#N)cc2)CC1";"IC50";"'='";"1919.0";"nM";"5.72";"";"";"UO_0000065";"8.30";"0.16";"-1.56";"5.97";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800119";"";"None";"698.10";"2";"8.07";"13a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccccc2Cl)CC1";"IC50";"'='";"2764.0";"nM";"5.56";"";"";"UO_0000065";"7.96";"0.16";"-2.51";"7.72";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800540";"";"None";"675.71";"2";"8.13";"11c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Cc2ccc(C)cc2)CC1";"IC50";"'='";"25801.0";"nM";"4.59";"";"";"UO_0000065";"6.79";"0.13";"-3.54";"7.31";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3799179";"";"None";"661.69";"2";"7.82";"10c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"'='";"5831.0";"nM";"5.23";"";"";"UO_0000065";"7.91";"0.15";"-2.59";"8.34";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3657037";"";"None";"605.57";"2";"7.95";"BDBM129944";"COc1ccc(C(=O)NC(C)C)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"5.39";"nM";"8.27";"";"261674";"UO_0000065";"13.65";"0.27";"0.32";"10.81";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687313";"";"None";"582.46";"2";"6.92";"BDBM143442";"CCOC(=O)C1(c2ccc(Cl)cc2)c2c(nn(-c3ccccc3OC)c2C(C)C)C(=O)N1c1ccc(F)c(Cl)c1";"IC50";"'='";"5.2";"nM";"8.28";"";"279581";"UO_0000065";"14.22";"0.28";"1.36";"11.25";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691710";"";"None";"594.50";"2";"5.43";"BDBM143474";"CNC(=O)c1ccc(OC)c(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1";"IC50";"'='";"0.259";"nM";"9.59";"";"279760";"UO_0000065";"16.13";"0.32";"4.16";"9.74";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683116";"";"None";"592.14";"2";"5.36";"BDBM161750";"CC[C@@H](C)Oc1cc2c(cc1OCC(=O)N1CCN(C)CC1)CC(=O)N(c1ccc(OC)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"1381.1";"nM";"5.86";"";"304962";"UO_0000065";"9.90";"0.19";"0.50";"8.19";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691743";"";"None";"554.44";"1";"4.61";"BDBM143558";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"279784";"UO_0000065";"17.83";"0.36";"5.28";"9.05";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236665";"";"None";"659.63";"2";"6.72";"47";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@](C)(Cc2ccc(C(=O)O)cn2)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.16";"0.31";"3.28";"8.78";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236660";"";"None";"713.70";"2";"7.98";"41";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(F)C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.19";"0.26";"0.72";"8.31";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3683155";"";"None";"563.09";"2";"6.12";"BDBM162021";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCOCC3=O)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"26.9";"nM";"7.57";"";"305004";"UO_0000065";"13.44";"0.26";"1.45";"11.08";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3109049";"";"None";"615.49";"2";"5.62";"6";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3nc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.58";"0.25";"2.12";"5.97";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109052";"";"None";"615.49";"2";"5.62";"3";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"11.91";"0.24";"1.71";"5.65";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3650067";"";"None";"556.14";"2";"6.35";"BDBM135937";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"36.0";"nM";"7.44";"";"269515";"UO_0000065";"13.38";"0.26";"1.09";"10.91";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3220091";"";"None";"664.23";"2";"9.83";"4f";"Cc1ccc(N2C(=O)/C(=C\c3cc(-c4ccccc4)n(-c4ccc(Cl)cc4)c3-c3ccccc3)C(=O)N(c3ccccc3)C2=S)cc1C";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"9.92";"0.19";"-3.24";"14.47";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220100";"";"None";"489.58";"1";"5.86";"4p";"CC(C)(C)c1ccc(-n2c(-c3ccccc3)cc(C=C3C(=O)NC(=O)NC3=O)c2-c2ccccc2)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"11.69";"0.21";"-0.14";"7.13";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220109";"";"None";"471.94";"1";"6.19";"10a";"COC(=O)C(=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1)C(=O)OC";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3236640";"";"None";"677.72";"2";"7.38";"20";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nc(CC(=O)O)cs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"13.22";"0.28";"1.58";"8.56";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2152319";"";"None";"501.44";"1";"4.77";"9b";"CCC1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.46";"0.24";"0.97";"8.84";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL1689400";"";"None";"1918.20";"None";"None";"3b";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"4.04";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL178578";"";"None";"580.30";"2";"5.27";"5";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"9.94";"0.23";"0.50";"6.65";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1688282";"";"None";"447.96";"1";"5.29";"83";"Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.59";"0.24";"0.35";"11.33";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688287";"";"None";"512.83";"2";"5.75";"88";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccc(Br)c1";"IC50";"'='";"47000.0";"nM";"4.33";"";"";"UO_0000065";"8.44";"0.18";"-1.42";"8.70";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688304";"";"None";"478.93";"0";"4.89";"74b, (-)-(S)-enantiomer";"O=C1c2ccccc2[C@@](OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.29";"0.24";"1.00";"6.34";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL4267474";"Inhibition of recombinant p53 protein binding to recombinant human MDM2 by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265913";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL1689394";"";"None";"1835.10";"None";"None";"1";"COc1ccc(N2N=C3CC2(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)CCCCNC3=O)cc1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"3.93";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3653206";"";"None";"508.41";"2";"6.29";"BDBM129771";"COc1ncncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.39";"nM";"9.41";"";"261502";"UO_0000065";"18.51";"0.37";"3.12";"12.86";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL207013";"";"None";"653.34";"2";"6.55";"12h";"COCCOCCN1C(=O)[C@@H](c2ccc(Cl)cc2)N([C@@H](C)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'>'";"12500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3236639";"";"None";"657.66";"2";"7.38";"19";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cc(C(=O)O)ccn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.21";"0.31";"2.62";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236647";"";"None";"658.65";"2";"6.78";"27";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.18";"0.31";"3.22";"8.51";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236651";"";"None";"646.64";"2";"6.64";"31";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cn2cc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.46";"0.32";"3.36";"9.13";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233130";"";"None";"556.51";"2";"5.47";"48";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.63";"0.33";"3.23";"8.61";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236359";"";"None";"608.59";"2";"5.97";"7";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"14.60";"0.30";"2.92";"7.84";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236362";"";"None";"582.59";"2";"6.00";"11";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"14.47";"0.30";"2.43";"9.19";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236644";"";"None";"699.74";"2";"8.05";"24";"CC(C)(C(=O)O)c1ccc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)nc1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"12.53";"0.25";"0.72";"8.38";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236667";"";"None";"657.66";"2";"7.38";"50";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"12.31";"0.25";"0.72";"7.74";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3260812";"";"None";"437.33";"1";"6.83";"7";"Cc1cccc(-c2nc(C(=O)O)c(-c3cccc(Cl)c3)n2-c2cc(Cl)ccc2C)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.51";"0.37";"1.27";"14.69";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3291222";"";"None";"352.40";"0";"4.16";"14";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnc2nnnn12";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"17.24";"0.31";"1.92";"8.47";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3291439";"";"None";"609.55";"2";"6.56";"Diph. Imidazole, Diphenylimidazoline";"COc1ccc(-c2nc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)n2C(=O)N2CCN(CCO)CC2)c(OC(C)C)c1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"10.80";"0.21";"0.03";"8.23";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3691751";"";"None";"541.40";"1";"4.55";"BDBM143592";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.176";"nM";"9.75";"";"279792";"UO_0000065";"18.02";"0.36";"5.20";"8.47";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657002";"";"None";"542.04";"2";"5.90";"BDBM129906";"CCn1cc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)ccc2C)C3=O)cc1=O";"IC50";"'='";"0.57";"nM";"9.24";"";"261637";"UO_0000065";"17.05";"0.32";"3.34";"9.92";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691706";"";"None";"537.45";"2";"6.07";"BDBM143469";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"1.2";"nM";"8.92";"";"279601";"UO_0000065";"16.60";"0.33";"2.85";"12.86";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657008";"";"None";"527.39";"2";"5.71";"BDBM129912";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.49";"nM";"9.31";"";"261643";"UO_0000065";"17.65";"0.35";"3.60";"9.39";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653167";"";"None";"577.51";"2";"7.17";"BDBM129731";"CNC(=O)c1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.2";"nM";"9.70";"";"261462";"UO_0000065";"16.79";"0.33";"2.53";"12.69";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL207845";"";"None";"700.88";"2";"7.39";"22";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1040.0";"nM";"5.98";"";"";"UO_0000065";"8.54";"0.20";"-1.41";"6.87";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL377524";"";"None";"637.30";"2";"6.58";"17";"O=C(O)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL210913";"";"None";"563.48";"2";"6.91";"24";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3683121";"";"None";"525.05";"2";"6.40";"BDBM161812";"CCC(=O)Nc1ccc2c(c1)C(c1ccc(Cl)cc1)N(c1ccc(N(C)Cc3ccncc3)cc1)C(=O)C2";"IC50";"'='";"331.6";"nM";"6.48";"";"304967";"UO_0000065";"12.34";"0.23";"0.08";"9.89";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653273";"";"None";"549.42";"2";"5.87";"BDBM129841";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C#N)C3=O)c(OC)n1";"IC50";"'='";"0.57";"nM";"9.24";"";"261570";"UO_0000065";"16.83";"0.33";"3.37";"8.71";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653216";"";"None";"607.54";"2";"6.17";"BDBM129781";"COc1nc(N2CC(C)(O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261512";"UO_0000065";"16.04";"0.32";"3.57";"10.09";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683126";"";"None";"502.01";"2";"6.39";"BDBM161840";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(-n3cccn3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"876.9";"nM";"6.06";"";"304972";"UO_0000065";"12.07";"0.23";"-0.33";"10.70";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691788";"";"None";"562.99";"1";"3.96";"BDBM143711";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.215";"nM";"9.67";"";"279830";"UO_0000065";"17.17";"0.33";"5.71";"7.27";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653205";"";"None";"543.50";"2";"8.24";"BDBM129770";"CCc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.42";"nM";"9.38";"";"261501";"UO_0000065";"17.25";"0.34";"1.14";"15.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653235";"";"None";"532.96";"2";"5.35";"BDBM129800";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.36";"nM";"9.44";"";"261530";"UO_0000065";"17.72";"0.34";"4.09";"8.90";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639860";"";"None";"575.47";"2";"7.40";"BDBM143337";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3cc(=O)[nH]c4ccccc34)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"5.3";"nM";"8.28";"";"279497";"UO_0000065";"14.38";"0.28";"0.88";"11.66";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691781";"";"None";"573.41";"1";"4.70";"BDBM143682";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2F)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.437";"nM";"8.84";"";"279822";"UO_0000065";"15.42";"0.31";"4.14";"8.47";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601323";"";"None";"590.21";"2";"7.37";"BDBM162052";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)C(=O)C2";"IC50";"'='";"2.5";"nM";"8.60";"";"305007";"UO_0000065";"14.57";"0.28";"1.23";"19.01";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653225";"";"None";"623.51";"2";"6.81";"BDBM129790";"COc1ccc(C(=O)N2CCOCC2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261521";"UO_0000065";"15.63";"0.31";"2.93";"12.67";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653295";"";"None";"517.95";"1";"4.93";"BDBM129863";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"105.6";"nM";"6.98";"";"261593";"UO_0000065";"13.47";"0.26";"2.05";"5.67";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687237";"";"None";"544.46";"2";"5.96";"BDBM143345";"CCN1CCN(CCn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)C1=O";"IC50";"'='";"8.9";"nM";"8.05";"";"279505";"UO_0000065";"14.79";"0.30";"2.09";"13.05";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657118";"";"None";"572.42";"2";"5.76";"BDBM130036";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1[C@@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"43.73";"nM";"7.36";"";"261757";"UO_0000065";"12.86";"0.26";"1.60";"8.03";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687232";"";"None";"523.44";"2";"7.15";"BDBM143340";"Cc1cc(Cl)ccc1C1c2c(nn(CCc3ccccn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"9.9";"nM";"8.00";"";"279500";"UO_0000065";"15.29";"0.30";"0.85";"15.69";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691724";"";"None";"577.51";"2";"6.92";"BDBM143513";"COc1ccc(CNC=O)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.169";"nM";"9.77";"";"279769";"UO_0000065";"16.92";"0.33";"2.85";"12.78";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703663";"";"None";"511.40";"2";"6.34";"BDBM156528";"Cc1ccc2ccc(C(Nc3cccnc3)c3c(F)c(F)c(OCC(F)(F)F)c(F)c3F)c(O)c2n1";"IC50";"'='";"20000.0";"nM";"4.70";"";"298945";"UO_0000065";"9.19";"0.18";"-1.64";"6.99";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703666";"";"None";"435.91";"1";"5.52";"BDBM156617";"COc1ccc(C(Nc2ncc(Cl)cc2C)c2ccc3cccnc3c2O)cc1OC";"IC50";"'='";"24000.0";"nM";"4.62";"";"298949";"UO_0000065";"10.60";"0.20";"-0.90";"6.04";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703671";"";"None";"479.19";"1";"7.46";"BDBM156626";"Cc1nc(NC(c2ccc(Cl)c(Cl)c2)c2ccc3cccnc3c2O)c(Cl)cc1Cl";"IC50";"'='";"10000.0";"nM";"5.00";"";"298954";"UO_0000065";"10.43";"0.23";"-2.46";"8.61";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3407574";"";"None";"663.66";"2";"5.98";"24";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CC(C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"14.44";"0.30";"3.61";"8.55";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407561";"";"None";"699.70";"2";"7.78";"11";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccccc2C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"13.48";"0.27";"1.65";"7.80";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407560";"";"None";"699.70";"2";"7.78";"10";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2cccc(C(=O)O)c2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"13.83";"0.28";"1.90";"8.01";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"1";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"10.97";"0.27";"0.82";"7.35";"1";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL207364";"";"None";"591.54";"2";"5.57";"12j";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1N)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCN1CCOCC1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3675205";"";"None";"408.84";"0";"4.41";"BDBM111526";"Cc1cccc2c1C(O)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"2200.0";"nM";"5.66";"";"232323";"UO_0000065";"13.84";"0.27";"1.25";"6.76";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649955";"";"None";"635.17";"1";"4.78";"BDBM135324";"C[C@@H]1CN(C(=O)C2(C)COC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268833";"UO_0000065";"12.53";"0.24";"3.18";"5.88";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268747";"UO_0000065";"14.63";"0.28";"2.98";"7.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3939191";"";"None";"622.17";"2";"5.29";"BDBM135320";"CCN(C)C(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268829";"UO_0000065";"14.47";"0.28";"3.71";"6.96";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268637";"UO_0000065";"14.89";"0.29";"2.94";"7.31";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649824";"";"None";"522.05";"2";"5.55";"BDBM135153";"CC1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"9.0";"nM";"8.05";"";"268662";"UO_0000065";"15.41";"0.30";"2.50";"7.61";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"1.0";"nM";"9.00";"";"268691";"UO_0000065";"16.73";"0.32";"4.07";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649878";"";"None";"540.07";"2";"5.18";"BDBM135217";"CCCN(CCOC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268726";"UO_0000065";"14.90";"0.29";"2.87";"7.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3979791";"";"None";"586.04";"2";"5.32";"BDBM135255";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268764";"UO_0000065";"14.84";"0.29";"3.38";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639487";"";"None";"580.09";"1";"4.70";"BDBM135259";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2COCCC2O1";"IC50";"'='";"18.0";"nM";"7.75";"";"268768";"UO_0000065";"13.35";"0.26";"3.04";"6.24";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649918";"";"None";"516.99";"2";"5.45";"BDBM135279";"C[C@H]1CC[C@H](Cn2c(Nc3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"268788";"UO_0000065";"14.77";"0.28";"2.19";"6.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688281";"";"None";"559.83";"2";"5.59";"BDBM111559";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(I)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"232361";"UO_0000065";"10.40";"0.25";"0.23";"11.70";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688254";"";"None";"431.92";"0";"4.90";"BDBM50339439";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"232301";"UO_0000065";"13.05";"0.25";"0.74";"11.33";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688271";"";"None";"462.89";"0";"4.12";"BDBM111514";"O=C1c2ccccc2C(OCC#CCO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"656.0";"nM";"6.18";"";"232311";"UO_0000065";"13.36";"0.26";"2.06";"6.65";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688269";"";"None";"514.97";"2";"5.81";"BDBM111521";"O=C1c2ccccc2C(OCc2cccc(CO)c2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"732.0";"nM";"6.13";"";"232318";"UO_0000065";"11.91";"0.23";"0.33";"6.60";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649928";"";"None";"552.08";"2";"5.49";"BDBM135294";"CO[C@@H]1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268803";"UO_0000065";"15.44";"0.30";"3.03";"7.41";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649929";"";"None";"538.05";"1";"4.84";"BDBM135295";"CC([C@H]1CC[C@H](C)CC1)n1c(N2C[C@H](O)C[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"3.0";"nM";"8.52";"";"268805";"UO_0000065";"15.84";"0.31";"3.68";"6.77";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649930";"";"None";"565.08";"1";"4.37";"BDBM135298";"CC(=O)N1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"268807";"UO_0000065";"14.55";"0.28";"3.85";"6.52";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3986537";"";"None";"608.15";"1";"4.94";"BDBM135304";"CCNC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268813";"UO_0000065";"14.01";"0.27";"3.58";"6.17";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649941";"";"None";"622.17";"2";"5.33";"BDBM135310";"CCCNC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"268819";"UO_0000065";"13.98";"0.27";"3.37";"6.30";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268853";"UO_0000065";"16.06";"0.31";"2.60";"7.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693968";"";"None";"568.50";"1";"3.94";"BDBM112753";"CS(=O)(=O)CCNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234028";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693969";"";"None";"476.38";"0";"4.53";"BDBM112754";"CNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234029";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653162";"";"None";"520.46";"2";"7.81";"BDBM129726";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.25";"nM";"9.60";"";"261458";"UO_0000065";"18.45";"0.36";"1.79";"20.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649970";"";"None";"559.07";"2";"6.44";"BDBM135351";"CCOC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268861";"UO_0000065";"15.02";"0.29";"1.96";"7.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649973";"";"None";"575.07";"2";"5.20";"BDBM135355";"COCC(O)(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268864";"UO_0000065";"14.43";"0.28";"3.10";"6.29";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649975";"";"None";"560.06";"2";"5.84";"BDBM135357";"CCOC(c1cccnc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268866";"UO_0000065";"14.82";"0.28";"2.46";"6.66";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650022";"";"None";"623.13";"2";"5.42";"BDBM135425";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCN(C(=O)C3(F)CC3)C[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"268934";"UO_0000065";"14.44";"0.28";"3.58";"7.14";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688144";"";"None";"360.37";"0";"3.44";"BDBM111565";"O=C1c2ccccc2C(O)(c2ccccc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"87000.0";"nM";"4.06";"";"232366";"UO_0000065";"11.27";"0.21";"0.62";"4.85";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675228";"";"None";"431.25";"1";"5.38";"BDBM111575";"O=Nc1ccc(CN2C(=O)c3ccc(F)c(Cl)c3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"34000.0";"nM";"4.47";"";"232376";"UO_0000065";"10.36";"0.21";"-0.91";"6.39";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649946";"";"None";"617.15";"2";"5.30";"BDBM135315";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C4CC4)[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286334";"UO_0000065";"13.45";"0.26";"3.00";"6.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3948683";"";"None";"641.12";"2";"5.40";"BDBM135322";"C[C@H]1CN(C(=O)C2CC2(F)F)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286341";"UO_0000065";"13.10";"0.25";"3.00";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649960";"";"None";"551.09";"2";"6.58";"BDBM135330";"CCOC(c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286349";"UO_0000065";"14.92";"0.29";"1.64";"7.36";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2347381";"";"None";"545.27";"2";"6.10";"14";"COc1ccc(C[C@@H]2O[C@@H](c3ccc(Br)cc3)[C@@H](c3ccc(Br)cc3)N(C)C2=O)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"10.49";"0.25";"-0.38";"14.76";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3125520";"";"None";"579.55";"2";"5.35";"18";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.25";"0.36";"4.65";"10.53";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3798867";"";"None";"693.69";"2";"6.27";"20k";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(CN)cn2)CC1";"IC50";"'='";"801.0";"nM";"6.10";"";"";"UO_0000065";"8.79";"0.17";"-0.17";"5.50";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL2315846";"";"None";"557.55";"2";"5.93";"17b";"CC(C)C1=C(C(=O)N2CC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.29";"0.25";"0.92";"12.19";"0";"CHEMBL2321369";"Inhibition of human His-tagged p53 (1 to 132 amino acid residues)/GST-tagged MDM2 L33E mutant (25 to 108 amino acid residues) interaction by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"32";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.78";"0.28";"0.41";"10.34";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347401";"";"None";"426.34";"1";"5.88";"9";"CN1C(=O)[C@H](Cc2ccccc2)O[C@@H](c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.47";"0.27";"-0.14";"19.45";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2443392";"";"None";"375.28";"0";"3.34";"17";"O=c1nc2n(-c3cccc(F)c3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"12300.0";"nM";"4.91";"";"";"UO_0000065";"13.08";"0.25";"1.57";"7.25";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440447";"";"None";"375.28";"0";"3.34";"9";"O=c1nc2n(-c3ccccc3F)c3cc(C(F)(F)F)ccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3951933";"";"None";"564.05";"1";"4.93";"BDBM60492";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"221944";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639928";"";"None";"577.48";"1";"3.08";"BDBM112745";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCOCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"5000.0";"nM";"";"";"234020";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927923";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268772";"UO_0000065";"15.84";"0.31";"3.98";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3971736";"";"None";"564.09";"2";"5.64";"BDBM135284";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCO[C@H]3CCC[C@@H]32)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"268794";"UO_0000065";"15.95";"0.31";"3.36";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649928";"";"None";"552.08";"2";"5.49";"BDBM135294";"CO[C@@H]1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"268806";"UO_0000065";"15.76";"0.30";"3.21";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268852";"UO_0000065";"17.21";"0.33";"3.20";"8.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647061";"";"None";"566.11";"2";"5.71";"BDBM135123";"COC(C)(C)[C@@H]1CCCN1c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268632";"UO_0000065";"15.37";"0.30";"2.99";"7.57";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647066";"";"None";"562.00";"2";"5.85";"BDBM135130";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268639";"UO_0000065";"15.48";"0.30";"2.85";"8.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703647";"";"None";"425.41";"1";"5.74";"BDBM156415";"Cc1cccc(NC(c2ccc(OC(F)(F)F)cc2)c2ccc3cccnc3c2O)n1";"IC50";"'='";"9400.0";"nM";"5.03";"";"298927";"UO_0000065";"11.82";"0.22";"-0.71";"7.47";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703651";"";"None";"387.44";"0";"4.56";"BDBM156422";"COc1ccc(C(Nc2cccc(C)n2)c2ccc3cccnc3c2O)cc1O";"IC50";"'='";"4200.0";"nM";"5.38";"";"298932";"UO_0000065";"13.88";"0.25";"0.82";"6.14";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2443385";"";"None";"341.73";"0";"2.97";"27";"O=c1nc2n(-c3cccc(F)c3)c3c(Cl)cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3936690";"";"None";"537.59";"2";"6.98";"BDBM135103";"CC(C)c1ccnc(-c2nc3cc(C(=O)O)nc(N[C@@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"268612";"UO_0000065";"14.02";"0.26";"0.56";"8.11";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"2.0";"nM";"8.70";"";"268674";"UO_0000065";"14.50";"0.28";"2.42";"7.57";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649850";"";"None";"575.08";"2";"4.79";"BDBM135186";"Cn1cnc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"268695";"UO_0000065";"13.77";"0.26";"3.13";"5.81";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3125709";"";"None";"515.48";"2";"7.25";"9";"CC[C@@H](CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.31";"0.35";"1.67";"10.96";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407569";"";"None";"731.78";"2";"7.73";"19";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)NC23CCC(C(=O)O)(CC2)CC3)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407566";"";"None";"713.72";"2";"7.80";"16";"CN(C(=O)C[C@@]1(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)(C)C)C2CC2)C1=O)c1ccc(C(=O)O)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"12.25";"0.25";"0.94";"7.80";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236364";"";"None";"579.59";"2";"5.92";"5";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"16.86";"0.35";"3.85";"10.02";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407555";"";"None";"598.56";"2";"6.66";"4";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2F)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3109043";"";"None";"619.55";"2";"5.69";"13";"COc1cc(C(N)=O)ccc1NC(=O)C1NC(CC(C)(C)C)C2(C(=O)Nc3cc(Cl)sc32)C1c1cccc(Cl)c1F";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"11.94";"0.25";"1.71";"6.04";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2152330";"";"None";"529.54";"2";"6.27";"19";"CC(C)C1=C(C(=O)N2C[C@@H](C)N[C@@H](C)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"12.94";"0.27";"0.58";"14.30";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3220115";"";"None";"508.44";"2";"5.12";"11b";"CC(C)(C)c1cc(C=C2C(=O)NC(=S)NC2=O)c(-c2ccccc2)n1-c1ccc(Br)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"12.04";"0.26";"1.00";"9.69";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220313";"";"None";"629.64";"2";"7.02";"1a, WW298";"CN(C)CCCN(C)C1CCN(C(=O)c2[nH]c3cc(Cl)ccc3c2-c2c(Cc3ccc(Cl)cc3)ncn2-c2ccccc2)C1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"10.67";"0.21";"-0.30";"11.13";"0";"CHEMBL3223536";"Inhibition of human recombinant MDM2 (aminoacid residues 18 to 111) expressed in Escherichia coli BL21(DE3) RIL cells assessed as disruption of MDM2/fluorescent p53-derived P4 peptide interaction by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3139629";"";"None";"607.56";"1";"4.92";"1";"O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.28";"0.18";"0.72";"7.15";"0";"CHEMBL3802436";"Displacement of Ac-Phe-Arg-Dpr(fluorophore)-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2 from human N-terminal His6-tagged MDM2 (17 to 125 residues) expressed in Escherichia coli by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3799031";"";"None";"722.68";"2";"6.59";"20s";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C(=O)OC)n2)CC1";"IC50";"'='";"392.0";"nM";"6.41";"";"";"UO_0000065";"8.87";"0.17";"-0.18";"5.76";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3799552";"";"None";"693.69";"2";"6.27";"20j";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(CN)n2)CC1";"IC50";"'='";"173.0";"nM";"6.76";"";"";"UO_0000065";"9.75";"0.19";"0.49";"6.10";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798182";"";"None";"677.69";"2";"7.72";"12b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C)c2)CC1";"IC50";"'='";"668.0";"nM";"6.17";"";"";"UO_0000065";"9.11";"0.18";"-1.54";"8.58";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL427316";"";"None";"630.37";"2";"7.53";"11";"C[C@H](c1ccc(Cl)cc1)N1C(=O)C=C(c2ccccc2Br)N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"8.64";"0.19";"-2.09";"6.99";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3693969";"";"None";"476.38";"0";"4.53";"MI-2103";"CNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"48.1";"nM";"7.32";"";"";"UO_0000065";"15.36";"0.31";"2.79";"10.42";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4544452";"";"None";"722.29";"2";"5.28";"MC-215";"O=C1CCC(N2Cc3c(CCCCCNC(=O)[C@@H]4NC5(CCCCC5)[C@@]5(C(=O)Nc6cc(Cl)ccc65)[C@H]4c4ccccc4)cccc3C2=O)C(=O)N1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4453337";"";"None";"1818.74";"None";"None";"PS8";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](C)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3955477";"";"None";"520.43";"1";"4.28";"BDBM112735";"CC1(C)N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"201.0";"nM";"6.70";"";"234010";"UO_0000065";"12.87";"0.26";"2.42";"7.40";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693975";"";"None";"540.44";"1";"3.86";"BDBM112760";"CS(=O)(=O)NC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"500.0";"nM";"";"";"234035";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3220309";"";"None";"447.95";"0";"4.59";"11f";"O=C1NC(=S)NC(=O)C1=Cc1cc(C2CC2)n(-c2ccc(Cl)cc2)c1-c1ccccc1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"12.68";"0.25";"1.09";"8.99";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL1688152";"";"None";"399.88";"1";"5.34";"26";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccc2ccccc12";"IC50";"'='";"47000.0";"nM";"4.33";"";"";"UO_0000065";"10.82";"0.20";"-1.01";"10.68";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688266";"";"None";"511.37";"2";"5.00";"66";"O=C1c2ccccc2C(OCCCCO)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"12.21";"0.26";"1.24";"6.72";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688261";"";"None";"446.93";"0";"4.86";"61";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCCCCO)c2ccc(Cl)cc2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"12.21";"0.23";"0.60";"7.42";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL4095983";"";"None";"523.63";"2";"5.30";"12";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(OCCCNc2ccccn2)cc1)C(=O)O";"IC50";"'='";"7.85";"nM";"8.11";"";"";"UO_0000065";"15.48";"0.28";"2.81";"8.06";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4524057";"";"None";"1099.27";"None";"None";"26";"Cc1ccc(CCNC(=O)N(CC(CCCCN)N(CC(CCC(=O)O)NC(=O)CCC(C)C)C(=O)NCCCC2CCCCC2)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc2ccc(Br)cc2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"5.13";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL4524063";"";"None";"1204.20";"None";"None";"24";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(=O)CCC1CCCCC1)C(=O)NCCCC1CCCCC1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"4.61";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3627746";"";"None";"561.44";"2";"5.48";"20";"O=C(N[C@@H](CCCn1cc(-c2ccc(Br)cc2)nn1)C(=O)O)OCC1c2ccccc2-c2ccccc21";"IC50";"'='";"5510.0";"nM";"5.26";"";"";"UO_0000065";"9.37";"0.19";"-0.22";"4.95";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL4064911";"";"None";"479.58";"1";"5.60";"11";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"16.76";"0.30";"2.44";"10.63";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"32";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"11.91";"0.24";"-0.40";"8.94";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347386";"";"None";"336.22";"0";"4.26";"20";"CN1C(=O)CO[C@@H](c2ccc(Cl)cc2)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"31";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.00";"0.26";"0.07";"9.75";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347386";"";"None";"336.22";"0";"4.26";"20";"CN1C(=O)CO[C@@H](c2ccc(Cl)cc2)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347399";"";"None";"515.25";"2";"6.09";"10";"CN1C(=O)[C@H](Cc2ccccc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.64";"0.28";"-0.09";"20.31";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347398";"";"None";"425.12";"0";"4.48";"6";"CN1C(=O)CO[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"12.39";"0.33";"0.79";"17.83";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL377524";"";"None";"637.30";"2";"6.58";"17";"O=C(O)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL378998";"";"None";"651.38";"2";"6.25";"29";"CN(C)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"2830.0";"nM";"5.55";"";"";"UO_0000065";"8.52";"0.20";"-0.70";"7.94";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL2402737";"IDASANUTLIN";"3.0";"616.49";"2";"6.94";"12, RG7388";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.34";"0.27";"1.28";"7.38";"1";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402736";"";"None";"604.46";"2";"7.07";"11";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(=O)O)cc2F)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.58";"0.25";"0.53";"7.44";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402573";"";"None";"518.49";"1";"4.17";"1";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1";"IC50";"'='";"196.0";"nM";"6.71";"";"";"UO_0000065";"12.94";"0.26";"2.54";"6.37";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3649900";"";"None";"610.16";"2";"5.58";"BDBM135251";"COCCO[C@@H]1C[C@@H](C(C)C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'<'";"1.0";"nM";"";"";"286270";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649907";"";"None";"552.04";"1";"3.92";"BDBM135261";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286280";"UO_0000065";"15.44";"0.30";"4.60";"6.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649910";"";"None";"552.08";"2";"5.32";"BDBM135269";"CC1N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)CCOC1(C)C";"IC50";"'='";"17.0";"nM";"7.77";"";"286288";"UO_0000065";"14.07";"0.27";"2.45";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649973";"";"None";"575.07";"2";"5.20";"BDBM135355";"COCC(O)(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286374";"UO_0000065";"14.43";"0.28";"3.10";"6.29";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286404";"UO_0000065";"16.23";"0.31";"2.67";"7.63";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649994";"";"None";"511.03";"2";"5.46";"BDBM135390";"CCOCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286409";"UO_0000065";"15.84";"0.31";"2.64";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650019";"";"None";"511.03";"2";"5.97";"BDBM135421";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286441";"UO_0000065";"16.24";"0.31";"2.33";"7.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3923370";"";"None";"597.99";"2";"5.31";"BDBM135426";"O=c1nc(-c2cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(Cc4ccc(C(F)(F)F)cc4)c3c(-c3cncc(Cl)c3)n2)[nH]o1";"IC50";"'='";"39.0";"nM";"7.41";"";"286445";"UO_0000065";"12.39";"0.24";"2.10";"6.44";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268859";"UO_0000065";"14.75";"0.29";"2.72";"6.74";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649979";"";"None";"546.99";"2";"5.69";"BDBM135365";"C[C@H]1CC[C@H](Cn2c(C(=O)c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268874";"UO_0000065";"15.90";"0.30";"3.01";"7.28";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649985";"";"None";"548.02";"2";"5.94";"BDBM135376";"CC(F)(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268886";"UO_0000065";"15.87";"0.30";"2.76";"7.54";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650000";"";"None";"664.99";"2";"6.66";"BDBM135396";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3c(Br)c(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268905";"UO_0000065";"13.08";"0.28";"2.04";"7.57";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650002";"";"None";"568.05";"2";"5.21";"BDBM135398";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3c(F)c(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268907";"UO_0000065";"15.84";"0.31";"3.79";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3971378";"";"None";"610.12";"2";"4.45";"BDBM135436";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cc(Cl)cnc4OCCO)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268945";"UO_0000065";"14.75";"0.29";"4.55";"6.23";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653328";"";"None";"552.64";"1";"4.64";"BDBM135447";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cnccn4)c32)CC1";"IC50";"'='";"119.0";"nM";"6.92";"";"268956";"UO_0000065";"12.53";"0.23";"2.28";"5.42";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653330";"";"None";"552.64";"1";"4.64";"BDBM135449";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cccnn4)c32)CC1";"IC50";"'='";"112.0";"nM";"6.95";"";"268958";"UO_0000065";"12.58";"0.23";"2.31";"5.44";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653338";"";"None";"572.71";"2";"5.75";"BDBM135457";"CC(Oc1nc(-c2noc(=O)[nH]2)cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"28.0";"nM";"7.55";"";"268966";"UO_0000065";"13.19";"0.25";"1.80";"6.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286257";"UO_0000065";"14.63";"0.28";"2.98";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286263";"UO_0000065";"14.36";"0.28";"2.85";"6.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649896";"";"None";"540.09";"2";"5.26";"BDBM135247";"CC1CSCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286266";"UO_0000065";"14.90";"0.30";"2.79";"7.61";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3978215";"";"None";"591.12";"1";"4.76";"BDBM135299";"C[C@H]1CN(C(=O)C2CC2)CCN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286318";"UO_0000065";"14.04";"0.27";"3.54";"6.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3931299";"";"None";"605.14";"2";"5.15";"BDBM135300";"C[C@H]1CN(C(=O)C2CC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286320";"UO_0000065";"14.87";"0.29";"3.85";"7.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649949";"";"None";"631.18";"2";"5.69";"BDBM135318";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C4CCC4)[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286337";"UO_0000065";"13.15";"0.25";"2.61";"6.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286355";"UO_0000065";"15.40";"0.30";"2.35";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286369";"UO_0000065";"14.75";"0.29";"2.72";"6.74";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649998";"";"None";"525.05";"2";"5.70";"BDBM135394";"COCC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C(C)C";"IC50";"'='";"5.0";"nM";"8.30";"";"286413";"UO_0000065";"15.81";"0.31";"2.60";"7.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650005";"";"None";"553.11";"2";"5.49";"BDBM135401";"CN(C)c1c(C(=O)O)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@@H]3CCC[C@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"286420";"UO_0000065";"13.78";"0.27";"2.13";"7.89";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650015";"";"None";"560.10";"2";"6.34";"BDBM135415";"COC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"28.0";"nM";"7.55";"";"286434";"UO_0000065";"13.48";"0.26";"1.21";"9.17";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"286438";"UO_0000065";"14.68";"0.28";"1.53";"7.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649815";"";"None";"538.05";"1";"4.93";"BDBM135140";"CCC1COCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286159";"UO_0000065";"15.84";"0.31";"3.59";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649817";"";"None";"538.05";"1";"4.93";"BDBM135142";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)CO1";"IC50";"'='";"20.0";"nM";"7.70";"";"286165";"UO_0000065";"14.31";"0.28";"2.77";"6.70";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649821";"";"None";"521.97";"2";"6.20";"BDBM135147";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286166";"UO_0000065";"17.24";"0.34";"2.80";"10.70";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL2353483";"Inhibition of MDM2 (unknown origin) assessed as activation of p53";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346594";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL4107347";"";"None";"699.21";"3";"5.93";"BDBM135233";"CC1CCC(Cn2c(N3CCO[C@@H]4CN(C(=O)OCc5ccccc5)CC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"250.0";"nM";"6.60";"";"268742";"UO_0000065";"9.44";"0.18";"0.67";"4.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649890";"";"None";"536.04";"1";"4.42";"BDBM135236";"C[C@H]1CC[C@H](Cn2c(N3C4CCC3C(O)C4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"268745";"UO_0000065";"14.65";"0.28";"3.43";"6.24";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649898";"";"None";"570.07";"2";"5.27";"BDBM135249";"CCO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268758";"UO_0000065";"15.79";"0.31";"3.73";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3895119";"";"None";"591.12";"1";"4.91";"BDBM135250";"CCN1C(=O)CN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H]2CCC[C@@H]21";"IC50";"'='";"4.0";"nM";"8.40";"";"268759";"UO_0000065";"14.21";"0.27";"3.49";"6.66";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3916402";"";"None";"588.51";"2";"5.54";"BDBM112770";"O=C(O)C1CCC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"234045";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693987";"";"None";"543.50";"1";"4.46";"BDBM112772";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cncc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"234047";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649960";"";"None";"551.09";"2";"6.58";"BDBM135330";"CCOC(c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268839";"UO_0000065";"14.92";"0.29";"1.64";"7.36";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649962";"";"None";"511.03";"2";"5.80";"BDBM135334";"CCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268844";"UO_0000065";"15.84";"0.31";"2.30";"7.25";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693962";"";"None";"477.37";"0";"2.95";"BDBM112746";"CNC(=O)[C@@H]1NC2(CCNCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"234021";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693974";"";"None";"596.49";"2";"5.80";"BDBM112759";"O=C(O)c1ccc(CNC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'<'";"100.0";"nM";"";"";"234034";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693982";"";"None";"603.52";"1";"4.45";"BDBM112767";"O=C(O)CN1CCC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"234042";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693988";"";"None";"582.46";"2";"6.12";"BDBM112773";"O=C(O)c1cccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)c1";"IC50";"'<'";"100.0";"nM";"";"";"234048";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3945674";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@@H]1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"268732";"UO_0000065";"15.04";"0.29";"2.98";"7.22";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649915";"";"None";"564.09";"2";"5.46";"BDBM135274";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCC2O1";"IC50";"'='";"8.0";"nM";"8.10";"";"268783";"UO_0000065";"14.35";"0.28";"2.64";"7.04";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3986603";"";"None";"1851.62";"None";"None";"BDBM152964";"COc1cc(C(=O)OC(C)OC(=O)N[C@@H](CCC(=O)OCc2ccccc2)C(=O)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F.COc1cc(C(=O)OCOC(=O)NCC(=O)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.82";"nM";"8.23";"";"293788";"UO_0000065";"4.45";"None";"None";"None";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703357";"";"None";"866.70";"3";"4.70";"BDBM152988";"COc1cc(C(=O)OC(C)OC(=O)O[C@@H]2[C@@H](O)[C@@H](O)O[C@@H]2[C@H](O)CO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"3.4";"nM";"8.47";"";"293812";"UO_0000065";"9.77";"0.20";"3.77";"3.74";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL593841";"";"None";"1102.97";"None";"None";"14";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCc1ccccc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"4.43";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL593925";"";"None";"1004.08";"None";"None";"10";"Cc1ccc(CCCNC(=O)N(CCC(N)=O)CC(CCC(=O)O)N(CC(CCCCN)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCC(C)C)C(=O)NCCc2ccc(Br)cc2)cc1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"4.60";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3407571";"";"None";"705.74";"2";"7.15";"21";"CC1(C(=O)O)CCN(C(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)CC1";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"13.19";"0.27";"2.16";"8.31";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3627744";"";"None";"550.54";"2";"5.74";"18";"O=C(N[C@@H](CCCn1cc(-c2ccc(C(F)(F)F)cc2)nn1)C(=O)O)OCC1c2ccccc2-c2ccccc21";"IC50";"'='";"49800.0";"nM";"4.30";"";"";"UO_0000065";"7.82";"0.15";"-1.44";"4.05";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL208007";"";"None";"677.37";"2";"7.53";"20";"O=C(O)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(C(c2ccc(Cl)cc2)C2CC2)C(=O)c2cc(I)ccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL210545";"";"None";"668.36";"2";"6.13";"12i";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N([C@H](C)c2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3693976";"";"None";"612.49";"2";"6.13";"BDBM112761";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234036";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3931297";"";"None";"546.47";"1";"4.81";"BDBM112763";"CC1(O)CC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"100.0";"nM";"";"";"234038";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1689404";"";"None";"1954.27";"None";"None";"4";"COc1ccc(N2N=C(C(=O)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CO)C(N)=O)CC2C(N)=O)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"2.89";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689405";"";"None";"1605.82";"None";"None";"PDI-T2KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689409";"";"None";"1635.84";"None";"None";"PDI-A8KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'<'";"31.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2347399";"";"None";"515.25";"2";"6.09";"10";"CN1C(=O)[C@H](Cc2ccccc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347383";"";"None";"530.42";"2";"6.64";"16";"CCC[C@H](C(=O)O)N1C(=O)[C@H](Cc2ccc(F)cc2)O[C@@H](c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"10.44";"0.21";"-1.10";"8.28";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347384";"";"None";"336.22";"0";"4.26";"18";"CN1C(=O)CO[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"11700.0";"nM";"4.93";"";"";"UO_0000065";"14.67";"0.31";"0.67";"16.70";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3799712";"";"None";"677.69";"2";"7.72";"12a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccccc2C)CC1";"IC50";"'='";"6599.0";"nM";"5.18";"";"";"UO_0000065";"7.64";"0.15";"-2.54";"7.20";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4167167";"";"None";"516.56";"2";"1.66";"19";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCc2ccc(-c3ccccc3)cc2)c1";"IC50";"'='";"389.0";"nM";"6.41";"";"";"UO_0000065";"12.41";"0.23";"4.75";"3.44";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4293896";"";"None";"521.45";"2";"7.21";"12";"COc1ccncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"18.38";"0.36";"2.38";"15.91";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4064410";"";"None";"588.51";"2";"5.54";"33";"O=C(N[C@H]1CC[C@H](C(=O)O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"14.20";"0.29";"2.82";"7.77";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4064790";"";"None";"588.55";"2";"5.84";"15";"CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@H]1CC[C@H](O)CC1)[C@H](c1cccc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"13.91";"0.28";"2.35";"9.05";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL2381406";"";"None";"686.45";"2";"5.89";"Nutlin-2";"CCOc1cc(OC)ccc1C1=NC(c2ccc(Br)cc2)C(c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.98";"0.23";"0.96";"8.81";"0";"CHEMBL4267474";"Inhibition of recombinant p53 protein binding to recombinant human MDM2 by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265913";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL405395";"";"None";"1209.76";"None";"None";"Octapeptide inhibitor 1";"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"6.86";"None";"None";"None";"0";"CHEMBL4267483";"Inhibition of p53 protein binding to recombinant human GST-tagged MDM2 (1 to 118 residues) expressed in Escherichia coli BL21 (DE3) after 30 mins by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265913";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL3798150";"";"None";"732.64";"2";"7.83";"20c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C(F)(F)F)n2)CC1";"IC50";"'='";"2039.0";"nM";"5.69";"";"";"UO_0000065";"7.77";"0.15";"-2.14";"6.71";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3653307";"";"None";"595.50";"2";"6.97";"BDBM129875";"COc1ccc(CC(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261605";"UO_0000065";"16.41";"0.33";"2.80";"14.44";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691753";"";"None";"545.00";"1";"3.82";"BDBM143602";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.166";"nM";"9.78";"";"279794";"UO_0000065";"17.94";"0.34";"5.96";"7.35";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2152326";"";"None";"502.47";"2";"5.92";"15";"CC(C)C1=C(C(=O)N2CCOCC2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"12.87";"0.27";"0.55";"14.33";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1, Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"12.13";"0.24";"1.17";"8.45";"1";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3687268";"";"None";"540.54";"2";"5.93";"BDBM143394";"Cc1cc(Cl)ccc1C1c2c(nn(CCN3CCN(C)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"0.7";"nM";"9.15";"";"279536";"UO_0000065";"16.94";"0.34";"3.22";"20.52";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL382389";"";"None";"736.43";"2";"6.99";"16";"CCN(CC)C(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL3233588";"";"None";"680.65";"2";"5.55";"1b";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"9.58";"0.19";"0.97";"7.72";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3233592";"";"None";"712.69";"2";"6.92";"15";"COc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)C[C@H](c3ccccc3)CN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"7.75";"0.15";"-1.40";"7.34";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3233593";"";"None";"774.73";"2";"7.08";"16";"COCCOc1ccccc1N1CCN(C(=O)[C@@]2(Oc3ccc(C(F)(F)F)cc3)CN(C(=O)c3cnccc3C(F)(F)F)CC[C@H]2c2ccc(F)cc2)CC1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"6.98";"0.13";"-1.67";"6.41";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3233594";"";"None";"756.74";"2";"7.29";"17";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CC[C@H](c3ccccc3)N(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3233018";"";"None";"720.71";"2";"6.49";"25";"C=CC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ccccc2OCCOC)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"10.26";"0.20";"0.91";"8.76";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3653158";"";"None";"538.45";"2";"7.95";"10";"COc1ccc(F)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"";"UO_0000065";"18.30";"0.36";"1.90";"20.81";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL2402729";"";"None";"604.53";"2";"6.20";"4";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccn(CC(C)(C)O)n2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"12.00";"0.24";"1.05";"7.04";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL4095042";"";"None";"407.90";"0";"4.67";"7";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(Cl)cc1)C(=O)O";"IC50";"'='";"65.3";"nM";"7.18";"";"";"UO_0000065";"17.61";"0.34";"2.52";"10.82";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4080951";"";"None";"403.48";"0";"3.81";"3";"COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC(c1ccccc1)c1ccccc1";"IC50";"'='";"18.9";"nM";"7.72";"";"";"UO_0000065";"19.14";"0.35";"3.91";"10.21";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"8, MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866341";"Antiproliferative activity against human LnCAP cell line with wild type p53";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LNCaP";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148527";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307965";"";""
"CHEMBL3691722";"";"None";"549.50";"2";"7.14";"BDBM143511";"COc1ccc(CN)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.146";"nM";"9.84";"";"279767";"UO_0000065";"17.90";"0.35";"2.70";"13.40";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683167";"";"None";"577.12";"2";"6.51";"BDBM162100";"COC(=O)[C@@H]1CCCN1[C@@H](C)c1ccc(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"216.7";"nM";"6.66";"";"305020";"UO_0000065";"11.55";"0.22";"0.15";"9.76";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683128";"";"None";"521.06";"2";"6.30";"BDBM161845";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(=O)N(C)CC)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"190.4";"nM";"6.72";"";"304974";"UO_0000065";"12.90";"0.25";"0.42";"11.37";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4524068";"";"None";"1184.13";"None";"None";"19";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(=O)Cc1ccccc1)C(=O)NCCCC1CCCCC1";"IC50";"'='";"10500.0";"nM";"4.98";"";"";"UO_0000065";"4.20";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL611331";"";"None";"990.05";"2";"4.60";"7";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCCc1ccccc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCc1ccc(Br)cc1";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"4.46";"0.09";"-0.18";"1.49";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3653243";"";"None";"544.97";"2";"5.50";"BDBM129808";"COc1ncc(-c2nc3c(n2C2CCC2)C(c2ccc(C#N)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"31.7";"nM";"7.50";"";"261538";"UO_0000065";"13.76";"0.26";"2.00";"7.06";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691762";"";"None";"540.41";"1";"4.58";"BDBM143640";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.357";"nM";"9.45";"";"279803";"UO_0000065";"17.48";"0.35";"4.87";"8.00";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3604660";"";"None";"534.02";"2";"5.22";"BDBM161710";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(C)cc1OCc1nn[nH]n1)C(=O)C2";"IC50";"'='";"388.9";"nM";"6.41";"";"304955";"UO_0000065";"12.00";"0.23";"1.19";"6.26";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683113";"";"None";"523.03";"1";"4.75";"BDBM161740";"COc1ccc(N2C(=O)Cc3cc(OCCN4CCOCC4)c(OC)cc3C2c2ccc(Cl)cc2)cc1";"IC50";"'='";"10288.5";"nM";"4.99";"";"304959";"UO_0000065";"9.54";"0.18";"0.24";"8.25";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220312";"";"None";"518.90";"1";"2.51";"RO-5963";"Cc1c(Cl)ccc2c(/C=C3\NC(=O)N(C(C(=O)NC(CO)CO)c4ccc(F)c(F)c4)C3=O)c[nH]c12";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.97";"0.29";"5.26";"5.77";"0";"CHEMBL3223534";"Inhibition of GST-tagged MDM2/biotinylated p53 peptide interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2396674";"";"None";"548.49";"1";"4.91";"MI-888";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"14.89";"0.30";"3.26";"9.03";"0";"CHEMBL3223537";"Inhibition of MDM2-p53 interaction (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3665599";"";"None";"550.02";"1";"4.54";"BDBM119735";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'<'";"500.0";"nM";"";"";"314282";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649978";"";"None";"614.03";"2";"6.38";"BDBM135364";"C[C@H]1CC[C@H](Cn2c(C(OCC(F)(F)F)c3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268873";"UO_0000065";"13.88";"0.27";"2.14";"6.84";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649984";"";"None";"562.05";"2";"6.25";"BDBM135374";"Cc1cccnc1C(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268883";"UO_0000065";"14.16";"0.27";"1.71";"6.90";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650009";"";"None";"573.14";"2";"6.25";"BDBM135409";"CN(C)C(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"175.0";"nM";"6.76";"";"268918";"UO_0000065";"11.79";"0.23";"0.51";"8.85";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704487";"";"None";"621.58";"1";"3.82";"BDBM170241";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CN2CC[C@@H](O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314191";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704490";"";"None";"578.51";"1";"4.13";"BDBM170245";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC2CC(O)C(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314195";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704490";"";"None";"578.51";"1";"4.13";"BDBM170245";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC2CC(O)C(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314196";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704498";"";"None";"630.64";"2";"5.17";"BDBM170254";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCN2CCN(C3CC3)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"10000.0";"nM";"";"";"314204";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4107313";"";"None";"639.62";"1";"4.86";"BDBM170273";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(NS(C)(=O)=O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314221";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704521";"";"None";"671.64";"2";"5.25";"BDBM170284";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H]2CC[C@H](NS(C)(=O)=O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314232";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704524";"";"None";"603.52";"1";"3.69";"BDBM170287";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCNS(C)(=O)=O)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314235";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704527";"";"None";"547.50";"1";"4.75";"BDBM170290";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCNCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314238";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687311";"";"None";"510.40";"2";"7.20";"BDBM143440";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"2.3";"nM";"8.64";"";"279579";"UO_0000065";"16.92";"0.34";"1.44";"18.24";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657028";"";"None";"538.44";"2";"6.30";"BDBM129933";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.5";"nM";"9.30";"";"261663";"UO_0000065";"17.27";"0.34";"3.00";"11.29";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653238";"";"None";"532.96";"2";"5.35";"BDBM129803";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.4";"nM";"9.40";"";"261533";"UO_0000065";"17.63";"0.34";"4.05";"8.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"34";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"18100.0";"nM";"4.74";"";"";"UO_0000065";"10.97";"0.22";"-0.81";"8.23";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347378";"";"None";"432.35";"1";"5.55";"33";"O=C(O)C[C@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347378";"";"None";"432.35";"1";"5.55";"33";"O=C(O)C[C@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347378";"";"None";"432.35";"1";"5.55";"33";"O=C(O)C[C@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"27500.0";"nM";"4.56";"";"";"UO_0000065";"10.55";"0.21";"-0.99";"7.92";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347394";"";"None";"580.28";"2";"6.40";"2";"COc1cccc2c1C1=C([C@H](c3ccc(Br)cc3)n3ncnc3N1C)[C@@H](c1ccc(Br)cc1)O2";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.33";"0.29";"0.75";"13.65";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3653290";"";"None";"584.08";"2";"6.22";"BDBM129858";"CCOC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"1.62";"nM";"8.79";"";"261587";"UO_0000065";"15.05";"0.29";"2.57";"7.97";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657090";"";"None";"577.02";"1";"4.11";"BDBM130007";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"51.1";"nM";"7.29";"";"261728";"UO_0000065";"12.64";"0.24";"3.18";"5.97";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683125";"";"None";"519.04";"2";"6.33";"BDBM161836";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N3CCCC3=O)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"592.7";"nM";"6.23";"";"304971";"UO_0000065";"12.00";"0.23";"-0.10";"10.54";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601403";"";"None";"661.25";"2";"5.37";"BDBM162157";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1cnc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"4.3";"nM";"8.37";"";"305035";"UO_0000065";"12.65";"0.24";"3.00";"9.16";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650061";"";"None";"470.01";"1";"5.76";"BDBM135931";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)=O)CC1)C(=O)C2";"IC50";"'='";"993.0";"nM";"6.00";"";"269509";"UO_0000065";"12.77";"0.25";"0.24";"10.75";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653204";"";"None";"537.45";"2";"6.19";"BDBM129769";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.34";"nM";"9.47";"";"261500";"UO_0000065";"17.62";"0.35";"3.28";"9.55";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653288";"";"None";"537.02";"2";"6.18";"BDBM129856";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261585";"UO_0000065";"17.82";"0.34";"3.39";"8.87";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653301";"";"None";"554.43";"2";"5.28";"BDBM129869";"COc1ncc(-c2nc3c(n2[C@@H](C)CO)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"1.74";"nM";"8.76";"";"261599";"UO_0000065";"15.80";"0.31";"3.48";"8.54";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687296";"";"None";"502.42";"2";"6.86";"BDBM143424";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCOCC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"18.0";"nM";"7.75";"";"279564";"UO_0000065";"15.41";"0.31";"0.88";"16.35";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657013";"";"None";"542.40";"2";"6.13";"BDBM129917";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"261648";"UO_0000065";"17.88";"0.36";"3.57";"11.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4085388";"";"None";"544.41";"2";"6.18";"22";"CN1[C@@H](c2nc(C(=O)O)co2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"27.5";"nM";"7.56";"";"";"UO_0000065";"13.89";"0.28";"1.38";"7.90";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL208562";"";"None";"706.46";"2";"6.11";"15, TDP665759";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCN2CCN(C)CC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"704.0";"nM";"6.15";"";"";"UO_0000065";"8.71";"0.20";"0.04";"8.41";"1";"CHEMBL3391054";"Inhibition of human MDM2 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3390840";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3639627";"";"None";"536.02";"1";"3.23";"BDBM170386";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2ccc(F)c(Cl)c2)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314355";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL379505";"";"None";"559.54";"1";"4.19";"4";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866341";"Antiproliferative activity against human LnCAP cell line with wild type p53";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LNCaP";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148527";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307965";"";""
"CHEMBL3125519";"";"None";"567.54";"2";"5.20";"17";"CN(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.09";"0.36";"4.50";"10.21";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125521";"";"None";"593.57";"2";"5.74";"19";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.85";"0.35";"4.26";"10.53";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3683120";"";"None";"511.07";"2";"6.87";"BDBM161802";"CC(C)Nc1ccc2c(c1)C(c1ccc(Cl)cc1)N(c1ccc(N(C)Cc3ccncc3)cc1)C(=O)C2";"IC50";"'='";"81.8";"nM";"7.09";"";"304966";"UO_0000065";"13.87";"0.26";"0.22";"14.62";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL390761";"";"None";"391.74";"0";"3.85";"12";"O=c1nc2n(-c3ccc(Cl)cc3)c3ccc(C(F)(F)F)cc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440446";"";"None";"391.74";"0";"3.85";"11";"O=c1nc2n(-c3ccc(Cl)cc3)c3cccc(C(F)(F)F)c3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440445";"";"None";"391.74";"0";"3.85";"13";"O=c1nc2n(-c3ccc(Cl)cc3)c3cc(C(F)(F)F)ccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"2, nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866341";"Antiproliferative activity against human LnCAP cell line with wild type p53";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LNCaP";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148527";"1";"Scientific Literature";"J Med Chem";"2006";"CHEMBL3307965";"";""
"CHEMBL3663868";"";"None";"522.45";"1";"4.38";"BDBM170389";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314358";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649989";"";"None";"559.07";"2";"6.09";"BDBM135381";"COCC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268890";"UO_0000065";"15.56";"0.30";"2.61";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649996";"";"None";"511.03";"2";"5.46";"BDBM135392";"CCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268901";"UO_0000065";"16.09";"0.31";"2.76";"7.36";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650006";"";"None";"587.15";"1";"4.42";"BDBM135406";"CS(=O)(=O)NC(=O)c1cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"268915";"UO_0000065";"15.33";"0.31";"4.58";"7.54";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703330";"";"None";"777.65";"2";"5.82";"BDBM152955";"COc1cc(C(=O)OC(C)OC(=O)NCC(O)CO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"13.4";"nM";"7.87";"";"293779";"UO_0000065";"10.12";"0.20";"2.05";"4.39";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657099";"";"None";"541.40";"1";"3.98";"BDBM130016";"COc1nc(=O)[nH]cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"10.19";"nM";"7.99";"";"261737";"UO_0000065";"14.76";"0.29";"4.01";"6.94";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656987";"";"None";"533.42";"2";"6.17";"BDBM129889";"COc1cnc(C#N)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.16";"nM";"9.80";"";"261620";"UO_0000065";"18.36";"0.36";"3.63";"10.11";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653180";"";"None";"531.44";"2";"7.38";"BDBM129745";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.2";"nM";"9.70";"";"261476";"UO_0000065";"18.25";"0.36";"2.32";"13.63";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687254";"";"None";"522.45";"2";"7.75";"BDBM143377";"Cc1cc(Cl)ccc1C1c2c(nn(CCc3ccccc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"29.2";"nM";"7.54";"";"279522";"UO_0000065";"14.42";"0.29";"-0.22";"19.76";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657011";"";"None";"568.47";"1";"4.75";"BDBM129915";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.16";"nM";"9.80";"";"261646";"UO_0000065";"17.23";"0.34";"5.05";"9.96";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691738";"";"None";"520.46";"2";"7.68";"BDBM143547";"COc1ccccc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"505.8";"nM";"6.30";"";"279622";"UO_0000065";"12.10";"0.24";"-1.38";"13.29";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653198";"";"None";"542.04";"2";"6.26";"BDBM129763";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N(C)C)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)ccc2C)cc1";"IC50";"'='";"0.11";"nM";"9.96";"";"261494";"UO_0000065";"18.37";"0.35";"3.70";"12.33";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653299";"";"None";"582.46";"2";"6.02";"BDBM129867";"CNC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.66";"nM";"9.18";"";"261597";"UO_0000065";"15.76";"0.31";"3.16";"10.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653207";"";"None";"595.53";"2";"6.03";"BDBM129772";"COc1nc(N(C)CCO)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.16";"nM";"9.80";"";"261503";"UO_0000065";"16.45";"0.33";"3.77";"10.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650054";"";"None";"512.05";"1";"4.95";"BDBM135924";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N3CCNC3=O)CC1)C(=O)C2";"IC50";"'='";"681.0";"nM";"6.17";"";"269502";"UO_0000065";"12.04";"0.23";"1.22";"8.67";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687293";"";"None";"510.40";"2";"7.20";"BDBM143421";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"2.0";"nM";"8.70";"";"279561";"UO_0000065";"17.04";"0.34";"1.50";"18.37";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653184";"";"None";"538.44";"2";"6.30";"BDBM129749";"COc1cc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)nn1";"IC50";"'='";"0.62";"nM";"9.21";"";"261480";"UO_0000065";"17.10";"0.34";"2.91";"11.18";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650069";"";"None";"556.14";"2";"6.35";"BDBM135939";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(C1CCC([C@](C)(O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"158.0";"nM";"6.80";"";"269517";"UO_0000065";"12.23";"0.24";"0.45";"9.97";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657041";"";"None";"567.47";"2";"5.66";"BDBM129948";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(CCO)c1)C2=O";"IC50";"'='";"0.77";"nM";"9.11";"";"261678";"UO_0000065";"16.06";"0.32";"3.45";"10.17";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691768";"";"None";"554.44";"1";"4.59";"BDBM143653";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.371";"nM";"9.43";"";"279809";"UO_0000065";"17.01";"0.34";"4.84";"8.80";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691749";"";"None";"569.45";"1";"4.87";"BDBM143590";"COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.241";"nM";"9.62";"";"279790";"UO_0000065";"16.89";"0.34";"4.75";"9.22";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687273";"";"None";"540.50";"2";"5.90";"BDBM143399";"Cc1cc(Cl)ccc1C1c2c(nn(C(=O)N3CCN(C)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.7";"nM";"8.57";"";"279541";"UO_0000065";"15.85";"0.32";"2.67";"13.89";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691793";"";"None";"572.43";"1";"4.74";"BDBM143730";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.164";"nM";"9.79";"";"279835";"UO_0000065";"17.09";"0.34";"5.05";"8.96";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691731";"";"None";"563.45";"2";"5.33";"BDBM143530";"COc1cnc(C#N)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.75";"nM";"9.12";"";"279776";"UO_0000065";"16.19";"0.32";"3.79";"8.61";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691784";"";"None";"563.98";"1";"4.59";"BDBM143696";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cnc(OC)nc4OC)c3C(C)C)C(=O)N2c2cc(Cl)cn(C)c2=O)cc1F";"IC50";"'='";"1.292";"nM";"8.89";"";"279826";"UO_0000065";"15.76";"0.30";"4.30";"8.18";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4103467";"";"None";"572.42";"2";"5.71";"48";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)o1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"13.53";"0.27";"2.03";"6.42";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4075155";"";"None";"515.42";"2";"6.19";"24";"Cc1nnc([C@H]2[C@H](c3cccc(Cl)c3F)[C@]3(C(=O)Nc4cc(Cl)ccc43)C3(CCCCC3)N2C)o1";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"13.18";"0.27";"0.60";"9.53";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4101818";"";"None";"515.42";"2";"6.19";"23";"Cc1noc([C@H]2[C@H](c3cccc(Cl)c3F)[C@]3(C(=O)Nc4cc(Cl)ccc43)C3(CCCCC3)N2C)n1";"IC50";"'='";"603.0";"nM";"6.22";"";"";"UO_0000065";"12.07";"0.24";"0.03";"8.73";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3260813";"";"None";"445.25";"1";"6.49";"8";"O=C(O)c1nc(-c2ccccc2)n(-c2cccc(Cl)c2F)c1-c1ccc(F)c(Cl)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.14";"0.39";"2.03";"15.46";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260819";"";"None";"561.42";"2";"6.09";"14";"CNC(=O)Cc1ccc(Cl)c(F)c1-n1c(C2CCCCC2)nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.96";"0.30";"2.31";"7.51";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260811";"";"None";"427.26";"1";"6.35";"6";"O=C(O)c1nc(-c2ccccc2)n(-c2cccc(Cl)c2F)c1-c1cccc(Cl)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"19.09";"0.38";"1.80";"14.79";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260810";"";"None";"423.30";"1";"6.52";"5";"Cc1ccc(Cl)cc1-n1c(-c2ccccc2)nc(C(=O)O)c1-c1cccc(Cl)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.80";"0.37";"1.44";"14.44";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260815";"";"None";"450.32";"1";"6.27";"10";"NC(=O)c1nc(C2CCCCC2)n(-c2cccc(Cl)c2F)c1-c1ccc(F)c(Cl)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.20";"0.35";"1.47";"12.72";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3260817";"";"None";"489.35";"1";"7.53";"12";"Cc1nnc(-c2nc(C3CCCCC3)n(-c3cccc(Cl)c3F)c2-c2ccc(F)c(Cl)c2)o1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.54";"0.31";"0.07";"13.40";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3797577";"";"None";"694.67";"2";"6.82";"20b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(OC)n2)CC1";"IC50";"'='";"1146.0";"nM";"5.94";"";"";"UO_0000065";"8.55";"0.17";"-0.88";"6.31";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135402";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268911";"UO_0000065";"17.61";"0.34";"3.37";"8.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653318";"";"None";"580.09";"2";"5.08";"BDBM135438";"COc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"268947";"UO_0000065";"15.51";"0.30";"3.92";"7.25";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653321";"";"None";"624.14";"3";"5.10";"BDBM135440";"COCCOc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"21.0";"nM";"7.68";"";"268949";"UO_0000065";"12.30";"0.24";"2.58";"5.75";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268872";"UO_0000065";"14.41";"0.29";"2.25";"6.54";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135367";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"268877";"UO_0000065";"13.63";"0.26";"1.01";"7.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268894";"UO_0000065";"16.23";"0.31";"2.67";"7.63";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3971319";"";"None";"580.09";"2";"5.08";"BDBM135399";"COc1c(-c2nc(=O)o[nH]2)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@H]3CCC[C@@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268908";"UO_0000065";"15.51";"0.30";"3.92";"7.25";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268869";"UO_0000065";"15.37";"0.30";"2.80";"6.98";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649824";"";"None";"522.05";"2";"5.55";"BDBM135153";"CC1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"9.0";"nM";"8.05";"";"286172";"UO_0000065";"15.41";"0.30";"2.50";"7.61";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649857";"";"None";"551.05";"1";"3.98";"BDBM135193";"C[C@@H]1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286212";"UO_0000065";"14.44";"0.28";"3.98";"6.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135209";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"116.0";"nM";"6.94";"";"286229";"UO_0000065";"12.04";"0.23";"1.59";"4.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2386350";"";"None";"734.77";"2";"7.18";"2k";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CC(=O)N2CCOCC2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"10.54";"0.21";"0.56";"9.94";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL2386349";"";"None";"718.77";"2";"7.94";"2j";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CC(=O)N2CCCC2)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"10.93";"0.21";"-0.09";"11.43";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL2347393";"";"None";"452.33";"0";"4.25";"28";"CC[C@@H](CO)N1C(=O)[C@H](CC(=O)O)O[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"13.74";"0.28";"1.96";"7.14";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347382";"";"None";"545.27";"2";"6.10";"15";"COc1cccc(C[C@@H]2O[C@@H](c3ccc(Br)cc3)[C@@H](c3ccc(Br)cc3)N(C)C2=O)c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"10.41";"0.25";"-0.42";"14.64";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3920895";"";"None";"564.05";"1";"4.93";"BDBM119740";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"137.94";"nM";"6.86";"";"246790";"UO_0000065";"12.16";"0.24";"1.93";"7.58";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665595";"";"None";"566.48";"2";"5.05";"BDBM119731";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"246819";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3985078";"";"None";"524.11";"1";"4.59";"BDBM119748";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](Cc2ccccc2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'>'";"5000.0";"nM";"";"";"246824";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665596";"";"None";"530.50";"1";"4.77";"BDBM119732";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"18.0";"nM";"7.75";"";"246834";"UO_0000065";"14.60";"0.29";"2.97";"8.56";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3960238";"";"None";"580.50";"2";"5.44";"BDBM119739";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"260.4";"nM";"6.58";"";"246789";"UO_0000065";"11.34";"0.23";"1.14";"7.28";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2381408";"SAR-405838";"1.0";"562.51";"2";"5.30";"119";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.44";"0.25";"1.70";"7.74";"0";"CHEMBL4687754";"Inhibition of MDM2 (unknown origin) by cell-based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680279";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL3125709";"";"None";"515.48";"2";"7.25";"9";"CC[C@@H](CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"14.86";"0.30";"0.41";"9.41";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125533";"";"None";"622.53";"2";"7.07";"31";"CC(C)(C)S(=O)(=O)C[C@H](CC(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.06";"0.34";"2.93";"10.90";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125531";"";"None";"568.52";"2";"5.12";"29";"CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.06";"0.36";"4.58";"9.60";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3650014";"";"None";"534.07";"1";"4.91";"BDBM135414";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4nnn[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268923";"UO_0000065";"";"";"";"";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650019";"";"None";"511.03";"2";"5.97";"BDBM135421";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268931";"UO_0000065";"16.24";"0.31";"2.33";"7.43";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653315";"";"None";"564.09";"2";"5.38";"BDBM135435";"Cc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"268944";"UO_0000065";"15.95";"0.31";"3.62";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703327";"";"None";"772.68";"2";"6.79";"BDBM152952";"COc1cc(C(=O)OC(C)OC(=O)N2CCNCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"14.2";"nM";"7.85";"";"293776";"UO_0000065";"10.16";"0.20";"1.06";"5.53";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665580";"";"None";"548.49";"1";"4.91";"BDBM119712";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314215";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704529";"";"None";"591.55";"1";"4.46";"BDBM170292";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(CCO)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"500.0";"nM";"";"";"314240";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4107182";"";"None";"633.59";"2";"5.20";"BDBM170314";"C[C@@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314272";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665598";"";"None";"566.48";"2";"5.05";"BDBM119734";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"314281";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704552";"";"None";"586.49";"1";"3.94";"BDBM170317";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCc2ccccc2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"314289";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663820";"";"None";"576.45";"1";"3.53";"BDBM170332";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCc2ccco2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314304";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663821";"";"None";"578.51";"1";"4.28";"BDBM60496";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2CCCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"314307";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663853";"";"None";"583.51";"1";"4.11";"BDBM170371";"CNC[C@@H](O)CCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1ccc(F)c(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314341";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703322";"";"None";"786.70";"2";"9.23";"BDBM152947";"COc1cc(C(=O)OC(C)OC(=O)OC2CCCCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"53.6";"nM";"7.27";"";"293770";"UO_0000065";"9.24";"0.18";"-1.96";"5.35";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703340";"";"None";"747.58";"2";"6.17";"BDBM152965";"COc1cc(C(=O)OCOC(=O)NCC(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"8.19";"nM";"8.09";"";"293789";"UO_0000065";"10.82";"0.22";"1.92";"4.59";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703353";"";"None";"1126.97";"None";"None";"BDBM152984";"COc1cc(C(=O)OCOC(=O)OCCOCCOCCOCCOP(=O)(OCc2ccccc2)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"80.1";"nM";"7.10";"";"293808";"UO_0000065";"6.30";"None";"None";"None";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4113856";"";"None";"534.46";"1";"4.52";"BDBM170260";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CC(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314210";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663855";"";"None";"553.46";"1";"3.14";"BDBM170373";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cncc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"314343";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3260816";"";"None";"475.33";"1";"6.35";"11";"Fc1ccc(-c2c(-c3nnn[nH]3)nc(C3CCCCC3)n2-c2cccc(Cl)c2F)cc1Cl";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.93";"0.36";"2.17";"11.79";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3109044";"";"None";"620.53";"2";"6.29";"12";"COc1cc(C(=O)O)ccc1NC(=O)C1NC(CC(C)(C)C)C2(C(=O)Nc3cc(Cl)sc32)C1c1cccc(Cl)c1F";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"12.06";"0.25";"1.19";"6.41";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3657058";"";"None";"564.00";"2";"5.55";"BDBM129966";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.08";"nM";"10.10";"";"261695";"UO_0000065";"17.90";"0.34";"4.55";"10.08";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687310";"";"None";"542.41";"2";"7.65";"BDBM143439";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(F)cc1F)C2=O";"IC50";"'='";"1.9";"nM";"8.72";"";"279578";"UO_0000065";"16.08";"0.32";"1.07";"18.41";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663816";"";"None";"620.57";"1";"4.73";"BDBM170328";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CCCc1cccs1";"IC50";"'>'";"5000.0";"nM";"";"";"314300";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663863";"";"None";"554.01";"1";"3.37";"BDBM170381";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314351";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687307";"";"None";"520.46";"2";"7.68";"BDBM143436";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.1";"nM";"8.96";"";"279575";"UO_0000065";"17.21";"0.34";"1.28";"18.92";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657105";"";"None";"586.46";"1";"4.89";"BDBM130023";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1F)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.313";"nM";"9.50";"";"261744";"UO_0000065";"16.21";"0.32";"4.61";"9.66";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691712";"";"None";"458.36";"1";"6.85";"BDBM143478";"Cc1cc(Cl)ccc1C1c2c(nn(C3CC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.671";"nM";"8.06";"";"279762";"UO_0000065";"17.59";"0.36";"1.21";"21.14";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687265";"";"None";"476.38";"1";"5.89";"BDBM143390";"Cc1cc(Cl)ccc1C1c2c(nn(CCCO)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"279533";"UO_0000065";"17.26";"0.35";"2.33";"14.09";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691763";"";"None";"541.40";"1";"4.55";"BDBM143644";"COc1ncc(-n2nc3c(c2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"14.83";"nM";"7.83";"";"279804";"UO_0000065";"14.46";"0.29";"3.28";"6.79";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683137";"";"None";"633.23";"2";"7.03";"BDBM161879";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCN(C(=O)N(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"12.3";"nM";"7.91";"";"304985";"UO_0000065";"12.49";"0.24";"0.88";"12.07";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220117";"";"None";"447.95";"0";"4.59";"11d";"O=C1NC(=S)NC(=O)C1=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1C1CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.94";"0.26";"1.21";"9.18";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3650072";"";"None";"566.11";"2";"7.22";"BDBM135942";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(O)c3cccc(F)c3)CC1)C(=O)C2";"IC50";"'='";"61.0";"nM";"7.21";"";"269520";"UO_0000065";"12.74";"0.25";"-0.01";"12.23";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683171";"";"None";"675.27";"2";"6.25";"BDBM162120";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1OC)C(=O)C2";"IC50";"'='";"2.0";"nM";"8.70";"";"305025";"UO_0000065";"12.88";"0.25";"2.45";"10.41";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653263";"";"None";"541.41";"2";"6.03";"BDBM129830";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.35";"nM";"9.46";"";"261559";"UO_0000065";"17.47";"0.35";"3.43";"13.63";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691767";"";"None";"559.03";"1";"3.83";"BDBM143652";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.129";"nM";"9.89";"";"279808";"UO_0000065";"17.69";"0.34";"6.06";"8.09";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691777";"";"None";"554.44";"1";"4.61";"BDBM143674";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"24.43";"nM";"7.61";"";"279818";"UO_0000065";"13.73";"0.27";"3.00";"6.97";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663826";"";"None";"582.06";"1";"4.10";"BDBM170343";"CCC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314314";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663845";"";"None";"576.54";"2";"5.55";"BDBM170363";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCC2CCC(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314333";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665586";"";"None";"530.50";"1";"4.77";"BDBM119718";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314248";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3924221";"";"None";"546.06";"1";"4.79";"BDBM119716";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314253";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2443387";"";"None";"358.18";"0";"3.49";"25";"O=c1nc2n(-c3ccc(Cl)cc3)c3c(Cl)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"13.47";"0.27";"1.33";"7.12";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2443390";"";"None";"371.32";"0";"3.51";"20";"Cc1ccc(-n2c3nc(=O)[nH]c(=O)c-3cc3cccc(C(F)(F)F)c32)cc1";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"12.11";"0.23";"0.98";"6.63";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL225454";"";"None";"375.28";"0";"3.34";"10";"O=c1nc2n(-c3ccccc3F)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"19600.0";"nM";"4.71";"";"";"UO_0000065";"12.54";"0.24";"1.37";"6.95";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440449";"";"None";"368.74";"0";"2.74";"7";"O=c1nc2n(-c3ccc(Cl)cc3)c3c([N+](=O)[O-])cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3683145";"";"None";"562.15";"2";"6.61";"BDBM161951";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)NC3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"42.6";"nM";"7.37";"";"304994";"UO_0000065";"13.11";"0.25";"0.76";"11.73";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236638";"";"None";"612.66";"2";"8.29";"18";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccccc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"11.20";"0.23";"-1.43";"12.60";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236646";"";"None";"671.69";"2";"7.69";"26";"Cc1cc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ncc1C(=O)O";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"14.18";"0.29";"1.83";"9.10";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236653";"";"None";"663.69";"2";"7.45";"33";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.07";"0.32";"2.55";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236360";"";"None";"699.64";"2";"6.40";"8";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)NS(=O)(=O)C(F)(F)F)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"10.92";"0.24";"1.24";"6.49";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236639";"";"None";"657.66";"2";"7.38";"19";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cc(C(=O)O)ccn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"13.46";"0.27";"1.47";"8.46";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236646";"";"None";"671.69";"2";"7.69";"26";"Cc1cc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ncc1C(=O)O";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"12.25";"0.25";"0.54";"7.86";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233049";"";"None";"659.63";"2";"6.72";"46";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"13.38";"0.27";"2.10";"7.75";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"27, enantiomer 2";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"15700.0";"nM";"4.80";"";"";"UO_0000065";"11.06";"0.23";"-0.09";"7.19";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"34";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"17.27";"0.35";"1.92";"12.96";"1";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347402";"";"None";"515.25";"2";"6.09";"11";"CN1C(=O)[C@@H](Cc2ccccc2)O[C@H](c2ccc(Br)cc2)[C@@H]1c1ccc(Br)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2397154";"";"None";"988.23";"3";"4.75";"2, KPYB00497";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CSSc1ncccc1[N+](=O)[O-])NC(=O)OC(C)(C)C)C(=O)N[C@@H](CCCNC(=N)NS(=O)(=O)c1c(C)cc(C)cc1C)C(=O)OC";"IC50";"'='";"22200.0";"nM";"4.65";"";"";"UO_0000065";"4.71";"0.09";"-0.10";"1.60";"0";"CHEMBL2399741";"Inhibition of MDM2 (unknown origin) binding to FAM-LTFEHYWAQLTS-NH2 after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396614";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3233595";"";"None";"648.60";"2";"5.53";"24";"COc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)C[C@@H]3C[C@@H]3N(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"8.10";"0.16";"-0.28";"6.98";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3649984";"";"None";"562.05";"2";"6.25";"BDBM135374";"Cc1cccnc1C(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268884";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649992";"";"None";"464.96";"1";"5.35";"BDBM135386";"C=C(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268895";"UO_0000065";"17.54";"0.34";"2.80";"7.96";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650015";"";"None";"560.10";"2";"6.34";"BDBM135415";"COC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"28.0";"nM";"7.55";"";"268924";"UO_0000065";"13.48";"0.26";"1.21";"9.17";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650020";"";"None";"541.05";"2";"5.60";"BDBM135423";"CCOC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268932";"UO_0000065";"15.34";"0.30";"2.70";"6.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3984644";"";"None";"566.06";"1";"4.78";"BDBM135441";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cc(Cl)cnc4O)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268950";"UO_0000065";"15.37";"0.30";"3.92";"6.43";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703325";"";"None";"773.66";"2";"7.21";"BDBM152950";"COc1cc(C(=O)O[C@@H](C)OC(=O)N2CCOCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"10.1";"nM";"8.00";"";"293773";"UO_0000065";"10.33";"0.21";"0.79";"5.74";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704519";"";"None";"632.61";"1";"4.51";"BDBM170281";"CN(C)CCC(=O)N1CCN(C(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"10000.0";"nM";"";"";"314230";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704522";"";"None";"593.55";"2";"5.66";"BDBM170285";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H]2CC[C@H](N)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314233";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3894836";"";"None";"633.59";"2";"5.20";"BDBM170288";"C[C@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"314236";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704537";"";"None";"604.55";"1";"4.80";"BDBM170301";"CC(C)NC(=O)N1CC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"3000.0";"nM";"";"";"314259";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4111476";"";"None";"619.56";"1";"4.81";"BDBM170308";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(OC(=O)CN)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314266";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665595";"";"None";"566.48";"2";"5.05";"BDBM119731";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"314278";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703344";"";"None";"836.71";"3";"7.19";"BDBM152969";"COCCOCCOCCOC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"9.09";"nM";"8.04";"";"293793";"UO_0000065";"9.61";"0.19";"0.85";"4.91";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703358";"";"None";"1140.99";"None";"None";"BDBM152989";"COc1cc(C(=O)OC(C)OC(=O)OCCOCCOCCOCCOP(=O)(OCc2ccccc2)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.21";"nM";"8.38";"";"293813";"UO_0000065";"7.34";"None";"None";"None";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704492";"";"None";"478.40";"0";"4.63";"BDBM170248";"CNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"314198";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663860";"";"None";"535.45";"1";"3.31";"BDBM170378";"CC[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"314348";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663871";"";"None";"560.09";"2";"5.04";"BDBM170393";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCC2CCC(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314361";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691758";"";"None";"545.99";"1";"3.78";"BDBM143622";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.447";"nM";"8.84";"";"279799";"UO_0000065";"16.19";"0.31";"5.06";"6.90";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653176";"";"None";"540.42";"2";"6.83";"BDBM129741";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261472";"UO_0000065";"18.08";"0.36";"2.94";"14.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691747";"";"None";"559.03";"1";"3.83";"BDBM143581";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.37";"nM";"9.43";"";"279788";"UO_0000065";"16.87";"0.32";"5.60";"7.72";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3914742";"";"None";"646.23";"2";"5.64";"BDBM162140";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)CC3CCC(N4CCNC(=O)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"4.7";"nM";"8.33";"";"305030";"UO_0000065";"12.89";"0.25";"2.69";"9.55";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657048";"";"None";"583.45";"2";"5.83";"BDBM129956";"COc1nnc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"2.22";"nM";"8.65";"";"261685";"UO_0000065";"14.83";"0.30";"2.82";"9.26";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687290";"";"None";"511.93";"2";"6.82";"BDBM143418";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(F)c(F)c1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"3.3";"nM";"8.48";"";"279558";"UO_0000065";"16.57";"0.32";"1.66";"17.91";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657044";"";"None";"551.47";"2";"6.69";"BDBM129951";"CCn1cc(N2C(=O)c3nc(-c4ccccc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"0.97";"nM";"9.01";"";"261681";"UO_0000065";"16.34";"0.32";"2.32";"12.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135402";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"286423";"UO_0000065";"14.40";"0.28";"1.73";"6.58";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691786";"";"None";"577.02";"1";"3.97";"BDBM143703";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.376";"nM";"9.43";"";"279828";"UO_0000065";"16.33";"0.31";"5.45";"7.71";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2094875";"";"None";"361.83";"1";"5.19";"BDBM47303";"Oc1c(C(Nc2ccccn2)c2ccccc2Cl)ccc2cccnc12";"IC50";"'='";"18000.0";"nM";"4.75";"";"198815";"UO_0000065";"13.11";"0.25";"-0.45";"8.17";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650066";"";"None";"540.10";"2";"6.16";"BDBM135936";"COc1cc2c(cc1OC(C)C)[C@@H](c1ccc(Cl)cc1)N(C1CCC(C(=O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"4546.0";"nM";"5.34";"";"269514";"UO_0000065";"9.89";"0.19";"-0.82";"8.21";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691715";"";"None";"537.45";"2";"6.77";"BDBM143483";"COc1cnc(Cl)cc1N1C(=O)c2nn(-c3ccccc3OC)c(C(C)C)c2C1c1ccc(Cl)cc1C";"IC50";"'='";"2.1";"nM";"8.68";"";"279611";"UO_0000065";"16.15";"0.32";"1.91";"12.49";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687250";"";"None";"454.40";"1";"6.87";"BDBM143370";"C=CCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.4";"nM";"8.85";"";"279518";"UO_0000065";"19.48";"0.39";"1.98";"23.22";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691746";"";"None";"559.03";"1";"3.83";"BDBM143577";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.25";"nM";"9.60";"";"279787";"UO_0000065";"17.18";"0.33";"5.77";"7.86";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL576342";"";"None";"552.47";"1";"3.74";"8, MI-220";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"157.0";"nM";"6.80";"";"";"UO_0000065";"12.32";"0.25";"3.06";"6.15";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3653335";"";"None";"573.12";"2";"5.10";"BDBM135454";"CC(C)C(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286473";"UO_0000065";"14.48";"0.29";"3.20";"6.08";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665596";"";"None";"530.50";"1";"4.77";"BDBM119732";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"107.66";"nM";"6.97";"";"246785";"UO_0000065";"13.13";"0.26";"2.20";"7.70";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665593";"";"None";"532.03";"1";"4.40";"BDBM119729";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"111.52";"nM";"6.95";"";"246793";"UO_0000065";"13.07";"0.26";"2.55";"7.69";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3986239";"";"None";"562.51";"2";"5.30";"BDBM119713";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"62.1";"nM";"7.21";"";"246803";"UO_0000065";"12.81";"0.26";"1.91";"7.97";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1689403";"";"None";"1971.69";"None";"None";"3e";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"3.98";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689411";"";"None";"1605.82";"None";"None";"PDI-T11KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'<'";"48.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"figure 2, compound 4";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"10.97";"0.27";"0.82";"7.35";"0";"CHEMBL930244";"Binding affinity to human HDM2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142223";"1";"Scientific Literature";"Nature";"2007";"None";"";""
"CHEMBL3653226";"";"None";"581.48";"2";"7.04";"BDBM129791";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"261522";"UO_0000065";"16.95";"0.34";"2.81";"14.56";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687226";"";"None";"509.41";"2";"6.95";"54";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"10.03";"0.20";"-1.84";"10.01";"0";"CHEMBL4353002";"Inhibition of p53 derived Cy5-TFSDLWKLL peptide binding to human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3653247";"";"None";"521.03";"1";"4.44";"BDBM129812";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"0.45";"nM";"9.35";"";"261542";"UO_0000065";"17.94";"0.35";"4.91";"9.92";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657071";"";"None";"519.99";"1";"4.75";"BDBM129981";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)nc(C)n2)C3=O)c(OC)n1";"IC50";"'='";"92.7";"nM";"7.03";"";"261708";"UO_0000065";"13.53";"0.26";"2.28";"6.50";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683176";"";"None";"646.23";"2";"5.94";"BDBM162141";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"5.7";"nM";"8.24";"";"305031";"UO_0000065";"12.76";"0.24";"2.30";"10.51";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649983";"";"None";"566.01";"2";"6.08";"BDBM135372";"CC(F)(c1ccncc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268882";"UO_0000065";"15.90";"0.31";"2.92";"7.80";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649986";"";"None";"514.99";"2";"5.15";"BDBM135378";"COCC(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"268887";"UO_0000065";"14.91";"0.29";"2.53";"6.87";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649995";"";"None";"525.05";"2";"5.84";"BDBM135391";"CC(C)OCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268900";"UO_0000065";"15.42";"0.30";"2.26";"7.25";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650001";"";"None";"584.51";"2";"5.73";"BDBM135397";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3c(Cl)c(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268906";"UO_0000065";"15.40";"0.31";"3.27";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650011";"";"None";"546.00";"2";"5.68";"BDBM135411";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(-c4nnn[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268920";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3347643";"";"None";"428.87";"0";"4.10";"1.1; SJ-1722550";"CCOc1cc(/C=C2\C(=O)N(c3ccccc3)N=C2C)cc(Cl)c1OCC(=O)OC";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4074577";"";"None";"373.45";"0";"4.02";"6";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"19.73";"0.36";"3.35";"11.09";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3691730";"";"None";"546.46";"2";"6.94";"BDBM143526";"COc1cnc(C#N)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.267";"nM";"9.57";"";"279775";"UO_0000065";"17.52";"0.34";"2.63";"11.39";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653166";"";"None";"591.54";"2";"7.51";"BDBM129730";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.07";"nM";"10.15";"";"261461";"UO_0000065";"17.17";"0.34";"2.64";"15.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657025";"";"None";"524.41";"2";"5.99";"BDBM129929";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.63";"nM";"9.20";"";"261660";"UO_0000065";"17.54";"0.35";"3.21";"11.17";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657069";"";"None";"521.98";"2";"5.79";"BDBM129979";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.85";"nM";"9.07";"";"261706";"UO_0000065";"17.38";"0.33";"3.28";"11.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653192";"";"None";"551.48";"2";"6.36";"BDBM129757";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261488";"UO_0000065";"17.93";"0.36";"3.53";"12.94";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691759";"";"None";"554.44";"1";"4.59";"BDBM143625";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.317";"nM";"9.50";"";"279800";"UO_0000065";"17.13";"0.34";"4.91";"8.86";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691693";"";"None";"511.38";"2";"6.60";"BDBM143452";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cn1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"6.2";"nM";"8.21";"";"279588";"UO_0000065";"16.05";"0.32";"1.61";"13.62";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653222";"";"None";"568.47";"1";"4.75";"BDBM129787";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.23";"nM";"9.64";"";"261518";"UO_0000065";"16.95";"0.34";"4.89";"9.80";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650056";"";"None";"527.11";"2";"6.18";"BDBM135926";"CCCN(C(C)=O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"79.0";"nM";"7.10";"";"269504";"UO_0000065";"13.47";"0.26";"0.92";"12.02";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653214";"";"None";"546.01";"2";"6.09";"BDBM129779";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N(C)C)nc4OC)n3C(C)C)C(=O)N2c2ccc(F)c(Cl)c2)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"261510";"UO_0000065";"17.76";"0.34";"3.61";"12.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687309";"";"None";"522.41";"2";"7.26";"BDBM143438";"COc1ccccc1-n1nc2c(c1C1CC1)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"8.5";"nM";"8.07";"";"279577";"UO_0000065";"15.45";"0.31";"0.81";"17.04";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687285";"";"None";"515.46";"2";"6.78";"BDBM143413";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCN(C)CC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"20.7";"nM";"7.68";"";"279553";"UO_0000065";"14.91";"0.30";"0.90";"18.57";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657110";"";"None";"551.02";"1";"4.99";"BDBM130028";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C3CC3)nn1C)C2=O";"IC50";"'='";"3.224";"nM";"8.49";"";"261749";"UO_0000065";"15.41";"0.30";"3.50";"9.74";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691736";"";"None";"462.35";"1";"5.50";"BDBM143545";"Cc1cc(Cl)ccc1[C@@H]1c2c(nn(CCO)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"2085.9";"nM";"5.68";"";"279620";"UO_0000065";"12.29";"0.25";"0.18";"9.73";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601401";"";"None";"660.26";"2";"5.98";"BDBM162147";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)nc1)C(=O)C2";"IC50";"'='";"1.7";"nM";"8.77";"";"305033";"UO_0000065";"13.28";"0.25";"2.79";"11.18";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653245";"";"None";"550.49";"2";"7.31";"BDBM129810";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.04";"nM";"10.40";"";"261540";"UO_0000065";"18.89";"0.37";"3.09";"15.38";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691708";"";"None";"581.50";"2";"6.18";"BDBM143472";"COCCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"0.267";"nM";"9.57";"";"279758";"UO_0000065";"16.46";"0.33";"3.39";"12.18";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653279";"";"None";"582.46";"2";"6.02";"BDBM129847";"CNC(=O)Cc1cc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)cn1";"IC50";"'='";"0.24";"nM";"9.62";"";"261576";"UO_0000065";"16.52";"0.33";"3.60";"10.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653262";"";"None";"563.45";"2";"5.36";"BDBM129829";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"1.1";"nM";"8.96";"";"261558";"UO_0000065";"15.90";"0.31";"3.60";"8.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1689402";"";"None";"1937.25";"None";"None";"3d";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"3.90";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689410";"";"None";"1578.79";"None";"None";"PDI-Q9KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'<'";"48.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3109048";"";"None";"615.49";"2";"5.62";"8";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cnc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"11.92";"0.24";"1.72";"5.66";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3653248";"";"None";"507.98";"1";"4.38";"BDBM129813";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)nn2C)C3=O)c(OC)n1";"IC50";"'='";"1.64";"nM";"8.79";"";"261543";"UO_0000065";"17.29";"0.33";"4.41";"8.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687257";"";"None";"529.47";"2";"7.32";"BDBM143380";"Cc1nc(Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)cs1";"IC50";"'='";"6.2";"nM";"8.21";"";"279525";"UO_0000065";"15.50";"0.32";"0.89";"16.09";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691703";"";"None";"493.94";"1";"6.69";"BDBM143466";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(F)c1)C2=O";"IC50";"'='";"0.701";"nM";"9.15";"";"279754";"UO_0000065";"18.53";"0.36";"2.46";"19.33";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657127";"";"None";"550.95";"2";"5.49";"BDBM130045";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(C#N)c(F)c2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.44";"nM";"9.36";"";"261617";"UO_0000065";"16.98";"0.33";"3.87";"8.81";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653300";"";"None";"573.03";"2";"5.24";"BDBM129868";"CNC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"1.83";"nM";"8.74";"";"261598";"UO_0000065";"15.25";"0.29";"3.50";"7.72";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657074";"";"None";"527.39";"2";"5.71";"BDBM129984";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261711";"UO_0000065";"18.48";"0.37";"4.03";"9.83";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691761";"";"None";"540.41";"1";"4.58";"BDBM143636";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.408";"nM";"9.39";"";"279802";"UO_0000065";"17.37";"0.35";"4.81";"7.96";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688299";"";"None";"450.92";"0";"3.62";"101";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc[n+]([O-])c1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688145";"";"None";"378.36";"0";"3.58";"19";"O=C1c2ccccc2C(O)(c2ccc(F)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"13.27";"0.24";"1.44";"6.00";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688272";"";"None";"521.01";"2";"5.92";"72";"O=C1c2ccccc2C(OC[C@@H]2CCCC[C@@H]2CO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"11.98";"0.23";"0.32";"6.72";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688295";"";"None";"434.92";"0";"4.38";"97";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccncc1";"IC50";"'='";"252000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688298";"";"None";"450.92";"0";"3.62";"100";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cc[n+]([O-])cc1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"13";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"7.78";"0.15";"-1.37";"5.42";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4548050";"";"None";"688.67";"2";"6.67";"17";"CC(C)C1=C(C(=O)N2C[C@H](F)C[C@H]2C(=O)N2CC3(CC3)NC[C@@H]2C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"12.95";"0.26";"2.25";"13.07";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3663861";"";"None";"554.01";"1";"3.37";"BDBM170379";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2ccc(F)c(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314349";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653324";"";"None";"529.65";"1";"4.73";"BDBM135443";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"268952";"UO_0000065";"12.61";"0.23";"1.95";"5.81";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4073512";"";"None";"388.47";"0";"3.60";"9";"Nc1ccc(C[C@H](NC(=O)CC(c2ccccc2)c2ccccc2)C(=O)O)cc1";"IC50";"'='";"50.3";"nM";"7.30";"";"";"UO_0000065";"18.79";"0.34";"3.70";"7.90";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3318756";"";"None";"567.54";"2";"5.25";"4";"CCNS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.079";"nM";"10.10";"";"";"UO_0000065";"17.80";"0.37";"4.85";"9.73";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3683139";"";"None";"618.26";"2";"8.15";"BDBM161883";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)CC)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"304988";"UO_0000065";"13.97";"0.27";"0.49";"19.09";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657129";"";"None";"555.42";"1";"4.69";"BDBM6863";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.34";"nM";"9.47";"";"261551";"UO_0000065";"17.05";"0.34";"4.78";"9.07";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691737";"";"None";"520.46";"2";"7.68";"BDBM143546";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.161";"nM";"9.79";"";"279780";"UO_0000065";"18.82";"0.37";"2.11";"20.68";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687230";"";"None";"590.45";"2";"5.77";"BDBM143338";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3cc(=O)[nH]c4c(C#N)cnn34)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"18.6";"nM";"7.73";"";"279498";"UO_0000065";"13.09";"0.26";"1.96";"6.90";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL462090";"";"None";"381.64";"1";"5.17";"3";"COc1c(C)c(CCN(C)C)c2c(c1OC)SSSSS2";"IC50";"'='";"120800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988050";"Inhibition of GST fused human Hdm2 assessed as polyubiquitylation by electrochemiluminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151701";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";""
"CHEMBL151233";"VARACIN";"None";"339.55";"0";"4.26";"2";"COc1cc(CCN)c2c(c1OC)SSSSS2";"IC50";"'>'";"295000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988050";"Inhibition of GST fused human Hdm2 assessed as polyubiquitylation by electrochemiluminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151701";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";""
"CHEMBL3683170";"";"None";"604.19";"2";"6.47";"BDBM162112";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(C(C)C(=O)N3CCC(N(C)C)CC3)cc1)C(=O)C2";"IC50";"'='";"98.3";"nM";"7.01";"";"305023";"UO_0000065";"11.60";"0.22";"0.54";"11.24";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653203";"";"None";"549.50";"2";"7.77";"BDBM129768";"CCc1nc(OC)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.4";"nM";"9.40";"";"261499";"UO_0000065";"17.10";"0.34";"1.63";"15.60";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650071";"";"None";"550.07";"2";"7.19";"BDBM135941";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(=O)c3cccc(F)c3)CC1)C(=O)C2";"IC50";"'='";"531.0";"nM";"6.28";"";"269519";"UO_0000065";"11.41";"0.22";"-0.92";"11.24";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3233125";"";"None";"667.56";"2";"6.53";"11";"CC[C@@H](CN(c1ccc(F)cc1F)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"13.93";"0.29";"2.77";"8.92";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233140";"";"None";"568.52";"2";"5.47";"4, AM-8735";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"11.95";"0.25";"1.33";"6.73";"0";"CHEMBL3243066";"Binding affinity to MDM2 in human HCT116 cells expressing p53 assessed as upregulation of p21 mRNA expression after 7 hrs by qRT-PCR analysis in presence of 10% human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308372";"";""
"CHEMBL3683115";"";"None";"480.00";"1";"6.60";"BDBM161745";"CCOc1cc2c(cc1O[C@H](C)CC)C(c1ccc(Cl)cc1)N(c1ccc(OC)cc1)C(=O)C2";"IC50";"'='";"245.8";"nM";"6.61";"";"304961";"UO_0000065";"13.77";"0.27";"0.01";"13.77";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220108";"";"None";"530.42";"2";"6.57";"9";"CC1(C)OC(=O)C(Cc2cc(-c3ccccc3)n(-c3ccc(Br)cc3)c2-c2ccccc2)C(=O)O1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"10.44";"0.22";"-1.03";"9.63";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL4100233";"";"None";"560.50";"2";"5.06";"14";"CC1(C)CC2(C1)N[C@@H](C(=O)N[C@H]1CC[C@H](O)CC1)[C@H](c1cccc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"14.01";"0.28";"2.79";"8.68";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4083764";"";"None";"562.47";"1";"4.05";"11";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCOCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"282.0";"nM";"6.55";"";"";"UO_0000065";"11.64";"0.24";"2.50";"6.57";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3703648";"";"None";"409.41";"1";"5.86";"BDBM156416";"Cc1cccc(NC(c2cccc(C(F)(F)F)c2)c2ccc3cccnc3c2O)n1";"IC50";"'='";"18000.0";"nM";"4.75";"";"298928";"UO_0000065";"11.59";"0.22";"-1.12";"8.17";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3693967";"";"None";"519.40";"1";"3.21";"BDBM112752";"CNC(=O)[C@@H]1NC2(CCN(C(C)=O)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"1000.0";"nM";"";"";"234027";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3797454";"";"None";"707.67";"2";"5.91";"20p";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cc(C(N)=O)ccn2)CC1";"IC50";"'='";"8721.0";"nM";"5.06";"";"";"UO_0000065";"7.15";"0.14";"-0.85";"3.95";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3687246";"";"None";"554.48";"1";"4.64";"BDBM143363";"Cc1cc(Cl)ccc1C1c2c(nn(CC(=O)N3CCNC(=O)C3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"4.4";"nM";"8.36";"";"279514";"UO_0000065";"15.07";"0.30";"3.72";"9.55";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3797513";"";"None";"708.66";"2";"6.50";"20t";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C(=O)O)n2)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"10.41";"0.20";"0.88";"6.04";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3355423";"";"None";"522.40";"1";"2.86";"25C";"O=C(NCC[C@H](O)CO)[C@@H]1NC2(CCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"9058.0";"nM";"5.04";"";"";"UO_0000065";"9.65";"0.20";"2.18";"4.56";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125517";"";"None";"593.57";"2";"5.73";"11";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"16.34";"0.34";"3.97";"10.21";"0";"CHEMBL4268704";"Inhibition of p53-MDM2 interaction (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265957";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL4173382";"";"None";"426.43";"1";"0.32";"6";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)Nc2ccccc2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4563607";"";"None";"3282.83";"None";"None";"Peptide 7";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)COCCOCCNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)[C@@H](C)O)C(N)=O";"IC50";"'='";"11.9";"nM";"7.92";"";"";"UO_0000065";"2.41";"None";"None";"None";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4548664";"";"None";"2839.27";"None";"None";"Peptide 5";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=O)CC[C@@H]2NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccc4ccccc4c3)NC(=O)[C@@H](Cc3ccccc3)NC2=O)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3355430";"";"None";"582.46";"2";"6.12";"MI-1061";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"13.77";"0.27";"1.90";"7.46";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3703658";"";"None";"464.27";"1";"6.86";"BDBM156492";"Oc1c(C(Nc2ccc(Cl)cn2)c2ccc(Cl)c(C(F)(F)F)c2)ccc2cccnc12";"IC50";"'='";"8000.0";"nM";"5.10";"";"298940";"UO_0000065";"10.98";"0.22";"-1.76";"8.78";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703342";"";"None";"819.64";"2";"6.40";"BDBM152967";"COc1cc(C(=O)OCOC(=O)N[C@@H](CCC(=O)O)C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"162.0";"nM";"6.79";"";"293791";"UO_0000065";"8.28";"0.17";"0.39";"3.18";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin 3A";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"10.69";"0.21";"0.32";"7.45";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL2381406";"";"None";"686.45";"2";"5.89";"7";"CCOc1cc(OC)ccc1C1=NC(c2ccc(Br)cc2)C(c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"10.20";"0.23";"1.11";"8.99";"0";"CHEMBL2383516";"Antagonist activity at human GST-tagged MDM2 assessed as inhibition of binding to full length p53";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3798126";"";"None";"699.09";"2";"7.46";"20d";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(Cl)n2)CC1";"IC50";"'='";"2359.0";"nM";"5.63";"";"";"UO_0000065";"8.05";"0.16";"-1.83";"6.63";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3797331";"";"None";"664.65";"2";"6.81";"15c";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccncc2)CC1";"IC50";"'='";"224.0";"nM";"6.65";"";"";"UO_0000065";"10.00";"0.19";"-0.16";"7.84";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3236361";"";"None";"608.58";"2";"6.09";"10";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.43";"0.34";"3.91";"9.19";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236635";"";"None";"677.69";"2";"6.37";"15";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CC[C@@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.76";"0.30";"3.63";"8.92";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236664";"";"None";"660.66";"2";"6.64";"45";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"13.36";"0.27";"2.18";"7.33";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3703660";"";"None";"424.33";"1";"6.46";"BDBM156506";"Cc1cccc(NC(c2ccc(Cl)c(Cl)c2)c2ccc3ccc(C)nc3c2O)n1";"IC50";"'='";"6000.0";"nM";"5.22";"";"298942";"UO_0000065";"12.31";"0.25";"-1.24";"9.00";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703670";"";"None";"486.36";"1";"5.87";"BDBM156621";"COc1ccc(C(Nc2cc(Cl)c(Cl)cn2)c2ccc3cccnc3c2O)c(OC)c1OC";"IC50";"'='";"18000.0";"nM";"4.75";"";"298953";"UO_0000065";"9.76";"0.20";"-1.13";"5.53";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220095";"";"None";"339.42";"0";"2.32";"4j";"Cc1ccc(-n2c(C)cc(C=C3C(=O)NC(=S)NC3=O)c2C)cc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"15.70";"0.30";"3.01";"8.44";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL416288";"(S)APOMORPHINE";"None";"267.33";"0";"2.85";"1b";"CN1CCc2cccc3c2[C@@H]1Cc1ccc(O)c(O)c1-3";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4017941";"Inhibition of biotin-labelled D-p53 binding to D-MDM2 (25 to 109 residues) (unknown origin) by FAM labeled P4 peptide based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3647042";"";"None";"551.61";"2";"7.29";"BDBM135102";"Cc1c(C(=O)O)nc(N[C@H](C)C2CCC2)c2c1nc(-c1cc(C(C)C)ccn1)n2Cc1ccc(C(F)(F)F)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"286121";"UO_0000065";"13.09";"0.25";"-0.07";"7.77";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647064";"";"None";"538.05";"1";"4.93";"BDBM135126";"C[C@@H]1COC[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286145";"UO_0000065";"16.17";"0.31";"3.77";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"5";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.59";"0.37";"3.48";"10.90";"1";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236365";"";"None";"615.64";"2";"5.34";"14";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CS(N)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"14.55";"0.31";"3.62";"7.82";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236643";"";"None";"671.69";"2";"7.31";"23";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(CC(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"14.44";"0.29";"2.39";"9.27";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236657";"";"None";"677.72";"2";"7.38";"38";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.76";"0.31";"2.62";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236658";"";"None";"705.77";"2";"8.11";"39";"CC(C)(C(=O)O)c1cnc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)s1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"13.74";"0.29";"1.59";"9.27";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236667";"";"None";"657.66";"2";"7.38";"50";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"14.14";"0.29";"1.92";"8.89";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"9";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.43";"0.32";"2.44";"9.76";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236645";"";"None";"671.69";"2";"7.69";"25";"Cc1nc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"12.32";"0.25";"0.59";"7.91";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236647";"";"None";"658.65";"2";"6.78";"27";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"13.81";"0.28";"2.32";"7.74";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3663856";"";"None";"553.46";"1";"3.14";"BDBM170374";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cc(Cl)ccn2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"314344";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647059";"";"None";"550.06";"2";"5.07";"BDBM135119";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"59.0";"nM";"7.23";"";"268628";"UO_0000065";"13.14";"0.25";"2.16";"6.29";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3907252";"";"None";"594.12";"2";"5.09";"BDBM135245";"CO[C@H]1C[C@H](C2(OC)CC2)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"268754";"UO_0000065";"14.64";"0.28";"3.61";"7.00";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649962";"";"None";"511.03";"2";"5.80";"BDBM135334";"CCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286353";"UO_0000065";"16.43";"0.32";"2.60";"7.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286368";"UO_0000065";"15.73";"0.30";"3.27";"7.19";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665585";"";"None";"532.03";"1";"4.40";"BDBM119717";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'='";"3339.44";"nM";"5.48";"";"246784";"UO_0000065";"10.29";"0.20";"1.08";"6.05";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665613";"";"None";"662.03";"2";"5.52";"BDBM119751";"CC(C)(C)C[C@@H]1N(N(C(=O)C(F)(F)F)C2CC(C)(O)C2)[C@@H](C(=O)O)[C@H](c2cccc(F)c2F)C12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"473.01";"nM";"6.33";"";"246787";"UO_0000065";"9.55";"0.19";"0.81";"5.74";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665580";"";"None";"548.49";"1";"4.91";"BDBM119712";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"246814";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3233130";"";"None";"556.51";"2";"5.47";"5";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.71";"0.35";"3.83";"9.21";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233141";"";"None";"570.54";"2";"5.86";"6";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.25";"0.32";"2.84";"8.61";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"25";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"1";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3220310";"";"None";"492.40";"0";"4.70";"11g";"O=C1NC(=S)NC(=O)C1=Cc1cc(C2CC2)n(-c2ccc(Br)cc2)c1-c1ccccc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"11.49";"0.25";"0.96";"8.96";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2402732";"";"None";"587.45";"2";"6.33";"7";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(=O)O)cn2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"13.00";"0.26";"1.31";"6.64";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3233128";"";"None";"528.45";"1";"4.69";"14";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.13";"0.34";"3.83";"8.44";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3675221";"";"None";"429.26";"0";"4.75";"BDBM111557";"O=C1c2c(Cl)cccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"4540.0";"nM";"5.34";"";"232359";"UO_0000065";"12.45";"0.25";"0.59";"6.38";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675223";"";"None";"613.45";"2";"5.96";"BDBM111568";"O=C(O)CCC(=O)OCC1(COC2(c3ccc(Cl)cc3)c3c(Cl)cccc3C(=O)N2Cc2ccc([N+](=O)[O-])cc2)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"232369";"UO_0000065";"12.59";"0.25";"1.76";"5.67";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3683135";"";"None";"604.19";"2";"6.90";"BDBM161877";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCN(C(C)=O)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"304983";"UO_0000065";"13.61";"0.26";"1.32";"13.19";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236639";"";"None";"657.66";"2";"7.38";"19";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cc(C(=O)O)ccn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"11.14";"0.23";"-0.05";"7.00";"0";"CHEMBL3241501";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3109047";"";"None";"614.51";"2";"5.02";"9";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cnc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"11.85";"0.24";"2.26";"5.38";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2443386";"";"None";"358.18";"0";"3.49";"26";"O=c1nc2n(-c3cccc(Cl)c3)c3c(Cl)cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL223723";"";"None";"375.28";"0";"3.34";"18";"O=c1nc2n(-c3ccc(F)cc3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"13100.0";"nM";"4.88";"";"";"UO_0000065";"13.01";"0.25";"1.54";"7.21";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3657093";"";"None";"535.00";"1";"4.35";"BDBM130010";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)cc(=O)n2C)C3=O)c(OC)n1";"IC50";"'='";"2.406";"nM";"8.62";"";"261731";"UO_0000065";"16.11";"0.31";"4.27";"8.26";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2443388";"";"None";"341.73";"0";"2.97";"23";"O=c1nc2n(-c3ccccc3F)c3ccc(Cl)cc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1236726";"";"None";"629.64";"2";"7.15";"14, WK298";"CN(C)CCCN(C)[C@H]1CCN(C(=O)c2[nH]c3cc(Cl)ccc3c2-c2c(-c3ccccc3)ncn2Cc2ccc(Cl)cc2)C1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"10.67";"0.21";"-0.43";"11.13";"0";"CHEMBL3391053";"Inhibition of human MDM2 (2 to 185) after 5 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3390840";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3627750";"";"None";"1563.77";"None";"None";"P53";"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"14450.0";"nM";"4.84";"";"";"UO_0000065";"3.10";"None";"None";"None";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3125526";"";"None";"554.54";"2";"6.13";"24";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.49";"0.37";"3.57";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125518";"";"None";"595.59";"2";"5.98";"16";"CC(C)[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"16.28";"0.34";"3.72";"10.21";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233130";"";"None";"556.51";"2";"5.47";"5";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"11.90";"0.25";"1.15";"6.56";"0";"CHEMBL3243052";"Binding affinity to MDM2 in human SJSA1 cells assessed as upregulation of p21 mRNA expression after 7 hrs by qRT-PCR analysis in absence of human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3233131";"";"None";"570.53";"2";"5.72";"16";"CC[C@@H](CS(=O)(=O)CC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.77";"0.33";"3.28";"8.91";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233132";"";"None";"568.52";"2";"5.61";"17";"CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.60";"0.31";"2.69";"8.22";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233135";"";"None";"556.46";"1";"4.07";"20";"CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"13.73";"0.29";"3.57";"6.93";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3220116";"";"None";"463.99";"1";"5.01";"11c";"CC(C)(C)c1cc(C=C2C(=O)NC(=S)NC2=O)c(-c2ccccc2)n1-c1ccc(Cl)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.84";"0.25";"0.95";"9.44";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3653320";"";"None";"624.14";"3";"5.10";"BDBM135439";"COCCOc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"286458";"UO_0000065";"14.42";"0.28";"3.90";"6.75";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653326";"";"None";"602.10";"2";"5.19";"BDBM135445";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cc(Cl)c[nH]c4=O)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286464";"UO_0000065";"14.95";"0.29";"3.81";"6.67";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286139";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649835";"";"None";"538.05";"1";"4.93";"BDBM135166";"CO[C@@H]1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"286185";"UO_0000065";"15.61";"0.30";"3.47";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649837";"";"None";"565.08";"1";"4.37";"BDBM135170";"CN(C)C(=O)[C@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"54.0";"nM";"7.27";"";"286189";"UO_0000065";"12.86";"0.25";"2.90";"5.77";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649839";"";"None";"603.13";"2";"6.52";"BDBM135172";"CCc1noc(C)c1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"286191";"UO_0000065";"12.88";"0.25";"1.25";"5.90";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649844";"";"None";"544.01";"2";"5.55";"BDBM135178";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286197";"UO_0000065";"16.54";"0.32";"3.45";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649865";"";"None";"535.96";"2";"5.31";"BDBM135201";"CN(CC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286220";"UO_0000065";"16.79";"0.33";"3.69";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135209";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'<'";"1.0";"nM";"";"";"286228";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649883";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"286243";"UO_0000065";"14.03";"0.27";"2.42";"6.74";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654188";"";"None";"699.21";"3";"5.93";"BDBM148145";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CN(C(=O)OCc5ccccc5)CC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"250.0";"nM";"6.60";"";"286252";"UO_0000065";"9.44";"0.18";"0.67";"4.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649912";"";"None";"530.03";"2";"5.93";"BDBM135271";"C[C@H]1CC[C@H](Cn2c(NCc3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286290";"UO_0000065";"15.66";"0.30";"2.37";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649913";"";"None";"512.01";"1";"4.76";"BDBM135272";"COCC(C)Nc1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"286291";"UO_0000065";"15.34";"0.30";"3.09";"6.35";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649915";"";"None";"564.09";"2";"5.46";"BDBM135274";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCC2O1";"IC50";"'='";"1.0";"nM";"9.00";"";"286294";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3949194";"";"None";"607.16";"2";"5.54";"BDBM135307";"CCCC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286326";"UO_0000065";"14.04";"0.27";"2.98";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649943";"";"None";"579.11";"1";"4.76";"BDBM135312";"CC(=O)N1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)C1C";"IC50";"'='";"82.0";"nM";"7.09";"";"286331";"UO_0000065";"12.24";"0.24";"2.33";"5.62";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649945";"";"None";"607.16";"2";"5.40";"BDBM135314";"CC(C)C(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286333";"UO_0000065";"14.04";"0.27";"3.12";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3911237";"";"None";"623.13";"2";"5.24";"BDBM135321";"C[C@H]1CN(C(=O)C2(F)CC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286340";"UO_0000065";"14.44";"0.28";"3.76";"7.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649959";"";"None";"551.09";"2";"6.58";"BDBM135328";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286347";"UO_0000065";"15.79";"0.30";"2.12";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286362";"UO_0000065";"17.21";"0.33";"3.20";"8.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286379";"UO_0000065";"15.37";"0.30";"2.80";"6.98";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286382";"UO_0000065";"14.41";"0.29";"2.25";"6.54";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649978";"";"None";"614.03";"2";"6.38";"BDBM135364";"C[C@H]1CC[C@H](Cn2c(C(OCC(F)(F)F)c3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286383";"UO_0000065";"13.88";"0.27";"2.14";"6.84";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135367";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286386";"UO_0000065";"15.93";"0.31";"2.31";"8.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649982";"";"None";"566.01";"2";"6.08";"BDBM135370";"CC(F)(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286389";"UO_0000065";"14.21";"0.27";"1.97";"6.97";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649983";"";"None";"566.01";"2";"6.08";"BDBM135372";"CC(F)(c1ccncc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286392";"UO_0000065";"15.90";"0.31";"2.92";"7.80";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649985";"";"None";"548.02";"2";"5.94";"BDBM135376";"CC(F)(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286395";"UO_0000065";"15.55";"0.30";"2.58";"7.39";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649987";"";"None";"548.02";"2";"6.00";"BDBM135379";"CC(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286398";"UO_0000065";"15.32";"0.29";"2.40";"7.28";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649990";"";"None";"493.01";"1";"6.13";"BDBM135382";"C=C(CCC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286401";"UO_0000065";"17.64";"0.34";"2.57";"8.49";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286406";"UO_0000065";"16.01";"0.31";"2.89";"7.12";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135402";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286422";"UO_0000065";"17.61";"0.34";"3.37";"8.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650012";"";"None";"539.06";"2";"5.00";"BDBM135412";"Cn1[nH]c(-c2cc3nc(N4CCC[C@H]4CF)n(C[C@H]4CC[C@H](C)CC4)c3c(-c3cncc(Cl)c3)n2)nc1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"286431";"UO_0000065";"14.28";"0.28";"2.70";"7.89";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286437";"UO_0000065";"16.20";"0.31";"2.34";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286439";"UO_0000065";"15.64";"0.30";"2.04";"7.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3959820";"";"None";"623.13";"2";"5.42";"BDBM135425";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCN(C(=O)C3(F)CC3)C[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"286444";"UO_0000065";"14.44";"0.28";"3.58";"7.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3951089";"";"None";"564.09";"2";"5.46";"BDBM135427";"CC[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286446";"UO_0000065";"14.72";"0.28";"2.84";"7.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653315";"";"None";"564.09";"2";"5.38";"BDBM135434";"Cc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"33.0";"nM";"7.48";"";"286453";"UO_0000065";"13.26";"0.26";"2.10";"6.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653318";"";"None";"580.09";"2";"5.08";"BDBM135437";"COc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"24.0";"nM";"7.62";"";"286456";"UO_0000065";"13.14";"0.25";"2.54";"6.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3233127";"";"None";"623.53";"2";"5.86";"13";"CC[C@@H](CN(c1ccccc1F)S(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"15.07";"0.31";"3.54";"9.02";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233140";"";"None";"568.52";"2";"5.47";"4, AM-8735";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"16.53";"0.35";"3.93";"9.31";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233128";"";"None";"528.45";"1";"4.69";"14";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.35";"0.30";"2.90";"7.51";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233131";"";"None";"570.53";"2";"5.72";"16";"CC[C@@H](CS(=O)(=O)CC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"13.57";"0.29";"2.02";"7.67";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355410";"";"None";"520.43";"1";"4.28";"12D";"CC1(C)N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"13.11";"0.27";"2.54";"7.54";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3892878";"";"None";"544.52";"2";"5.16";"BDBM119741";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"20.1";"nM";"7.70";"";"246812";"UO_0000065";"14.14";"0.28";"2.54";"8.51";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703646";"";"None";"387.44";"0";"4.56";"BDBM156414";"COc1ccc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)cc1O";"IC50";"'='";"4200.0";"nM";"5.38";"";"298922";"UO_0000065";"13.88";"0.25";"0.82";"6.14";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703650";"";"None";"375.86";"1";"5.50";"BDBM156420";"Cc1ccnc(NC(c2ccccc2Cl)c2ccc3cccnc3c2O)c1";"IC50";"'='";"9200.0";"nM";"5.04";"";"298931";"UO_0000065";"13.40";"0.25";"-0.46";"8.68";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703653";"";"None";"413.37";"1";"5.40";"BDBM156430";"Cc1cccc(NC(c2ccc3cccnc3c2O)c2c(F)c(F)cc(F)c2F)n1";"IC50";"'='";"5200.0";"nM";"5.28";"";"298935";"UO_0000065";"12.78";"0.24";"-0.12";"9.10";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703668";"";"None";"456.33";"1";"5.86";"BDBM156619";"COc1ccc(C(Nc2cc(Cl)c(Cl)cn2)c2ccc3cccnc3c2O)cc1OC";"IC50";"'='";"26000.0";"nM";"4.58";"";"298951";"UO_0000065";"10.05";"0.20";"-1.27";"5.99";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2386346";"RO-5045337";"1.0";"727.80";"2";"7.75";"RG7112";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"10.64";"0.22";"-0.01";"9.39";"1";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402731";"";"None";"586.47";"2";"6.93";"6";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(=O)O)cc2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"13.06";"0.26";"0.73";"7.49";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402730";"";"None";"586.47";"2";"6.93";"5";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2cccc(C(=O)O)c2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"12.58";"0.25";"0.45";"7.22";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2398479";"";"None";"611.57";"1";"4.08";"10";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@H](NS(C)(=O)=O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"13.28";"0.28";"4.04";"6.98";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2398473";"";"None";"534.46";"1";"4.52";"3";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"7.1";"nM";"8.15";"";"";"UO_0000065";"15.25";"0.31";"3.63";"9.01";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3691695";"";"None";"584.48";"2";"6.10";"BDBM143454";"COc1ccccc1-n1nc2c(c1C(C)C)C(CC(O)CO)(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"1.5";"nM";"8.82";"";"279590";"UO_0000065";"15.10";"0.30";"2.72";"10.05";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601319";"";"None";"562.15";"2";"6.64";"BDBM161876";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"3.5";"nM";"8.46";"";"304982";"UO_0000065";"15.04";"0.29";"1.82";"15.65";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683144";"";"None";"618.22";"2";"7.11";"BDBM161949";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(CC)C(=O)C3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"47.2";"nM";"7.33";"";"304993";"UO_0000065";"11.85";"0.23";"0.22";"10.30";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653275";"";"None";"541.40";"2";"5.10";"BDBM129843";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cnc2O)C3=O)c(OC)n1";"IC50";"'='";"0.25";"nM";"9.60";"";"261572";"UO_0000065";"17.74";"0.35";"4.50";"8.31";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704488";"";"None";"566.50";"1";"4.13";"BDBM170242";"CC(O)C(O)CCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"2000.0";"nM";"";"";"314193";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663830";"";"None";"534.48";"1";"3.60";"BDBM170347";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1c(Cl)cccc12";"IC50";"'>'";"10000.0";"nM";"";"";"314318";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663833";"";"None";"621.14";"1";"4.98";"BDBM170350";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314321";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4218896";"";"None";"1914.89";"None";"None";"D-MIPC-n11a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](C)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"10500.0";"nM";"4.98";"";"";"UO_0000065";"2.60";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3665588";"";"None";"550.02";"1";"4.54";"BDBM119720";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'='";"402.0";"nM";"6.40";"";"246830";"UO_0000065";"11.63";"0.23";"1.86";"7.07";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665597";"";"None";"548.49";"1";"4.91";"BDBM119733";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"61.0";"nM";"7.21";"";"246835";"UO_0000065";"13.15";"0.27";"2.30";"7.98";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3960238";"";"None";"580.50";"2";"5.44";"BDBM119739";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"35400.0";"nM";"4.45";"";"246839";"UO_0000065";"7.67";"0.16";"-0.99";"4.92";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4215179";"";"None";"1929.86";"None";"None";"D-MIPC-v7a";"CC(C)C[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"20100.0";"nM";"4.70";"";"";"UO_0000065";"2.43";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4203765";"";"None";"1915.83";"None";"None";"D-MIPC-l6a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"143000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL199341";"HEXYLITACONIC ACID";"None";"214.26";"0";"2.30";"1";"C=C(C(=O)O)C(CCCCCC)C(=O)O";"IC50";"'='";"50.0";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL869434";"Inhibition of p53-HDM2 interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148535";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"6";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"11.53";"0.29";"1.14";"7.73";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL360540";"";"None";"551.47";"2";"6.76";"10";"C[C@H](c1ccc(Cl)cc1)N1C(=O)C=C(c2ccccc2)N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"8.86";"0.18";"-1.87";"6.27";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL208625";"";"None";"655.32";"1";"4.97";"51";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)nc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"11600.0";"nM";"4.94";"";"";"UO_0000065";"7.53";"0.18";"-0.03";"5.04";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3691773";"";"None";"555.42";"1";"4.56";"BDBM143670";"COc1ncc(-n2nc3c(c2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"266.77";"nM";"6.57";"";"279814";"UO_0000065";"11.84";"0.24";"2.01";"6.30";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691783";"";"None";"573.41";"1";"4.70";"BDBM143689";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.553";"nM";"9.26";"";"279824";"UO_0000065";"16.14";"0.32";"4.56";"8.87";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683106";"";"None";"508.06";"2";"5.73";"BDBM161695";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1CN";"IC50";"'='";"5660.2";"nM";"5.25";"";"304951";"UO_0000065";"10.33";"0.20";"-0.48";"7.71";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650055";"";"None";"529.08";"1";"4.76";"BDBM135925";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(C)C(=O)CCO)CC1)C(=O)C2";"IC50";"'='";"406.0";"nM";"6.39";"";"269503";"UO_0000065";"12.08";"0.24";"1.63";"8.06";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691698";"";"None";"660.65";"2";"7.50";"BDBM143461";"COc1ccc(C(=O)NCCN2CCCC2)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.8";"nM";"8.74";"";"279593";"UO_0000065";"13.24";"0.26";"1.24";"10.97";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687269";"";"None";"490.41";"1";"6.28";"BDBM143395";"Cc1cc(Cl)ccc1C1c2c(nn(CC(C)(C)O)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"4.0";"nM";"8.40";"";"279537";"UO_0000065";"17.12";"0.35";"2.12";"14.39";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657007";"";"None";"529.40";"1";"4.51";"BDBM129911";"COc1nc(N)ncc1C1=NC2C(=O)N(c3cccc(Cl)c3F)C(c3ccc(Cl)cc3)C2N1C(C)C";"IC50";"'='";"0.42";"nM";"9.38";"";"261642";"UO_0000065";"17.71";"0.36";"4.87";"9.67";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656999";"";"None";"555.44";"2";"6.19";"BDBM129903";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.31";"nM";"9.51";"";"261634";"UO_0000065";"17.12";"0.34";"3.32";"12.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687243";"";"None";"583.56";"2";"6.30";"BDBM143356";"Cc1cc(Cl)ccc1C1c2c(nn(CC(=O)N3CCC(CCO)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"4.2";"nM";"8.38";"";"279511";"UO_0000065";"14.35";"0.29";"2.08";"10.65";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653220";"";"None";"524.42";"2";"7.64";"BDBM129785";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.41";"nM";"9.39";"";"261516";"UO_0000065";"17.90";"0.36";"1.75";"19.82";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1818538";"";"None";"609.55";"2";"6.62";"Nutlin-1";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"10.80";"0.21";"-0.03";"8.82";"0";"CHEMBL4267474";"Inhibition of recombinant p53 protein binding to recombinant human MDM2 by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265913";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"0";"CHEMBL4616379";"Inhibition of 6xHis-taged MDM2 (unknown origin) expressed in Escherichia coli Gold (DE3)";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613322";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"";""
"CHEMBL2397471";"";"None";"2211.61";"None";"None";"D-stingin";"CC(C)C[C@@H](NC(=O)[C@H]1CSSC[C@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H]3CCCN3C(=O)[C@@H](C)NC(=O)[C@@H](CCCCN)NC2=O)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](Cc1cnc[nH]1)C(=O)O";"IC50";"'='";"20300.0";"nM";"4.69";"";"";"UO_0000065";"2.12";"None";"None";"None";"0";"CHEMBL2398954";"Inhibition of TMRA-p53 binding to MDM2 (25 to 109 amino acids) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396557";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3291438";"";"None";"398.46";"1";"5.19";"23b";"CCOC(=O)c1ccc(-c2c(C)[nH]c(-c3ccccc3)c2-c2ccccc2)[nH]c1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"15.71";"0.28";"1.07";"8.35";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL1256049";"";"None";"756.90";"2";"1.77";"3";"CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC1=O";"IC50";"'='";"209000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1261727";"Inhibition of GST-tagged p53 binding to Hdm2 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255504";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"34";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.65";"0.26";"-0.08";"9.49";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"23";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"5700.0";"nM";"5.24";"";"";"UO_0000065";"12.07";"0.25";"0.35";"7.85";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"23";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"12.31";"0.25";"0.46";"8.00";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347388";"";"None";"420.34";"0";"4.80";"22";"O=C1[C@H](CCO)O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"880.0";"nM";"6.06";"";"";"UO_0000065";"14.41";"0.30";"1.26";"12.17";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347380";"";"None";"533.24";"2";"6.23";"13";"CN1C(=O)[C@H](Cc2ccc(F)cc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.77";"0.26";"-0.49";"19.45";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3355418";"";"None";"563.50";"1";"4.09";"BDBM112739";"CCC1(CC)N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"234014";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693957";"";"None";"611.49";"1";"4.47";"BDBM112740";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCC(F)(F)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"1000.0";"nM";"";"";"234015";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3943264";"";"None";"562.47";"1";"4.05";"BDBM112743";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCOCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"5000.0";"nM";"";"";"234018";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3920081";"";"None";"562.47";"1";"4.05";"BDBM112744";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCOCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"5000.0";"nM";"";"";"234019";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3946174";"";"None";"627.10";"2";"5.15";"BDBM135317";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C(F)F)[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268826";"UO_0000065";"13.59";"0.26";"3.37";"6.76";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649959";"";"None";"551.09";"2";"6.58";"BDBM135328";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268838";"UO_0000065";"15.47";"0.30";"1.94";"7.63";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649962";"";"None";"511.03";"2";"5.80";"BDBM135334";"CCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268843";"UO_0000065";"16.43";"0.32";"2.60";"7.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649964";"";"None";"525.05";"2";"6.19";"BDBM135339";"CCCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268848";"UO_0000065";"16.23";"0.31";"2.33";"7.63";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649966";"";"None";"527.03";"2";"5.04";"BDBM135341";"CCOC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268850";"UO_0000065";"15.27";"0.30";"3.01";"6.65";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3675219";"";"None";"473.71";"0";"4.86";"BDBM111550";"O=C1c2ccc(Br)cc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"5680.0";"nM";"5.25";"";"232347";"UO_0000065";"11.07";"0.25";"0.39";"6.27";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3260822";"";"None";"603.50";"2";"7.26";"17";"CC(C)(C)NC(=O)Cc1ccc(Cl)c(F)c1-n1c(C2CCCCC2)nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.41";"0.29";"1.44";"7.78";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3236640";"";"None";"677.72";"2";"7.38";"20";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nc(CC(=O)O)cs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"14.31";"0.30";"2.32";"9.27";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3703662";"";"None";"397.81";"1";"5.47";"BDBM156527";"Oc1c(C(Nc2ccc(F)cn2)c2ccc(F)cc2Cl)ccc2cccnc12";"IC50";"'='";"10000.0";"nM";"5.00";"";"298944";"UO_0000065";"12.57";"0.24";"-0.47";"8.61";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3797705";"";"None";"693.69";"2";"6.27";"20m";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ncccc2CN)CC1";"IC50";"'='";"7744.0";"nM";"5.11";"";"";"UO_0000065";"7.37";"0.14";"-1.16";"4.61";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3797521";"";"None";"665.63";"2";"6.20";"18";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccncn2)CC1";"IC50";"'='";"376.0";"nM";"6.42";"";"";"UO_0000065";"9.65";"0.19";"0.22";"6.57";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3797879";"";"None";"679.73";"2";"8.13";"10b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Sc2ccccc2)CC1";"IC50";"'='";"1981.0";"nM";"5.70";"";"";"UO_0000065";"8.39";"0.17";"-2.43";"9.09";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3687305";"";"None";"519.41";"2";"7.37";"BDBM143434";"Cc1cc(Cl)ccc1C1c2c(nn(-c3cccc(C#N)c3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.4";"nM";"8.08";"";"279573";"UO_0000065";"15.55";"0.31";"0.71";"13.04";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691722";"";"None";"549.50";"2";"7.14";"BDBM143511";"COc1ccc(CN)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.2";"nM";"8.92";"";"279618";"UO_0000065";"16.23";"0.32";"1.78";"12.16";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691795";"";"None";"548.05";"1";"4.27";"BDBM143740";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)cn(C)c1=O)C2=O";"IC50";"'='";"0.528";"nM";"9.28";"";"279837";"UO_0000065";"16.93";"0.32";"5.01";"9.43";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691739";"";"None";"593.55";"2";"7.31";"BDBM143548";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"0.101";"nM";"10.00";"";"279781";"UO_0000065";"16.84";"0.33";"2.69";"16.71";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653261";"";"None";"546.46";"2";"6.97";"BDBM129828";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.32";"nM";"9.49";"";"261557";"UO_0000065";"17.38";"0.34";"2.52";"11.30";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657046";"";"None";"582.50";"2";"8.02";"BDBM129953";"COc1ccc(C(O)C(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.29";"nM";"9.54";"";"261683";"UO_0000065";"16.37";"0.33";"1.52";"14.11";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688302";"";"None";"566.00";"2";"5.28";"104";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(S(=O)(=O)C(F)(F)F)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"nutlin-3, enantiomer 1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"13600.0";"nM";"4.87";"";"";"UO_0000065";"8.37";"0.17";"-1.02";"5.83";"0";"CHEMBL965739";"Binding affinity to MDM2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153888";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";""
"CHEMBL3627743";"";"None";"496.57";"1";"5.03";"17";"Cc1ccc(-c2cn(CCC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)nn2)cc1";"IC50";"'='";"24260.0";"nM";"4.62";"";"";"UO_0000065";"9.29";"0.17";"-0.41";"4.34";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3233135";"";"None";"556.46";"1";"4.07";"20";"CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.92";"0.31";"4.23";"7.53";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233124";"";"None";"649.57";"2";"6.39";"10";"CC[C@@H](CN(c1ccc(F)cc1)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"12.66";"0.26";"1.83";"7.89";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3703659";"";"None";"417.34";"1";"5.23";"BDBM156495";"Oc1c(C(Nc2ccc(F)cn2)c2c(F)c(F)cc(F)c2F)ccc2cccnc12";"IC50";"'='";"8000.0";"nM";"5.10";"";"298941";"UO_0000065";"12.21";"0.23";"-0.13";"8.78";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647047";"";"None";"586.10";"2";"5.89";"BDBM135107";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286126";"UO_0000065";"15.36";"0.29";"3.11";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647051";"";"None";"526.02";"2";"5.25";"BDBM135111";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286130";"UO_0000065";"17.11";"0.33";"3.75";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286134";"UO_0000065";"14.89";"0.29";"2.94";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647067";"";"None";"546.07";"2";"6.25";"BDBM135131";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286150";"UO_0000065";"16.48";"0.32";"2.75";"9.64";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647069";"";"None";"538.05";"1";"4.93";"BDBM135133";"C[C@H]1COC[C@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"157.0";"nM";"6.80";"";"286152";"UO_0000065";"12.65";"0.24";"1.87";"5.92";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649818";"";"None";"538.05";"1";"4.93";"BDBM135143";"CC1COCCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"286162";"UO_0000065";"14.49";"0.28";"2.87";"6.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649820";"";"None";"522.05";"2";"5.69";"BDBM135145";"C[C@@H]1CC[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286164";"UO_0000065";"16.66";"0.32";"3.01";"8.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286170";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649833";"";"None";"485.99";"1";"5.61";"BDBM135164";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286183";"UO_0000065";"17.54";"0.34";"2.91";"10.13";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649858";"";"None";"552.08";"2";"5.32";"BDBM135194";"COC1CC[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286213";"UO_0000065";"15.44";"0.30";"3.20";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649864";"";"None";"556.04";"1";"4.88";"BDBM135200";"CO[C@@H]1C[C@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"353.0";"nM";"6.45";"";"286219";"UO_0000065";"11.60";"0.23";"1.57";"5.61";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649876";"";"None";"512.01";"1";"4.40";"BDBM135214";"COCCN(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"286233";"UO_0000065";"14.43";"0.28";"2.99";"6.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649883";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"5.0";"nM";"8.30";"";"286242";"UO_0000065";"15.04";"0.29";"2.98";"7.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649891";"";"None";"566.11";"2";"5.30";"BDBM135239";"CC(C)[C@@H]1C[C@](C)(O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286258";"UO_0000065";"15.90";"0.31";"3.70";"7.15";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"286260";"UO_0000065";"13.06";"0.25";"2.10";"6.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286261";"UO_0000065";"14.74";"0.28";"3.07";"6.77";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649894";"";"None";"594.12";"2";"5.09";"BDBM135245";"CO[C@@H]1C[C@@H](C2(OC)CC2)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"286264";"UO_0000065";"14.64";"0.28";"3.61";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649899";"";"None";"591.12";"1";"4.91";"BDBM135250";"CCN1C(=O)CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H]2CCC[C@H]21";"IC50";"'='";"4.0";"nM";"8.40";"";"286269";"UO_0000065";"14.21";"0.27";"3.49";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649906";"";"None";"566.06";"1";"4.31";"BDBM135258";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCOCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"286277";"UO_0000065";"13.56";"0.26";"3.37";"6.18";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639487";"";"None";"580.09";"1";"4.70";"BDBM135259";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2COCCC2O1";"IC50";"'='";"63.0";"nM";"7.20";"";"286279";"UO_0000065";"12.41";"0.24";"2.50";"5.80";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3933957";"";"None";"552.08";"2";"5.32";"BDBM135276";"CC1CN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)[C@H](C)O1";"IC50";"'='";"17.0";"nM";"7.77";"";"286295";"UO_0000065";"14.07";"0.27";"2.45";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649923";"";"None";"564.09";"2";"5.64";"BDBM135284";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCO[C@@H]3CCC[C@H]32)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"286304";"UO_0000065";"15.95";"0.31";"3.36";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649937";"";"None";"619.17";"2";"5.54";"BDBM135306";"C[C@@H]1CN(C(=O)C2CCC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286325";"UO_0000065";"14.54";"0.28";"3.46";"7.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3941220";"";"None";"615.98";"2";"5.45";"BDBM135429";"O=c1nc(-c2cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(Cc4ccc(C(F)(F)F)c(F)c4)c3c(-c3cncc(Cl)c3)n2)[nH]o1";"IC50";"'='";"244.0";"nM";"6.61";"";"286448";"UO_0000065";"10.74";"0.21";"1.16";"5.75";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3976723";"";"None";"560.54";"2";"5.92";"BDBM119724";"O=C(NC1CCC(O)CC1)[C@@H]1N[C@H](CC2CCCC2)[C@]2(CNc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"3000.0";"nM";"";"";"246818";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4761727";"";"None";"1730.09";"None";"None";"14";"CC(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@H]1CCC(=O)NCCCC[C@@H](CN(CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)CN(CC(=O)N[C@@H](C)C(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)NC(=O)[C@H](C)NC(=O)CN(S(=O)(=O)c2ccc3ccccc3c2)C[C@H](Cc2ccc(O)cc2)NC1=O)S(C)(=O)=O)[C@@H](C)O";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"3.07";"None";"None";"None";"0";"CHEMBL4704883";"Binding affinity to human recombinant MDM2 (1 to 150 residue) expressed in Escherichia coli using presence of FITC-labelled compound by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699617";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL2347377";"";"None";"434.32";"0";"4.89";"30";"O=C(O)C[C@@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"15300.0";"nM";"4.82";"";"";"UO_0000065";"11.09";"0.23";"-0.07";"7.20";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"27, enantiomer 2";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"13.28";"0.27";"0.88";"8.63";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347388";"";"None";"420.34";"0";"4.80";"22";"O=C1[C@H](CCO)O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"14400.0";"nM";"4.84";"";"";"UO_0000065";"11.52";"0.24";"0.04";"9.73";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347384";"";"None";"336.22";"0";"4.26";"18";"CN1C(=O)CO[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.45";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347376";"";"None";"434.32";"0";"4.89";"29";"O=C(O)C[C@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"15.05";"0.31";"1.65";"9.78";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347392";"";"None";"434.32";"0";"4.89";"26, enantiomer 1";"O=C(O)C[C@H]1O[C@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"11.81";"0.24";"0.24";"7.68";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347385";"";"None";"376.28";"1";"5.04";"19";"O=C1CO[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"15.27";"0.31";"0.70";"19.45";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3657014";"";"None";"532.96";"2";"5.35";"BDBM129918";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.16";"nM";"9.80";"";"261649";"UO_0000065";"18.38";"0.35";"4.45";"9.23";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657095";"";"None";"548.05";"1";"4.41";"BDBM130012";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)cn(C)c1=O)C2=O";"IC50";"'='";"0.253";"nM";"9.60";"";"261733";"UO_0000065";"17.51";"0.34";"5.19";"9.75";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693964";"";"None";"491.39";"0";"3.29";"BDBM112749";"CNC(=O)[C@@H]1NC2(CCN(C)CC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"5000.0";"nM";"";"";"234024";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693965";"";"None";"491.39";"0";"3.29";"BDBM112750";"CNC(=O)[C@@H]1NC2(CCN(C)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"5000.0";"nM";"";"";"234025";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3125532";"";"None";"588.55";"2";"6.78";"30";"CC[C@@H](CS(=O)(=O)c1ccccc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"14.31";"0.29";"1.64";"9.18";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125530";"";"None";"580.57";"2";"6.67";"28";"CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"15.15";"0.32";"2.13";"9.59";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125522";"";"None";"526.48";"2";"5.35";"20";"CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"16.71";"0.35";"3.45";"9.59";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125706";"";"None";"492.44";"1";"6.08";"6";"CC[C@@H](C[C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"16.76";"0.34";"2.17";"10.60";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125538";"";"None";"594.60";"2";"6.91";"36";"CC(C)(C)S(=O)(=O)C[C@H](C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.82";"0.35";"3.09";"10.90";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"35";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"1";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125703";"";"None";"492.44";"1";"6.08";"3";"CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"17.98";"0.37";"2.77";"11.37";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125514";"";"None";"567.54";"2";"5.39";"12";"CC[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.39";"0.34";"3.91";"8.96";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3691718";"";"None";"521.45";"2";"7.07";"BDBM143496";"COc1ccncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.99";"nM";"8.70";"";"279764";"UO_0000065";"16.69";"0.33";"1.63";"14.44";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657129";"";"None";"555.42";"1";"4.69";"BDBM6863";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.318";"nM";"9.50";"";"13377";"UO_0000065";"17.10";"0.34";"4.81";"9.10";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657084";"";"None";"541.40";"2";"5.10";"BDBM130001";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cnc2O)C3=O)c(OC)n1";"IC50";"'='";"0.1015";"nM";"9.99";"";"261722";"UO_0000065";"18.46";"0.37";"4.89";"8.65";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691717";"";"None";"511.38";"2";"6.60";"BDBM143493";"COc1ccncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"6.9";"nM";"8.16";"";"279613";"UO_0000065";"15.96";"0.32";"1.56";"13.55";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650057";"";"None";"513.08";"2";"5.79";"BDBM135927";"CCCN(C=O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"189.0";"nM";"6.72";"";"269505";"UO_0000065";"13.10";"0.26";"0.93";"11.38";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3705041";"";"None";"581.54";"1";"4.23";"BDBM170339";"CC(C)(C)C[C@@H]1[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@@H](c2cccc(Cl)c2)[C@H](C(=O)NCC[C@H](O)CO)[N+]1(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"314311";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663857";"";"None";"582.50";"2";"3.10";"BDBM170375";"CC(C)(CCO)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314345";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663859";"";"None";"590.52";"1";"4.37";"BDBM170377";"O=C(NCC[C@H](O)CO)[C@H]1[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]2CC3(CCCC3)CCN12";"IC50";"'>'";"3000.0";"nM";"";"";"314347";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3941220";"";"None";"615.98";"2";"5.45";"BDBM135429";"O=c1nc(-c2cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(Cc4ccc(C(F)(F)F)c(F)c4)c3c(-c3cncc(Cl)c3)n2)[nH]o1";"IC50";"'='";"28.0";"nM";"7.55";"";"286449";"UO_0000065";"12.26";"0.24";"2.10";"6.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653334";"";"None";"559.09";"1";"4.85";"BDBM135453";"CCC(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286472";"UO_0000065";"14.59";"0.29";"3.30";"5.97";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653338";"";"None";"572.71";"2";"5.75";"BDBM135457";"CC(Oc1nc(-c2noc(=O)[nH]2)cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"28.0";"nM";"7.55";"";"286476";"UO_0000065";"13.19";"0.25";"1.80";"6.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647063";"";"None";"550.06";"2";"5.07";"BDBM135125";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286144";"UO_0000065";"15.81";"0.30";"3.63";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286157";"UO_0000065";"16.42";"0.32";"2.91";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3916078";"";"None";"522.05";"2";"5.70";"BDBM135159";"C[C@H]1CCCCN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286178";"UO_0000065";"16.09";"0.31";"2.70";"7.94";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135402";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"161.0";"nM";"6.79";"";"286424";"UO_0000065";"13.29";"0.26";"1.16";"6.08";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649867";"";"None";"575.08";"2";"4.79";"BDBM135203";"Cn1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)nn1";"IC50";"'='";"13.0";"nM";"7.89";"";"286222";"UO_0000065";"13.71";"0.26";"3.10";"5.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654190";"";"None";"655.20";"2";"5.80";"BDBM148147";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CN(Cc5ccccc5)CC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"129.0";"nM";"6.89";"";"286254";"UO_0000065";"10.51";"0.20";"1.09";"5.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"286256";"UO_0000065";"14.28";"0.28";"2.78";"6.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649908";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286284";"UO_0000065";"14.78";"0.29";"3.38";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649908";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"48.0";"nM";"7.32";"";"286285";"UO_0000065";"12.88";"0.25";"2.30";"6.37";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649911";"";"None";"578.12";"2";"5.85";"BDBM135270";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCCC2O1";"IC50";"'='";"3.0";"nM";"8.52";"";"286289";"UO_0000065";"14.74";"0.28";"2.67";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649933";"";"None";"615.16";"1";"4.17";"BDBM135302";"C[C@@H]1CN(S(C)(=O)=O)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286321";"UO_0000065";"13.85";"0.28";"4.35";"5.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3930337";"";"None";"609.13";"1";"4.39";"BDBM135327";"COCC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"286346";"UO_0000065";"13.13";"0.25";"3.61";"5.91";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704503";"";"None";"593.55";"2";"5.43";"BDBM170259";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(CCF)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314209";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704518";"";"None";"618.58";"1";"4.12";"BDBM170280";"CN(C)CC(=O)N1CCN(C(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"10000.0";"nM";"";"";"314229";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704520";"";"None";"591.56";"1";"4.46";"BDBM170283";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314231";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4113676";"";"None";"561.53";"2";"5.27";"BDBM170289";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(N)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314237";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3950747";"";"None";"709.69";"2";"6.42";"BDBM170312";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(OC(=O)[C@@H](N)Cc3ccccc3)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314270";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3960238";"";"None";"580.50";"2";"5.44";"BDBM119739";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"314286";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704553";"";"None";"524.42";"1";"3.11";"BDBM170318";"CCC[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'>'";"1000.0";"nM";"";"";"314290";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663874";"";"None";"547.50";"1";"4.88";"BDBM170398";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2CC[C@@H](N)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314366";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663876";"";"None";"579.52";"2";"5.04";"BDBM170400";"CN1CC[C@@H](NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)[C@@H](F)C1";"IC50";"'<'";"1000.0";"nM";"";"";"314368";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"8";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.04";"0.24";"1.11";"8.39";"0";"CHEMBL2383516";"Antagonist activity at human GST-tagged MDM2 assessed as inhibition of binding to full length p53";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3355420";"";"None";"547.46";"1";"3.45";"22D";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"589.0";"nM";"6.23";"";"";"UO_0000065";"11.38";"0.23";"2.78";"7.53";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3647050";"";"None";"585.11";"2";"6.50";"BDBM135110";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268619";"UO_0000065";"13.75";"0.26";"1.55";"7.88";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647057";"";"None";"566.11";"2";"5.71";"BDBM135117";"COC(C)(C)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268626";"UO_0000065";"15.90";"0.31";"3.29";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649825";"";"None";"534.06";"2";"5.70";"BDBM135154";"C[C@H]1CC[C@H](Cn2c(N3CCCC3C3CC3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268663";"UO_0000065";"16.85";"0.32";"3.30";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268670";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649840";"";"None";"566.11";"2";"5.71";"BDBM135173";"CC(C)OCC1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268682";"UO_0000065";"15.37";"0.30";"2.99";"7.57";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649859";"";"None";"572.09";"1";"3.94";"BDBM135195";"CC1CS(=O)(=O)CCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268704";"UO_0000065";"14.15";"0.28";"4.16";"5.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927925";"";"None";"556.04";"1";"4.88";"BDBM135200";"CO[C@H]1C[C@@H](CF)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"353.0";"nM";"6.45";"";"268709";"UO_0000065";"11.60";"0.23";"1.57";"5.61";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649871";"";"None";"574.09";"2";"5.39";"BDBM135207";"Cn1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"268716";"UO_0000065";"14.20";"0.27";"2.76";"6.60";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135209";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"116.0";"nM";"6.94";"";"268719";"UO_0000065";"12.04";"0.23";"1.59";"4.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135228";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268737";"UO_0000065";"14.24";"0.27";"3.68";"6.38";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649891";"";"None";"566.11";"2";"5.30";"BDBM135239";"CC(C)[C@@H]1C[C@](C)(O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268748";"UO_0000065";"15.90";"0.31";"3.70";"7.15";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3925339";"";"None";"594.12";"2";"5.09";"BDBM135246";"CO[C@H]1C[C@@H](C2(OC)CC2)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"268755";"UO_0000065";"13.47";"0.26";"2.91";"6.44";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649896";"";"None";"540.09";"2";"5.26";"BDBM135247";"CC1CSCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268756";"UO_0000065";"14.90";"0.30";"2.79";"7.61";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3944443";"";"None";"574.03";"2";"5.18";"BDBM135248";"CO[C@H]1C[C@H](C(F)F)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268757";"UO_0000065";"15.68";"0.31";"3.82";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649914";"";"None";"544.06";"2";"5.95";"BDBM135273";"CN(Cc1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"268782";"UO_0000065";"14.19";"0.27";"1.77";"7.30";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649915";"";"None";"564.09";"2";"5.46";"BDBM135274";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCC2O1";"IC50";"'='";"1.0";"nM";"9.00";"";"268784";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649922";"";"None";"516.01";"2";"6.06";"BDBM135283";"C[C@H]1CC[C@H](Cn2c(Nc3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"268792";"UO_0000065";"15.01";"0.29";"1.68";"6.76";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3957580";"";"None";"565.08";"1";"4.54";"BDBM135288";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CC(=O)N(C)C[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"4.0";"nM";"8.40";"";"268797";"UO_0000065";"14.86";"0.29";"3.86";"6.66";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649938";"";"None";"607.16";"2";"5.54";"BDBM135307";"CCCC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268816";"UO_0000065";"14.04";"0.27";"2.98";"6.76";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649939";"";"None";"595.10";"1";"4.98";"BDBM135308";"COC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"268817";"UO_0000065";"14.62";"0.28";"3.72";"6.43";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649942";"";"None";"622.17";"2";"5.33";"BDBM135311";"CC(C)NC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268820";"UO_0000065";"13.70";"0.26";"3.19";"6.17";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649943";"";"None";"579.11";"1";"4.76";"BDBM135312";"CC(=O)N1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)C1C";"IC50";"'='";"82.0";"nM";"7.09";"";"268821";"UO_0000065";"12.24";"0.24";"2.33";"5.62";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3909218";"";"None";"617.15";"2";"5.30";"BDBM135315";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C4CC4)[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268824";"UO_0000065";"13.45";"0.26";"3.00";"6.59";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688273";"";"None";"480.95";"1";"5.14";"BDBM111512";"CC(C)(CO)COC1(c2ccc(Cl)cc2)c2ccccc2C(=O)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"395.0";"nM";"6.40";"";"232309";"UO_0000065";"13.31";"0.26";"1.26";"6.89";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"268898";"UO_0000065";"15.63";"0.30";"2.70";"6.95";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688262";"";"None";"470.40";"1";"6.20";"BDBM111519";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCCCCO)c1ccc(Cl)cc1";"IC50";"'='";"869.0";"nM";"6.06";"";"232316";"UO_0000065";"12.88";"0.26";"-0.14";"12.18";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834379";"";"None";"496.92";"1";"5.03";"BDBM111543";"O=C1c2cc(F)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"852.0";"nM";"6.07";"";"232340";"UO_0000065";"12.21";"0.24";"1.04";"6.53";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688285";"";"None";"482.41";"1";"6.20";"BDBM50339380";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"8900.0";"nM";"5.05";"";"232352";"UO_0000065";"10.47";"0.21";"-1.15";"10.15";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL4524084";"";"None";"1131.28";"None";"None";"34";"CC(C)CCC(=O)N[C@@H](CCCC(=O)O)CN(C(=O)NCCCC1CCCCC1)[C@@H](CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)[C@@H](CCCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(F)cc1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"4.62";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL611624";"";"None";"1147.96";"None";"None";"16";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"4.36";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL611332";"";"None";"1054.92";"None";"None";"8";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCc1ccc(Br)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"4.52";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL611023";"";"None";"931.58";"2";"4.10";"2";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Cl)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCc1ccccc1";"IC50";"'='";"85000.0";"nM";"4.07";"";"";"UO_0000065";"4.37";"0.09";"-0.03";"1.38";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL594148";"";"None";"1084.35";"None";"None";"36";"CC(C)CCC(=O)NC(CCC(=O)O)CN(CCC1CCC2(CCCCC2)CC1)C(CCCCN)CN(CCCCc1ccc(Br)cc1)[C@@H](CCC(=O)O)CN(CCCCCc1ccc(F)cc1)CCC(N)=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3233129";"";"None";"542.48";"2";"5.08";"15";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.1";"nM";"8.00";"";"";"UO_0000065";"14.74";"0.31";"2.92";"7.92";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233139";"";"None";"584.56";"2";"6.11";"24";"CC(C)(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.1";"nM";"8.29";"";"";"UO_0000065";"14.19";"0.30";"2.18";"8.21";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3657080";"";"None";"563.98";"1";"4.05";"BDBM129997";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.99";"nM";"9.00";"";"261718";"UO_0000065";"15.97";"0.31";"4.95";"7.03";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691705";"";"None";"537.45";"2";"6.24";"BDBM143468";"CCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2)cc(Cl)c1=O";"IC50";"'='";"2.2";"nM";"8.66";"";"279600";"UO_0000065";"16.11";"0.32";"2.42";"12.48";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2397155";"";"None";"904.10";"3";"4.17";"1, KPYA52218";"COc1ccc(COC(=O)N[C@H](C(=O)N[C@@H](CCC(C)=O)C(=O)N[C@@H](Cc2cn(S(=O)(=O)c3c(C)cc(C)cc3C)c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)NN)C(C)C)cc1";"IC50";"'='";"8510.0";"nM";"5.07";"";"";"UO_0000065";"5.61";"0.11";"0.90";"2.06";"0";"CHEMBL2399741";"Inhibition of MDM2 (unknown origin) binding to FAM-LTFEHYWAQLTS-NH2 after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396614";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3703675";"";"None";"497.95";"1";"5.92";"BDBM156644";"CCc1c(Cl)cnc(NC(c2ccc(OC)c(OC)c2OC)c2ccc3cccnc3c2O)c1F";"IC50";"'='";"30000.0";"nM";"4.52";"";"298958";"UO_0000065";"9.08";"0.18";"-1.40";"5.28";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703649";"";"None";"410.30";"1";"6.15";"BDBM156418";"Cc1cccc(NC(c2cccc(Cl)c2Cl)c2ccc3cccnc3c2O)n1";"IC50";"'='";"14000.0";"nM";"4.85";"";"298929";"UO_0000065";"11.83";"0.24";"-1.30";"8.36";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703657";"";"None";"497.83";"1";"7.23";"BDBM156487";"Oc1c(C(Nc2ccc(C(F)(F)F)nc2)c2cc(C(F)(F)F)ccc2Cl)ccc2cccnc12";"IC50";"'='";"44000.0";"nM";"4.36";"";"298939";"UO_0000065";"8.75";"0.17";"-2.87";"7.51";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL424876";"";"None";"655.32";"2";"5.70";"49";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2O)C(=O)c2cc(I)ccc21";"IC50";"'='";"2440.0";"nM";"5.61";"";"";"UO_0000065";"8.56";"0.21";"-0.09";"7.08";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210913";"";"None";"563.48";"2";"6.91";"24";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.57";"0.21";"-0.96";"7.64";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL380214";"";"None";"549.45";"2";"6.52";"23";"C#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"11.19";"0.22";"-0.37";"7.89";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210151";"";"None";"651.33";"2";"7.14";"19";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL207845";"";"None";"700.88";"2";"7.39";"22";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"67000.0";"nM";"4.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL207505";"";"None";"651.33";"2";"7.14";"18";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"128000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3233591";"";"None";"708.70";"2";"6.18";"11";"COCCOc1ccccc1N1CCN(C(=O)[C@@]2(Oc3ccc(C(F)(F)F)cc3)CN(C(=O)c3cnccc3C(F)(F)F)CC(C)(C)C2)CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"8.47";"0.16";"-0.18";"7.11";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3683114";"";"None";"452.94";"0";"4.37";"BDBM161744";"COc1ccc(N2C(=O)Cc3cc(OCCN)c(OC)cc3C2c2ccc(Cl)cc2)cc1";"IC50";"'='";"25290.4";"nM";"4.60";"";"304960";"UO_0000065";"10.15";"0.20";"0.23";"6.21";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657047";"";"None";"554.45";"2";"7.39";"BDBM129954";"COc1ccc(C(C)O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.21";"nM";"9.68";"";"261684";"UO_0000065";"17.45";"0.35";"2.29";"14.32";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691702";"";"None";"591.54";"2";"7.38";"BDBM143465";"COc1ccc(C(=O)N(C)C)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"2.1";"nM";"8.68";"";"279597";"UO_0000065";"14.67";"0.29";"1.30";"12.82";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683157";"";"None";"640.25";"2";"6.36";"BDBM162064";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](NS(C)(=O)=O)CC3)cc1)C(=O)C2";"IC50";"'='";"3.6";"nM";"8.44";"";"305009";"UO_0000065";"13.19";"0.26";"2.08";"9.58";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL513108";"DIPLAMINE B";"None";"321.41";"0";"3.40";"4";"CSC1=C(CCN)c2nc3ccccc3c3ccnc(c23)C1=O";"IC50";"'='";"101300.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL988050";"Inhibition of GST fused human Hdm2 assessed as polyubiquitylation by electrochemiluminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151701";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";""
"CHEMBL3798889";"";"None";"689.66";"2";"6.68";"20g";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(C#N)cn2)CC1";"IC50";"'='";"492.0";"nM";"6.31";"";"";"UO_0000065";"9.15";"0.18";"-0.37";"5.81";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798014";"";"None";"688.67";"2";"7.28";"14b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C#N)c2)CC1";"IC50";"'='";"399.0";"nM";"6.40";"";"";"UO_0000065";"9.29";"0.18";"-0.88";"6.68";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL2152332";"";"None";"581.50";"2";"5.89";"Nutlin-3b";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"13600.0";"nM";"4.87";"";"";"UO_0000065";"8.37";"0.17";"-1.02";"5.83";"0";"CHEMBL2156544";"Inhibition of MDM2 binding to p53";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152328";"";"None";"545.54";"2";"5.20";"17";"CC(C)C1=C(C(=O)N2CCN(CCO)CC2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.53";"0.22";"0.54";"9.67";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152331";"";"None";"515.47";"2";"5.02";"(-)-9c";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"11900.0";"nM";"4.92";"";"";"UO_0000065";"9.55";"0.20";"-0.10";"7.57";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL611334";"";"None";"1020.08";"None";"None";"12";"COc1ccc(CCCNC(=O)N(CCC(N)=O)CC(CCC(=O)O)N(CC(CCCCN)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCC(C)C)C(=O)NCCc2ccc(Br)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL4524058";"";"None";"1046.23";"None";"None";"35";"NCCCC[C@@H](CN(C(=O)NCCCC1CCCCC1)[C@@H](CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)[C@@H](CCCCN)CN(CCC(N)=O)C(=O)NCCCc1ccc(F)cc1)NC(N)=O";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3236364";"";"None";"579.59";"2";"5.92";"13";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.25";"0.36";"4.08";"10.25";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236666";"";"None";"556.51";"2";"5.47";"49";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.46";"0.31";"2.58";"7.97";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236364";"";"None";"579.59";"2";"5.92";"13";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"15.09";"0.31";"2.82";"8.97";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL2156544";"Inhibition of MDM2 binding to p53";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL1688251";"";"None";"478.93";"1";"5.04";"51";"O=C1c2ccccc2C(OC2CCC(O)C2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"12.85";"0.25";"1.11";"6.62";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3703672";"";"None";"465.94";"1";"5.52";"BDBM156632";"COc1ccc(C(Nc2ncc(Cl)cc2C)c2ccc3cccnc3c2O)c(OC)c1OC";"IC50";"'='";"13000.0";"nM";"4.89";"";"298955";"UO_0000065";"10.49";"0.20";"-0.63";"5.70";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL548572";"";"None";"396.28";"1";"5.84";"BDBM156654";"Oc1c(C(Nc2ccccn2)c2ccc(Cl)cc2Cl)ccc2cccnc12";"IC50";"'='";"7400.0";"nM";"5.13";"";"298924";"UO_0000065";"12.95";"0.26";"-0.71";"8.84";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703652";"";"None";"396.28";"1";"5.84";"BDBM156423";"Oc1c(C(Nc2ccccn2)c2cc(Cl)ccc2Cl)ccc2cccnc12";"IC50";"'='";"7500.0";"nM";"5.12";"";"298933";"UO_0000065";"12.93";"0.26";"-0.72";"8.83";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703655";"";"None";"430.72";"1";"6.50";"BDBM156479";"Oc1c(C(Nc2ccc(Cl)cn2)c2ccc(Cl)c(Cl)c2)ccc2cccnc12";"IC50";"'='";"9000.0";"nM";"5.05";"";"298937";"UO_0000065";"11.71";"0.25";"-1.45";"8.69";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647048";"";"None";"564.69";"2";"6.15";"BDBM135108";"Cc1cccc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCOC[C@H]4c4ccccc4)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"268617";"UO_0000065";"15.09";"0.28";"2.37";"8.35";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647059";"";"None";"550.06";"2";"5.07";"BDBM135112";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268621";"UO_0000065";"16.36";"0.32";"3.93";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268629";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647062";"";"None";"550.06";"2";"5.07";"BDBM135125";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268634";"UO_0000065";"15.81";"0.30";"3.63";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649843";"";"None";"538.05";"1";"4.93";"BDBM135176";"COC[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268685";"UO_0000065";"15.84";"0.31";"3.59";"7.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649849";"";"None";"561.05";"1";"4.78";"BDBM135185";"C[C@H]1CC[C@H](Cn2c(N3CCCC3c3cnn[nH]3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268694";"UO_0000065";"16.04";"0.31";"4.22";"6.11";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649874";"";"None";"540.07";"2";"5.18";"BDBM135212";"COC(C)(C)CN(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268721";"UO_0000065";"14.90";"0.29";"2.87";"7.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3909594";"";"None";"552.08";"2";"5.32";"BDBM135254";"CC[C@H]1[C@H](C)OCCN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268763";"UO_0000065";"16.30";"0.32";"3.68";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649954";"";"None";"615.09";"2";"5.01";"BDBM135323";"C[C@@H]1CN(C(=O)C(F)F)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268832";"UO_0000065";"13.65";"0.27";"3.39";"6.66";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688265";"";"None";"497.35";"0";"4.61";"BDBM111525";"O=C1c2ccccc2C(OCCCO)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"232322";"UO_0000065";"11.77";"0.25";"1.24";"6.30";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834378";"";"None";"535.04";"2";"6.19";"BDBM111532";"CC(C)(C)c1ccc2c(c1)C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"152.0";"nM";"6.82";"";"232329";"UO_0000065";"12.74";"0.25";"0.63";"7.34";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834373";"";"None";"492.96";"1";"5.20";"BDBM111546";"Cc1cccc2c1C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"274.0";"nM";"6.56";"";"232343";"UO_0000065";"13.31";"0.26";"1.36";"7.06";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688280";"";"None";"512.83";"2";"5.75";"BDBM50339375";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"232350";"UO_0000065";"11.55";"0.25";"0.17";"11.90";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649850";"";"None";"575.08";"2";"4.79";"BDBM135186";"Cn1cnc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"286205";"UO_0000065";"13.77";"0.26";"3.13";"5.81";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649854";"";"None";"589.10";"2";"6.26";"BDBM135190";"Cc1noc(C)c1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286209";"UO_0000065";"13.51";"0.26";"1.70";"6.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268865";"UO_0000065";"15.53";"0.30";"2.86";"6.98";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135367";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268876";"UO_0000065";"15.93";"0.31";"2.31";"8.78";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649981";"";"None";"583.01";"2";"6.83";"BDBM135369";"CC(F)(c1ccc(F)cc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268878";"UO_0000065";"14.92";"0.29";"1.87";"8.49";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2347379";"";"None";"432.35";"1";"5.55";"35";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347391";"";"None";"448.35";"1";"5.28";"25";"O=C(O)CC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"13.13";"0.27";"0.61";"8.81";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"13.32";"0.26";"1.85";"9.28";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL1688158";"";"None";"417.81";"1";"5.21";"32";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(C(F)(F)F)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688260";"";"None";"466.92";"0";"4.89";"60";"O=C1c2ccccc2C(OCCCCO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"13.80";"0.27";"1.55";"6.94";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688280";"";"None";"512.83";"2";"5.75";"81";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.55";"0.25";"0.17";"11.90";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688289";"";"None";"480.03";"1";"5.71";"90";"CSc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"175000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688147";"";"None";"439.27";"0";"4.21";"21";"O=C1c2ccccc2C(O)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"12.54";"0.27";"1.30";"6.58";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688136";"";"None";"301.77";"0";"3.40";"10";"CCCN1C(=O)c2ccccc2C1(O)c1ccc(Cl)cc1";"IC50";"'='";"69000.0";"nM";"4.16";"";"";"UO_0000065";"13.79";"0.27";"0.76";"10.26";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688255";"";"None";"466.36";"1";"5.56";"55";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"12.49";"0.25";"0.26";"11.70";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688265";"";"None";"497.35";"0";"4.61";"65";"O=C1c2ccccc2C(OCCCO)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.77";"0.25";"1.24";"6.30";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL210545";"";"None";"668.36";"2";"6.13";"21";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N([C@H](C)c2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"9.21";"0.22";"0.02";"7.23";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL379487";"";"None";"706.46";"2";"5.94";"32";"CN1CCN(CCCCN2C(=O)[C@H](c3ccc(Cl)cc3)N(Cc3ccc(Cl)cc3N)C(=O)c3cc(I)ccc32)CC1";"IC50";"'='";"5660.0";"nM";"5.25";"";"";"UO_0000065";"7.43";"0.17";"-0.69";"7.18";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210545";"";"None";"668.36";"2";"6.13";"12i";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N([C@H](C)c2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL2386348";"";"None";"692.73";"2";"7.46";"2i";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCNC(C)=O)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"10.80";"0.21";"0.02";"9.66";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3691703";"";"None";"493.94";"1";"6.69";"BDBM143466";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(F)c1)C2=O";"IC50";"'='";"1.7";"nM";"8.77";"";"279598";"UO_0000065";"17.75";"0.34";"2.08";"18.52";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683158";"";"None";"657.21";"2";"7.23";"BDBM162068";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](NC(=O)c4cocn4)CC3)cc1)C(=O)C2";"IC50";"'='";"4.9";"nM";"8.31";"";"305010";"UO_0000065";"12.64";"0.24";"1.08";"8.55";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3798136";"";"None";"707.67";"2";"5.91";"20n";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C(N)=O)n2)CC1";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"9.83";"0.19";"1.04";"5.44";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL425528";"";"None";"539.29";"2";"5.78";"4";"O=C(O)C(c1ccccc1)N(Cc1ccc(C(F)(F)F)cc1)C(=O)c1cccc(I)c1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"8.94";"0.21";"-0.96";"8.37";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1688259";"";"None";"452.89";"0";"4.50";"59";"O=C1c2ccccc2C(OCCCO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"14.01";"0.27";"1.85";"6.83";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688305";"";"None";"564.28";"2";"6.70";"6, NU8231";"Cc1ccc2c(c1)C1=C([C@H](c3ccc(Br)cc3)n3ncnc3N1C)[C@@H](c1ccc(Br)cc1)O2";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"8.50";"0.20";"-1.90";"11.11";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688137";"";"None";"349.82";"0";"4.19";"11";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"74000.0";"nM";"4.13";"";"";"UO_0000065";"11.81";"0.23";"-0.06";"10.19";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688154";"";"None";"395.91";"0";"4.91";"28";"CSc1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688291";"";"None";"477.94";"0";"4.68";"92";"O=C(O)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688294";"";"None";"538.04";"2";"6.22";"96";"O=C(c1ccccc1)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL4524092";"";"None";"1052.39";"None";"None";"28";"Cc1ccc(CCNC(=O)N(CC(CCCCN)N(CC(CCC(=O)O)NC(=O)CCC(C)C)C(=O)NCCCC2CCCCC2)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCCc2ccc(F)cc2)cc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"4.64";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"1, MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"28.3";"nM";"7.55";"";"";"UO_0000065";"13.07";"0.26";"3.22";"9.13";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL1688167";"";"None";"366.80";"0";"2.82";"41";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc[n+]([O-])c1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688254";"";"None";"431.92";"0";"4.90";"54";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"12.34";"0.23";"0.43";"10.71";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688256";"";"None";"445.95";"1";"5.21";"56";"Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2C=C[C@@H](O)C2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.13";"0.25";"0.64";"11.76";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688264";"";"None";"480.95";"0";"4.94";"64";"O=C1c2ccccc2C(OCCCCO)(c2ccc(Cl)cc2)N1CCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"11.42";"0.22";"0.55";"5.91";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688268";"";"None";"521.01";"2";"5.92";"68";"O=C1c2ccccc2C(OC[C@H]2CC[C@H](CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"11.97";"0.23";"0.32";"6.71";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688269";"";"None";"514.97";"2";"5.81";"69";"O=C1c2ccccc2C(OCc2cccc(CO)c2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"11.92";"0.23";"0.33";"6.60";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688297";"";"None";"434.92";"0";"4.38";"99";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccccn1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"11.40";"0.22";"0.58";"7.91";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1689397";"";"None";"1798.04";"None";"None";"2";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"3.76";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689399";"";"None";"1861.15";"None";"None";"3a";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"4.20";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1688264";"";"None";"480.95";"0";"4.94";"BDBM111506";"O=C1c2ccccc2C(OCCCCO)(c2ccc(Cl)cc2)N1CCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"232302";"UO_0000065";"11.42";"0.22";"0.55";"5.91";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688274";"";"None";"478.93";"0";"4.89";"BDBM111513";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"298.0";"nM";"6.53";"";"232310";"UO_0000065";"13.63";"0.26";"1.64";"7.02";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834287";"";"None";"547.28";"2";"6.40";"BDBM111540";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"169.0";"nM";"6.77";"";"232337";"UO_0000065";"12.37";"0.28";"0.37";"13.61";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675216";"";"None";"398.85";"0";"4.31";"BDBM111541";"O=C1C2=C(CCCC2)C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"2810.0";"nM";"5.55";"";"232338";"UO_0000065";"13.92";"0.27";"1.24";"6.63";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688276";"";"None";"490.94";"1";"5.20";"76";"O=C1c2ccccc2C(O[C@@H]2C=C[C@@H](O)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"13.26";"0.25";"1.31";"7.01";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3649971";"";"None";"567.00";"2";"5.68";"BDBM135353";"C[C@H]1CC[C@H](Cn2c(C(O)c3ccc(F)cc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"268862";"UO_0000065";"13.62";"0.26";"2.04";"6.29";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688141";"";"None";"475.71";"0";"4.79";"15";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(I)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688159";"";"None";"407.85";"0";"3.98";"33";"COC(=O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"12.16";"0.23";"0.98";"7.42";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3647049";"";"None";"585.11";"2";"6.50";"BDBM135109";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286128";"UO_0000065";"14.57";"0.28";"2.02";"8.35";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"286140";"UO_0000065";"13.77";"0.27";"2.31";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647062";"";"None";"550.06";"2";"5.07";"BDBM135124";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"164.0";"nM";"6.79";"";"286143";"UO_0000065";"12.34";"0.24";"1.72";"5.90";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647068";"";"None";"524.03";"1";"4.54";"BDBM135132";"C[C@@H]1COCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286151";"UO_0000065";"16.03";"0.31";"3.86";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286153";"UO_0000065";"15.87";"0.30";"2.61";"8.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"63.0";"nM";"7.20";"";"286155";"UO_0000065";"13.14";"0.25";"1.11";"6.81";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649816";"";"None";"522.01";"1";"4.29";"BDBM135141";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"286160";"UO_0000065";"14.11";"0.27";"3.08";"6.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649828";"";"None";"564.13";"2";"6.72";"BDBM135157";"CCC(C)(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286176";"UO_0000065";"15.42";"0.30";"1.98";"8.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"286181";"UO_0000065";"12.32";"0.24";"1.75";"4.91";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3942009";"";"None";"510.04";"2";"5.43";"BDBM135163";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286182";"UO_0000065";"17.06";"0.33";"3.27";"9.32";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286363";"UO_0000065";"16.06";"0.31";"2.60";"7.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286364";"UO_0000065";"15.34";"0.30";"2.88";"7.19";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649971";"";"None";"567.00";"2";"5.68";"BDBM135353";"C[C@H]1CC[C@H](Cn2c(C(O)c3ccc(F)cc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"286372";"UO_0000065";"13.62";"0.26";"2.04";"6.29";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649975";"";"None";"560.06";"2";"5.84";"BDBM135357";"CCOC(c1cccnc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286376";"UO_0000065";"14.82";"0.28";"2.46";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649977";"";"None";"563.06";"2";"5.18";"BDBM135361";"CCOC(c1ccn(C)n1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286380";"UO_0000065";"15.14";"0.29";"3.34";"6.58";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649979";"";"None";"546.99";"2";"5.69";"BDBM135365";"C[C@H]1CC[C@H](Cn2c(C(=O)c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286384";"UO_0000065";"15.90";"0.30";"3.01";"7.28";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649985";"";"None";"548.02";"2";"5.94";"BDBM135376";"CC(F)(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286396";"UO_0000065";"15.87";"0.30";"2.76";"7.54";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649988";"";"None";"527.03";"2";"6.38";"BDBM135380";"C=C(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286399";"UO_0000065";"15.93";"0.30";"2.02";"8.19";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650003";"";"None";"580.09";"2";"5.08";"BDBM135399";"COc1c(-c2noc(=O)[nH]2)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@@H]3CCC[C@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286418";"UO_0000065";"15.51";"0.30";"3.92";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135402";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286421";"UO_0000065";"17.61";"0.34";"3.37";"8.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'<'";"1.0";"nM";"";"";"286436";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653319";"";"None";"580.09";"2";"5.08";"BDBM135438";"COc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"286457";"UO_0000065";"15.51";"0.30";"3.92";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653324";"";"None";"529.65";"1";"4.73";"BDBM135443";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCO[C@H]5CCC[C@@H]54)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"286462";"UO_0000065";"12.61";"0.23";"1.95";"5.81";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654194";"";"None";"595.15";"2";"6.91";"BDBM148151";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4cccc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"70.0";"nM";"7.16";"";"286474";"UO_0000065";"12.02";"0.23";"0.24";"8.05";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649907";"";"None";"552.04";"1";"3.92";"BDBM135261";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"286188";"UO_0000065";"13.65";"0.26";"3.62";"6.07";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649870";"";"None";"588.12";"2";"5.87";"BDBM135206";"CCn1nccc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286225";"UO_0000065";"14.49";"0.28";"2.65";"6.90";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649882";"";"None";"552.08";"2";"5.32";"BDBM135221";"CO[C@@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"286244";"UO_0000065";"14.28";"0.28";"2.57";"6.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649884";"";"None";"577.09";"1";"4.52";"BDBM135227";"CN1C(=O)CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H]2CCC[C@@H]21";"IC50";"'='";"32.0";"nM";"7.50";"";"286246";"UO_0000065";"12.99";"0.25";"2.97";"5.95";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649848";"";"None";"564.09";"2";"5.32";"BDBM135184";"C[C@H]1CC[C@H](Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"286250";"UO_0000065";"13.36";"0.26";"2.22";"6.56";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649921";"";"None";"490.01";"1";"6.44";"BDBM135282";"CN(c1ccccc1)c1nc2cc(C(=O)O)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"86.0";"nM";"7.07";"";"286301";"UO_0000065";"14.42";"0.28";"0.63";"8.40";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649924";"";"None";"538.05";"2";"5.10";"BDBM135286";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"3.0";"nM";"8.52";"";"286305";"UO_0000065";"15.84";"0.31";"3.42";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3894245";"";"None";"552.08";"2";"5.49";"BDBM135294";"CO[C@H]1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286313";"UO_0000065";"15.44";"0.30";"3.03";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL582845";"";"None";"1702.31";"None";"None";"PMDM6-F";"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CCNC(=O)CCNC(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Cc2cc(O)ccc21)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"4.03";"None";"None";"None";"0";"CHEMBL1040560";"Binding affinity to his-tagged human recombinant MDM2 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL1689406";"";"None";"1577.81";"None";"None";"PDI-E4KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2397153";"";"None";"981.16";"3";"2.63";"3, KPYB00556";"COc1ccc(COC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)OCc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)OC2CCCCCC2)C(=O)N[C@@H](C)C(=O)NN)C(C)C)cc1";"IC50";"'='";"21300.0";"nM";"4.67";"";"";"UO_0000065";"4.76";"0.09";"2.04";"1.55";"0";"CHEMBL2399741";"Inhibition of MDM2 (unknown origin) binding to FAM-LTFEHYWAQLTS-NH2 after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396614";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL1688273";"";"None";"480.95";"1";"5.14";"73";"CC(C)(CO)COC1(c2ccc(Cl)cc2)c2ccccc2C(=O)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.30";"0.26";"1.26";"6.89";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688170";"";"None";"433.94";"1";"5.13";"50";"O=C1c2ccccc2C(OC2CCC(O)C2)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.73";"0.24";"0.39";"11.10";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688278";"";"None";"451.93";"1";"5.13";"79";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(F)cc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"12.36";"0.24";"0.46";"11.22";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688144";"";"None";"360.37";"0";"3.44";"18";"O=C1c2ccccc2C(O)(c2ccccc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"87000.0";"nM";"4.06";"";"";"UO_0000065";"11.27";"0.21";"0.62";"4.85";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688166";"";"None";"366.80";"0";"2.82";"40";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cc[n+]([O-])cc1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1689401";"";"None";"1880.19";"None";"None";"3c";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"3.94";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL567426";"";"None";"536.23";"2";"6.02";"1a";"Brc1ccc([C@H]2C3=C(N=C4NC=NN42)c2ccccc2O[C@@H]3c2ccc(Br)cc2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052161";"Inhibition of ligase activity of human MDM2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3649873";"";"None";"522.01";"1";"4.30";"BDBM135211";"C[C@H]1CC[C@H](Cn2c(N3CCC34COC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"286230";"UO_0000065";"14.79";"0.29";"3.42";"6.72";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649877";"";"None";"526.04";"1";"4.79";"BDBM135215";"CCN(CCOC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286234";"UO_0000065";"15.13";"0.29";"3.17";"6.92";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649881";"";"None";"582.11";"1";"4.95";"BDBM135220";"COC[C@@H]1CC[C@@H](COC)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286239";"UO_0000065";"14.94";"0.29";"3.75";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135228";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286247";"UO_0000065";"14.24";"0.27";"3.68";"6.38";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654189";"";"None";"565.08";"1";"3.88";"BDBM148146";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CNCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"512.0";"nM";"6.29";"";"286253";"UO_0000065";"11.13";"0.21";"2.41";"4.95";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649843";"";"None";"538.05";"1";"4.93";"BDBM135176";"COC[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286195";"UO_0000065";"15.84";"0.31";"3.59";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3355414";"";"None";"532.44";"1";"4.42";"15D";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"12.82";"0.26";"2.41";"7.55";"1";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355418";"";"None";"563.50";"1";"4.09";"21D";"CCC1(CC)N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"12.03";"0.24";"2.69";"8.20";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355426";"";"None";"534.46";"1";"4.67";"27D";"CCC1(CC)N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"118.0";"nM";"6.93";"";"";"UO_0000065";"12.96";"0.26";"2.26";"7.66";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355427";"";"None";"518.42";"1";"4.03";"28C";"C[C@]1(O)C[C@@H](NC(=O)[C@@H]2NC3(CCC3)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'='";"7505.0";"nM";"5.12";"";"";"UO_0000065";"9.89";"0.20";"1.09";"5.67";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268854";"UO_0000065";"15.34";"0.30";"2.88";"7.19";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135403";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268912";"UO_0000065";"17.61";"0.34";"3.37";"8.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650010";"";"None";"595.17";"2";"5.92";"BDBM135410";"CS(=O)(=O)Nc1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"122.0";"nM";"6.91";"";"268919";"UO_0000065";"11.62";"0.23";"0.99";"6.76";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650017";"";"None";"538.05";"2";"5.80";"BDBM135417";"CCON(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'<'";"1.0";"nM";"";"";"268926";"UO_0000065";"";"";"";"";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650019";"";"None";"511.03";"2";"5.97";"BDBM135421";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268930";"UO_0000065";"16.43";"0.32";"2.43";"7.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688268";"";"None";"521.01";"2";"5.92";"BDBM111515";"O=C1c2ccccc2C(OC[C@H]2CC[C@H](CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"582.0";"nM";"6.24";"";"232312";"UO_0000065";"11.97";"0.23";"0.32";"6.71";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675215";"";"None";"463.16";"1";"5.61";"BDBM111538";"O=C1c2cccc(Cl)c2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"847.0";"nM";"6.07";"";"232335";"UO_0000065";"13.11";"0.31";"0.46";"14.98";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834375";"";"None";"492.96";"1";"5.20";"BDBM111545";"Cc1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"492.0";"nM";"6.31";"";"232342";"UO_0000065";"12.80";"0.25";"1.11";"6.79";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688277";"";"None";"458.95";"0";"4.86";"BDBM50339372";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1790.0";"nM";"5.75";"";"232348";"UO_0000065";"12.52";"0.24";"0.89";"7.81";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688286";"";"None";"484.00";"1";"6.14";"BDBM111563";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccc2ccccc12";"IC50";"'='";"49000.0";"nM";"4.31";"";"232364";"UO_0000065";"8.90";"0.17";"-1.83";"8.66";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649897";"";"None";"574.03";"2";"5.18";"BDBM135248";"CO[C@@H]1C[C@@H](C(F)F)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286267";"UO_0000065";"15.68";"0.31";"3.82";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654192";"";"None";"550.11";"2";"6.32";"BDBM148149";"CCOC(c1nc2cc(-c3n[nH]c(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286348";"UO_0000065";"15.49";"0.30";"2.20";"7.45";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653322";"";"None";"566.06";"1";"4.37";"BDBM135441";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cc(Cl)c[nH]c4=O)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286460";"UO_0000065";"15.37";"0.30";"4.33";"6.45";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653330";"";"None";"552.64";"1";"4.64";"BDBM135449";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cccnn4)c32)CC1";"IC50";"'='";"112.0";"nM";"6.95";"";"286468";"UO_0000065";"12.58";"0.23";"2.31";"5.44";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653331";"";"None";"513.07";"2";"5.78";"BDBM135450";"CSCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286469";"UO_0000065";"15.89";"0.32";"2.37";"7.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286141";"UO_0000065";"14.46";"0.28";"2.69";"7.09";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647066";"";"None";"562.00";"2";"5.85";"BDBM135130";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286149";"UO_0000065";"15.48";"0.30";"2.85";"8.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286154";"UO_0000065";"15.87";"0.30";"2.61";"8.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"286156";"UO_0000065";"13.20";"0.25";"1.15";"6.84";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3932760";"";"None";"546.06";"1";"4.79";"BDBM119738";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"61.7";"nM";"7.21";"";"246810";"UO_0000065";"13.20";"0.26";"2.42";"7.97";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL593825";"";"None";"1004.08";"None";"None";"6";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccccc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"4.68";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3703323";"";"None";"746.64";"2";"8.31";"BDBM152948";"COc1cc(C(=O)OC(C)OC(=O)OC(C)C)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"116.0";"nM";"6.94";"";"293771";"UO_0000065";"9.29";"0.19";"-1.37";"5.10";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703332";"";"None";"850.74";"3";"7.58";"BDBM152957";"COCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"13.1";"nM";"7.88";"";"293781";"UO_0000065";"9.27";"0.19";"0.30";"4.82";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703343";"";"None";"878.79";"3";"8.21";"BDBM152968";"COCCOCCOCCOC(=O)OC(OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1)C(C)C";"IC50";"'='";"8.22";"nM";"8.09";"";"293792";"UO_0000065";"9.20";"0.18";"-0.12";"4.94";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703349";"";"None";"1026.95";"None";"None";"BDBM152976";"COCCOCCOCCOCCOCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.18";"nM";"8.29";"";"293800";"UO_0000065";"8.07";"None";"None";"None";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703351";"";"None";"791.68";"2";"6.74";"BDBM152980";"COCCOCCNC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"30.3";"nM";"7.52";"";"293806";"UO_0000065";"9.50";"0.19";"0.78";"4.78";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236644";"";"None";"699.74";"2";"8.05";"24";"CC(C)(C(=O)O)c1ccc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)nc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"13.86";"0.28";"1.65";"9.27";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236648";"";"None";"676.64";"2";"6.92";"28";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.78";"0.30";"3.08";"8.51";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236357";"";"None";"695.71";"2";"7.51";"4, AM-6761";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"13.08";"0.28";"1.59";"8.69";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236358";"";"None";"592.59";"2";"5.80";"6";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"15.35";"0.32";"3.30";"8.35";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236636";"";"None";"677.69";"2";"6.37";"16";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CC[C@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"13.51";"0.28";"2.78";"8.17";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236654";"";"None";"677.72";"2";"6.92";"34";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)CO)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"12.94";"0.27";"1.85";"8.38";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236655";"";"None";"681.68";"2";"7.59";"35";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"13.43";"0.28";"1.56";"8.75";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236663";"";"None";"661.65";"2";"6.04";"44";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nnc(CC(=O)O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"13.60";"0.28";"2.96";"6.75";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL4290086";"";"None";"520.46";"2";"7.81";"3";"COc1ccccc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.074";"nM";"10.13";"";"";"UO_0000065";"19.47";"0.38";"2.32";"21.39";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.70";"0.21";"0.33";"7.45";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4080118";"";"None";"596.49";"2";"6.05";"42";"O=C(O)Cc1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.03";"0.26";"1.72";"7.23";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4098834";"";"None";"691.65";"2";"5.07";"58";"CS(=O)(=O)NC(=O)C12CCC(NC(=O)[C@@H]3NC4(CCCCC4)[C@@]4(C(=O)Nc5cc(Cl)ccc54)[C@H]3c3cccc(Cl)c3F)(CC1)CC2";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"11.86";"0.24";"3.13";"6.14";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3687302";"";"None";"462.35";"1";"5.50";"BDBM143430";"Cc1cc(Cl)ccc1C1c2c(nn(CCO)c2C(C)C)C(=O)N1c1ccc(F)c(Cl)c1";"IC50";"'='";"4.1";"nM";"8.39";"";"279570";"UO_0000065";"18.14";"0.37";"2.89";"14.37";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3318763";"";"None";"607.60";"2";"6.17";"11";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)NC2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"16.33";"0.34";"3.75";"9.56";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318771";"";"None";"643.63";"2";"7.17";"22";"CCN(c1ccccc1)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.075";"nM";"10.12";"";"";"UO_0000065";"15.73";"0.32";"2.95";"10.66";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318776";"";"None";"597.61";"2";"6.23";"27";"CCN(C)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"15.73";"0.33";"3.17";"9.89";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318785";"";"None";"657.66";"2";"7.34";"36";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCc2ccccc21)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.42";"nM";"9.38";"";"";"UO_0000065";"14.26";"0.29";"2.04";"9.87";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318759";"";"None";"607.60";"2";"6.03";"7";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)NCC2CCC2)C2CC2)C1=O";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"16.08";"0.33";"3.74";"9.41";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318778";"";"None";"645.60";"2";"6.62";"29";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCC(F)(F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"14.45";"0.30";"2.71";"9.82";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318782";"";"None";"624.63";"2";"5.18";"33";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCNCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.088";"nM";"10.06";"";"";"UO_0000065";"16.10";"0.33";"4.88";"9.40";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318783";"";"None";"673.68";"2";"5.01";"34";"CC(C)(C)[C@@H](CS(=O)(=O)N1CCS(=O)(=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.059";"nM";"10.23";"";"";"UO_0000065";"15.18";"0.32";"5.22";"7.92";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3703350";"";"None";"805.70";"2";"7.13";"BDBM152979";"COCCOCCNC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"4.86";"nM";"8.31";"";"293803";"UO_0000065";"10.32";"0.21";"1.18";"5.29";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3898360";"";"None";"551.05";"1";"3.98";"BDBM135193";"C[C@H]1CN(C)C(=O)CN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268702";"UO_0000065";"14.44";"0.28";"3.98";"6.31";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649863";"";"None";"556.04";"1";"4.88";"BDBM135199";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268708";"UO_0000065";"16.19";"0.32";"4.12";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649884";"";"None";"577.09";"1";"4.52";"BDBM135227";"CN1C(=O)CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H]2CCC[C@@H]21";"IC50";"'='";"32.0";"nM";"7.50";"";"268736";"UO_0000065";"12.99";"0.25";"2.97";"5.95";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649965";"";"None";"513.00";"1";"4.39";"BDBM135340";"CCOC(CO)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"268849";"UO_0000065";"15.25";"0.30";"3.43";"5.93";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268893";"UO_0000065";"16.57";"0.32";"2.85";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649990";"";"None";"493.01";"1";"6.13";"BDBM135382";"C=C(CCC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268891";"UO_0000065";"17.64";"0.34";"2.57";"8.49";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649997";"";"None";"527.03";"1";"4.69";"BDBM135393";"COCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268902";"UO_0000065";"15.36";"0.30";"3.41";"6.69";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657126";"";"None";"559.99";"2";"5.58";"BDBM130044";"COc1ncc(CC(=O)O)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"4.74";"nM";"8.32";"";"261588";"UO_0000065";"14.86";"0.28";"2.74";"6.86";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688300";"";"None";"450.92";"0";"3.62";"102";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccc[n+]1[O-]";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"9.94";"0.19";"0.86";"5.84";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL182051";"";"None";"453.37";"1";"5.82";"7";"C[C@H](c1ccc(Cl)cc1)N(C(=O)/C=C/c1ccccc1)[C@H](C(N)=O)c1ccc(Cl)cc1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.98";"0.20";"-1.30";"7.13";"0";"CHEMBL874553";"Binding affinity between MDM2 and p53 protein in fluorescence peptide assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1689393";"";"None";"1536.71";"None";"None";"PDI";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)[C@@H](C)O";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"4.79";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL211045";"";"None";"581.50";"2";"5.89";"2";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"104.5";"nM";"6.98";"";"";"UO_0000065";"12.00";"0.24";"1.09";"8.36";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3818586";"";"None";"491.59";"0";"3.86";"8";"COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C";"IC50";"'='";"24.8";"nM";"7.61";"";"";"UO_0000065";"15.47";"0.29";"3.75";"6.48";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL572933";"";"None";"552.47";"1";"3.74";"1, MI-219";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"44.6";"nM";"7.35";"";"";"UO_0000065";"13.31";"0.27";"3.61";"6.64";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402734";"";"None";"616.49";"2";"6.94";"9";"COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.49";"0.25";"0.76";"6.91";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL1689398";"";"None";"1833.09";"None";"None";"3";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CO)C(N)=O";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"4.48";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1689407";"";"None";"1569.78";"None";"None";"PDI-H5KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"4.53";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3924221";"";"None";"546.06";"1";"4.79";"BDBM119723";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'='";"520.0";"nM";"6.28";"";"246806";"UO_0000065";"11.51";"0.23";"1.49";"6.95";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647062";"";"None";"550.06";"2";"5.07";"BDBM135124";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"164.0";"nM";"6.79";"";"268633";"UO_0000065";"12.34";"0.24";"1.72";"5.90";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"268671";"UO_0000065";"12.32";"0.24";"1.75";"4.91";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3291218";"";"None";"375.48";"1";"6.51";"7";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnn1-c1ccccc1";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"16.01";"0.28";"-0.50";"17.89";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3291437";"";"None";"351.41";"0";"4.88";"23a";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(C#N)c(=O)[nH]1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"17.77";"0.32";"1.36";"8.62";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3109050";"";"None";"581.04";"1";"4.97";"5";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3ncccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"12.54";"0.24";"2.31";"5.62";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109051";"";"None";"614.51";"2";"5.02";"4";"COc1cc(C(N)=O)ccc1NC(=O)C1NC(CC(C)(C)C)C2(C(=O)Nc3cc(Cl)ncc32)C1c1cccc(Cl)c1F";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"12.64";"0.25";"2.75";"5.74";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109041";"";"None";"620.53";"2";"6.29";"15";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)sc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.14";"0.27";"1.86";"6.98";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3109053";"";"None";"580.06";"1";"4.37";"2";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3ccncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"11.82";"0.23";"2.48";"5.06";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL4524062";"";"None";"1205.19";"None";"None";"21";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(=O)NCC1CCCCC1)C(=O)NCCCC1CCCCC1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"4.30";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL4524067";"";"None";"1149.08";"None";"None";"20";"C=CCNC(=O)NC(CCC(=O)O)CN(C(=O)NCCCC1CCCCC1)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"4.15";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL593807";"";"None";"990.05";"2";"4.60";"5";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccccc1";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"4.79";"0.10";"0.14";"1.60";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL1689408";"";"None";"1543.75";"None";"None";"PDI-Y6KAc";"CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"3.75";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2398246";"";"None";"654.71";"2";"6.78";"1";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)[C@H](C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"11.95";"0.24";"1.04";"13.16";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL1688150";"";"None";"408.84";"0";"4.14";"24";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1CCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"12.74";"0.25";"1.07";"6.22";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688142";"";"None";"363.84";"0";"4.50";"16";"Cc1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"13.26";"0.25";"0.32";"11.90";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688155";"";"None";"411.91";"0";"3.93";"29";"C[S+]([O-])c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL461462";"LISSOCLINIDINE B";"None";"321.41";"0";"3.90";"5";"NCCc1c2c(c3nccc4c3c1Nc1ccccc1-4)OCS2";"IC50";"'='";"58600.0";"nM";"4.23";"";"";"UO_0000065";"13.17";"0.25";"0.33";"7.03";"0";"CHEMBL988050";"Inhibition of GST fused human Hdm2 assessed as polyubiquitylation by electrochemiluminescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151701";"1";"Scientific Literature";"Bioorg Med Chem";"2008";"None";"";""
"CHEMBL3663871";"";"None";"560.09";"2";"5.04";"BDBM170393";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCC2CCC(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"314362";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4107983";"";"None";"647.62";"2";"5.59";"BDBM170315";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(OC(=O)C(C)(C)N)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314273";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2094874";"";"None";"361.47";"1";"5.22";"BDBM156660";"Cc1ccnc(NC(c2ccc3cccnc3c2O)c2sccc2C)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"298926";"UO_0000065";"15.77";"0.30";"0.48";"9.82";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL524251";"";"None";"410.30";"1";"6.15";"BDBM156419";"Cc1ccnc(NC(c2cccc(Cl)c2Cl)c2ccc3cccnc3c2O)c1";"IC50";"'='";"4400.0";"nM";"5.36";"";"298930";"UO_0000065";"13.06";"0.26";"-0.79";"9.23";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703656";"";"None";"478.30";"1";"7.17";"BDBM156483";"Cc1cc(Cl)cnc1NC(c1cc(C(F)(F)F)ccc1Cl)c1ccc2cccnc2c1O";"IC50";"'='";"41000.0";"nM";"4.39";"";"298938";"UO_0000065";"9.17";"0.19";"-2.78";"7.56";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703664";"";"None";"393.85";"1";"5.64";"BDBM156543";"Cc1cc(NC(c2ccccc2Cl)c2ccc3cccnc3c2O)ncc1F";"IC50";"'='";"13000.0";"nM";"4.89";"";"298947";"UO_0000065";"12.41";"0.24";"-0.75";"8.42";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703674";"";"None";"481.94";"1";"5.22";"BDBM156639";"COc1cc(Cl)cnc1NC(c1ccc(OC)c(OC)c1OC)c1ccc2cccnc2c1O";"IC50";"'='";"20000.0";"nM";"4.70";"";"298957";"UO_0000065";"9.75";"0.19";"-0.52";"4.95";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL379293";"";"None";"651.33";"2";"7.14";"1";"CC(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"9.32";"0.22";"-1.07";"7.79";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3653268";"";"None";"585.47";"2";"5.55";"BDBM129835";"COc1cnc(N(C)CCO)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.7";"nM";"9.15";"";"261564";"UO_0000065";"15.64";"0.31";"3.60";"9.48";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691721";"";"None";"545.47";"2";"7.55";"BDBM143507";"COc1ccc(C#N)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.7";"nM";"8.77";"";"279617";"UO_0000065";"16.08";"0.32";"1.22";"12.33";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657067";"";"None";"572.42";"2";"5.76";"BDBM129977";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261704";"UO_0000065";"17.16";"0.34";"4.06";"10.72";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687288";"";"None";"466.32";"1";"5.33";"BDBM143416";"CC(C)c1c2c(nn1CCO)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)c(F)c1";"IC50";"'='";"7.8";"nM";"8.11";"";"279556";"UO_0000065";"17.39";"0.36";"2.78";"13.89";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653246";"";"None";"550.49";"2";"7.31";"BDBM129811";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.1";"nM";"8.96";"";"261541";"UO_0000065";"16.27";"0.32";"1.65";"13.25";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653161";"";"None";"545.47";"2";"7.68";"BDBM129725";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.14";"nM";"9.85";"";"261457";"UO_0000065";"18.06";"0.35";"2.17";"13.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683123";"";"None";"582.19";"2";"6.83";"BDBM161814";"CC(C)N(CCN(C)C)c1ccc2c(c1)C(c1ccc(Cl)cc1)N(c1ccc(N(C)Cc3ccncc3)cc1)C(=O)C2";"IC50";"'='";"153.8";"nM";"6.81";"";"304969";"UO_0000065";"11.70";"0.22";"-0.02";"15.87";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653168";"";"None";"607.54";"2";"6.54";"BDBM129732";"COc1ccc(C(=O)NCCO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261463";"UO_0000065";"16.17";"0.32";"3.28";"10.16";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688140";"";"None";"428.71";"0";"4.95";"14";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"12.47";"0.28";"0.40";"13.19";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688270";"";"None";"521.01";"2";"6.21";"70";"O=C1c2ccccc2C(O[C@H]2CCC[C@H](O)CCC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"12.32";"0.24";"0.21";"6.91";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688277";"";"None";"458.95";"0";"4.86";"78";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.52";"0.24";"0.88";"7.81";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688290";"";"None";"491.97";"0";"4.77";"91";"COC(=O)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3649917";"";"None";"526.04";"1";"4.79";"BDBM135278";"COCC(C)N(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"286297";"UO_0000065";"14.02";"0.27";"2.59";"6.42";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653328";"";"None";"552.64";"1";"4.64";"BDBM135447";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cnccn4)c32)CC1";"IC50";"'='";"119.0";"nM";"6.92";"";"286466";"UO_0000065";"12.53";"0.23";"2.28";"5.42";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286215";"UO_0000065";"14.63";"0.28";"2.98";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688274";"";"None";"478.93";"0";"4.89";"74";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"13.86";"0.27";"1.75";"7.14";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688162";"";"None";"453.93";"1";"5.42";"36";"O=C(c1ccccc1)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688285";"";"None";"482.41";"1";"6.20";"86";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"10.47";"0.21";"-1.15";"10.15";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688292";"";"None";"476.96";"0";"4.09";"94";"NC(=O)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3236363";"";"None";"567.58";"2";"5.92";"12";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"15.29";"0.32";"2.76";"8.90";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236643";"";"None";"671.69";"2";"7.31";"23";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(CC(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.95";"0.26";"1.39";"8.31";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236649";"";"None";"658.65";"2";"6.78";"29";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cnc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"13.90";"0.28";"2.37";"7.79";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL407632";"NUTLIN-2";"None";"686.45";"2";"5.89";"4";"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.98";"0.23";"0.96";"8.81";"1";"CHEMBL2156544";"Inhibition of MDM2 binding to p53";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152322";"";"None";"513.45";"1";"4.77";"9e";"O=C1CN(C(=O)C2=C(C3CC3)N3C(=N[C@@H](c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CCN1";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"9.78";"0.20";"0.25";"7.73";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152329";"";"None";"515.51";"2";"5.84";"18";"CC(C)C1=C(C(=O)N2CCN(C)CC2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.49";"0.24";"0.08";"15.12";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3653232";"";"None";"552.46";"2";"6.61";"15b";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"14.27";"0.28";"1.28";"9.57";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL1256047";"";"None";"871.09";"2";"4.67";"2b";"CC[C@H](C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCCCC1)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1261727";"Inhibition of GST-tagged p53 binding to Hdm2 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255504";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";""
"CHEMBL4524094";"";"None";"1109.02";"None";"None";"18";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCC1CCCCC1";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"4.68";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL2347400";"";"None";"501.26";"2";"6.57";"8";"CN1C[C@H](Cc2ccccc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL2173003";"Inhibition of HDM2 binding to p53";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2169777";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL3653159";"";"None";"538.45";"2";"7.95";"11";"COc1cccc(F)c1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"";"UO_0000065";"18.14";"0.36";"1.82";"20.63";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3691737";"";"None";"520.46";"2";"7.68";"1";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"18.99";"0.38";"2.21";"20.87";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3236652";"";"None";"663.69";"2";"7.45";"32";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nc(C(=O)O)cs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"14.16";"0.30";"1.95";"8.98";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236655";"";"None";"681.68";"2";"7.59";"35";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.67";"0.31";"2.41";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236635";"";"None";"677.69";"2";"6.37";"15";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CC[C@@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"12.90";"0.27";"2.37";"7.80";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3704493";"";"None";"464.37";"0";"4.37";"BDBM170249";"CC(C)(C)C[C@H]1N[C@@H](C(N)=O)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314199";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704499";"";"None";"654.64";"1";"3.58";"BDBM170255";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCN(S(C)(=O)=O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314205";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704500";"";"None";"464.37";"0";"4.37";"BDBM170256";"CC(C)(C)C[C@H]1N[C@@H](C(N)=O)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314206";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665579";"";"None";"548.49";"1";"4.91";"BDBM119711";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314214";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704509";"";"None";"604.60";"1";"4.64";"BDBM170269";"CN1CCN(CCCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314218";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704510";"";"None";"566.50";"1";"4.13";"BDBM170270";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCC(C)(O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314219";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663858";"";"None";"608.54";"2";"3.64";"BDBM170376";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2(CCO)CCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"314346";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704483";"";"None";"550.46";"1";"3.95";"BDBM170237";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCC(=O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314187";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704541";"";"None";"561.49";"1";"4.23";"BDBM170305";"CC(=O)N1CC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"3000.0";"nM";"";"";"314263";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3959463";"";"None";"675.67";"2";"6.23";"BDBM170310";"CC(C)C[C@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"3000.0";"nM";"";"";"314268";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3961782";"";"None";"562.51";"2";"5.30";"BDBM119726";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314275";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663809";"";"None";"600.52";"1";"4.33";"BDBM170320";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCCc2ccccc2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"1000.0";"nM";"";"";"314292";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663813";"";"None";"566.50";"1";"4.08";"BDBM60498";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'>'";"3000.0";"nM";"";"";"314296";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663814";"";"None";"614.55";"1";"4.67";"BDBM170326";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CCCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"314298";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663818";"";"None";"592.54";"1";"4.62";"BDBM170330";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CCC1CCCC1";"IC50";"'<'";"10000.0";"nM";"";"";"314302";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663865";"";"None";"537.55";"1";"2.85";"BDBM170384";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2ccc(F)c(F)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"314354";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663869";"";"None";"451.37";"0";"4.88";"BDBM170390";"CC(C)(C)C[C@H]1N[C@@H](CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314359";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663813";"";"None";"566.50";"1";"4.08";"BDBM60498";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'>'";"3000.0";"nM";"";"";"314309";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663827";"";"None";"594.56";"1";"4.91";"BDBM170344";"CCCCC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314315";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663828";"";"None";"594.56";"1";"4.77";"BDBM170345";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314316";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663862";"";"None";"536.02";"1";"3.23";"BDBM170380";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314350";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663878";"";"None";"583.48";"1";"4.95";"BDBM170404";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CN(CC(F)F)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314370";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4109822";"";"None";"661.65";"2";"5.84";"BDBM170313";"CC(C)[C@@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314271";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647043";"";"None";"537.59";"2";"6.98";"BDBM135103";"CC(C)c1ccnc(-c2nc3cc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"286122";"UO_0000065";"14.02";"0.26";"0.56";"8.11";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647053";"";"None";"562.00";"2";"5.85";"BDBM135113";"C[C@H]1CC[C@H](Cn2c(N3CCCC3C(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286132";"UO_0000065";"16.01";"0.32";"3.15";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647061";"";"None";"566.11";"2";"5.71";"BDBM135123";"COC(C)(C)[C@@H]1CCCN1c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286142";"UO_0000065";"15.37";"0.30";"2.99";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703347";"";"None";"968.87";"3";"7.24";"BDBM152974";"COCCOCCOCCOCCOCCOCCOC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.06";"nM";"8.30";"";"293798";"UO_0000065";"8.56";"0.17";"1.06";"4.34";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3932760";"";"None";"546.06";"1";"4.79";"BDBM119738";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"308.32";"nM";"6.51";"";"246776";"UO_0000065";"11.92";"0.23";"1.72";"7.20";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3929802";"";"None";"562.51";"2";"5.30";"BDBM119742";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"184.74";"nM";"6.73";"";"246792";"UO_0000065";"11.97";"0.24";"1.43";"7.44";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135209";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'<'";"1.0";"nM";"";"";"268718";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3945674";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@@H]1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"268731";"UO_0000065";"14.57";"0.28";"2.73";"7.00";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3894230";"";"None";"615.16";"1";"4.17";"BDBM135302";"C[C@H]1CN(S(C)(=O)=O)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268811";"UO_0000065";"13.85";"0.28";"4.35";"5.96";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649944";"";"None";"605.14";"2";"5.15";"BDBM135313";"CC1C(C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)CCN1C(=O)C1CC1";"IC50";"'='";"68.0";"nM";"7.17";"";"268822";"UO_0000065";"11.84";"0.23";"2.02";"5.69";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649953";"";"None";"641.12";"2";"5.40";"BDBM135322";"C[C@@H]1CN(C(=O)C2CC2(F)F)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268831";"UO_0000065";"13.10";"0.25";"3.00";"6.66";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649959";"";"None";"551.09";"2";"6.58";"BDBM135328";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268837";"UO_0000065";"15.79";"0.30";"2.12";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649961";"";"None";"497.00";"1";"5.41";"BDBM135332";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268841";"UO_0000065";"16.19";"0.31";"2.64";"7.20";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268845";"UO_0000065";"15.40";"0.30";"2.35";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650059";"";"None";"569.14";"2";"5.95";"BDBM135929";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(C(C)=O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"602.0";"nM";"6.22";"";"269507";"UO_0000065";"10.93";"0.21";"0.27";"9.11";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657032";"";"None";"607.54";"2";"6.54";"BDBM129938";"COc1cc(C(=O)NCCO)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.25";"nM";"9.60";"";"261668";"UO_0000065";"15.80";"0.31";"3.06";"9.93";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653178";"";"None";"550.49";"2";"7.31";"BDBM129743";"COc1cc(CO)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261474";"UO_0000065";"17.96";"0.36";"2.58";"14.63";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703352";"";"None";"761.61";"2";"6.55";"BDBM152983";"COc1cc(C(=O)OCOC(=O)N[C@@H](C)C(=O)O)ccc1NC(=O)[C@@H]1NC(CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)C1c1cccc(Cl)c1F";"IC50";"'='";"6.96";"nM";"8.16";"";"293807";"UO_0000065";"10.71";"0.21";"1.61";"4.63";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649903";"";"None";"552.08";"2";"5.32";"BDBM135254";"CC[C@@H]1[C@@H](C)OCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286273";"UO_0000065";"16.30";"0.32";"3.68";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649936";"";"None";"593.13";"2";"5.15";"BDBM135305";"CCC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286324";"UO_0000065";"14.37";"0.28";"3.37";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3942694";"";"None";"623.16";"2";"5.76";"BDBM135309";"CC(C)OC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286328";"UO_0000065";"13.68";"0.26";"2.76";"6.30";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649851";"";"None";"575.08";"2";"4.79";"BDBM135187";"Cn1ncnc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"286206";"UO_0000065";"13.35";"0.26";"2.89";"5.63";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649880";"";"None";"565.08";"1";"4.42";"BDBM135219";"CCNC(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"50.0";"nM";"7.30";"";"286238";"UO_0000065";"12.92";"0.25";"2.88";"5.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649920";"";"None";"530.03";"2";"6.08";"BDBM135281";"CN(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"132.0";"nM";"6.88";"";"286300";"UO_0000065";"12.98";"0.25";"0.80";"6.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649922";"";"None";"516.01";"2";"6.06";"BDBM135283";"C[C@H]1CC[C@H](Cn2c(Nc3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"286302";"UO_0000065";"15.01";"0.29";"1.68";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649923";"";"None";"564.09";"2";"5.64";"BDBM135284";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCO[C@@H]3CCC[C@H]32)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"2.0";"nM";"8.70";"";"286303";"UO_0000065";"15.42";"0.30";"3.06";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3945283";"";"None";"538.05";"1";"4.84";"BDBM135295";"CC([C@H]1CC[C@H](C)CC1)n1c(N2C[C@@H](O)C[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"4.0";"nM";"8.40";"";"286314";"UO_0000065";"15.61";"0.30";"3.56";"6.67";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649948";"";"None";"627.10";"2";"5.15";"BDBM135317";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C(F)F)[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286336";"UO_0000065";"13.59";"0.26";"3.37";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649970";"";"None";"559.07";"2";"6.44";"BDBM135351";"CCOC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286370";"UO_0000065";"16.10";"0.31";"2.56";"8.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286377";"UO_0000065";"14.68";"0.28";"2.38";"6.60";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649980";"";"None";"565.02";"2";"6.69";"BDBM135367";"CC(F)(c1ccccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"286387";"UO_0000065";"13.63";"0.26";"1.01";"7.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650000";"";"None";"664.99";"2";"6.66";"BDBM135396";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3c(Br)c(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286415";"UO_0000065";"13.08";"0.28";"2.04";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650020";"";"None";"541.05";"2";"5.60";"BDBM135423";"CCOC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286442";"UO_0000065";"15.34";"0.30";"2.70";"6.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650020";"";"None";"541.05";"2";"5.60";"BDBM135423";"CCOC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286443";"UO_0000065";"15.75";"0.31";"2.92";"7.05";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650013";"";"None";"525.03";"1";"4.99";"BDBM135413";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4n[nH]c(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"286432";"UO_0000065";"15.24";"0.30";"3.01";"7.38";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653314";"";"None";"593.13";"2";"5.14";"BDBM135433";"CN(C)c1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"286452";"UO_0000065";"14.67";"0.28";"3.56";"7.36";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649962";"";"None";"511.03";"2";"5.80";"BDBM135334";"CCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286354";"UO_0000065";"15.84";"0.31";"2.30";"7.25";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663836";"";"None";"626.57";"2";"5.25";"BDBM170353";"CC(C)CC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'>'";"1000.0";"nM";"";"";"314324";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663847";"";"None";"582.50";"2";"2.79";"BDBM170365";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC[C@H](O)[C@H](O)CO)[C@H](Cc2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314335";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704505";"";"None";"611.57";"1";"4.08";"BDBM170261";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@H](NS(C)(=O)=O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314211";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4113856";"";"None";"534.46";"1";"4.52";"BDBM170260";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CC(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314213";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3929636";"";"None";"546.06";"1";"4.79";"BDBM119721";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314251";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286177";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3938767";"";"None";"524.03";"1";"4.28";"BDBM135160";"C[C@H]1C[C@H](O)CN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286179";"UO_0000065";"15.69";"0.30";"3.94";"6.53";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703346";"";"None";"792.66";"3";"7.17";"BDBM152971";"COCCOCCOC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"4.21";"nM";"8.38";"";"293797";"UO_0000065";"10.57";"0.21";"1.21";"5.42";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1689395";"";"None";"1891.17";"None";"None";"1a";"C=C(C)C(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCNC(=O)c1nnn(-c2ccc(OC)cc2)n1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"3.78";"None";"None";"None";"0";"CHEMBL1694393";"Inhibition of human GST-tagged Mdm2 expressed in Escherichia coli harboring integrated p53-Mmd2 protein assessed as blockade of enzyme-p53 interaction by ELISA assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687880";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135228";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286248";"UO_0000065";"14.55";"0.28";"3.85";"6.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3952705";"";"None";"534.07";"1";"4.91";"BDBM135414";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nn[nH]n4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286433";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286366";"UO_0000065";"15.03";"0.29";"2.70";"7.05";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688156";"";"None";"427.91";"0";"3.59";"30";"CS(=O)(=O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688293";"";"None";"475.97";"1";"5.19";"95";"CC(=O)c1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"10.02";"0.19";"-0.42";"7.14";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL2347394";"";"None";"580.28";"2";"6.40";"2";"COc1cccc2c1C1=C([C@H](c3ccc(Br)cc3)n3ncnc3N1C)[C@@H](c1ccc(Br)cc1)O2";"IC50";"'='";"960.0";"nM";"6.02";"";"";"UO_0000065";"10.37";"0.24";"-0.38";"11.48";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347378";"";"None";"432.35";"1";"5.55";"33";"O=C(O)C[C@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"12.81";"0.26";"-0.01";"9.61";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3693983";"";"None";"559.47";"1";"4.13";"38";"CC(=O)N1CC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'='";"16.9";"nM";"7.77";"";"";"UO_0000065";"13.89";"0.28";"3.64";"8.58";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693982";"";"None";"603.52";"1";"4.45";"37";"O=C(O)CN1CCC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"12.79";"0.26";"3.27";"6.97";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3704540";"";"None";"647.58";"1";"4.55";"BDBM170304";"CC(=O)OC(C)(C)C(=O)N1CC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"1000.0";"nM";"";"";"314262";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704542";"";"None";"618.58";"2";"5.19";"BDBM170306";"CCCCNC(=O)N1CC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"100.0";"nM";"";"";"314264";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703350";"";"None";"805.70";"2";"7.13";"BDBM152977";"COCCOCCNC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.09";"nM";"8.29";"";"293801";"UO_0000065";"10.29";"0.21";"1.16";"5.27";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601402";"";"None";"660.26";"2";"5.98";"BDBM162142";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"7.0";"nM";"8.15";"";"305032";"UO_0000065";"12.35";"0.24";"2.17";"10.40";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650051";"";"None";"501.07";"1";"4.85";"BDBM135921";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(C)CCO)CC1)C(=O)C2";"IC50";"'='";"6429.0";"nM";"5.19";"";"269499";"UO_0000065";"10.36";"0.20";"0.34";"8.34";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4585112";"";"None";"2745.15";"None";"None";"Peptide 3";"CC(C)C[C@H](NC(=O)COCCOCCNC(=O)CC[C@@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H](Cc2ccccc2)NC1=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"2.78";"None";"None";"None";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4443840";"";"None";"3418.98";"None";"None";"Peptide 6";"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)COCCOCCNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCCNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)[C@@H](C)O)C(N)=O";"IC50";"'='";"11.9";"nM";"7.92";"";"";"UO_0000065";"2.32";"None";"None";"None";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3703316";"";"None";"838.71";"2";"10.11";"BDBM152941";"COc1cc(C(=O)OCOP(=O)(OC(C)(C)C)OC(C)(C)C)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"10.8";"nM";"7.97";"";"293764";"UO_0000065";"9.50";"0.19";"-2.14";"5.49";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703318";"";"None";"786.70";"2";"7.13";"BDBM152943";"COc1cc(C(=O)OC(C)OC(=O)N2CCN(C)CC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"18.7";"nM";"7.73";"";"293766";"UO_0000065";"9.82";"0.20";"0.60";"5.80";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"5.0";"nM";"8.30";"";"286198";"UO_0000065";"15.43";"0.30";"3.37";"7.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649874";"";"None";"540.07";"2";"5.18";"BDBM135212";"COC(C)(C)CN(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286231";"UO_0000065";"14.90";"0.29";"2.87";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704482";"";"None";"550.46";"1";"3.95";"BDBM170236";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)C=O)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314186";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704488";"";"None";"566.50";"1";"4.13";"BDBM170242";"CC(O)C(O)CCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"2000.0";"nM";"";"";"314192";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704497";"";"None";"604.60";"1";"4.64";"BDBM170253";"CN1CCN(CCCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314203";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704501";"";"None";"548.49";"1";"4.91";"BDBM170257";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2CC[C@@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314207";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663817";"";"None";"578.51";"1";"4.28";"BDBM170329";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCC2CCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"3000.0";"nM";"";"";"314301";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4592815";"";"None";"1895.39";"None";"None";"PS3";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"2.72";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4586161";"";"None";"1645.12";"None";"None";"PS2";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(N)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"3.03";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4585139";"";"None";"1879.44";"None";"None";"PS6";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"3.11";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4441886";"";"None";"1945.88";"None";"None";"PS10";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC1CCC1)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'='";"891.0";"nM";"6.05";"";"";"UO_0000065";"3.11";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4474794";"";"None";"2014.00";"None";"None";"PS12";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN1CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)CN(S(C)(=O)=O)CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(=O)(=O)CC/C=C/CCCCS1(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"2.70";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3407569";"";"None";"731.78";"2";"7.73";"19";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)NC23CCC(C(=O)O)(CC2)CC3)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"12.51";"0.26";"1.42";"7.58";"0";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407570";"";"None";"691.72";"2";"6.76";"20";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CCC(C(=O)O)CC2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.79";"nM";"9.10";"";"";"UO_0000065";"13.16";"0.27";"2.34";"8.12";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407565";"";"None";"713.72";"2";"7.70";"15";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccc(CC(=O)O)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"13.56";"0.28";"1.98";"8.01";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407556";"";"None";"655.69";"2";"8.08";"6";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccccc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.37";"nM";"9.43";"";"";"UO_0000065";"14.38";"0.29";"1.35";"11.29";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3703319";"";"None";"702.58";"2";"7.31";"BDBM152944";"COc1cc(C(=O)OC(C)OC(C)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"10.4";"nM";"7.98";"";"293767";"UO_0000065";"11.36";"0.23";"0.67";"6.30";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703329";"";"None";"817.71";"2";"7.62";"BDBM152954";"COc1cc(C(=O)OC(C)OC(=O)NCC2COC(C)(C)O2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"12.8";"nM";"7.89";"";"293778";"UO_0000065";"9.65";"0.19";"0.27";"5.02";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703333";"";"None";"894.79";"3";"7.59";"BDBM152958";"COCCOCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"51.4";"nM";"7.29";"";"293782";"UO_0000065";"8.15";"0.16";"-0.30";"4.22";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"2.0";"nM";"8.70";"";"286184";"UO_0000065";"14.50";"0.28";"2.42";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649879";"";"None";"545.05";"2";"5.88";"BDBM135218";"CC(Nc1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)c1ccccn1";"IC50";"'='";"2.0";"nM";"8.70";"";"286237";"UO_0000065";"15.96";"0.30";"2.82";"6.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649904";"";"None";"586.04";"2";"5.32";"BDBM135255";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"286275";"UO_0000065";"11.75";"0.23";"1.57";"5.99";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649909";"";"None";"564.09";"2";"5.46";"BDBM135267";"C[C@H]1CC[C@H](Cn2c(N3CCCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286287";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3355428";"";"None";"518.42";"1";"4.03";"28D";"C[C@]1(O)C[C@@H](NC(=O)[C@@H]2NC3(CCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'='";"396.0";"nM";"6.40";"";"";"UO_0000065";"12.35";"0.25";"2.37";"7.08";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3691765";"";"None";"545.00";"1";"3.81";"BDBM143646";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.247";"nM";"8.90";"";"279806";"UO_0000065";"16.34";"0.31";"5.09";"6.80";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687261";"";"None";"472.42";"1";"6.33";"BDBM143384";"COCCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"4.4";"nM";"8.36";"";"279529";"UO_0000065";"17.69";"0.36";"2.03";"17.64";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653211";"";"None";"546.01";"2";"6.09";"BDBM129776";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N(C)C)nc4OC)n3C(C)C)C(=O)N2c2cccc(Cl)c2F)cc1";"IC50";"'='";"0.19";"nM";"9.72";"";"261507";"UO_0000065";"17.80";"0.34";"3.63";"12.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1256073";"";"None";"757.93";"2";"4.14";"2a";"CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)N1CCCCC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1261727";"Inhibition of GST-tagged p53 binding to Hdm2 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255504";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";""
"CHEMBL3891292";"";"None";"827.80";"2";"8.13";"BDBM60495";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(OC(=O)[C@H](Cc3ccccc3)NC(=O)OC(C)(C)C)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"221946";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4110236";"";"None";"568.04";"1";"3.71";"BDBM60500";"CN1[C@@H](C(=O)NCC[C@@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]2(C(=O)Nc3cc(F)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'<'";"10000.0";"nM";"";"";"221949";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL379656";"";"None";"595.22";"2";"5.95";"2";"O=C(O)C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL3649926";"";"None";"570.07";"2";"5.44";"BDBM135290";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286309";"UO_0000065";"15.79";"0.31";"3.56";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3945283";"";"None";"538.05";"1";"4.84";"BDBM135295";"CC([C@H]1CC[C@H](C)CC1)n1c(N2C[C@@H](O)C[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"3.0";"nM";"8.52";"";"286315";"UO_0000065";"15.84";"0.31";"3.68";"6.77";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653311";"";"None";"615.98";"2";"5.45";"BDBM135429";"O=c1[nH]c(-c2cc3nc(N4CCO[C@@H]5CCC[C@H]54)n(Cc4ccc(C(F)(F)F)c(F)c4)c3c(-c3cncc(Cl)c3)n2)no1";"IC50";"'='";"244.0";"nM";"6.61";"";"268938";"UO_0000065";"10.74";"0.21";"1.16";"5.75";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3675206";"";"None";"408.84";"0";"4.41";"BDBM111527";"Cc1cccc2c1C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(O)c1ccc(Cl)cc1";"IC50";"'='";"6900.0";"nM";"5.16";"";"232324";"UO_0000065";"12.62";"0.24";"0.75";"6.17";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675214";"";"None";"409.27";"0";"4.71";"BDBM111537";"N#Cc1ccc(CN2C(=O)c3c(Cl)cccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"8950.0";"nM";"5.05";"";"232334";"UO_0000065";"12.33";"0.25";"0.34";"7.85";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL2347379";"";"None";"432.35";"1";"5.55";"35";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347385";"";"None";"376.28";"1";"5.04";"19";"O=C1CO[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347379";"";"None";"432.35";"1";"5.55";"35";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"11.78";"0.24";"-0.46";"8.84";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3665578";"";"None";"552.47";"1";"3.74";"BDBM119710";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"104.0";"nM";"6.98";"";"246801";"UO_0000065";"12.64";"0.26";"3.24";"6.31";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3920895";"";"None";"564.05";"1";"4.93";"BDBM119740";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"70.2";"nM";"7.15";"";"246811";"UO_0000065";"12.68";"0.25";"2.22";"7.91";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703677";"";"None";"389.89";"1";"5.81";"BDBM47300";"Cc1ccc(C)c(C(Nc2cccnc2)c2cc(Cl)c3cccnc3c2O)c1";"IC50";"'='";"17000.0";"nM";"4.77";"";"198814";"UO_0000065";"12.23";"0.23";"-1.04";"8.22";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3288447";"";"None";"717.11";"2";"5.55";"13";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"169.0";"nM";"6.77";"";"";"UO_0000065";"9.95";"0.19";"1.22";"8.02";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3649833";"";"None";"485.99";"1";"5.61";"BDBM135164";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268673";"UO_0000065";"17.54";"0.34";"2.91";"10.13";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649868";"";"None";"565.08";"1";"4.37";"BDBM135204";"CN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268713";"UO_0000065";"14.43";"0.28";"3.78";"6.47";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649872";"";"None";"576.06";"3";"5.35";"BDBM135208";"Cc1nc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"268717";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3945674";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@@H]1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"18.0";"nM";"7.75";"";"268733";"UO_0000065";"14.03";"0.27";"2.42";"6.74";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649901";"";"None";"586.04";"2";"5.32";"BDBM135252";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC(F)(F)[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268761";"UO_0000065";"15.36";"0.30";"3.68";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3944856";"";"None";"524.03";"1";"4.54";"BDBM135132";"C[C@H]1COCCN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268641";"UO_0000065";"16.03";"0.31";"3.86";"7.31";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649814";"";"None";"574.01";"2";"5.70";"BDBM135139";"C[C@H]1CC[C@H](Cn2c(N3CCC4C3C4C(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"268648";"UO_0000065";"13.06";"0.26";"1.79";"7.09";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3112895";"";"None";"410.30";"1";"6.15";"BDBM50447144";"Cc1ccnc(NC(c2ccc(Cl)c(Cl)c2)c2ccc3cccnc3c2O)c1";"IC50";"'='";"3600.0";"nM";"5.44";"";"298934";"UO_0000065";"13.27";"0.27";"-0.71";"9.38";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703654";"";"None";"429.83";"1";"6.21";"BDBM156478";"Oc1c(C(Nc2ccc(Cl)cn2)c2ccc(C(F)(F)F)cc2)ccc2cccnc12";"IC50";"'='";"12000.0";"nM";"4.92";"";"298936";"UO_0000065";"11.45";"0.22";"-1.29";"8.48";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703661";"";"None";"424.33";"1";"6.46";"BDBM156517";"Cc1cccc(NC(c2ccc3ccc(C)nc3c2O)c2c(Cl)cccc2Cl)n1";"IC50";"'='";"16000.0";"nM";"4.80";"";"298943";"UO_0000065";"11.30";"0.23";"-1.66";"8.26";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3640025";"";"None";"414.27";"1";"5.98";"BDBM156540";"Oc1c(C(Nc2ccc(F)cn2)c2ccc(Cl)c(Cl)c2)ccc2cccnc12";"IC50";"'='";"9000.0";"nM";"5.05";"";"298946";"UO_0000065";"12.18";"0.25";"-0.93";"8.69";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703678";"";"None";"409.41";"1";"5.86";"BDBM47305";"Cc1cccc(NC(c2ccc(C(F)(F)F)cc2)c2ccc3cccnc3c2O)n1";"IC50";"'='";"4000.0";"nM";"5.40";"";"298925";"UO_0000065";"13.18";"0.25";"-0.46";"9.30";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703665";"";"None";"428.29";"1";"6.29";"BDBM156545";"Cc1cc(NC(c2cc(Cl)ccc2Cl)c2ccc3cccnc3c2O)ncc1F";"IC50";"'='";"24000.0";"nM";"4.62";"";"298948";"UO_0000065";"10.79";"0.22";"-1.67";"7.96";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657016";"";"None";"596.48";"1";"3.87";"BDBM129920";"COc1nc(N2CC(O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.26";"nM";"9.59";"";"261651";"UO_0000065";"16.07";"0.32";"5.72";"8.08";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653189";"";"None";"535.48";"2";"7.46";"BDBM129754";"CCc1nc(OC)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.47";"nM";"9.33";"";"261485";"UO_0000065";"17.42";"0.34";"1.87";"15.48";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657022";"";"None";"564.47";"2";"6.29";"BDBM129926";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cncc(Cl)c1)C2=O";"IC50";"'='";"1.05";"nM";"8.98";"";"261657";"UO_0000065";"15.91";"0.31";"2.69";"11.15";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687238";"";"None";"583.56";"2";"7.86";"BDBM143347";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCN(C(=O)OC(C)(C)C)C3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"41.7";"nM";"7.38";"";"279506";"UO_0000065";"12.65";"0.25";"-0.48";"10.91";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687240";"";"None";"484.36";"1";"5.97";"BDBM143349";"CC(C)c1c2c(nn1Cc1ncc[nH]1)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)cc1";"IC50";"'='";"33.9";"nM";"7.47";"";"279508";"UO_0000065";"15.42";"0.31";"1.50";"11.18";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653228";"";"None";"525.40";"2";"5.39";"BDBM129793";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cncc(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"1.02";"nM";"8.99";"";"261523";"UO_0000065";"17.11";"0.34";"3.60";"9.44";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683131";"";"None";"507.03";"2";"6.19";"BDBM161868";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C(C)=O)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"607.2";"nM";"6.22";"";"304978";"UO_0000065";"12.26";"0.24";"0.03";"10.52";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2443384";"";"None";"337.77";"0";"3.14";"28";"Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3ccc(Cl)cc3)c2c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL4524070";"";"None";"1038.36";"None";"None";"27";"Cc1ccc(CCNC(=O)N(CC(CCCCN)N(CC(CCC(=O)O)NC(=O)CCC(C)C)C(=O)NCCCC2CCCCC2)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc2ccc(F)cc2)cc1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"5.33";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL611330";"";"None";"945.60";"2";"4.49";"4";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Cl)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccccc1";"IC50";"'='";"43000.0";"nM";"4.37";"";"";"UO_0000065";"4.62";"0.09";"-0.12";"1.48";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3687250";"";"None";"454.40";"1";"6.87";"BDBM143370";"C=CCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.099";"nM";"8.96";"";"279750";"UO_0000065";"19.72";"0.39";"2.09";"23.50";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639521";"";"None";"529.00";"2";"5.52";"BDBM129840";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(C#N)cc2C)C3=O)c(OC)n1";"IC50";"'='";"4.97";"nM";"8.30";"";"261569";"UO_0000065";"15.70";"0.30";"2.78";"7.82";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2443389";"";"None";"371.32";"0";"3.26";"21";"O=c1nc2n(Cc3ccccc3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1688257";"";"None";"476.92";"0";"4.81";"57";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"12.00";"0.23";"0.91";"6.16";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688263";"";"None";"470.40";"1";"6.20";"63";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCCCCO)c1ccc(Cl)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"11.91";"0.24";"-0.60";"11.26";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688283";"";"None";"463.96";"0";"4.99";"84";"COc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"11.97";"0.23";"0.56";"9.41";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688286";"";"None";"484.00";"1";"6.14";"87";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccc2ccccc12";"IC50";"'='";"49000.0";"nM";"4.31";"";"";"UO_0000065";"8.90";"0.17";"-1.83";"8.66";"1";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688296";"";"None";"434.92";"0";"4.38";"98";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccnc1";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"10.43";"0.20";"0.16";"7.24";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688303";"";"None";"478.93";"0";"4.89";"74a, (+)-(R)-enantiomer";"O=C1c2ccccc2[C@](OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.13";"0.27";"1.88";"7.29";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL4436594";"";"None";"1933.87";"None";"None";"PS5";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"2.75";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4448426";"";"None";"1853.36";"None";"None";"PS7";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](CO)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"4140.0";"nM";"5.38";"";"";"UO_0000065";"2.90";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3402518";"";"None";"671.67";"2";"6.11";"5";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCNC3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"11.65";"0.24";"1.71";"9.64";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3402521";"";"None";"703.69";"2";"6.45";"8, DS-5272";"CC[C@@H]1CNC2(CC2)CN1C(=O)[C@@H]1C[C@@H](F)CN1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)nc3)[C@H]2c2ccc(Cl)c(F)c2)S1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"12.25";"0.25";"2.17";"10.62";"0";"CHEMBL3405562";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with His-tagged p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400057";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";""
"CHEMBL3691734";"";"None";"536.04";"2";"7.45";"BDBM143541";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cc(C#N)ccc4OC)c3C(C)C)C(=O)N2c2cc(Cl)ccc2C)c(C)c1";"IC50";"'='";"0.176";"nM";"9.75";"";"279779";"UO_0000065";"18.20";"0.34";"2.30";"12.92";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687292";"";"None";"489.98";"1";"6.86";"BDBM143420";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(C)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"1.8";"nM";"8.74";"";"279560";"UO_0000065";"17.85";"0.34";"1.88";"18.46";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653282";"";"None";"553.07";"1";"3.56";"BDBM129850";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CN(C)C(=O)N(C)C1)C2=O";"IC50";"'='";"0.41";"nM";"9.39";"";"261579";"UO_0000065";"16.97";"0.33";"5.83";"9.39";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653250";"";"None";"560.06";"1";"4.81";"BDBM129815";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(C(N)=O)cc1C)C2=O";"IC50";"'='";"0.32";"nM";"9.49";"";"261545";"UO_0000065";"16.95";"0.32";"4.68";"7.95";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650074";"";"None";"528.13";"2";"6.97";"BDBM135944";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(O)CC(C)C)CC1)C(=O)C2";"IC50";"'='";"3.9";"nM";"8.41";"";"269522";"UO_0000065";"15.92";"0.31";"1.44";"14.25";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3355417";"";"None";"574.52";"2";"5.59";"18D";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"15.6";"nM";"7.81";"";"";"UO_0000065";"13.59";"0.27";"2.22";"8.63";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2443382";"";"None";"402.63";"0";"3.59";"30";"O=c1nc2n(-c3ccc(Cl)cc3)c3c(Br)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"49500.0";"nM";"4.30";"";"";"UO_0000065";"10.69";"0.24";"0.72";"6.35";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440448";"";"None";"357.29";"0";"3.20";"8";"O=c1nc2n(-c3ccccc3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"17500.0";"nM";"4.76";"";"";"UO_0000065";"13.31";"0.25";"1.56";"7.02";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1818538";"";"None";"609.55";"2";"6.62";"6";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"11.48";"0.23";"0.38";"9.37";"0";"CHEMBL2383516";"Antagonist activity at human GST-tagged MDM2 assessed as inhibition of binding to full length p53";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3236641";"";"None";"657.66";"2";"7.38";"21";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cccc(C(=O)O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"13.56";"0.28";"1.54";"8.53";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236649";"";"None";"658.65";"2";"6.78";"29";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2cnc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.18";"0.31";"3.22";"8.51";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3653260";"";"None";"560.49";"2";"7.27";"BDBM129827";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.28";"nM";"9.55";"";"261556";"UO_0000065";"17.04";"0.33";"2.28";"11.37";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687314";"";"None";"507.42";"2";"6.76";"BDBM143443";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cncc(Cl)c1)C2=O";"IC50";"'='";"83.3";"nM";"7.08";"";"279582";"UO_0000065";"13.95";"0.28";"0.32";"11.75";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657034";"";"None";"518.49";"2";"8.37";"BDBM129940";"CCc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.24";"nM";"9.62";"";"261670";"UO_0000065";"18.55";"0.36";"1.25";"25.23";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657122";"";"None";"585.45";"1";"4.32";"BDBM130040";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.135";"nM";"9.87";"";"261761";"UO_0000065";"16.86";"0.34";"5.55";"8.69";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650063";"";"None";"542.12";"2";"5.96";"BDBM135933";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"106.0";"nM";"6.97";"";"269511";"UO_0000065";"12.87";"0.25";"1.01";"10.22";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649927";"";"None";"566.11";"2";"5.47";"BDBM135292";"CC(C)[C@@H]1C[C@@H](O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268801";"UO_0000065";"15.90";"0.31";"3.53";"7.15";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL611333";"";"None";"1035.05";"None";"None";"11";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"41000.0";"nM";"4.39";"";"";"UO_0000065";"4.24";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.32";"0.20";"0.11";"7.19";"0";"CHEMBL1068495";"Binding to HDM2 expressed in Escherichia coli BL21 (DE3) by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3657065";"";"None";"562.99";"1";"4.98";"BDBM129975";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.28";"nM";"9.55";"";"261702";"UO_0000065";"16.97";"0.33";"4.57";"8.28";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683119";"";"None";"464.99";"1";"5.88";"BDBM161756";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(c1ccc(N(C)C)cc1)C(=O)C2";"IC50";"'='";"115.3";"nM";"6.94";"";"304965";"UO_0000065";"14.92";"0.29";"1.06";"16.52";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653271";"";"None";"554.43";"2";"5.28";"BDBM129838";"COc1ncc(-c2nc3c(n2[C@H](C)CO)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.09";"nM";"10.05";"";"261567";"UO_0000065";"18.12";"0.36";"4.77";"9.79";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653264";"";"None";"537.45";"2";"6.20";"BDBM129831";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.23";"nM";"9.64";"";"261560";"UO_0000065";"17.93";"0.36";"3.44";"13.90";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2443383";"";"None";"368.19";"0";"2.94";"29";"O=c1nc2n(-c3ccccc3)c3c(Br)cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3657112";"";"None";"602.07";"2";"5.30";"BDBM130030";"COc1nc(N2CCC[C@H](O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.319";"nM";"9.50";"";"261751";"UO_0000065";"15.77";"0.30";"4.20";"7.89";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650070";"";"None";"552.09";"2";"7.04";"BDBM135940";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(O)c3cccc(F)c3)CC1)C(=O)C2";"IC50";"'='";"72.0";"nM";"7.14";"";"269518";"UO_0000065";"12.94";"0.25";"0.10";"12.11";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2381404";"";"None";"1599.86";"None";"None";"Page No 2480, R24C2";"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O";"IC50";"'='";"313.0";"nM";"6.50";"";"";"UO_0000065";"4.07";"None";"None";"None";"0";"CHEMBL2383517";"Antagonist activity at human MDM2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2386168";"";"None";"621.61";"2";"7.13";"2a";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCNC(=O)C1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"11.72";"0.23";"0.15";"9.81";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL2152318";"";"None";"487.41";"0";"4.38";"9a";"CC1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"11.42";"0.24";"1.19";"8.57";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2151052";"";"None";"517.44";"1";"4.01";"9g";"COCC1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"9.95";"0.21";"1.14";"6.94";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"32";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"12.13";"0.24";"1.17";"8.45";"0";"CHEMBL4620014";"Inhibition of MDM2 (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619711";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL443053";"";"None";"595.22";"2";"5.58";"8";"CN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"2180.0";"nM";"5.66";"";"";"UO_0000065";"9.51";"0.23";"0.08";"7.27";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL380214";"";"None";"549.45";"2";"6.52";"23";"C#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL382422";"";"None";"624.26";"1";"4.58";"3";"O=C(NCCO)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL380214";"";"None";"549.45";"2";"6.52";"23";"C#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"69000.0";"nM";"4.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL210409";"";"None";"695.34";"2";"6.30";"15";"COC(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"67000.0";"nM";"4.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL207364";"";"None";"591.54";"2";"5.57";"12j";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1N)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCN1CCOCC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL377614";"";"None";"666.34";"2";"6.73";"12a";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.91";"0.24";"-0.13";"6.35";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL208562";"";"None";"706.46";"2";"6.11";"12k";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCN2CCN(C)CC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"546.0";"nM";"6.26";"";"";"UO_0000065";"8.87";"0.21";"0.15";"8.57";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL379656";"";"None";"595.22";"2";"5.95";"2";"O=C(O)C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"10.53";"0.26";"0.32";"7.23";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210151";"";"None";"651.33";"2";"7.14";"12b";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"67000.0";"nM";"4.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL380178";"";"None";"679.39";"2";"5.63";"23";"Nc1cc(Cl)ccc1CN1C(=O)c2cc(I)ccc2N(CCCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"8.01";"0.19";"-0.19";"6.88";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL593926";"";"None";"1082.98";"None";"None";"13";"CC(C)CCCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"4.51";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL382389";"";"None";"736.43";"2";"6.99";"16";"CCN(CC)C(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2130.0";"nM";"5.67";"";"";"UO_0000065";"7.70";"0.18";"-1.32";"5.77";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL209156";"";"None";"639.23";"2";"5.04";"11";"O=C(O)CN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"10200.0";"nM";"4.99";"";"";"UO_0000065";"7.81";"0.19";"-0.05";"4.33";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL209169";"";"None";"681.31";"2";"6.21";"13";"O=C(O)CCCCN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL209169";"";"None";"681.31";"2";"6.21";"13";"O=C(O)CCCCN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"128000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL377614";"";"None";"666.34";"2";"6.73";"12a";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"80000.0";"nM";"4.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL377203";"";"None";"679.39";"2";"5.80";"12e";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL208562";"";"None";"706.46";"2";"6.11";"12k";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCN2CCN(C)CC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL207364";"";"None";"591.54";"2";"5.57";"12j";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1N)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCN1CCOCC1";"IC50";"'='";"787.0";"nM";"6.10";"";"";"UO_0000065";"10.32";"0.20";"0.53";"7.72";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210545";"";"None";"668.36";"2";"6.13";"12i";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N([C@H](C)c2ccc(Cl)cc2N)C(=O)c2cc(I)ccc21";"IC50";"'='";"394.0";"nM";"6.41";"";"";"UO_0000065";"9.58";"0.23";"0.27";"7.53";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL1256072";"";"None";"1251.45";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)O";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"3.83";"None";"None";"None";"0";"CHEMBL1261727";"Inhibition of GST-tagged p53 binding to Hdm2 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255504";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";""
"CHEMBL3657078";"";"None";"539.42";"2";"5.70";"BDBM129995";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"2.813";"nM";"8.55";"";"261716";"UO_0000065";"15.85";"0.32";"2.85";"8.98";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691716";"";"None";"470.34";"1";"5.91";"BDBM143488";"CC(C)c1c2c(nn1-c1cn[nH]c1)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)cc1";"IC50";"'='";"22.5";"nM";"7.65";"";"279612";"UO_0000065";"16.26";"0.33";"1.74";"11.45";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687287";"";"None";"537.42";"2";"6.60";"BDBM143415";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccc(C(N)=O)cc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"11.5";"nM";"7.94";"";"279555";"UO_0000065";"14.77";"0.29";"1.34";"9.78";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656990";"";"None";"553.42";"2";"6.43";"BDBM129892";"COc1ccc(C(N)=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.08";"nM";"10.10";"";"261623";"UO_0000065";"18.24";"0.36";"3.67";"11.16";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657083";"";"None";"568.47";"1";"4.75";"BDBM130000";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.081";"nM";"10.09";"";"261721";"UO_0000065";"17.75";"0.35";"5.34";"10.26";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653200";"";"None";"545.00";"1";"4.62";"BDBM129765";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(NC)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)c(=O)n(C)c2)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"261496";"UO_0000065";"16.92";"0.32";"4.60";"8.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657064";"";"None";"540.99";"2";"6.01";"BDBM129974";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"60.4";"nM";"7.22";"";"261701";"UO_0000065";"13.34";"0.25";"1.21";"6.69";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653199";"";"None";"559.03";"1";"4.65";"BDBM129764";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N(C)C)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)c(=O)n(C)c2)cc1";"IC50";"'='";"0.27";"nM";"9.57";"";"261495";"UO_0000065";"17.12";"0.33";"4.92";"9.31";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653255";"";"None";"559.03";"1";"3.97";"BDBM129821";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.64";"nM";"9.19";"";"261550";"UO_0000065";"16.45";"0.31";"5.22";"7.53";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687258";"";"None";"476.38";"1";"6.16";"BDBM143381";"COCCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"4.2";"nM";"8.38";"";"279526";"UO_0000065";"17.58";"0.36";"2.22";"17.69";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650065";"";"None";"540.10";"2";"6.16";"BDBM135935";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(C1CCC(C(=O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"386.0";"nM";"6.41";"";"269513";"UO_0000065";"11.87";"0.23";"0.25";"9.86";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691711";"";"None";"580.52";"2";"5.78";"BDBM143477";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(CCN(C)C)c1)C2=O";"IC50";"'='";"3.8";"nM";"8.42";"";"279606";"UO_0000065";"14.50";"0.29";"2.64";"11.60";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683130";"";"None";"465.98";"1";"5.70";"BDBM161863";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(CO)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"410.5";"nM";"6.39";"";"304976";"UO_0000065";"13.71";"0.26";"0.69";"10.82";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691712";"";"None";"458.36";"1";"6.85";"BDBM143478";"Cc1cc(Cl)ccc1C1c2c(nn(C3CC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.3";"nM";"8.08";"";"279607";"UO_0000065";"17.63";"0.36";"1.23";"21.19";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2386351";"";"None";"755.85";"2";"8.54";"2l";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](CC)(c2ccc(Cl)cc2)[C@@](CC)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"2163.0";"nM";"5.67";"";"";"UO_0000065";"7.49";"0.15";"-2.88";"6.86";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL2386347";"";"None";"728.79";"2";"6.87";"2h";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCNS(C)(=O)=O)CC1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"10.07";"0.20";"0.47";"7.76";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3657088";"";"None";"569.45";"1";"4.87";"BDBM130005";"COc1ncc(-c2nc3c(n2C(C)C)C(C)(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.71";"nM";"9.15";"";"261726";"UO_0000065";"16.07";"0.32";"4.28";"8.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1834374";"";"None";"496.92";"1";"5.03";"BDBM111542";"O=C1c2ccc(F)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"295.0";"nM";"6.53";"";"232339";"UO_0000065";"13.14";"0.25";"1.50";"7.03";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL377639";"";"None";"679.39";"2";"5.80";"12f";"C[C@@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"13100.0";"nM";"4.88";"";"";"UO_0000065";"7.19";"0.17";"-0.92";"6.17";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3236358";"";"None";"592.59";"2";"5.80";"6";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.88";"0.35";"4.20";"9.18";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236636";"";"None";"677.69";"2";"6.37";"16";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N2CC[C@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.76";"0.30";"3.63";"8.92";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236650";"";"None";"656.67";"2";"7.99";"30";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"11.28";"0.23";"-0.58";"8.08";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236657";"";"None";"677.72";"2";"7.38";"38";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"13.22";"0.28";"1.58";"8.56";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236658";"";"None";"705.77";"2";"8.11";"39";"CC(C)(C(=O)O)c1cnc(C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)s1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"12.30";"0.26";"0.57";"8.29";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233134";"";"None";"543.47";"1";"4.15";"19";"CC[C@@H](CS(=O)(=O)N(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"16.64";"0.35";"4.90";"8.68";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233127";"";"None";"623.53";"2";"5.86";"13";"CC[C@@H](CN(c1ccccc1F)S(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.47";"0.28";"2.54";"8.06";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233132";"";"None";"568.52";"2";"5.61";"17";"CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.54";"0.28";"2.09";"7.62";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355411";"";"None";"548.49";"2";"5.06";"13D";"CCC1(CC)N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"13.64";"0.28";"2.42";"8.27";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355419";"";"None";"547.46";"1";"3.45";"22C";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"9516.0";"nM";"5.02";"";"";"UO_0000065";"9.17";"0.19";"1.57";"6.07";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355422";"";"None";"538.45";"1";"3.50";"24D";"CCC1(CC)N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"175.0";"nM";"6.76";"";"";"UO_0000065";"12.55";"0.26";"3.26";"6.10";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL377614";"";"None";"666.34";"2";"6.73";"12a";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"";"16000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL383727";"";"None";"684.88";"2";"7.51";"21";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"8.77";"0.21";"-1.50";"7.71";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL377462";"";"None";"652.32";"2";"5.52";"14";"CN(C)CCN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"6.81";"0.16";"-1.08";"5.48";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210443";"";"None";"652.27";"1";"4.70";"9";"CNC(=O)CN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"3330.0";"nM";"5.48";"";"";"UO_0000065";"8.40";"0.20";"0.78";"5.12";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"1";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL207255";"";"None";"652.27";"2";"5.07";"4";"O=C(O)CCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL4788734";"";"None";"1781.18";"None";"None";"13";"CC(C)C[C@H](NC(=O)CN(C[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)CN(C[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CCc2ccccc2)[C@@H](C)O)S(C)(=O)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)CN(S(=O)(=O)c2ccc3ccccc3c2)CC(=O)N[C@@H](C)C(=O)N1)S(=O)(=O)CC(C)C)C(=O)N[C@@H](CO)CN(CC(=O)N[C@@H](C)C(N)=O)S(C)(=O)=O";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"2.82";"None";"None";"None";"0";"CHEMBL4704883";"Binding affinity to human recombinant MDM2 (1 to 150 residue) expressed in Escherichia coli using presence of FITC-labelled compound by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699617";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL210853";"";"None";"697.38";"2";"5.94";"27";"C[C@H](c1cc(F)c(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"8.01";"0.19";"-0.35";"7.06";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL380209";"";"None";"695.38";"2";"6.56";"50";"C=CCOc1cc(Cl)ccc1CN1C(=O)c2cc(I)ccc2N(CCOCCOC)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'>'";"12500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL383727";"";"None";"684.88";"2";"7.51";"21";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL383727";"";"None";"684.88";"2";"7.51";"21";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL379656";"";"None";"595.22";"2";"5.95";"2";"O=C(O)C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"70000.0";"nM";"4.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"32";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"25200.0";"nM";"4.60";"";"";"UO_0000065";"10.64";"0.22";"-0.95";"7.98";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347379";"";"None";"432.35";"1";"5.55";"35";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"31";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347376";"";"None";"434.32";"0";"4.89";"29";"O=C(O)C[C@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"16700.0";"nM";"4.78";"";"";"UO_0000065";"11.00";"0.22";"-0.11";"7.15";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347383";"";"None";"530.42";"2";"6.64";"16";"CCC[C@H](C(=O)O)N1C(=O)[C@H](Cc2ccc(F)cc2)O[C@@H](c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"9.86";"0.20";"-1.41";"7.82";"0";"CHEMBL2351553";"Inhibition of MDM2-induced proliferation of human SJSA1 cells assessed as EdU incorporation by High content screening assay in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2347390";"";"None";"433.38";"1";"5.02";"24";"CNCC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347390";"";"None";"433.38";"1";"5.02";"24";"CNCC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"9900.0";"nM";"5.00";"";"";"UO_0000065";"11.55";"0.24";"-0.02";"12.04";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347387";"";"None";"416.35";"1";"5.99";"21";"C=CC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.06";"0.29";"-0.14";"19.82";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347397";"";"None";"362.34";"1";"6.41";"5";"CC(C)N[C@@H]1CC[C@H](c2ccc(Cl)cc2)[C@H](c2ccc(Cl)cc2)C1";"IC50";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"13.39";"0.28";"-1.56";"40.32";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3653160";"";"None";"574.43";"2";"8.70";"BDBM129724";"Cc1cc(Cl)ccc1C1c2c(nc(-c3ccccc3OC(F)(F)F)n2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"0.65";"nM";"9.19";"";"261456";"UO_0000065";"15.99";"0.32";"0.49";"19.40";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL239274";"";"None";"368.74";"0";"2.74";"6";"O=c1nc2n(-c3ccc(Cl)cc3)c3ccc([N+](=O)[O-])cc3cc-2c(=O)[nH]1";"IC50";"'>'";"75000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL4213908";"";"None";"1913.91";"None";"None";"D-MIPC-d1a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"2.68";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3649848";"";"None";"564.09";"2";"5.32";"BDBM135184";"C[C@H]1CC[C@H](Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286251";"UO_0000065";"14.35";"0.28";"2.78";"7.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649902";"";"None";"564.09";"2";"5.46";"BDBM135253";"CC1CO[C@@H]2CCC[C@H]2N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286272";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649944";"";"None";"605.14";"2";"5.15";"BDBM135313";"CC1C(C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)CCN1C(=O)C1CC1";"IC50";"'='";"68.0";"nM";"7.17";"";"286332";"UO_0000065";"11.84";"0.23";"2.02";"5.69";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649947";"";"None";"591.12";"1";"4.91";"BDBM135316";"CC(=O)N1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H]2CCC[C@H]21";"IC50";"'='";"4.0";"nM";"8.40";"";"286335";"UO_0000065";"14.21";"0.27";"3.49";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654185";"";"None";"552.08";"1";"4.91";"BDBM148142";"CC(C)[C@@H]1C[C@@H](O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286217";"UO_0000065";"16.30";"0.32";"4.09";"7.15";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3916778";"";"None";"564.09";"2";"5.88";"BDBM135428";"CC[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nnc(O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"286447";"UO_0000065";"13.48";"0.26";"1.72";"6.60";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647052";"";"None";"550.06";"2";"5.07";"BDBM135112";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286131";"UO_0000065";"16.36";"0.32";"3.93";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649819";"";"None";"536.08";"2";"5.94";"BDBM135144";"CC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286163";"UO_0000065";"16.79";"0.32";"3.06";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286167";"UO_0000065";"14.90";"0.29";"2.97";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649823";"";"None";"552.08";"2";"5.32";"BDBM135149";"COC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286169";"UO_0000065";"15.44";"0.30";"3.20";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3929802";"";"None";"562.51";"2";"5.30";"BDBM119742";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"224.96";"nM";"6.65";"";"246780";"UO_0000065";"11.82";"0.24";"1.35";"7.35";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665586";"";"None";"530.50";"1";"4.77";"BDBM119718";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"48.0";"nM";"7.32";"";"246829";"UO_0000065";"13.80";"0.28";"2.55";"8.09";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL207332";"";"None";"666.34";"2";"6.73";"2";"CC(c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.91";"0.24";"-0.13";"6.35";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL425780";"";"None";"201.61";"0";"2.30";"2";"CC(O)c1ccc(Cl)cc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL869349";"Antiproliferative activity against wild type p53 MCF7 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL425780";"";"None";"201.61";"0";"2.30";"2";"CC(O)c1ccc(Cl)cc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3693966";"";"None";"519.40";"1";"3.21";"BDBM112751";"CNC(=O)[C@@H]1NC2(CCN(C(C)=O)CC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"5000.0";"nM";"";"";"234026";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693972";"";"None";"548.44";"1";"4.76";"BDBM112757";"O=C(O)CCCNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234032";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693977";"";"None";"544.42";"1";"3.61";"BDBM112762";"O=C(NCc1nnn[nH]1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234037";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693981";"";"None";"583.45";"2";"5.51";"BDBM112766";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cn1";"IC50";"'<'";"100.0";"nM";"";"";"234041";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3675198";"";"None";"456.93";"0";"4.77";"BDBM111504";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2C=C[C@@H](O)C2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"232297";"UO_0000065";"12.34";"0.23";"0.87";"7.66";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688263";"";"None";"470.40";"1";"6.20";"BDBM111507";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCCCCO)c1ccc(Cl)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"232303";"UO_0000065";"11.91";"0.24";"-0.60";"11.26";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675209";"";"None";"450.92";"1";"5.40";"BDBM111530";"CC(C)(C)c1ccc2c(c1)C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(O)c1ccc(Cl)cc1";"IC50";"'='";"837.0";"nM";"6.08";"";"232327";"UO_0000065";"13.48";"0.26";"0.68";"7.26";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675220";"";"None";"482.41";"1";"6.20";"BDBM111551";"CC(c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"8800.0";"nM";"5.06";"";"232351";"UO_0000065";"10.48";"0.21";"-1.14";"10.16";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675226";"";"None";"464.91";"0";"4.67";"BDBM111573";"C=C(CO)COC1(c2ccc(Cl)cc2)c2ccccc2C(=O)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"680.0";"nM";"6.17";"";"232374";"UO_0000065";"13.27";"0.26";"1.50";"6.64";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3318758";"";"None";"593.57";"2";"5.64";"6";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)NCC2CC2)C2CC2)C1=O";"IC50";"'='";"0.081";"nM";"10.09";"";"";"UO_0000065";"17.00";"0.35";"4.45";"9.72";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318765";"";"None";"595.59";"2";"5.98";"14";"CCN(CC)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.15";"nM";"9.82";"";"";"UO_0000065";"16.49";"0.34";"3.84";"10.34";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2381405";"";"None";"1059.21";"None";"None";"page no 2481, R1C1";"CSCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"4.77";"None";"None";"None";"0";"CHEMBL2383517";"Antagonist activity at human MDM2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380265";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL208554";"";"None";"652.32";"2";"6.17";"52";"Nc1cc(Cl)ccc1CN1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"9.34";"0.22";"-0.08";"5.86";"0";"CHEMBL865541";"Inhibition of p53-Hdm2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138098";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL383471";"";"None";"651.33";"2";"5.15";"6";"CN(C)CCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"7.01";"0.17";"-0.58";"5.59";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"47";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"17.27";"0.35";"1.92";"12.96";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4546186";"";"None";"501.97";"2";"2.81";"40";"CC(C)C[C@H](N[C@H](C(=O)NCc1ccccc1)c1c(C(=O)NO)[nH]c2cc(Cl)ccc12)C(=O)NO";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.77";"0.35";"6.11";"5.73";"0";"CHEMBL4353000";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL378662";"";"None";"692.39";"1";"4.90";"12m";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(C(=O)CN2CCNCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"1550.0";"nM";"5.81";"";"";"UO_0000065";"8.39";"0.20";"0.91";"5.87";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL377203";"";"None";"679.39";"2";"5.80";"12e";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"367.0";"nM";"6.43";"";"";"UO_0000065";"9.47";"0.23";"0.64";"8.13";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3649960";"";"None";"551.09";"2";"6.58";"BDBM135330";"CCOC(c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"286350";"UO_0000065";"14.52";"0.28";"1.42";"7.16";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649840";"";"None";"566.11";"2";"5.71";"BDBM135173";"CC(C)OCC1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286192";"UO_0000065";"15.37";"0.30";"2.99";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649847";"";"None";"564.09";"2";"5.47";"BDBM135181";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCOCC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286200";"UO_0000065";"15.11";"0.29";"3.05";"7.41";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"1.0";"nM";"9.00";"";"286201";"UO_0000065";"16.73";"0.32";"4.07";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654187";"";"None";"579.11";"1";"4.76";"BDBM148144";"CCN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286223";"UO_0000065";"14.08";"0.27";"3.39";"6.47";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649908";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286282";"UO_0000065";"15.84";"0.31";"3.98";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649914";"";"None";"544.06";"2";"5.95";"BDBM135273";"CN(Cc1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"286292";"UO_0000065";"14.19";"0.27";"1.77";"7.30";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649926";"";"None";"570.07";"2";"5.44";"BDBM135290";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286310";"UO_0000065";"15.79";"0.31";"3.56";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3894245";"";"None";"552.08";"2";"5.49";"BDBM135294";"CO[C@H]1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"286316";"UO_0000065";"15.76";"0.30";"3.21";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3894749";"";"None";"622.17";"2";"5.33";"BDBM135311";"CC(C)NC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286330";"UO_0000065";"13.70";"0.26";"3.19";"6.17";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3952603";"";"None";"635.17";"1";"4.78";"BDBM135324";"C[C@H]1CN(C(=O)C2(C)COC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286343";"UO_0000065";"12.53";"0.24";"3.18";"5.88";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286378";"UO_0000065";"15.53";"0.30";"2.86";"6.98";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653312";"";"None";"604.03";"2";"5.62";"BDBM135431";"O=c1[nH]c(-c2cc3nc(N4CCO[C@@H]5CCC[C@H]54)n(C[C@H]4CC[C@H](C(F)(F)F)CC4)c3c(-c3cncc(Cl)c3)n2)no1";"IC50";"'='";"38.0";"nM";"7.42";"";"286450";"UO_0000065";"12.28";"0.24";"1.80";"6.45";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649925";"";"None";"565.08";"1";"4.54";"BDBM135288";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CC(=O)N(C)C[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"13.0";"nM";"7.89";"";"286308";"UO_0000065";"13.96";"0.27";"3.35";"6.26";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653327";"";"None";"552.64";"1";"4.64";"BDBM135446";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncnc4)c32)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"286465";"UO_0000065";"13.01";"0.24";"2.55";"5.62";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3981908";"";"None";"530.07";"1";"4.52";"BDBM119747";"O=C(NC1CCC(O)CC1)[C@@H]1N[C@@H](c2ccccc2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1Cc1ccccc1";"IC50";"'>'";"5000.0";"nM";"";"";"246823";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665583";"";"None";"532.03";"1";"4.40";"BDBM119715";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"167.0";"nM";"6.78";"";"246827";"UO_0000065";"12.74";"0.25";"2.38";"7.49";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4447592";"";"None";"582.48";"2";"6.37";"38";"CC(C)(C)NC(=O)[C@H](c1c(C(=O)O)[nH]c2cc(Cl)ccc12)N(C=O)Cc1ccc(OCc2ccc(Cl)cc2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.68";"0.21";"-0.15";"5.57";"0";"CHEMBL4353000";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3687272";"";"None";"504.46";"2";"7.73";"BDBM143398";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccc3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"3.4";"nM";"8.47";"";"279540";"UO_0000065";"16.79";"0.33";"0.74";"22.21";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683102";"";"None";"536.07";"2";"6.23";"BDBM161687";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1NC(C)=O";"IC50";"'='";"50653.6";"nM";"4.29";"";"304947";"UO_0000065";"8.01";"0.15";"-1.93";"6.04";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691725";"";"None";"562.46";"2";"5.94";"BDBM143514";"COc1ccc(C#N)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.382";"nM";"9.42";"";"279770";"UO_0000065";"16.74";"0.33";"3.48";"10.11";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653284";"";"None";"537.02";"2";"6.18";"BDBM129852";"COc1ncc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.65";"nM";"8.78";"";"261581";"UO_0000065";"16.35";"0.31";"2.60";"8.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653175";"";"None";"536.46";"2";"7.00";"BDBM129740";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261471";"UO_0000065";"18.31";"0.36";"2.82";"14.53";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691698";"";"None";"660.65";"2";"7.50";"BDBM143461";"COc1ccc(C(=O)NCCN2CCCC2)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.238";"nM";"9.62";"";"279752";"UO_0000065";"14.57";"0.29";"2.12";"12.07";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703667";"";"None";"435.91";"1";"5.52";"BDBM156618";"COc1ccc(C(Nc2cc(C)c(Cl)cn2)c2ccc3cccnc3c2O)cc1OC";"IC50";"'='";"26000.0";"nM";"4.58";"";"298950";"UO_0000065";"10.52";"0.20";"-0.93";"5.99";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2443391";"";"None";"371.32";"0";"3.51";"19";"Cc1cccc(-n2c3nc(=O)[nH]c(=O)c-3cc3cccc(C(F)(F)F)c32)c1";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"13.67";"0.26";"1.57";"7.49";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2440442";"";"None";"426.18";"0";"4.50";"16";"O=c1nc2n(-c3ccc(Cl)c(Cl)c3)c3c(C(F)(F)F)cccc3cc-2c(=O)[nH]1";"IC50";"'='";"10700.0";"nM";"4.97";"";"";"UO_0000065";"11.66";"0.24";"0.47";"7.34";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3649817";"";"None";"538.05";"1";"4.93";"BDBM135142";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)CO1";"IC50";"'='";"156.0";"nM";"6.81";"";"286161";"UO_0000065";"12.65";"0.24";"1.88";"5.92";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649827";"";"None";"534.06";"2";"5.84";"BDBM135156";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286175";"UO_0000065";"15.16";"0.29";"2.26";"7.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649868";"";"None";"565.08";"1";"4.37";"BDBM135204";"CN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"286235";"UO_0000065";"13.90";"0.27";"3.48";"6.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649878";"";"None";"540.07";"2";"5.18";"BDBM135217";"CCCN(CCOC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286236";"UO_0000065";"14.90";"0.29";"2.87";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3923676";"";"None";"615.09";"2";"5.01";"BDBM135323";"C[C@H]1CN(C(=O)C(F)F)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286342";"UO_0000065";"13.65";"0.27";"3.39";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649961";"";"None";"497.00";"1";"5.41";"BDBM135332";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286351";"UO_0000065";"16.19";"0.31";"2.64";"7.20";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286356";"UO_0000065";"14.69";"0.29";"1.95";"7.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286375";"UO_0000065";"15.53";"0.30";"2.86";"6.98";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654184";"";"None";"577.11";"2";"6.11";"BDBM148141";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3c3nccs3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286207";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3941748";"";"None";"568.05";"2";"5.21";"BDBM135398";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3c(F)c(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286417";"UO_0000065";"15.84";"0.31";"3.79";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650010";"";"None";"595.17";"2";"5.92";"BDBM135410";"CS(=O)(=O)Nc1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"122.0";"nM";"6.91";"";"286429";"UO_0000065";"11.62";"0.23";"0.99";"6.76";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653317";"";"None";"610.12";"2";"4.45";"BDBM135436";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cc(Cl)cnc4OCCO)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286455";"UO_0000065";"14.75";"0.29";"4.55";"6.23";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3929802";"";"None";"562.51";"2";"5.30";"BDBM119742";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"32.0";"nM";"7.50";"";"246813";"UO_0000065";"13.32";"0.27";"2.19";"8.29";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647058";"";"None";"526.02";"2";"5.25";"BDBM135118";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286137";"UO_0000065";"15.97";"0.31";"3.15";"7.94";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"286146";"UO_0000065";"12.78";"0.25";"1.75";"6.27";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665597";"";"None";"548.49";"1";"4.91";"BDBM119733";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"270.09";"nM";"6.57";"";"246786";"UO_0000065";"11.98";"0.24";"1.66";"7.26";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2396674";"";"None";"548.49";"1";"4.91";"BDBM119725";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"5.6";"nM";"8.25";"";"246807";"UO_0000065";"15.04";"0.30";"3.34";"9.12";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665593";"";"None";"532.03";"1";"4.40";"BDBM119729";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"27.0";"nM";"7.57";"";"246832";"UO_0000065";"14.23";"0.28";"3.17";"8.37";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665594";"";"None";"550.02";"1";"4.54";"BDBM119730";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"35.0";"nM";"7.46";"";"246833";"UO_0000065";"13.56";"0.27";"2.92";"8.24";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665597";"";"None";"548.49";"1";"4.91";"BDBM119733";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"100.0";"nM";"";"";"314280";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704485";"";"None";"548.49";"1";"4.91";"BDBM170239";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2CC[C@@H](O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314189";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704496";"";"None";"632.65";"2";"5.42";"BDBM170252";"CC(C)N1CCN(CCCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"10000.0";"nM";"";"";"314202";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704507";"";"None";"576.54";"1";"3.90";"BDBM170267";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCNCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314216";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653316";"";"None";"564.09";"2";"5.38";"BDBM135435";"Cc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"286454";"UO_0000065";"15.95";"0.31";"3.62";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653315";"";"None";"564.09";"2";"5.38";"BDBM135434";"Cc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"33.0";"nM";"7.48";"";"268943";"UO_0000065";"13.26";"0.26";"2.10";"6.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3407567";"";"None";"705.74";"2";"7.20";"17";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N[C@H]2CC[C@H](C(=O)O)CC2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.73";"nM";"9.14";"";"";"UO_0000065";"12.95";"0.27";"1.94";"7.56";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407557";"";"None";"699.70";"2";"7.78";"7";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccc(C(=O)O)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"13.18";"0.27";"1.44";"7.63";"0";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"2";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.43";"0.32";"2.44";"9.76";"1";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL207505";"";"None";"651.33";"2";"7.14";"18";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"13300.0";"nM";"4.88";"";"";"UO_0000065";"7.49";"0.18";"-2.26";"6.26";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL381185";"";"None";"537.18";"2";"5.93";"7";"O=C1Nc2ccc(I)cc2C(=O)N(Cc2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3961782";"";"None";"562.51";"2";"5.30";"BDBM119726";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.2";"nM";"8.09";"";"246808";"UO_0000065";"14.38";"0.29";"2.79";"8.94";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665611";"";"None";"576.54";"2";"5.64";"BDBM119749";"CCN1[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2F)[C@@H]1C(=O)N[C@H]1C[C@@](C)(O)C1";"IC50";"'<'";"100.0";"nM";"";"";"246825";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927643";"";"None";"562.51";"2";"5.30";"BDBM119728";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"5900.0";"nM";"5.23";"";"246831";"UO_0000065";"9.30";"0.19";"-0.07";"5.78";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649988";"";"None";"527.03";"2";"6.38";"BDBM135380";"C=C(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268889";"UO_0000065";"15.93";"0.30";"2.02";"8.19";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649999";"";"None";"544.06";"2";"6.50";"BDBM135395";"CC(C)c1ccnc(-c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"268904";"UO_0000065";"15.44";"0.29";"1.90";"7.28";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135404";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"268913";"UO_0000065";"14.40";"0.28";"1.73";"6.58";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135418";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268927";"UO_0000065";"16.20";"0.31";"2.34";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286357";"UO_0000065";"15.40";"0.30";"2.35";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649966";"";"None";"527.03";"2";"5.04";"BDBM135341";"CCOC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286360";"UO_0000065";"15.27";"0.30";"3.01";"6.65";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649981";"";"None";"583.01";"2";"6.83";"BDBM135369";"CC(F)(c1ccc(F)cc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286388";"UO_0000065";"14.92";"0.29";"1.87";"8.49";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286402";"UO_0000065";"16.57";"0.32";"2.85";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286403";"UO_0000065";"16.57";"0.32";"2.85";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650009";"";"None";"573.14";"2";"6.25";"BDBM135409";"CN(C)C(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"175.0";"nM";"6.76";"";"286428";"UO_0000065";"11.79";"0.23";"0.51";"8.85";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650011";"";"None";"546.00";"2";"5.68";"BDBM135411";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(-c4nnn[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286430";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654193";"";"None";"574.13";"2";"6.73";"BDBM148150";"CCOC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"53.0";"nM";"7.28";"";"286435";"UO_0000065";"12.67";"0.24";"0.55";"8.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3971741";"";"None";"579.11";"2";"5.12";"BDBM135444";"CNc1ncc(Cl)cc1-c1nc(-c2nc(=O)o[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"286463";"UO_0000065";"15.02";"0.29";"3.58";"6.85";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665596";"";"None";"530.50";"1";"4.77";"BDBM119732";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"85.61";"nM";"7.07";"";"246797";"UO_0000065";"13.32";"0.27";"2.30";"7.81";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665598";"";"None";"566.48";"2";"5.05";"BDBM119734";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"246820";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286180";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647054";"";"None";"550.06";"2";"5.07";"BDBM135114";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286133";"UO_0000065";"15.81";"0.30";"3.63";"7.57";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647065";"";"None";"538.05";"1";"4.93";"BDBM135129";"C[C@@H]1COC[C@@H](C)N1c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286148";"UO_0000065";"15.16";"0.29";"3.22";"7.09";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649814";"";"None";"574.01";"2";"5.70";"BDBM135139";"C[C@H]1CC[C@H](Cn2c(N3CCC4C3C4C(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"286158";"UO_0000065";"13.06";"0.26";"1.79";"7.09";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL5182359";"";"None";"699.16";"1";"4.85";"H109";"CC(C)(C)Oc1cc(C(=O)CC(N)=O)ccc1C1=N[C@@H](c2ccc(C(=O)O)cc2)[C@@H](c2c[nH]c3ccc(Cl)cc23)N1C(=O)N1CCNC(=O)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"11.76";"0.22";"3.37";"4.39";"0";"CHEMBL5110385";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3691727";"";"None";"608.53";"2";"5.70";"BDBM143518";"COc1ccc(CNC(C)=O)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.396";"nM";"9.40";"";"279772";"UO_0000065";"15.45";"0.31";"3.70";"9.55";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653159";"";"None";"538.45";"2";"7.95";"BDBM129723";"COc1cccc(F)c1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261455";"UO_0000065";"18.14";"0.36";"1.82";"20.63";"1";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687278";"";"None";"508.42";"2";"7.56";"BDBM143406";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"24.2";"nM";"7.62";"";"279546";"UO_0000065";"14.98";"0.30";"0.06";"19.97";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687248";"";"None";"553.53";"2";"6.94";"BDBM143365";"CC(=O)N1CCC(Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)CC1";"IC50";"'='";"2.4";"nM";"8.62";"";"279516";"UO_0000065";"15.57";"0.31";"1.68";"14.75";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653197";"";"None";"528.02";"2";"6.23";"BDBM129762";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(NC)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)ccc2C)cc1";"IC50";"'='";"0.15";"nM";"9.82";"";"261493";"UO_0000065";"18.61";"0.35";"3.59";"10.97";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2152327";"";"None";"529.49";"2";"5.41";"16";"CC(C)C1=C(C(=O)N2CCNC(=O)CC2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.25";"0.23";"0.55";"9.17";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL578238";"";"None";"534.48";"1";"3.60";"6, MI-188";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"13.57";"0.28";"3.65";"6.55";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL578028";"";"None";"552.47";"1";"3.74";"5, MI-147";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"16.4";"nM";"7.79";"";"";"UO_0000065";"14.09";"0.29";"4.05";"7.03";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3657043";"";"None";"537.45";"2";"6.20";"BDBM129950";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.77";"nM";"9.11";"";"261680";"UO_0000065";"16.96";"0.34";"2.91";"13.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4460091";"";"None";"1837.36";"None";"None";"PS1";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O";"IC50";"'='";"3950.0";"nM";"5.40";"";"";"UO_0000065";"2.94";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3601398";"CGM-097";"1.0";"659.27";"2";"6.58";"NVP-CGM097";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"7.58";"0.15";"-1.58";"7.63";"0";"CHEMBL4353005";"Inhibition of p53 derived Cy5-p53 peptide (18 to 26 residues) binding to human MDM2 (2 to 188 residues) after 30 mins by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4524109";"";"None";"1103.23";"None";"None";"25";"CC(C)CCC(=O)NC(CCC(=O)O)CN(C(=O)NCCCC1CCCCC1)C(CCCCN)CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(F)cc1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"5.06";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL593927";"";"None";"1181.86";"None";"None";"17";"NCCCCC(CN(C(=O)NCCc1ccc(Br)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCCc1ccc(Br)cc1)N(CC(CCC(=O)O)NC(N)=O)C(=O)NCCCc1ccc(Br)cc1";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"4.30";"None";"None";"None";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL575538";"";"None";"566.50";"1";"4.66";"4, MI-142";"COCCOCCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"32.4";"nM";"7.49";"";"";"UO_0000065";"13.22";"0.27";"2.83";"8.44";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL566955";"";"None";"538.45";"1";"3.35";"9, MI-221";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"189.0";"nM";"6.72";"";"";"UO_0000065";"12.49";"0.26";"3.37";"6.07";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"nutlin-3";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL930243";"Binding affinity to human HDM2 assessed as inhibition of HDM2-p53 interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142223";"1";"Scientific Literature";"Nature";"2007";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268857";"UO_0000065";"15.73";"0.30";"3.27";"7.19";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268858";"UO_0000065";"15.73";"0.30";"3.27";"7.19";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649983";"";"None";"566.01";"2";"6.08";"BDBM135372";"CC(F)(c1ccncc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268881";"UO_0000065";"14.84";"0.29";"2.32";"7.28";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649991";"";"None";"525.05";"2";"5.85";"BDBM135383";"CCCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268892";"UO_0000065";"16.57";"0.32";"2.85";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650024";"";"None";"564.09";"2";"5.46";"BDBM135427";"CC[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268936";"UO_0000065";"14.72";"0.28";"2.84";"7.22";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653310";"";"None";"564.09";"2";"5.46";"BDBM135428";"CC[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"268937";"UO_0000065";"13.48";"0.26";"2.14";"6.61";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688258";"";"None";"464.91";"0";"4.67";"BDBM111509";"O=C1c2ccccc2C(OC/C=C\CO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"402.0";"nM";"6.40";"";"232306";"UO_0000065";"13.76";"0.26";"1.73";"6.88";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675201";"";"None";"521.01";"2";"6.21";"BDBM111511";"O=C1c2ccccc2C(O[C@H]2CCC[C@@H](O)CCC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"375.0";"nM";"6.43";"";"232308";"UO_0000065";"12.33";"0.24";"0.22";"6.92";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675203";"";"None";"451.91";"0";"4.47";"BDBM111522";"NCCCOC1(c2ccc(Cl)cc2)c2ccccc2C(=O)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"2460.0";"nM";"5.61";"";"232319";"UO_0000065";"12.41";"0.24";"1.14";"5.68";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688287";"";"None";"512.83";"2";"5.75";"BDBM111564";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1cccc(Br)c1";"IC50";"'='";"47000.0";"nM";"4.33";"";"232365";"UO_0000065";"8.44";"0.18";"-1.42";"8.70";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3650012";"";"None";"539.06";"2";"5.00";"BDBM135412";"Cn1[nH]c(-c2cc3nc(N4CCC[C@H]4CF)n(C[C@H]4CC[C@H](C)CC4)c3c(-c3cncc(Cl)c3)n2)nc1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"268921";"UO_0000065";"14.28";"0.28";"2.70";"7.89";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650013";"";"None";"525.03";"1";"4.99";"BDBM135413";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4n[nH]c(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"268922";"UO_0000065";"15.24";"0.30";"3.01";"7.38";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650018";"";"None";"537.06";"2";"6.36";"BDBM135419";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268929";"UO_0000065";"15.64";"0.30";"2.04";"7.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653335";"";"None";"573.12";"2";"5.10";"BDBM135454";"CC(C)C(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268963";"UO_0000065";"14.48";"0.29";"3.20";"6.08";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3928363";"";"None";"492.96";"1";"5.43";"BDBM111517";"O=C1c2ccccc2C(OC2CCC(O)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"388.0";"nM";"6.41";"";"232314";"UO_0000065";"13.01";"0.25";"0.98";"6.90";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688266";"";"None";"511.37";"2";"5.00";"BDBM111523";"O=C1c2ccccc2C(OCCCCO)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"232320";"UO_0000065";"12.21";"0.26";"1.24";"6.72";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675207";"";"None";"408.84";"0";"4.41";"BDBM111528";"Cc1ccc2c(c1)C(O)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"5080.0";"nM";"5.29";"";"232325";"UO_0000065";"12.95";"0.25";"0.88";"6.33";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"BDBM111547";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1260.0";"nM";"5.90";"";"232358";"UO_0000065";"11.49";"0.23";"0.35";"6.35";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675227";"";"None";"462.48";"0";"4.38";"BDBM111574";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(F)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"232375";"UO_0000065";"12.04";"0.22";"1.19";"5.99";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3693970";"";"None";"651.63";"1";"4.41";"BDBM112755";"CS(=O)(=O)CCN1CCC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"234030";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3942080";"";"None";"602.53";"2";"5.79";"BDBM112758";"O=C(O)C1CCC(CNC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"100.0";"nM";"";"";"234033";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3799390";"";"None";"665.63";"2";"6.20";"17";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cnccn2)CC1";"IC50";"'='";"1065.0";"nM";"5.97";"";"";"UO_0000065";"8.97";"0.17";"-0.23";"6.11";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3704489";"";"None";"577.53";"1";"4.07";"BDBM170244";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CC[C@H](O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314194";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4111089";"";"None";"566.50";"1";"4.13";"BDBM170296";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@](C)(O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314254";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665601";"";"None";"548.49";"1";"4.91";"BDBM119737";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cc(F)cc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314284";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663825";"";"None";"579.06";"1";"3.96";"BDBM170341";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314313";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663829";"";"None";"608.58";"2";"5.11";"BDBM170346";"CC(C)CC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314317";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649925";"";"None";"565.08";"1";"4.54";"BDBM135288";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CC(=O)N(C)C[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"4.0";"nM";"8.40";"";"286307";"UO_0000065";"14.86";"0.29";"3.86";"6.66";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649935";"";"None";"608.15";"1";"4.94";"BDBM135304";"CCNC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"286323";"UO_0000065";"14.01";"0.27";"3.58";"6.17";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649951";"";"None";"622.17";"2";"5.29";"BDBM135320";"CCN(C)C(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286339";"UO_0000065";"14.47";"0.28";"3.71";"6.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649961";"";"None";"497.00";"1";"5.41";"BDBM135332";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"286352";"UO_0000065";"15.58";"0.30";"2.33";"6.93";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649965";"";"None";"513.00";"1";"4.39";"BDBM135340";"CCOC(CO)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"286359";"UO_0000065";"15.25";"0.30";"3.43";"5.93";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649969";"";"None";"553.06";"2";"5.43";"BDBM135348";"COCCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286367";"UO_0000065";"15.73";"0.30";"3.27";"7.19";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649976";"";"None";"566.09";"2";"5.90";"BDBM135360";"CCOC(c1cscn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286381";"UO_0000065";"15.06";"0.30";"2.62";"6.84";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653333";"";"None";"527.09";"2";"6.17";"BDBM135452";"CCC(CSC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286471";"UO_0000065";"16.50";"0.33";"2.53";"8.49";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654183";"";"None";"489.66";"1";"6.74";"BDBM148140";"CC(C)c1ccnc(-c2nc3cc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2C[C@H]2CC[C@H](C)CC2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"286124";"UO_0000065";"17.15";"0.32";"1.66";"9.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653318";"";"None";"580.09";"2";"5.08";"BDBM135437";"COc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"24.0";"nM";"7.62";"";"268946";"UO_0000065";"13.14";"0.25";"2.54";"6.14";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653331";"";"None";"513.07";"2";"5.78";"BDBM135450";"CSCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268959";"UO_0000065";"15.89";"0.32";"2.37";"7.96";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL593921";"";"None";"966.02";"2";"4.76";"3";"CC(C)CCCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Cl)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCc1ccc(Cl)cc1";"IC50";"'='";"63000.0";"nM";"4.20";"";"";"UO_0000065";"4.35";"0.09";"-0.56";"1.42";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL593845";"";"None";"917.55";"2";"3.71";"1";"CC(C)CCNC(=O)N(CC(CCC(=O)O)NC(N)=O)C(CCCCN)CN(C(=O)NCCc1ccc(Cl)cc1)C(CCC(=O)O)CN(CCC(N)=O)C(=O)NCCc1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1068493";"Inhibition of HDM2 expressed in Escherichia coli BL21 (DE3) assessed as inhibition of HDM2 binding to p53 protein by fluorescence anisotropy competition method";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153086";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";""
"CHEMBL3650047";"";"None";"427.97";"1";"5.94";"BDBM135917";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCCCC1)C(=O)C2";"IC50";"'='";"894.0";"nM";"6.05";"";"269495";"UO_0000065";"14.13";"0.28";"0.11";"15.60";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"MK-8242; SCH 900242";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"31.65";"0.62";"10.26";"5.88";"0";"CHEMBL4268705";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265957";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL4566706";"";"None";"476.36";"0";"4.79";"39";"CC(C)(C)NC(=O)[C@H](c1c(C(=O)O)[nH]c2cc(Cl)ccc12)N(C=O)Cc1ccc(Cl)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.43";"0.27";"1.61";"6.24";"0";"CHEMBL4353000";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3675211";"";"None";"412.80";"0";"4.24";"BDBM111533";"O=C1c2ccc(F)cc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3760.0";"nM";"5.42";"";"232330";"UO_0000065";"13.14";"0.26";"1.18";"6.48";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688161";"";"None";"391.85";"0";"4.39";"BDBM111558";"CC(=O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"89000.0";"nM";"4.05";"";"232360";"UO_0000065";"10.34";"0.20";"-0.34";"7.03";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL4437666";"";"None";"419.26";"1";"5.77";"41";"O=C1Nc2cc(Cl)ccc2[C@@]1(Cc1cccc(Cl)c1)Nc1c(F)cccc1F";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"21.28";"0.44";"3.15";"21.69";"0";"CHEMBL4353000";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL2396744";"";"None";"581.19";"2";"5.56";"23";"O=C1Nc2ccc(I)cc2C(=O)N([C@@H](C(=O)O)c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"10.86";"0.27";"0.75";"7.28";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3288449";"";"None";"759.19";"2";"6.72";"10";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ccccc2OCCOC)CC1.Cl";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"10.54";"0.20";"0.90";"9.02";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2398477";"";"None";"536.48";"1";"4.77";"7";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC(C)(C)O)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"16.3";"nM";"7.79";"";"";"UO_0000065";"14.52";"0.30";"3.02";"8.61";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2398476";"";"None";"548.49";"1";"4.91";"6";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"14.72";"0.30";"3.17";"8.93";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2386343";"";"None";"649.66";"2";"7.87";"2d";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(C(C)=O)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"11.76";"0.23";"-0.23";"11.67";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3653289";"";"None";"550.42";"2";"6.80";"BDBM129857";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.2";"nM";"9.70";"";"261586";"UO_0000065";"17.62";"0.35";"2.90";"11.54";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691715";"";"None";"537.45";"2";"6.77";"BDBM143483";"COc1cnc(Cl)cc1N1C(=O)c2nn(-c3ccccc3OC)c(C(C)C)c2C1c1ccc(Cl)cc1C";"IC50";"'='";"0.926";"nM";"9.03";"";"279763";"UO_0000065";"16.81";"0.33";"2.26";"13.00";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687279";"";"None";"514.47";"2";"8.09";"BDBM143407";"Cc1cc(Cl)ccc1C1c2c(nn(CC3CCCCC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"20.5";"nM";"7.69";"";"279547";"UO_0000065";"14.94";"0.30";"-0.40";"20.16";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691785";"";"None";"563.98";"1";"4.59";"BDBM143700";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cnc(OC)nc4OC)c3C(C)C)C(=O)N2c2cc(Cl)cn(C)c2=O)c(F)c1";"IC50";"'='";"10.3";"nM";"7.99";"";"279827";"UO_0000065";"14.16";"0.27";"3.40";"7.35";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687245";"";"None";"582.53";"2";"5.37";"BDBM143360";"CC(=O)N1CCN(C(=O)Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)CC1";"IC50";"'='";"2.9";"nM";"8.54";"";"279513";"UO_0000065";"14.66";"0.29";"3.17";"10.84";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653272";"";"None";"513.99";"2";"5.10";"BDBM129839";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(C#N)cc1C)C2=O";"IC50";"'='";"4.29";"nM";"8.37";"";"261568";"UO_0000065";"16.28";"0.31";"3.27";"6.81";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687266";"";"None";"525.48";"2";"6.30";"BDBM143392";"Cc1cc(Cl)ccc1C1c2c(nn(CC(=O)N3CCCC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"279534";"UO_0000065";"16.55";"0.33";"2.40";"14.89";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683111";"";"None";"424.88";"1";"5.51";"BDBM161731";"COc1ccc(N2C(=O)Nc3cc(OC)c(OC)cc3C2c2ccc(Cl)cc2)cc1";"IC50";"'='";"970.6";"nM";"6.01";"";"304957";"UO_0000065";"14.15";"0.27";"0.50";"10.02";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4167230";"";"None";"493.52";"1";"0.52";"10";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCCc2c[nH]c3ccccc23)c1";"IC50";"'='";"308.0";"nM";"6.51";"";"";"UO_0000065";"13.19";"0.25";"5.99";"3.22";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3656989";"";"None";"551.48";"2";"6.36";"BDBM129891";"COc1cnc(N(C)C)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.29";"nM";"9.54";"";"261622";"UO_0000065";"17.29";"0.34";"3.18";"12.49";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653223";"";"None";"540.41";"1";"4.27";"BDBM129788";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"1.15";"nM";"8.94";"";"261519";"UO_0000065";"16.54";"0.33";"4.67";"7.38";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2152332";"";"None";"581.50";"2";"5.89";"1.2";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"11.98";"0.24";"1.08";"8.35";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4092607";"";"None";"445.56";"1";"5.20";"10";"CC(C)(C)Oc1ccc(C[C@H](NC(=O)CC(c2ccccc2)c2ccccc2)C(=O)O)cc1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"15.57";"0.29";"1.74";"9.18";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3910704";"";"None";"492.38";"0";"3.50";"BDBM112738";"O=C(NC1CCC(O)CC1)[C@@H]1NC[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"234013";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL502723";"";"None";"1495.66";"None";"None";"3, pDI";"CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"5.35";"None";"None";"None";"0";"CHEMBL3390999";"Inhibition of human GST-tagged MDM2 (1 to 150) expressed in Escherichia coli by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3390840";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3949967";"";"None";"566.11";"2";"5.47";"BDBM135292";"CC(C)[C@H]1C[C@H](O)CN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286312";"UO_0000065";"15.90";"0.31";"3.53";"7.15";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286361";"UO_0000065";"16.63";"0.32";"2.90";"7.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"5.0";"nM";"8.30";"";"286365";"UO_0000065";"14.64";"0.28";"2.48";"6.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"286408";"UO_0000065";"15.63";"0.30";"2.70";"6.95";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653321";"";"None";"624.14";"3";"5.10";"BDBM135440";"COCCOc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"21.0";"nM";"7.68";"";"286459";"UO_0000065";"12.30";"0.24";"2.58";"5.75";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665597";"";"None";"548.49";"1";"4.91";"BDBM119733";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"220.41";"nM";"6.66";"";"246798";"UO_0000065";"12.14";"0.25";"1.75";"7.36";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657050";"";"None";"555.01";"2";"6.32";"BDBM129958";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.54";"nM";"9.27";"";"261687";"UO_0000065";"16.70";"0.32";"2.95";"8.59";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL208562";"";"None";"706.46";"2";"6.11";"24";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCN2CCN(C)CC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"704.0";"nM";"6.15";"";"";"UO_0000065";"8.71";"0.20";"0.04";"8.41";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3687300";"";"None";"530.38";"2";"7.78";"BDBM143428";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccc(F)cc3F)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"14.3";"nM";"7.84";"";"279568";"UO_0000065";"14.79";"0.30";"0.06";"20.57";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683177";"";"None";"660.26";"2";"6.33";"BDBM162151";"CCN1CN([C@H]2CC[C@H](CN(C)c3ccc(N4C(=O)Cc5cc(OC)c(OC(C)C)cc5[C@@H]4c4ccc(Cl)cc4)cn3)CC2)CC1=O";"IC50";"'='";"4.1";"nM";"8.39";"";"305034";"UO_0000065";"12.70";"0.24";"2.06";"10.69";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687291";"";"None";"481.36";"1";"6.59";"BDBM143419";"CC(C)c1c2c(nn1-c1ccncc1)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)cc1";"IC50";"'='";"107.9";"nM";"6.97";"";"279559";"UO_0000065";"14.47";"0.29";"0.38";"13.66";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650077";"";"None";"538.08";"2";"6.67";"BDBM135947";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(O)c3ccoc3)CC1)C(=O)C2";"IC50";"'='";"27.6";"nM";"7.56";"";"269525";"UO_0000065";"14.05";"0.27";"0.89";"10.48";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687226";"";"None";"509.41";"2";"6.95";"BDBM143333";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"6.507";"nM";"8.19";"";"279749";"UO_0000065";"16.07";"0.32";"1.24";"16.05";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691699";"";"None";"531.44";"2";"7.92";"BDBM143462";"[C-]#[N+]c1cc(Cl)cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2C)c1";"IC50";"'='";"3.8";"nM";"8.42";"";"279594";"UO_0000065";"15.84";"0.31";"0.50";"16.28";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3233587";"";"None";"636.59";"2";"5.53";"1a";"COc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.77";"0.19";"0.69";"8.27";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3233590";"";"None";"694.67";"2";"5.79";"10";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)C[C@H](C)CN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"8.02";"0.16";"-0.22";"6.59";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3407554";"";"None";"598.56";"2";"6.66";"3";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"15.5";"nM";"7.81";"";"";"UO_0000065";"13.05";"0.27";"1.15";"8.51";"0";"CHEMBL3412297";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 gene level after 7 hrs by qRT-PCR assay in presence of 10% human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"2";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"18.1";"nM";"7.74";"";"";"UO_0000065";"13.34";"0.28";"1.22";"8.44";"0";"CHEMBL3412297";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 gene level after 7 hrs by qRT-PCR assay in presence of 10% human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3407572";"";"None";"677.69";"2";"6.42";"22";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N[C@H]2C[C@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"13.70";"0.28";"2.86";"7.68";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3656992";"";"None";"549.46";"2";"6.60";"BDBM129894";"COc1ccc(C(N)=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.1";"nM";"10.00";"";"261626";"UO_0000065";"18.20";"0.36";"3.40";"11.06";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3220094";"";"None";"415.52";"0";"4.23";"4i";"Cc1ccc(-n2c(C)cc(/C=C3\C(=O)NC(=S)N(c4ccccc4)C3=O)c2C)cc1";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"12.22";"0.23";"0.85";"9.34";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3656979";"";"None";"559.03";"1";"3.97";"BDBM129881";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"153.2";"nM";"6.82";"";"261611";"UO_0000065";"12.19";"0.23";"2.84";"5.58";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683146";"";"None";"604.19";"2";"6.87";"BDBM161953";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(C(C)=O)C3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"114.2";"nM";"6.94";"";"304995";"UO_0000065";"11.49";"0.22";"0.07";"9.76";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220088";"";"None";"483.98";"1";"5.38";"4c";"O=C1NC(=S)NC(=O)C1=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.38";"0.28";"1.58";"11.02";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220092";"";"None";"512.03";"2";"6.06";"4g";"CN1C(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Cl)cc3)c2-c2ccccc2)C(=O)N(C)C1=S";"IC50";"";"";"";"";"";"ND(Insoluble)";"";"";"";"";"";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220102";"";"None";"474.55";"0";"4.60";"4r";"N#Cc1ccc(-n2c(-c3ccccc3)cc(C=C3C(=O)NC(=S)NC3=O)c2-c2ccccc2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"14.12";"0.26";"2.10";"7.71";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220104";"";"None";"540.09";"2";"6.84";"4u";"CCN1C(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Cl)cc3)c2-c2ccccc2)C(=O)N(CC)C1=S";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"12.08";"0.23";"-0.32";"14.32";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3653306";"";"None";"577.51";"2";"6.79";"BDBM129874";"CNC(=O)Cc1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.17";"nM";"9.77";"";"261604";"UO_0000065";"16.92";"0.33";"2.98";"12.78";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657021";"";"None";"523.42";"2";"5.88";"BDBM129925";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"82.5";"nM";"7.08";"";"261656";"UO_0000065";"13.53";"0.27";"1.20";"7.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687239";"";"None";"512.42";"2";"6.29";"BDBM143348";"Cc1cc(Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)n(C)n1";"IC50";"'='";"7.9";"nM";"8.10";"";"279507";"UO_0000065";"15.81";"0.32";"1.81";"14.48";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691776";"";"None";"554.44";"1";"4.61";"BDBM143673";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.6";"nM";"9.22";"";"279626";"UO_0000065";"16.63";"0.33";"4.61";"8.44";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653195";"";"None";"567.48";"2";"5.70";"BDBM129760";"COc1nc(NCCO)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261491";"UO_0000065";"17.22";"0.34";"4.07";"9.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL224408";"";"None";"358.18";"0";"3.49";"24";"O=c1nc2n(-c3ccc(Cl)cc3)c3cccc(Cl)c3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2420495";"";"None";"323.74";"0";"2.83";"22";"O=c1nc2n(-c3ccccc3)c3c(Cl)cccc3cc-2c(=O)[nH]1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2447327";"Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440041";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3125528";"";"None";"566.55";"2";"6.14";"26";"CC[C@@H](CS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"15.44";"0.32";"2.60";"9.53";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125708";"";"None";"473.40";"1";"6.22";"8";"CC[C@@H](CC#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.18";"0.33";"1.44";"9.41";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125705";"";"None";"520.50";"2";"6.86";"5";"CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"16.00";"0.32";"1.47";"10.70";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125535";"";"None";"582.59";"2";"6.77";"33";"CC(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"15.83";"0.33";"2.45";"10.05";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125707";"";"None";"492.44";"1";"6.08";"7";"CC[C@@H](C[C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"18.59";"0.38";"3.07";"11.76";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125708";"";"None";"473.40";"1";"6.22";"8";"CC[C@@H](CC#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"18.84";"0.38";"2.70";"10.96";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125515";"";"None";"597.61";"2";"6.37";"13";"CC[C@@H](CN(C)S(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"15.32";"0.32";"2.78";"9.64";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3220118";"";"None";"492.40";"0";"4.70";"11e";"O=C1NC(=S)NC(=O)C1=Cc1cc(-c2ccccc2)n(-c2ccc(Br)cc2)c1C1CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"11.77";"0.26";"1.10";"9.18";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3693967";"";"None";"519.40";"1";"3.21";"10";"CNC(=O)[C@@H]1NC2(CCN(C(C)=O)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"2110.0";"nM";"5.68";"";"";"UO_0000065";"10.93";"0.22";"2.47";"6.27";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4064867";"";"None";"628.57";"2";"6.42";"59";"CN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"13.28";"0.27";"1.93";"8.45";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4091801";"APG115";"2.0";"642.60";"2";"6.81";"60";"CCN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"13.10";"0.26";"1.61";"8.53";"1";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3656986";"";"None";"538.44";"2";"6.30";"BDBM129888";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.11";"nM";"9.96";"";"261619";"UO_0000065";"18.50";"0.37";"3.66";"12.09";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3291220";"";"None";"375.44";"1";"5.24";"10";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnc2c(C#N)cnn12";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"16.09";"0.28";"0.80";"8.66";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3286447";"";"None";"400.49";"1";"6.52";"16";"Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccnc2nc3ccccc3n12";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"16.09";"0.28";"-0.08";"14.01";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3653265";"";"None";"568.46";"2";"5.93";"BDBM129832";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.25";"nM";"9.60";"";"261561";"UO_0000065";"16.89";"0.34";"3.67";"10.48";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4203525";"";"None";"1872.81";"None";"None";"D-MIPC-R17A";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](C)C(N)=O";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"2.56";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL572933";"";"None";"552.47";"1";"3.74";"7, MI-219";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"12.29";"0.25";"3.05";"6.13";"0";"CHEMBL1039715";"Inhibition of his-tagged human recombinant MDM2 binding to p53-based peptide PMDM6-F by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154717";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL207202";"";"None";"653.34";"2";"6.55";"12g";"COCCOCCN1C(=O)[C@H](c2ccc(Cl)cc2)N([C@H](C)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"2390.0";"nM";"5.62";"";"";"UO_0000065";"8.60";"0.21";"-0.93";"9.52";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL411220";"";"None";"653.26";"2";"5.43";"12";"O=C(O)CCN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"1090.0";"nM";"5.96";"";"";"UO_0000065";"9.13";"0.22";"0.53";"5.17";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3683172";"";"None";"645.24";"2";"6.54";"BDBM162122";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.8";"nM";"8.74";"";"305026";"UO_0000065";"13.55";"0.26";"2.20";"13.34";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691794";"";"None";"535.00";"1";"4.21";"BDBM143734";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"2.13";"nM";"8.67";"";"279836";"UO_0000065";"16.21";"0.31";"4.46";"8.31";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657062";"";"None";"537.02";"2";"6.18";"BDBM129972";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"57.7";"nM";"7.24";"";"261699";"UO_0000065";"13.48";"0.25";"1.06";"6.71";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691692";"";"None";"581.04";"2";"7.39";"BDBM143450";"CNC(=O)c1ccc(C)c(-n2nc3c(c2C(C)C)C(c2ccc(C(F)(F)F)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"5.7";"nM";"8.24";"";"279587";"UO_0000065";"14.19";"0.27";"0.85";"12.26";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657010";"";"None";"623.51";"2";"6.81";"BDBM129914";"COc1ccc(C(=O)N2CCOCC2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261645";"UO_0000065";"15.76";"0.31";"3.01";"12.77";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL426321";"";"None";"680.33";"2";"5.85";"5";"O=C(O)CCCCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"8.91";"0.21";"0.21";"5.23";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3220112";"";"None";"469.97";"1";"5.34";"10d";"CNC(=O)C(=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1)C(=O)NC";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"10.89";"0.21";"-0.22";"8.11";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220113";"";"None";"530.02";"1";"4.07";"10e";"O=C(NCCO)C(=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1)C(=O)NCCO";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"9.10";"0.17";"0.75";"4.66";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL1688168";"";"None";"366.80";"0";"2.82";"42";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccc[n+]1[O-]";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL4463050";"";"None";"540.51";"2";"5.95";"51; AM-232";"CC(C)[C@H](N1C(=O)[C@@H](CC(=O)O)C[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C(C)C";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"14.88";"0.31";"2.09";"8.76";"0";"CHEMBL4353006";"Inhibition of p53 protein binding to MDM2 in human SJSA1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3627749";"";"None";"597.67";"2";"6.06";"23";"CC(C)(C)OC(=O)Nc1ccc(-c2cn(CCC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)nn2)cc1";"IC50";"'='";"57360.0";"nM";"4.24";"";"";"UO_0000065";"7.10";"0.13";"-1.82";"2.93";"0";"CHEMBL3629965";"Inhibition of human MDM2 (17 to 125 residues) assessed as reduction in MDM2 interaction with FAM-LTFEHYWAQLTS-CONH2 peptide incubated for 30 mins by fluorescence polarisation assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3627641";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3649882";"";"None";"552.08";"2";"5.32";"BDBM135225";"CO[C@@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"31.0";"nM";"7.51";"";"268735";"UO_0000065";"13.60";"0.26";"2.19";"6.53";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135229";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268738";"UO_0000065";"14.55";"0.28";"3.85";"6.52";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3966426";"";"None";"610.16";"2";"5.58";"BDBM135251";"COCCO[C@H]1C[C@H](C(C)C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'<'";"1.0";"nM";"";"";"268760";"UO_0000065";"";"";"";"";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639487";"";"None";"580.09";"1";"4.70";"BDBM135259";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2COCCC2O1";"IC50";"'='";"63.0";"nM";"7.20";"";"268769";"UO_0000065";"12.41";"0.24";"2.50";"5.80";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647045";"";"None";"483.62";"1";"6.27";"BDBM135105";"Cc1ccc(Cn2c(-c3cc(C(C)C)ccn3)nc3cc(C(=O)O)nc(N[C@H](C)C4CCC4)c32)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"268614";"UO_0000065";"17.36";"0.32";"2.13";"9.04";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268643";"UO_0000065";"15.87";"0.30";"2.61";"8.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"16.0";"nM";"7.80";"";"268677";"UO_0000065";"12.99";"0.25";"1.52";"6.78";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3654187";"";"None";"579.11";"1";"4.76";"BDBM135171";"CCN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"35.0";"nM";"7.46";"";"268680";"UO_0000065";"12.87";"0.25";"2.70";"5.92";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649844";"";"None";"544.01";"2";"5.55";"BDBM135178";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268687";"UO_0000065";"16.54";"0.32";"3.45";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"5.0";"nM";"8.30";"";"268688";"UO_0000065";"15.43";"0.30";"3.37";"7.22";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3981115";"";"None";"566.11";"2";"5.57";"BDBM135197";"CO[C@H]1C[C@H](C(C)C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'<'";"1.0";"nM";"";"";"268706";"UO_0000065";"";"";"";"";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649865";"";"None";"535.96";"2";"5.31";"BDBM135201";"CN(CC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268710";"UO_0000065";"16.79";"0.33";"3.69";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649873";"";"None";"522.01";"1";"4.30";"BDBM135211";"C[C@H]1CC[C@H](Cn2c(N3CCC34COC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"268720";"UO_0000065";"14.79";"0.29";"3.42";"6.72";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649875";"";"None";"591.14";"2";"6.42";"BDBM135213";"Cc1nc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)cs1";"IC50";"'='";"1.0";"nM";"9.00";"";"268722";"UO_0000065";"15.22";"0.30";"2.58";"7.59";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4077946";"";"None";"616.54";"2";"5.82";"51";"CS(=O)(=O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"11.18";"0.23";"1.07";"6.60";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693981";"";"None";"583.45";"2";"5.51";"47";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cn1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"13.75";"0.27";"2.51";"6.66";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL1688153";"";"None";"428.71";"0";"4.95";"27";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccc(Br)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688148";"";"None";"394.81";"0";"4.10";"22";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccc([N+](=O)[O-])c1";"IC50";"'='";"54000.0";"nM";"4.27";"";"";"UO_0000065";"10.81";"0.21";"0.17";"5.10";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688161";"";"None";"391.85";"0";"4.39";"35";"CC(=O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"88000.0";"nM";"4.06";"";"";"UO_0000065";"10.35";"0.20";"-0.33";"7.04";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688253";"";"None";"458.95";"0";"5.00";"53";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2CC[C@@H](O)C2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.29";"0.23";"0.64";"7.66";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3220114";"";"None";"399.88";"1";"6.56";"10f";"O=C(O)/C=C/c1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"11.93";"0.22";"-1.79";"11.29";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3693984";"";"None";"561.44";"1";"4.26";"BDBM112769";"O=C(NC1CN(C(=O)O)C1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234044";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3663849";"";"None";"656.51";"1";"3.91";"BDBM170367";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)COC(=O)CC(=O)O)[C@H](c2ccc(F)c(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314337";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665587";"";"None";"532.03";"1";"4.40";"BDBM119719";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314249";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663877";"";"None";"611.54";"2";"5.38";"BDBM170401";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@@H]2CCN(CCF)C[C@@H]2F)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314369";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653236";"";"None";"500.96";"2";"6.55";"BDBM129801";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.27";"nM";"9.57";"";"261531";"UO_0000065";"19.10";"0.36";"3.02";"13.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691737";"";"None";"520.46";"2";"7.68";"BDBM143546";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.6";"nM";"9.22";"";"279621";"UO_0000065";"17.72";"0.35";"1.54";"19.47";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665588";"";"None";"550.02";"1";"4.54";"BDBM119720";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'<'";"3000.0";"nM";"";"";"314250";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691776";"";"None";"554.44";"1";"4.61";"BDBM143673";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.068";"nM";"10.17";"";"279817";"UO_0000065";"18.34";"0.37";"5.56";"9.31";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650064";"";"None";"540.10";"2";"6.16";"BDBM135934";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(=O)C3CCOCC3)CC1)C(=O)C2";"IC50";"'='";"610.0";"nM";"6.21";"";"269512";"UO_0000065";"11.51";"0.22";"0.05";"9.55";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657023";"";"None";"542.40";"2";"6.13";"BDBM129927";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.15";"nM";"9.82";"";"261658";"UO_0000065";"18.11";"0.36";"3.69";"11.93";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL207845";"";"None";"700.88";"2";"7.39";"22";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL210409";"";"None";"695.34";"2";"6.30";"15";"COC(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL208562";"";"None";"706.46";"2";"6.11";"12k";"C[C@H](c1ccc(Cl)cc1N)N1C(=O)c2cc(I)ccc2N(CCCN2CCN(C)CC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869350";"Antiproliferative activity against mutant p53 MDA-MB-231 cell line";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL3703317";"";"None";"819.73";"2";"7.47";"BDBM152942";"COCCN(CCOC)C(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"16.3";"nM";"7.79";"";"293765";"UO_0000065";"9.50";"0.19";"0.32";"5.25";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3318757";"";"None";"581.56";"2";"5.64";"5";"CCCNS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"17.12";"0.36";"4.32";"9.60";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318786";"";"None";"685.71";"2";"8.07";"37";"CC1(C)CN(S(=O)(=O)C[C@@H](N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C(C)(C)C)c2ccccc21";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"14.47";"0.29";"1.85";"10.44";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3125710";"";"None";"541.50";"1";"4.86";"10";"CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.91";"0.36";"4.29";"8.82";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3691720";"";"None";"590.47";"2";"6.15";"BDBM143499";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1OCc1nn[nH]n1)C2=O";"IC50";"'='";"1.8";"nM";"8.74";"";"279616";"UO_0000065";"14.81";"0.29";"2.59";"7.87";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688139";"";"None";"384.26";"0";"4.84";"13";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"13.99";"0.28";"0.54";"13.26";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"12.41";"0.25";"1.32";"8.64";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688163";"";"None";"350.81";"0";"3.58";"37";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccncc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688164";"";"None";"350.81";"0";"3.58";"38";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccnc1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3653194";"";"None";"581.50";"2";"5.72";"BDBM129759";"COc1nc(N(C)CCO)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.19";"nM";"9.72";"";"261490";"UO_0000065";"16.72";"0.33";"4.00";"10.06";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657054";"";"None";"519.01";"1";"4.65";"BDBM129962";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nc(C)n1)C2=O";"IC50";"'='";"142.6";"nM";"6.85";"";"261691";"UO_0000065";"13.19";"0.25";"2.20";"7.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2402735";"";"None";"604.46";"2";"7.07";"10";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(=O)O)c(F)c2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"12.70";"0.26";"0.61";"7.51";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402733";"";"None";"636.53";"2";"8.08";"8";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc3cc(C(=O)O)ccc3c2)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"12.03";"0.24";"-0.42";"7.49";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2402574";"";"None";"554.47";"1";"4.45";"3";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"12.86";"0.26";"2.68";"6.77";"0";"CHEMBL2406002";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401690";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347375";"";"None";"577.53";"1";"4.33";"17";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"21.3";"nM";"7.67";"";"";"UO_0000065";"13.28";"0.27";"3.34";"9.28";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3647067";"";"None";"546.07";"2";"6.25";"BDBM135131";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268640";"UO_0000065";"16.48";"0.32";"2.75";"9.64";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647069";"";"None";"538.05";"1";"4.93";"BDBM135133";"C[C@H]1COC[C@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"157.0";"nM";"6.80";"";"268642";"UO_0000065";"12.65";"0.24";"1.87";"5.92";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649841";"";"None";"592.02";"2";"5.82";"BDBM135174";"C[C@H]1CC[C@H](Cn2c(N3CCCC3COC(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268683";"UO_0000065";"13.77";"0.27";"2.33";"7.09";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649840";"";"None";"566.11";"2";"5.71";"BDBM135173";"CC(C)OCC1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"47.0";"nM";"7.33";"";"268686";"UO_0000065";"12.94";"0.25";"1.62";"6.37";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649852";"";"None";"577.11";"2";"6.11";"BDBM135188";"C[C@H]1CC[C@H](Cn2c(N3CCCC3c3nccs3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268697";"UO_0000065";"";"";"";"";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649866";"";"None";"554.05";"1";"4.17";"BDBM135202";"CO[C@H]1COC[C@@H]1N(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"268711";"UO_0000065";"13.69";"0.27";"3.42";"6.11";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3929391";"";"None";"564.09";"2";"5.32";"BDBM135231";"CC1CCC(Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268741";"UO_0000065";"14.35";"0.28";"2.78";"7.04";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL209169";"";"None";"681.31";"2";"6.21";"13";"O=C(O)CCCCN1C(=O)C(c2ccc(Cl)cc2)N(C(C(=O)O)c2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"9.24";"0.22";"0.08";"5.46";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210913";"";"None";"563.48";"2";"6.91";"24";"CC#Cc1ccc2c(c1)C(=O)N([C@H](C)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2CCCCC(=O)O";"IC50";"'='";"10700.0";"nM";"4.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL3653237";"";"None";"572.04";"2";"6.26";"BDBM129802";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.35";"nM";"9.46";"";"261532";"UO_0000065";"16.53";"0.31";"3.20";"10.34";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657036";"";"None";"537.45";"2";"6.39";"BDBM129943";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccn1)C2=O";"IC50";"'='";"5.81";"nM";"8.24";"";"261673";"UO_0000065";"15.32";"0.30";"1.85";"10.23";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691787";"";"None";"577.02";"1";"3.97";"BDBM143708";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.213";"nM";"9.67";"";"279829";"UO_0000065";"16.76";"0.32";"5.70";"7.92";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683180";"";"None";"548.08";"2";"5.31";"BDBM162195";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc([C@H](C)N3CCNCC3=O)cc1)C(=O)C2";"IC50";"'='";"7.1";"nM";"8.15";"";"305038";"UO_0000065";"14.87";"0.29";"2.84";"11.46";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2152321";"";"None";"515.47";"2";"5.16";"9d";"CCCC1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"10.69";"0.22";"0.35";"8.47";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3657066";"";"None";"559.03";"2";"5.15";"BDBM129976";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261703";"UO_0000065";"17.48";"0.33";"4.62";"8.47";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656982";"";"None";"554.44";"2";"5.15";"BDBM129884";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)cnc1O)C2=O";"IC50";"'='";"0.1";"nM";"10.00";"";"261614";"UO_0000065";"18.04";"0.36";"4.85";"9.13";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653172";"";"None";"521.45";"2";"7.21";"BDBM129736";"COc1cnccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.22";"nM";"9.66";"";"261467";"UO_0000065";"18.52";"0.37";"2.45";"16.03";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691711";"";"None";"580.52";"2";"5.78";"BDBM143477";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(CCN(C)C)c1)C2=O";"IC50";"'='";"1.773";"nM";"8.75";"";"279761";"UO_0000065";"15.07";"0.30";"2.97";"12.05";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653274";"";"None";"581.50";"2";"5.72";"BDBM129842";"COc1cnc(N(C)CCO)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.26";"nM";"9.59";"";"261571";"UO_0000065";"16.48";"0.33";"3.87";"9.92";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657045";"";"None";"496.37";"1";"6.30";"BDBM129952";"CC(C)n1c(-c2ccnc(N)c2)nc2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"6.6";"nM";"8.18";"";"261682";"UO_0000065";"16.48";"0.33";"1.88";"10.62";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657094";"";"None";"535.00";"1";"4.35";"BDBM130011";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.16";"nM";"8.94";"";"261732";"UO_0000065";"16.70";"0.32";"4.59";"8.56";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687316";"";"None";"524.42";"2";"7.37";"BDBM143445";"COc1ccccc1-n1nc2c(c1C(C)C)C(C)(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"1.6";"nM";"8.80";"";"279584";"UO_0000065";"16.77";"0.33";"1.43";"18.57";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683136";"";"None";"640.25";"2";"6.31";"BDBM161878";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCN(S(C)(=O)=O)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"10.7";"nM";"7.97";"";"304984";"UO_0000065";"12.45";"0.25";"1.66";"10.04";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653224";"";"None";"594.50";"2";"5.60";"BDBM129789";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.71";"nM";"9.15";"";"261520";"UO_0000065";"15.39";"0.30";"3.55";"10.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683108";"";"None";"579.14";"2";"6.23";"BDBM161703";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(C)cc1OCCCN1CCOCC1)C(=O)C2";"IC50";"'='";"884.3";"nM";"6.05";"";"304953";"UO_0000065";"10.45";"0.20";"-0.18";"10.01";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687262";"";"None";"505.45";"2";"7.12";"BDBM143385";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3ccccn3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.6";"nM";"8.59";"";"279530";"UO_0000065";"16.98";"0.33";"1.47";"16.83";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657026";"";"None";"517.42";"2";"7.07";"BDBM129930";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"0.39";"nM";"9.41";"";"261661";"UO_0000065";"18.18";"0.36";"2.34";"13.22";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657100";"";"None";"535.99";"1";"4.45";"BDBM130018";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)nnc2OC)C3=O)c(OC)n1";"IC50";"'='";"5.926";"nM";"8.23";"";"261739";"UO_0000065";"15.35";"0.30";"3.78";"7.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691756";"";"None";"531.96";"1";"3.77";"BDBM143615";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.242";"nM";"8.91";"";"279797";"UO_0000065";"16.74";"0.32";"5.14";"6.41";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653309";"";"None";"581.48";"2";"6.62";"BDBM129877";"CNC(=O)Cc1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.27";"nM";"9.57";"";"261607";"UO_0000065";"16.46";"0.33";"2.95";"12.51";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687280";"";"None";"462.35";"1";"5.50";"BDBM143408";"Cc1cc(Cl)ccc1C1c2c(nn(CCO)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"5.9";"nM";"8.23";"";"279548";"UO_0000065";"17.80";"0.36";"2.73";"14.10";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601316";"";"None";"556.11";"2";"7.24";"BDBM161864";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"8.4";"nM";"8.08";"";"304977";"UO_0000065";"14.52";"0.28";"0.84";"14.71";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687301";"";"None";"471.36";"1";"6.42";"BDBM143429";"Cc1cc(Cl)ccc1C1c2c(nn(CCC#N)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"15.6";"nM";"7.81";"";"279569";"UO_0000065";"16.56";"0.33";"1.39";"12.61";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691694";"";"None";"507.42";"2";"6.76";"BDBM143453";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cn1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.9";"nM";"8.72";"";"279589";"UO_0000065";"17.19";"0.34";"1.96";"14.48";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657033";"";"None";"605.57";"2";"7.95";"BDBM129939";"COc1cc(C(=O)NC(C)C)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.24";"nM";"9.62";"";"261669";"UO_0000065";"15.89";"0.31";"1.67";"12.58";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691701";"";"None";"563.49";"2";"7.33";"BDBM143464";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)cc(NC(C)=O)c1)C2=O";"IC50";"'='";"2.9";"nM";"8.54";"";"279596";"UO_0000065";"15.15";"0.30";"1.21";"11.17";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691733";"";"None";"553.02";"2";"5.84";"BDBM143537";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cc(C#N)ccc4OC)c3C(C)C)C(=O)N2c2cc(Cl)c(=O)n(C)c2)c(C)c1";"IC50";"'='";"1.026";"nM";"8.99";"";"279778";"UO_0000065";"16.25";"0.31";"3.15";"9.22";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691764";"";"None";"541.40";"1";"4.55";"BDBM143645";"COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.161";"nM";"9.79";"";"279805";"UO_0000065";"18.09";"0.36";"5.24";"8.50";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687284";"";"None";"601.53";"2";"6.55";"BDBM143412";"CNS(=O)(=O)Cc1ccc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)cc1";"IC50";"'='";"6.8";"nM";"8.17";"";"279552";"UO_0000065";"13.58";"0.28";"1.62";"9.69";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653252";"";"None";"528.37";"2";"5.42";"BDBM129817";"COc1c[nH]c(=O)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.62";"nM";"9.21";"";"261547";"UO_0000065";"17.43";"0.35";"3.79";"9.89";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4163281";"";"None";"470.49";"1";"0.01";"16";"COc1ccc(CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)c2cccc(NC(=N)N)c2)cc1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"13.06";"0.25";"6.13";"3.14";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4173995";"";"None";"474.91";"1";"0.65";"15";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCc2ccc(Cl)cc2)c1";"IC50";"'='";"624.0";"nM";"6.21";"";"";"UO_0000065";"13.07";"0.26";"5.55";"3.33";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4163249";"";"None";"440.46";"1";"0.00";"8";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCc2ccccc2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4164619";"";"None";"454.49";"1";"0.04";"7";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCCc2ccccc2)c1";"IC50";"'='";"437.0";"nM";"6.36";"";"";"UO_0000065";"13.99";"0.26";"6.32";"3.41";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3703326";"";"None";"872.79";"2";"8.43";"BDBM152951";"COc1cc(C(=O)OC(C)OC(=O)N2CCN(C(=O)OC(C)(C)C)CC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"23.8";"nM";"7.62";"";"293775";"UO_0000065";"8.73";"0.17";"-0.81";"4.78";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268661";"UO_0000065";"13.40";"0.26";"2.07";"7.04";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649830";"";"None";"522.05";"2";"5.70";"BDBM135159";"C[C@@H]1CCCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268668";"UO_0000065";"16.09";"0.31";"2.70";"7.94";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3951933";"";"None";"564.05";"1";"4.93";"BDBM119714";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314242";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3942858";"";"None";"552.08";"2";"5.32";"BDBM135194";"COC1CC[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268703";"UO_0000065";"15.44";"0.30";"3.20";"7.41";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3972127";"";"None";"591.12";"1";"4.91";"BDBM135316";"CC(=O)N1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H]2CCC[C@@H]21";"IC50";"'='";"4.0";"nM";"8.40";"";"268825";"UO_0000065";"14.21";"0.27";"3.49";"6.66";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703321";"";"None";"688.56";"2";"6.92";"BDBM152946";"COc1cc(C(=O)OCOC(C)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"45.0";"nM";"7.35";"";"293769";"UO_0000065";"10.67";"0.21";"0.43";"5.80";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703348";"";"None";"1071.01";"None";"None";"BDBM152975";"COCCOCCOCCOCCOCCOCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"4.44";"nM";"8.35";"";"293799";"UO_0000065";"7.80";"None";"None";"None";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703350";"";"None";"805.70";"2";"7.13";"BDBM152977";"COCCOCCNC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.69";"nM";"8.24";"";"293802";"UO_0000065";"10.23";"0.20";"1.11";"5.24";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691772";"";"None";"555.42";"1";"4.56";"BDBM143669";"COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.157";"nM";"9.80";"";"279813";"UO_0000065";"17.65";"0.35";"5.24";"9.39";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688559";"";"None";"395.38";"1";"5.56";"BDBM47307";"Oc1c(C(Nc2cccnc2)c2ccc(C(F)(F)F)cc2)ccc2cccnc12";"IC50";"'='";"18000.0";"nM";"4.75";"";"198817";"UO_0000065";"12.00";"0.22";"-0.82";"8.17";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691754";"";"None";"545.00";"1";"3.82";"BDBM143606";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.222";"nM";"9.65";"";"279795";"UO_0000065";"17.71";"0.34";"5.83";"7.26";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3347576";"";"None";"1558.81";"None";"None";"12/1";"CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"4.38";"None";"None";"None";"0";"CHEMBL3390997";"Inhibition of human full length GST-tagged MDM2 expressed in Escherichia coli TG1 after 15 mins by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3390840";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3656978";"";"None";"559.03";"1";"3.97";"BDBM129880";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.33";"nM";"9.48";"";"261610";"UO_0000065";"16.96";"0.32";"5.51";"7.76";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683147";"";"None";"576.18";"2";"6.95";"BDBM161954";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N(C)C3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"259.9";"nM";"6.58";"";"304996";"UO_0000065";"11.43";"0.22";"-0.36";"12.19";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653183";"";"None";"538.44";"2";"6.30";"BDBM129748";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.137";"nM";"9.86";"";"261479";"UO_0000065";"18.32";"0.36";"3.56";"11.97";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657085";"";"None";"541.40";"1";"4.68";"BDBM130002";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"76.54";"nM";"7.12";"";"261723";"UO_0000065";"13.14";"0.26";"2.44";"6.18";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653202";"";"None";"551.48";"2";"6.64";"BDBM129767";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.16";"nM";"9.80";"";"261498";"UO_0000065";"17.76";"0.35";"3.16";"11.50";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656993";"";"None";"540.41";"1";"4.72";"BDBM129895";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.19";"nM";"9.72";"";"261627";"UO_0000065";"17.99";"0.36";"5.00";"8.24";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653303";"";"None";"569.07";"2";"5.41";"BDBM129871";"CNC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"1.95";"nM";"8.71";"";"261601";"UO_0000065";"15.31";"0.29";"3.30";"7.70";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687283";"";"None";"482.77";"1";"5.85";"BDBM143411";"CC(C)c1c2c(nn1CCO)C(=O)N(c1cccc(Cl)c1F)C2c1ccc(Cl)cc1Cl";"IC50";"'='";"13.2";"nM";"7.88";"";"279551";"UO_0000065";"16.32";"0.35";"2.03";"13.50";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653257";"";"None";"555.42";"1";"4.69";"BDBM129824";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"299.7";"nM";"6.52";"";"261553";"UO_0000065";"11.74";"0.23";"1.83";"6.25";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691744";"";"None";"568.47";"1";"4.62";"BDBM143571";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.12";"nM";"9.92";"";"279785";"UO_0000065";"17.45";"0.35";"5.30";"10.08";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2397470";"L-STINGIN";"None";"2211.61";"None";"None";"L-stingin";"CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC2=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O";"IC50";"'='";"214.0";"nM";"6.67";"";"";"UO_0000065";"3.02";"None";"None";"None";"0";"CHEMBL2398954";"Inhibition of TMRA-p53 binding to MDM2 (25 to 109 amino acids) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396557";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3653234";"";"None";"482.97";"1";"6.42";"BDBM129799";"Cc1ccc(Cl)cc1N1C(=O)c2nc(-c3ccccc3O)n(C(C)C)c2C1c1ccc(C#N)cc1";"IC50";"'='";"2.07";"nM";"8.68";"";"261529";"UO_0000065";"17.98";"0.34";"2.26";"10.57";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653269";"";"None";"524.07";"2";"6.43";"BDBM129836";"COc1ncc(-c2nc3c(n2C(C)C)C([C@H]2CC[C@H](C)CC2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.62";"nM";"9.21";"";"261565";"UO_0000065";"17.57";"0.34";"2.78";"11.18";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657114";"";"None";"553.45";"2";"5.50";"BDBM130032";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.213";"nM";"9.67";"";"261753";"UO_0000065";"17.48";"0.35";"4.17";"8.92";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653267";"";"None";"567.48";"2";"5.33";"BDBM129834";"COc1nc(N(C)C)ncc1-c1nc2c(n1[C@H](C)CO)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"261563";"UO_0000065";"17.55";"0.35";"4.63";"10.31";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687318";"";"None";"637.58";"2";"7.20";"BDBM143447";"COc1ccccc1-n1nc2c(c1C(C)C)C(CC(O)CN1CCCC1)(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"3.4";"nM";"8.47";"";"279586";"UO_0000065";"13.28";"0.26";"1.27";"11.96";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687282";"";"None";"512.39";"2";"7.64";"BDBM143410";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccccc3F)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"7.3";"nM";"8.14";"";"279550";"UO_0000065";"15.88";"0.32";"0.50";"21.34";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657030";"";"None";"607.54";"2";"6.54";"BDBM129936";"COc1ccc(C(=O)NCCO)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"13.4";"nM";"7.87";"";"261666";"UO_0000065";"12.96";"0.26";"1.33";"8.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687317";"";"None";"612.53";"2";"7.79";"BDBM143446";"COCCCOc1cc(Cl)ccc1C1(C)c2c(nn(-c3ccccc3OC)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"5.2";"nM";"8.28";"";"279585";"UO_0000065";"13.52";"0.27";"0.49";"12.59";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657102";"";"None";"549.04";"1";"4.51";"BDBM130020";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nnc1OC)C2=O";"IC50";"'='";"1.268";"nM";"8.90";"";"261741";"UO_0000065";"16.20";"0.31";"4.39";"7.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649977";"";"None";"563.06";"2";"5.18";"BDBM135361";"CCOC(c1ccn(C)n1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268870";"UO_0000065";"15.14";"0.29";"3.34";"6.58";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691704";"";"None";"523.42";"2";"5.76";"BDBM143467";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"1.3";"nM";"8.89";"";"279599";"UO_0000065";"16.98";"0.34";"3.13";"12.81";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601322";"";"None";"604.24";"2";"7.76";"BDBM162023";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)[C@H]2c1ccc(Cl)cc1";"IC50";"'='";"787.5";"nM";"6.10";"";"305006";"UO_0000065";"10.10";"0.19";"-1.66";"13.49";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683164";"";"None";"583.15";"2";"5.61";"BDBM162090";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc([C@H](C)N3CCS(=O)(=O)CC3)cc1)C(=O)C2";"IC50";"'='";"33.3";"nM";"7.48";"";"305017";"UO_0000065";"12.82";"0.26";"1.87";"9.82";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687233";"";"None";"561.49";"2";"8.23";"BDBM143341";"Cc1cc(Cl)ccc1C1c2c(nn(CCc3c[nH]c4ccccc34)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"22.8";"nM";"7.64";"";"279501";"UO_0000065";"13.61";"0.27";"-0.59";"14.17";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683162";"";"None";"676.26";"2";"5.08";"BDBM162076";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(CC(N)=O)CC(N)=O)CC3)cc1)C(=O)C2";"IC50";"'='";"1.8";"nM";"8.74";"";"305015";"UO_0000065";"12.93";"0.25";"3.66";"6.65";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657123";"";"None";"585.45";"1";"4.32";"BDBM130041";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"21.71";"nM";"7.66";"";"261762";"UO_0000065";"13.09";"0.26";"3.34";"6.75";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687276";"";"None";"568.55";"2";"6.83";"BDBM143404";"Cc1cc(Cl)ccc1C1c2c(nn(CC3CCCN3C(=O)N(C)C)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"1.6";"nM";"8.80";"";"279544";"UO_0000065";"15.47";"0.31";"1.97";"14.26";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657073";"";"None";"527.39";"2";"5.71";"BDBM129983";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"284.2";"nM";"6.55";"";"261710";"UO_0000065";"12.41";"0.25";"0.84";"6.60";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650050";"";"None";"485.02";"1";"5.06";"BDBM135920";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(NC(C)=O)CC1)C(=O)C2";"IC50";"'='";"969.0";"nM";"6.01";"";"269498";"UO_0000065";"12.40";"0.24";"0.95";"8.86";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683100";"";"None";"537.06";"2";"5.76";"BDBM161682";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1NC(N)=O";"IC50";"'='";"44923.5";"nM";"4.35";"";"304945";"UO_0000065";"8.10";"0.16";"-1.41";"4.48";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656994";"";"None";"565.03";"2";"2.80";"BDBM129898";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)c(=O)n(C)c1=O)C2=O";"IC50";"'='";"6.83";"nM";"8.17";"";"261629";"UO_0000065";"14.45";"0.28";"5.37";"6.78";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3233589";"";"None";"694.67";"2";"5.79";"9";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)C[C@@H](C)CN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"7.77";"0.15";"-0.39";"6.39";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4202754";"";"None";"1842.78";"None";"None";"D-MIPC-w3a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4091801";"APG115";"2.0";"642.60";"2";"6.81";"4; APG-115";"CCN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"13.10";"0.26";"1.61";"8.53";"0";"CHEMBL5164639";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3601398";"CGM-097";"1.0";"659.27";"2";"6.58";"6; NVP-CGM097";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"13.30";"0.25";"2.19";"13.38";"0";"CHEMBL5164642";"Inhibition of human MDM2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5180980";"";"None";"812.15";"2";"10.03";"10";"C[C@@H](c1ccc(Cl)cc1Cl)n1cnc(-c2ccccc2)c1-c1c(C(=O)Nc2cc(C(=O)O)ccc2N2CCC(N3CCCOC3=O)CC2)[nH]c2cc(Cl)ccc12";"IC50";"'<'";"0.1";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5164642";"Inhibition of human MDM2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3687281";"";"None";"519.41";"2";"7.37";"BDBM143409";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccc(C#N)cc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"6.9";"nM";"8.16";"";"279549";"UO_0000065";"15.71";"0.31";"0.79";"13.18";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4065471";"";"None";"599.73";"2";"6.50";"1";"O=C(CC(c1ccccc1)(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(OCCCNc2ccccn2)cc1)C(=O)O";"IC50";"'='";"93.7";"nM";"7.03";"";"";"UO_0000065";"11.72";"0.21";"0.53";"6.99";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4527016";"";"None";"687.84";"1";"4.63";"MC-216";"O=C1CCC(N2Cc3c(CCCCCNC(=O)[C@@H]4NC5(CCCCC5)[C@@]5(C(=O)Nc6ccccc65)[C@H]4c4ccccc4)cccc3C2=O)C(=O)N1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4105199";"";"None";"479.58";"1";"5.02";"2";"COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1";"IC50";"'='";"35.4";"nM";"7.45";"";"";"UO_0000065";"15.54";"0.28";"2.43";"9.85";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3683184";"";"None";"590.12";"2";"5.57";"BDBM162234";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc([C@H](C)N3CCN(C(C)=O)CC3=O)cc1)C(=O)C2";"IC50";"'='";"33.0";"nM";"7.48";"";"305042";"UO_0000065";"12.68";"0.24";"1.91";"9.42";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665593";"";"None";"532.03";"1";"4.40";"BDBM119729";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"149.49";"nM";"6.83";"";"246781";"UO_0000065";"12.83";"0.25";"2.43";"7.55";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665594";"";"None";"550.02";"1";"4.54";"BDBM119730";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"159.97";"nM";"6.80";"";"246782";"UO_0000065";"12.36";"0.24";"2.26";"7.51";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665607";"";"None";"548.49";"1";"4.91";"BDBM119744";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cc(Cl)ccc2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"159.0";"nM";"6.80";"";"246841";"UO_0000065";"12.40";"0.25";"1.89";"7.52";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653181";"";"None";"619.55";"2";"6.98";"BDBM129746";"COc1ccc(C(=O)N2CCOCC2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.16";"nM";"9.80";"";"261477";"UO_0000065";"15.81";"0.31";"2.82";"12.74";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691719";"";"None";"418.30";"1";"5.90";"BDBM143497";"CC(C)(C)c1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"110.1";"nM";"6.96";"";"279615";"UO_0000065";"16.63";"0.34";"1.06";"14.20";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647057";"";"None";"566.11";"2";"5.71";"BDBM135117";"COC(C)(C)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286136";"UO_0000065";"15.90";"0.31";"3.29";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649838";"";"None";"579.11";"1";"4.76";"BDBM135171";"CCN(C)C(=O)[C@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"35.0";"nM";"7.46";"";"286190";"UO_0000065";"12.87";"0.25";"2.70";"5.92";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649863";"";"None";"556.04";"1";"4.88";"BDBM135199";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286218";"UO_0000065";"16.19";"0.32";"4.12";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3933428";"";"None";"587.15";"1";"4.42";"BDBM135406";"CS(=O)(=O)NC(=O)c1cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"286425";"UO_0000065";"15.33";"0.31";"4.58";"7.54";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650007";"";"None";"616.19";"1";"4.27";"BDBM135407";"CN(C)S(=O)(=O)NC(=O)c1cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"286426";"UO_0000065";"14.12";"0.28";"4.43";"7.10";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653190";"";"None";"529.47";"2";"7.93";"BDBM129755";"CCc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.65";"nM";"9.19";"";"261486";"UO_0000065";"17.35";"0.34";"1.26";"14.84";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657077";"";"None";"533.03";"2";"5.56";"BDBM129987";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)ccc1OC)C2=O";"IC50";"'='";"1.16";"nM";"8.94";"";"261714";"UO_0000065";"16.76";"0.32";"3.38";"11.37";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657019";"";"None";"540.41";"1";"4.27";"BDBM129923";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"68.6";"nM";"7.16";"";"261654";"UO_0000065";"13.26";"0.26";"2.89";"5.91";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683178";"";"None";"674.29";"2";"6.71";"BDBM162165";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C(C)C)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"1.2";"nM";"8.92";"";"305036";"UO_0000065";"13.23";"0.25";"2.21";"11.37";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657104";"";"None";"573.41";"1";"4.83";"BDBM130022";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2F)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.065";"nM";"8.97";"";"261743";"UO_0000065";"15.65";"0.31";"4.14";"8.60";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657035";"";"None";"591.54";"2";"7.51";"BDBM129942";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.09";"nM";"10.05";"";"261672";"UO_0000065";"16.98";"0.33";"2.54";"14.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683161";"";"None";"659.23";"2";"5.77";"BDBM162074";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)NCC4=O)CC3)cc1)C(=O)C2";"IC50";"'='";"6.3";"nM";"8.20";"";"305014";"UO_0000065";"12.44";"0.24";"2.43";"8.97";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657120";"";"None";"585.45";"1";"4.32";"BDBM130038";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.81";"nM";"9.09";"";"261759";"UO_0000065";"15.53";"0.31";"4.77";"8.00";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657005";"";"None";"577.51";"2";"7.21";"BDBM129909";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261640";"UO_0000065";"17.12";"0.34";"2.68";"14.61";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639559";"";"None";"591.54";"2";"7.51";"BDBM129941";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"36.8";"nM";"7.43";"";"261671";"UO_0000065";"12.57";"0.25";"-0.08";"10.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4064261";"";"None";"617.53";"2";"5.07";"50";"NS(=O)(=O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"10.67";"0.22";"1.52";"5.06";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4095706";"";"None";"600.45";"2";"6.26";"46";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)c(F)c1";"IC50";"'='";"12.7";"nM";"7.90";"";"";"UO_0000065";"13.15";"0.26";"1.64";"7.34";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4072394";"";"None";"562.47";"1";"3.99";"19";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3nc(Cl)ncc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"56.8";"nM";"7.25";"";"";"UO_0000065";"12.88";"0.26";"3.26";"6.23";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693987";"";"None";"543.50";"1";"4.46";"16";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cncc(Cl)c1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"12.12";"0.24";"2.13";"6.37";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4062028";"";"None";"596.48";"2";"5.45";"12";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCC(F)(F)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"12.38";"0.25";"1.94";"8.17";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4093562";"";"None";"572.46";"1";"4.90";"55";"O=C(NC12CC(C(=O)O)(C1)C2)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"14.31";"0.29";"3.29";"7.62";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3657117";"";"None";"572.42";"2";"5.76";"BDBM130035";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1[C@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.089";"nM";"10.05";"";"261756";"UO_0000065";"17.56";"0.35";"4.29";"10.97";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649972";"";"None";"549.01";"2";"5.54";"BDBM135354";"C[C@H]1CC[C@H](Cn2c(C(O)c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268863";"UO_0000065";"15.84";"0.30";"3.16";"7.09";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL8320";"BENZOQUINONE";"None";"108.10";"0";"0.25";"5";"O=C1C=CC(=O)C=C1";"IC50";"'='";"13900.0";"nM";"4.86";"";"";"UO_0000065";"44.93";"0.83";"4.61";"14.23";"0";"CHEMBL4017936";"Inhibition of biotin-labelled p53 binding to MDM2 (25 to 109 residues) (unknown origin) by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3687315";"";"None";"593.55";"2";"7.31";"BDBM143444";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"1.7";"nM";"8.77";"";"279583";"UO_0000065";"14.77";"0.29";"1.46";"14.66";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3601398";"CGM-097";"1.0";"659.27";"2";"6.58";"BDBM162123";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"0.8";"nM";"9.10";"";"305027";"UO_0000065";"13.80";"0.26";"2.52";"13.88";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657017";"";"None";"554.44";"1";"4.73";"BDBM129921";"CNc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.19";"nM";"9.72";"";"261652";"UO_0000065";"17.53";"0.35";"4.99";"9.07";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691708";"";"None";"581.50";"2";"6.18";"BDBM143472";"COCCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"1.1";"nM";"8.96";"";"279603";"UO_0000065";"15.41";"0.31";"2.78";"11.40";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688151";"";"None";"378.86";"0";"3.81";"25";"Nc1ccc(CCN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"13.75";"0.26";"1.40";"7.82";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688149";"";"None";"363.84";"0";"4.23";"23";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1CCc1ccccc1";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"14.13";"0.27";"0.91";"12.69";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688146";"";"None";"394.81";"0";"4.10";"20";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"14.23";"0.27";"1.52";"6.72";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688143";"";"None";"374.83";"0";"4.06";"17";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"13.93";"0.26";"1.16";"8.12";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688138";"";"None";"367.81";"0";"4.33";"12";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc(F)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688157";"";"None";"428.90";"0";"2.84";"31";"NS(=O)(=O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688160";"";"None";"393.83";"0";"3.89";"34";"O=C(O)c1ccc(CN2C(=O)c3ccccc3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688165";"";"None";"350.81";"0";"3.58";"39";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccccn1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688262";"";"None";"470.40";"1";"6.20";"62";"C[C@@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCCCCO)c1ccc(Cl)cc1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"12.85";"0.26";"-0.15";"12.15";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688267";"";"None";"514.97";"2";"5.81";"67";"O=C1c2ccccc2C(OCc2ccc(CO)cc2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"11.67";"0.22";"0.20";"6.47";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688271";"";"None";"462.89";"0";"4.12";"71";"O=C1c2ccccc2C(OCC#CCO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"13.35";"0.26";"2.06";"6.65";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688284";"";"None";"482.41";"1";"6.20";"85";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"10.48";"0.21";"-1.14";"10.16";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688288";"";"None";"501.93";"2";"6.01";"89";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(C(F)(F)F)cc1";"IC50";"'='";"214000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL1688301";"";"None";"500.99";"1";"4.57";"103";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(-n2cnnc2)cc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1694433";"Inhibition of Mdm2 -p53 protein interaction by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687910";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";""
"CHEMBL3649815";"";"None";"538.05";"1";"4.93";"BDBM135140";"CCC1COCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268649";"UO_0000065";"15.84";"0.31";"3.59";"7.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649823";"";"None";"552.08";"2";"5.32";"BDBM135149";"COC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268659";"UO_0000065";"15.44";"0.30";"3.20";"7.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649868";"";"None";"565.08";"1";"4.37";"BDBM135170";"CN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"54.0";"nM";"7.27";"";"268679";"UO_0000065";"12.86";"0.25";"2.90";"5.77";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703336";"";"None";"806.69";"3";"7.56";"BDBM152972";"COCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"7.14";"nM";"8.15";"";"293796";"UO_0000065";"10.10";"0.20";"0.59";"5.27";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4114365";"";"None";"693.59";"2";"5.75";"BDBM170294";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(NS(=O)(=O)C(F)(F)F)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314243";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649862";"";"None";"552.08";"1";"4.91";"BDBM135198";"CC(C)C1C[C@@H](O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268707";"UO_0000065";"16.30";"0.32";"4.09";"7.15";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687263";"";"None";"489.38";"1";"5.26";"BDBM143386";"CNC(=O)Cn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"11.4";"nM";"7.94";"";"279531";"UO_0000065";"16.23";"0.33";"2.68";"11.81";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653256";"SIREMADLIN";"2.0";"555.42";"1";"4.69";"BDBM129823";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.23";"nM";"9.64";"";"261552";"UO_0000065";"17.35";"0.35";"4.95";"9.23";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657039";"";"None";"521.45";"2";"7.21";"BDBM129946";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)cnc1C)C2=O";"IC50";"'='";"0.37";"nM";"9.43";"";"261676";"UO_0000065";"18.09";"0.36";"2.22";"15.65";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653283";"";"None";"540.00";"2";"6.62";"BDBM129851";"COc1ccc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261580";"UO_0000065";"18.05";"0.34";"3.12";"10.26";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691775";"";"None";"559.03";"1";"3.83";"BDBM143672";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"22.7";"nM";"7.64";"";"279816";"UO_0000065";"13.67";"0.26";"3.81";"6.26";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691709";"";"None";"551.47";"2";"6.55";"BDBM143473";"CCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"0.42";"nM";"9.38";"";"279759";"UO_0000065";"17.00";"0.34";"2.83";"13.52";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657061";"";"None";"537.02";"2";"6.18";"BDBM129971";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.2";"nM";"9.70";"";"261698";"UO_0000065";"18.06";"0.34";"3.52";"8.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653182";"";"None";"531.44";"2";"7.38";"BDBM129747";"COc1cc(C#N)ccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.23";"nM";"9.64";"";"261478";"UO_0000065";"18.14";"0.36";"2.26";"13.55";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650060";"";"None";"543.10";"2";"5.15";"BDBM135930";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(CCCO)C(C)=O)CC1)C(=O)C2";"IC50";"'='";"720.0";"nM";"6.14";"";"269508";"UO_0000065";"11.31";"0.22";"0.99";"7.75";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691702";"";"None";"591.54";"2";"7.38";"BDBM143465";"COc1ccc(C(=O)N(C)C)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.195";"nM";"9.71";"";"279753";"UO_0000065";"16.41";"0.32";"2.33";"14.35";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683165";"";"None";"576.14";"2";"6.04";"BDBM162092";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc([C@H](C)N3CCN(C(C)=O)CC3)cc1)C(=O)C2";"IC50";"'='";"34.9";"nM";"7.46";"";"305018";"UO_0000065";"12.94";"0.25";"1.42";"11.97";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653291";"";"None";"551.43";"2";"5.39";"BDBM129859";"COc1cnc(C(N)=O)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.66";"nM";"9.18";"";"261589";"UO_0000065";"16.65";"0.33";"3.79";"7.90";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683140";"";"None";"533.11";"2";"7.36";"BDBM161941";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"189.8";"nM";"6.72";"";"304989";"UO_0000065";"12.61";"0.24";"-0.64";"16.00";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650076";"";"None";"542.16";"2";"7.36";"BDBM135946";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(O)CCC(C)C)CC1)C(=O)C2";"IC50";"'='";"7.0";"nM";"8.15";"";"269524";"UO_0000065";"15.04";"0.29";"0.79";"13.82";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3799374";"";"None";"721.70";"2";"6.17";"20r";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C(=O)NC)n2)CC1";"IC50";"'='";"114.0";"nM";"6.94";"";"";"UO_0000065";"9.62";"0.19";"0.77";"6.09";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798875";"";"None";"707.67";"2";"5.91";"20q";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ncccc2C(N)=O)CC1";"IC50";"'='";"4276.0";"nM";"5.37";"";"";"UO_0000065";"7.59";"0.15";"-0.54";"4.20";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800178";"";"None";"665.63";"2";"6.20";"19";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cncnc2)CC1";"IC50";"'='";"525.0";"nM";"6.28";"";"";"UO_0000065";"9.43";"0.18";"0.08";"6.42";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3797254";"";"None";"688.67";"2";"7.28";"14a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccccc2C#N)CC1";"IC50";"'='";"8714.0";"nM";"5.06";"";"";"UO_0000065";"7.35";"0.14";"-2.22";"5.28";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3797816";"";"None";"693.75";"2";"8.43";"11b";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Sc2ccc(C)cc2)CC1";"IC50";"'='";"9359.0";"nM";"5.03";"";"";"UO_0000065";"7.25";"0.14";"-3.40";"8.02";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3683156";"";"None";"604.24";"2";"7.76";"BDBM162061";"CCN(C[C@H]1CC[C@H](N(C)C)CC1)c1ccc(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"2.7";"nM";"8.57";"";"305008";"UO_0000065";"14.18";"0.27";"0.81";"18.94";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268647";"UO_0000065";"16.42";"0.32";"2.91";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3966472";"";"None";"538.05";"2";"5.10";"BDBM135286";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"3.0";"nM";"8.52";"";"268795";"UO_0000065";"15.84";"0.31";"3.42";"7.41";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3957580";"";"None";"565.08";"1";"4.54";"BDBM135288";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CC(=O)N(C)C[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"13.0";"nM";"7.89";"";"268798";"UO_0000065";"13.96";"0.27";"3.35";"6.26";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649926";"";"None";"570.07";"2";"5.44";"BDBM135290";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268799";"UO_0000065";"15.79";"0.31";"3.56";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649927";"";"None";"566.11";"2";"5.47";"BDBM135292";"CC(C)[C@@H]1C[C@@H](O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268802";"UO_0000065";"15.90";"0.31";"3.53";"7.15";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3355421";"";"None";"575.51";"1";"4.23";"BDBM112748";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234023";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693971";"";"None";"463.34";"0";"4.87";"BDBM112756";"O=C(O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"500.0";"nM";"";"";"234031";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693979";"";"None";"560.48";"1";"4.63";"BDBM112764";"CNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cc(Cl)ccc1OC(C)(C)C(=O)O";"IC50";"'>'";"10000.0";"nM";"";"";"234039";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649968";"";"None";"567.09";"2";"5.82";"BDBM135345";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCOCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268856";"UO_0000065";"15.03";"0.29";"2.70";"7.05";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649998";"";"None";"525.05";"2";"5.70";"BDBM135394";"COCC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C(C)C";"IC50";"'='";"5.0";"nM";"8.30";"";"268903";"UO_0000065";"15.81";"0.31";"2.60";"7.43";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3663873";"";"None";"575.56";"2";"5.34";"BDBM170396";"CN1CCC(CNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314365";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL1688255";"";"None";"466.36";"1";"5.56";"BDBM50339440";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"232298";"UO_0000065";"12.49";"0.25";"0.26";"11.70";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688272";"";"None";"521.01";"2";"5.92";"BDBM111516";"O=C1c2ccccc2C(OC[C@@H]2CCCC[C@@H]2CO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"569.0";"nM";"6.25";"";"232313";"UO_0000065";"11.99";"0.23";"0.32";"6.72";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688276";"";"None";"490.94";"1";"5.20";"BDBM111518";"O=C1c2ccccc2C(O[C@@H]2C=C[C@@H](O)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"306.0";"nM";"6.51";"";"232315";"UO_0000065";"13.27";"0.25";"1.31";"7.01";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688267";"";"None";"514.97";"2";"5.81";"BDBM111520";"O=C1c2ccccc2C(OCc2ccc(CO)cc2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"983.0";"nM";"6.01";"";"232317";"UO_0000065";"11.67";"0.22";"0.20";"6.47";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3703328";"";"None";"821.73";"2";"6.61";"BDBM152953";"COc1cc(C(=O)OC(C)OC(=O)N2CCS(=O)(=O)CC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"12.0";"nM";"7.92";"";"293777";"UO_0000065";"9.64";"0.20";"1.31";"4.83";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703337";"";"None";"851.73";"2";"8.21";"BDBM152962";"COc1cc(C(=O)OC(C)OC(=O)NCC(=O)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"11.0";"nM";"7.96";"";"293786";"UO_0000065";"9.34";"0.18";"-0.25";"4.82";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703346";"";"None";"792.66";"3";"7.17";"BDBM152971";"COCCOCCOC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"20.2";"nM";"7.70";"";"293795";"UO_0000065";"9.71";"0.19";"0.52";"4.98";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649877";"";"None";"526.04";"1";"4.79";"BDBM135215";"CCN(CCOC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268724";"UO_0000065";"15.13";"0.29";"3.17";"6.92";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649879";"";"None";"545.05";"2";"5.88";"BDBM135218";"CC(Nc1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)c1ccccn1";"IC50";"'='";"2.0";"nM";"8.70";"";"268727";"UO_0000065";"15.96";"0.30";"2.82";"6.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649882";"";"None";"552.08";"2";"5.32";"BDBM135225";"CO[C@@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"268734";"UO_0000065";"14.28";"0.28";"2.57";"6.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3929391";"";"None";"564.09";"2";"5.32";"BDBM135231";"CC1CCC(Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"268740";"UO_0000065";"13.36";"0.26";"2.22";"6.56";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649892";"";"None";"568.08";"1";"4.56";"BDBM135240";"COC[C@@H]1C[C@@H](OC)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268749";"UO_0000065";"15.00";"0.29";"3.96";"6.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927923";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268774";"UO_0000065";"14.78";"0.29";"3.38";"7.31";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649909";"";"None";"564.09";"2";"5.46";"BDBM135267";"C[C@H]1CC[C@H](Cn2c(N3CCCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268777";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649913";"";"None";"512.01";"1";"4.76";"BDBM135272";"COCC(C)Nc1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"268781";"UO_0000065";"15.34";"0.30";"3.09";"6.35";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649920";"";"None";"530.03";"2";"6.08";"BDBM135281";"CN(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"132.0";"nM";"6.88";"";"268790";"UO_0000065";"12.98";"0.25";"0.80";"6.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649929";"";"None";"538.05";"1";"4.84";"BDBM135295";"CC([C@H]1CC[C@H](C)CC1)n1c(N2C[C@H](O)C[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"4.0";"nM";"8.40";"";"268804";"UO_0000065";"15.61";"0.30";"3.56";"6.67";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649932";"";"None";"605.14";"2";"5.15";"BDBM135300";"C[C@@H]1CN(C(=O)C2CC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268809";"UO_0000065";"14.87";"0.29";"3.85";"7.14";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3978308";"";"None";"619.17";"2";"5.54";"BDBM135306";"C[C@H]1CN(C(=O)C2CCC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268815";"UO_0000065";"14.54";"0.28";"3.46";"7.14";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649961";"";"None";"497.00";"1";"5.41";"BDBM135332";"CCOC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"268842";"UO_0000065";"15.58";"0.30";"2.33";"6.93";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268847";"UO_0000065";"15.40";"0.30";"2.35";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647046";"";"None";"586.10";"2";"5.89";"BDBM135106";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268615";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647047";"";"None";"586.10";"2";"5.89";"BDBM135107";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268616";"UO_0000065";"15.36";"0.29";"3.11";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647058";"";"None";"526.02";"2";"5.25";"BDBM135118";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268627";"UO_0000065";"15.97";"0.31";"3.15";"7.94";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268644";"UO_0000065";"15.87";"0.30";"2.61";"8.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649847";"";"None";"564.09";"2";"5.47";"BDBM135181";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCOCC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268690";"UO_0000065";"15.11";"0.29";"3.05";"7.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649869";"";"None";"534.00";"2";"6.20";"BDBM135205";"C[C@H]1CC[C@H](Cn2c(Nc3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268714";"UO_0000065";"16.85";"0.32";"2.80";"7.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649870";"";"None";"588.12";"2";"5.87";"BDBM135206";"CCn1nccc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268715";"UO_0000065";"14.49";"0.28";"2.65";"6.90";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4071840";"";"None";"650.52";"2";"6.32";"57";"O=C(NC12CCC(C(=O)O)(CC1)CC2)[C@@H]1NC2(CCC(F)(F)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"11.5";"nM";"7.94";"";"";"UO_0000065";"12.20";"0.25";"1.62";"7.38";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3799375";"";"None";"664.65";"2";"6.81";"15a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccccn2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.27";"0.20";"0.01";"8.04";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3704484";"";"None";"607.60";"2";"5.14";"BDBM170238";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CNC(C)(C)C)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"2000.0";"nM";"";"";"314188";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3920895";"";"None";"564.05";"1";"4.93";"BDBM119740";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"500.0";"nM";"";"";"314287";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663875";"";"None";"643.55";"2";"6.42";"BDBM170399";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(CCC(F)(F)F)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314367";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135209";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"286210";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649856";"";"None";"565.08";"1";"4.42";"BDBM135192";"CCNC(=O)[C@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"144.0";"nM";"6.84";"";"286211";"UO_0000065";"12.11";"0.23";"2.42";"5.07";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647044";"";"None";"508.54";"2";"6.77";"BDBM135104";"Cc1cccc(-c2nc3cc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"122.0";"nM";"6.91";"";"286123";"UO_0000065";"13.60";"0.26";"0.14";"8.64";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657087";"";"None";"586.46";"1";"4.89";"BDBM130004";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.19";"nM";"9.72";"";"261725";"UO_0000065";"16.58";"0.33";"4.83";"9.88";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653196";"";"None";"513.99";"2";"5.77";"BDBM129761";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(N)nc4OC)n3C(C)C)C(=O)N2c2cc(Cl)ccc2C)cc1";"IC50";"'='";"0.74";"nM";"9.13";"";"261492";"UO_0000065";"17.76";"0.34";"3.36";"8.82";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653232";"";"None";"552.46";"2";"6.61";"BDBM129797";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"14.7";"nM";"7.83";"";"261527";"UO_0000065";"14.18";"0.28";"1.22";"9.51";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657049";"";"None";"577.47";"2";"5.66";"BDBM129957";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"1.09";"nM";"8.96";"";"261686";"UO_0000065";"15.52";"0.31";"3.30";"8.45";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687235";"";"None";"457.95";"1";"6.73";"BDBM143343";"CC(C)CCn1nc2c(c1C(C)C)C(c1ccc(F)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"31.4";"nM";"7.50";"";"279503";"UO_0000065";"16.38";"0.32";"0.77";"19.68";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653239";"";"None";"493.01";"0";"4.96";"BDBM129804";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCC(=O)N(C)C1)C2=O";"IC50";"'='";"1.47";"nM";"8.83";"";"261534";"UO_0000065";"17.92";"0.34";"3.87";"13.05";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653298";"";"None";"556.02";"2";"5.75";"BDBM129866";"COc1ncc(CC(=O)O)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"2.4";"nM";"8.62";"";"261596";"UO_0000065";"15.50";"0.29";"2.87";"7.10";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3639820";"";"None";"502.01";"2";"6.06";"BDBM162113";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(Cn3ccnc3)cc1)C(=O)C2";"IC50";"'='";"104.0";"nM";"6.98";"";"305024";"UO_0000065";"13.91";"0.26";"0.92";"12.34";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656991";"";"None";"553.42";"2";"6.43";"BDBM129893";"COc1ccc(C(N)=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"261625";"UO_0000065";"17.99";"0.36";"3.53";"11.01";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653292";"";"None";"569.42";"2";"6.36";"BDBM129860";"COc1ncc(CC(=O)O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"1.32";"nM";"8.88";"";"261590";"UO_0000065";"15.59";"0.31";"2.52";"9.10";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653229";"";"None";"563.49";"2";"6.90";"BDBM129794";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"0.42";"nM";"9.38";"";"261524";"UO_0000065";"16.64";"0.33";"2.48";"13.86";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657027";"";"None";"619.55";"2";"6.98";"BDBM129932";"COc1ccc(C(=O)N2CCOCC2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"0.54";"nM";"9.27";"";"261662";"UO_0000065";"14.96";"0.29";"2.29";"12.05";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691782";"";"None";"573.41";"1";"4.70";"BDBM143685";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.384";"nM";"9.42";"";"279823";"UO_0000065";"16.42";"0.33";"4.72";"9.02";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656980";"";"None";"568.43";"2";"6.96";"BDBM129882";"COc1ccc(CC(=O)O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.32";"nM";"9.49";"";"261612";"UO_0000065";"16.70";"0.33";"2.53";"11.22";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683109";"";"None";"509.99";"2";"5.59";"BDBM161708";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(C)cc1OCC(=O)O)C(=O)C2";"IC50";"'='";"1677.5";"nM";"5.78";"";"304954";"UO_0000065";"11.32";"0.22";"0.19";"6.77";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653231";"";"None";"552.46";"2";"6.61";"BDBM129796";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.07";"nM";"10.15";"";"261526";"UO_0000065";"18.38";"0.36";"3.54";"12.33";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691726";"";"None";"566.49";"2";"5.53";"BDBM143517";"COc1ccc(CN)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.551";"nM";"9.26";"";"279771";"UO_0000065";"16.34";"0.32";"3.73";"9.71";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125700";"";"None";"540.51";"2";"5.60";"42";"CC(C)[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"17.62";"0.37";"3.92";"10.38";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125528";"";"None";"566.55";"2";"6.14";"26";"CC[C@@H](CS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.12";"0.36";"3.56";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125523";"";"None";"540.51";"2";"5.74";"21";"CC[C@@H](CCS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"16.44";"0.35";"3.15";"9.69";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125706";"";"None";"492.44";"1";"6.08";"6";"CC[C@@H](C[C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"19.08";"0.39";"3.32";"12.07";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125704";"";"None";"506.47";"2";"6.47";"4";"CC[C@@H](CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.77";"0.36";"2.53";"11.56";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125705";"";"None";"520.50";"2";"6.86";"5";"CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"17.01";"0.35";"1.99";"11.37";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3653186";"";"None";"522.44";"2";"6.60";"BDBM129751";"COc1ncncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.37";"nM";"9.43";"";"261482";"UO_0000065";"18.05";"0.36";"2.83";"12.90";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653179";"";"None";"577.51";"2";"7.21";"BDBM129744";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"261475";"UO_0000065";"17.12";"0.34";"2.68";"14.61";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647053";"";"None";"562.00";"2";"5.85";"BDBM135113";"C[C@H]1CC[C@H](Cn2c(N3CCCC3C(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268622";"UO_0000065";"16.01";"0.32";"3.15";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"63.0";"nM";"7.20";"";"268645";"UO_0000065";"13.14";"0.25";"1.11";"6.81";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649846";"";"None";"550.06";"2";"5.08";"BDBM135180";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCOC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268689";"UO_0000065";"14.95";"0.29";"3.14";"7.15";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649853";"";"None";"575.07";"2";"5.95";"BDBM135189";"Cc1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)on1";"IC50";"'='";"2.0";"nM";"8.70";"";"268698";"UO_0000065";"15.13";"0.29";"2.75";"6.60";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649867";"";"None";"575.08";"2";"4.79";"BDBM135203";"Cn1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)nn1";"IC50";"'='";"13.0";"nM";"7.89";"";"268712";"UO_0000065";"13.71";"0.26";"3.10";"5.78";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649876";"";"None";"512.01";"1";"4.40";"BDBM135214";"COCCN(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"268723";"UO_0000065";"14.43";"0.28";"2.99";"6.43";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3969880";"";"None";"552.08";"2";"5.32";"BDBM135221";"CO[C@H]1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"268730";"UO_0000065";"14.12";"0.27";"2.48";"6.78";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4113308";"";"None";"655.20";"2";"5.80";"BDBM135235";"CC1CCC(Cn2c(N3CCO[C@@H]4CN(Cc5ccccc5)CC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"129.0";"nM";"6.89";"";"268744";"UO_0000065";"10.51";"0.20";"1.09";"5.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268752";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3971691";"";"None";"564.09";"2";"5.46";"BDBM135253";"CC1CO[C@H]2CCC[C@@H]2N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268762";"UO_0000065";"15.95";"0.31";"3.54";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3979791";"";"None";"586.04";"2";"5.32";"BDBM135255";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"268765";"UO_0000065";"11.75";"0.23";"1.57";"5.99";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649910";"";"None";"552.08";"2";"5.32";"BDBM135269";"CC1N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)CCOC1(C)C";"IC50";"'='";"17.0";"nM";"7.77";"";"268778";"UO_0000065";"14.07";"0.27";"2.45";"6.76";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3675208";"";"None";"450.92";"1";"5.40";"BDBM111529";"CC(C)(C)c1ccc2c(c1)C(O)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"12700.0";"nM";"4.90";"";"232326";"UO_0000065";"10.86";"0.21";"-0.50";"5.85";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675210";"";"None";"429.26";"0";"4.75";"BDBM111531";"O=C1c2cccc(Cl)c2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"510.0";"nM";"6.29";"";"232328";"UO_0000065";"14.66";"0.30";"1.54";"7.52";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688279";"";"None";"468.38";"1";"5.64";"BDBM50339374";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"2310.0";"nM";"5.64";"";"232349";"UO_0000065";"12.03";"0.24";"0.00";"11.32";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3915460";"";"None";"508.54";"2";"6.77";"BDBM135104";"Cc1cccc(-c2nc3cc(C(=O)O)nc(N[C@@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"122.0";"nM";"6.91";"";"268613";"UO_0000065";"13.60";"0.26";"0.14";"8.64";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647051";"";"None";"526.02";"2";"5.25";"BDBM135111";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268620";"UO_0000065";"17.11";"0.33";"3.75";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647069";"";"None";"538.05";"1";"4.93";"BDBM135126";"C[C@H]1COC[C@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268635";"UO_0000065";"16.17";"0.31";"3.77";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3931087";"";"None";"538.05";"2";"5.34";"BDBM135129";"C[C@H]1COC[C@H](C)N1c1nc2cc(-c3nnc(O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268638";"UO_0000065";"15.16";"0.29";"2.81";"7.08";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647070";"";"None";"548.09";"2";"6.09";"BDBM135134";"C[C@H]1CC[C@H](Cn2c(N3CCCC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"268646";"UO_0000065";"13.20";"0.25";"1.15";"6.84";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649818";"";"None";"538.05";"1";"4.93";"BDBM135143";"CC1COCCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"268652";"UO_0000065";"14.49";"0.28";"2.87";"6.78";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649829";"";"None";"576.06";"3";"5.35";"BDBM135158";"Cc1nonc1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268667";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649836";"";"None";"551.05";"1";"4.53";"BDBM135169";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)cc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"29.0";"nM";"7.54";"";"268678";"UO_0000065";"13.68";"0.26";"3.01";"6.77";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649868";"";"None";"565.08";"1";"4.37";"BDBM135216";"CN(C)C(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"268725";"UO_0000065";"13.90";"0.27";"3.48";"6.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649860";"";"None";"550.06";"2";"5.07";"BDBM135196";"COC1CC2CCC1N2c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"268746";"UO_0000065";"14.28";"0.28";"2.78";"6.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649912";"";"None";"530.03";"2";"5.93";"BDBM135271";"C[C@H]1CC[C@H](Cn2c(NCc3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268780";"UO_0000065";"15.66";"0.30";"2.37";"7.25";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688261";"";"None";"446.93";"0";"4.86";"BDBM111508";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCCCCO)c2ccc(Cl)cc2)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"232304";"UO_0000065";"12.21";"0.23";"0.60";"7.42";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3800088";"";"None";"693.69";"2";"6.27";"20l";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cc(CN)ccn2)CC1";"IC50";"'='";"4026.0";"nM";"5.39";"";"";"UO_0000065";"7.78";"0.15";"-0.87";"4.87";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3798271";"";"None";"689.66";"2";"6.68";"20h";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cc(C#N)ccn2)CC1";"IC50";"'='";"293.0";"nM";"6.53";"";"";"UO_0000065";"9.47";"0.18";"-0.15";"6.01";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3799050";"";"None";"689.66";"2";"6.68";"20f";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(C#N)n2)CC1";"IC50";"'='";"686.0";"nM";"6.16";"";"";"UO_0000065";"8.94";"0.17";"-0.52";"5.67";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3800573";"";"None";"677.69";"2";"7.72";"11a";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ccc(C)cc2)CC1";"IC50";"'='";"8766.0";"nM";"5.06";"";"";"UO_0000065";"7.46";"0.14";"-2.66";"7.03";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3960776";"";"None";"574.52";"2";"5.59";"BDBM112737";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"15.6";"nM";"7.81";"";"234012";"UO_0000065";"13.59";"0.27";"2.22";"8.63";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691713";"";"None";"516.44";"2";"6.99";"BDBM143479";"Cc1cc(Cl)ccc1C1c2c(nn(C3CCC(O)CC3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"12.9";"nM";"7.89";"";"279608";"UO_0000065";"15.28";"0.31";"0.90";"13.52";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687253";"";"None";"612.60";"2";"6.62";"BDBM143376";"Cc1cc(Cl)ccc1C1c2c(nn(CC3(O)CCN(C(=O)NC(C)C)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.2";"nM";"8.66";"";"279521";"UO_0000065";"14.13";"0.28";"2.04";"9.55";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687304";"";"None";"474.36";"1";"5.65";"BDBM143433";"Cc1cc(Cl)ccc1C1c2c(nn(CCO)c2C2CCC2)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"5.6";"nM";"8.25";"";"279572";"UO_0000065";"17.40";"0.35";"2.60";"14.14";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683182";"";"None";"658.24";"2";"6.08";"BDBM162221";"COc1cc2c(cc1OC1CCC1)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)nc1)C(=O)C2";"IC50";"'='";"2.1";"nM";"8.68";"";"305040";"UO_0000065";"13.18";"0.25";"2.60";"11.06";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656983";"";"None";"582.46";"2";"7.05";"BDBM129885";"COC(=O)Cc1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.32";"nM";"9.49";"";"261615";"UO_0000065";"16.30";"0.32";"2.44";"12.89";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"12";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.59";"0.37";"3.48";"10.90";"0";"CHEMBL4268704";"Inhibition of p53-MDM2 interaction (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265957";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";""
"CHEMBL3233124";"";"None";"649.57";"2";"6.39";"10";"CC[C@@H](CN(c1ccc(F)cc1)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"14.20";"0.29";"2.83";"8.85";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233138";"";"None";"570.54";"2";"5.72";"23";"CC(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.25";"0.32";"2.98";"8.61";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233139";"";"None";"584.56";"2";"6.11";"24";"CC(C)(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"15.91";"0.33";"3.19";"9.21";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233123";"";"None";"649.57";"2";"6.39";"9";"CC[C@@H](CN(c1ccccc1F)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"13.30";"0.27";"2.25";"8.29";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233133";"";"None";"576.50";"2";"5.73";"18";"CC[C@@H](CS(=O)(=O)c1ccccc1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"13.48";"0.28";"2.04";"7.69";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233141";"";"None";"570.54";"2";"5.86";"6";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.30";"0.34";"3.44";"9.21";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268657";"UO_0000065";"14.90";"0.29";"2.97";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135230";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"268739";"UO_0000065";"13.45";"0.26";"3.23";"6.03";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"28.0";"nM";"7.55";"";"268750";"UO_0000065";"13.06";"0.25";"2.10";"6.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927923";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"113.0";"nM";"6.95";"";"268773";"UO_0000065";"12.23";"0.24";"1.93";"6.04";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649909";"";"None";"564.09";"2";"5.46";"BDBM135267";"C[C@H]1CC[C@H](Cn2c(N3CCCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"268776";"UO_0000065";"12.58";"0.24";"1.64";"6.17";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649911";"";"None";"578.12";"2";"5.85";"BDBM135270";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2CCCCC2O1";"IC50";"'='";"3.0";"nM";"8.52";"";"268779";"UO_0000065";"14.74";"0.28";"2.67";"7.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649916";"";"None";"552.08";"2";"5.32";"BDBM135276";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)[C@@H](C)O1";"IC50";"'='";"17.0";"nM";"7.77";"";"268785";"UO_0000065";"14.07";"0.27";"2.45";"6.76";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649917";"";"None";"526.04";"1";"4.79";"BDBM135278";"COCC(C)N(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"268787";"UO_0000065";"14.02";"0.27";"2.59";"6.42";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649919";"";"None";"476.97";"1";"5.81";"BDBM135280";"C[C@H]1CC[C@H](Cn2c(Nc3ccccn3)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"268789";"UO_0000065";"15.51";"0.30";"1.59";"6.99";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3971736";"";"None";"564.09";"2";"5.64";"BDBM135284";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCO[C@H]3CCC[C@@H]32)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"2.0";"nM";"8.70";"";"268793";"UO_0000065";"15.42";"0.30";"3.06";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649931";"";"None";"591.12";"1";"4.76";"BDBM135299";"C[C@@H]1CN(C(=O)C2CC2)CCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268808";"UO_0000065";"14.04";"0.27";"3.54";"6.59";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649952";"";"None";"623.13";"2";"5.24";"BDBM135321";"C[C@@H]1CN(C(=O)C2(F)CC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268830";"UO_0000065";"14.44";"0.28";"3.76";"7.14";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649963";"";"None";"565.00";"2";"6.35";"BDBM135336";"CCC(OCC(F)(F)F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268846";"UO_0000065";"14.69";"0.29";"1.95";"7.43";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3892878";"";"None";"544.52";"2";"5.16";"BDBM119741";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"289.62";"nM";"6.54";"";"246779";"UO_0000065";"12.01";"0.24";"1.38";"7.23";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665613";"";"None";"662.03";"2";"5.52";"BDBM119751";"CC(C)(C)C[C@@H]1N(N(C(=O)C(F)(F)F)C2CC(C)(O)C2)[C@@H](C(=O)O)[C@H](c2cccc(F)c2F)C12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"388.72";"nM";"6.41";"";"246799";"UO_0000065";"9.68";"0.19";"0.89";"5.82";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL572933";"";"None";"552.47";"1";"3.74";"BDBM50300121";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"180.0";"nM";"6.75";"";"246800";"UO_0000065";"12.21";"0.25";"3.00";"6.09";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704523";"";"None";"617.55";"1";"4.08";"BDBM170286";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCNS(C)(=O)=O)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314234";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704543";"";"None";"618.58";"2";"5.15";"BDBM170307";"CCN(CC)C(=O)N1CC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"1000.0";"nM";"";"";"314265";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663866";"";"None";"518.03";"1";"3.09";"BDBM170387";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314356";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3233125";"";"None";"667.56";"2";"6.53";"11";"CC[C@@H](CN(c1ccc(F)cc1F)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.03";"0.27";"2.17";"8.35";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233126";"";"None";"651.58";"2";"6.64";"12";"CC[C@@H](CN(c1ccccc1F)S(=O)(=O)C(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"13.23";"0.27";"1.98";"8.27";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3663837";"";"None";"610.12";"1";"4.74";"BDBM170354";"CC(C)CC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'>'";"5000.0";"nM";"";"";"314325";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665583";"";"None";"532.03";"1";"4.40";"BDBM119715";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314245";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3935478";"";"None";"675.67";"2";"6.23";"BDBM170311";"CC[C@H](C)[C@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314269";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3233123";"";"None";"649.57";"2";"6.39";"9";"CC[C@@H](CN(c1ccccc1F)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"14.66";"0.30";"3.13";"9.14";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233137";"";"None";"610.48";"2";"6.01";"22";"CC(C)(C)S(=O)(=O)C[C@H](CC(F)(F)F)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"14.21";"0.30";"2.67";"8.59";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL2152323";"";"None";"529.49";"2";"5.41";"9f";"CC(C)(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.43";"0.22";"0.11";"8.50";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL211045";"";"None";"581.50";"2";"5.89";"Nutlin-3";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"11.60";"0.23";"0.85";"8.08";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2152325";"";"None";"571.57";"2";"6.39";"14";"CC(C)C1=C(C(=O)N2CCC(C(=O)N(C)C)CC2)SC2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"9.37";"0.19";"-1.03";"9.53";"0";"CHEMBL2156543";"Inhibition of GST-tagged MDM2 binding to p53 by ELISA";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150912";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286147";"UO_0000065";"14.89";"0.29";"2.94";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649825";"";"None";"534.06";"2";"5.70";"BDBM135154";"C[C@H]1CC[C@H](Cn2c(N3CCCC3C3CC3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286173";"UO_0000065";"16.85";"0.32";"3.30";"8.51";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649826";"";"None";"550.11";"2";"6.33";"BDBM135155";"CC(C)(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286174";"UO_0000065";"15.49";"0.30";"2.19";"8.06";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3318760";"";"None";"581.56";"2";"5.64";"8";"CC(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.098";"nM";"10.01";"";"";"UO_0000065";"17.21";"0.36";"4.37";"9.64";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318769";"";"None";"633.57";"2";"6.89";"20";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)Nc2ccccc2F)C2CC2)C1=O";"IC50";"'='";"0.12";"nM";"9.92";"";"";"UO_0000065";"15.66";"0.32";"3.03";"9.56";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3704538";"";"None";"563.50";"1";"3.68";"BDBM170302";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CN(CCO)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314260";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704539";"";"None";"644.62";"2";"5.73";"BDBM170303";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CN(C(=O)NC3CCCCC3)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"3000.0";"nM";"";"";"314261";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3236356";"";"None";"657.66";"2";"7.38";"3, AM-1900";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.21";"0.31";"2.62";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"9";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"5";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.76";"0.33";"2.44";"9.76";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3949967";"";"None";"566.11";"2";"5.47";"BDBM135292";"CC(C)[C@H]1C[C@H](O)CN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286311";"UO_0000065";"15.90";"0.31";"3.53";"7.15";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3907671";"";"None";"565.08";"1";"4.37";"BDBM135298";"CC(=O)N1CCN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"6.0";"nM";"8.22";"";"286317";"UO_0000065";"14.55";"0.28";"3.85";"6.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649972";"";"None";"549.01";"2";"5.54";"BDBM135354";"C[C@H]1CC[C@H](Cn2c(C(O)c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"286373";"UO_0000065";"15.84";"0.30";"3.16";"7.09";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649986";"";"None";"514.99";"2";"5.15";"BDBM135378";"COCC(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"286397";"UO_0000065";"14.91";"0.29";"2.53";"6.87";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286407";"UO_0000065";"16.19";"0.31";"2.98";"7.20";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650008";"";"None";"559.11";"2";"5.91";"BDBM135408";"CNC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"286427";"UO_0000065";"12.15";"0.23";"0.89";"7.98";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"1.0";"nM";"9.00";"";"286186";"UO_0000065";"15.00";"0.29";"2.72";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649841";"";"None";"592.02";"2";"5.82";"BDBM135174";"C[C@H]1CC[C@H](Cn2c(N3CCCC3COC(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"286193";"UO_0000065";"13.77";"0.27";"2.33";"7.09";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649842";"";"None";"508.03";"2";"5.31";"BDBM135175";"C[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286194";"UO_0000065";"16.53";"0.32";"3.09";"7.94";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649840";"";"None";"566.11";"2";"5.71";"BDBM135173";"CC(C)OCC1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"47.0";"nM";"7.33";"";"286196";"UO_0000065";"12.94";"0.25";"1.62";"6.37";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649883";"";"None";"552.08";"2";"5.32";"BDBM135222";"CO[C@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"286241";"UO_0000065";"14.57";"0.28";"2.73";"7.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649882";"";"None";"552.08";"2";"5.32";"BDBM135221";"CO[C@@H]1CCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"31.0";"nM";"7.51";"";"286245";"UO_0000065";"13.60";"0.26";"2.19";"6.53";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649885";"";"None";"565.08";"1";"4.37";"BDBM135228";"CCC1CN(C)C(=O)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"286249";"UO_0000065";"13.45";"0.26";"3.23";"6.03";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649898";"";"None";"570.07";"2";"5.27";"BDBM135249";"CCO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286268";"UO_0000065";"15.79";"0.31";"3.73";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639487";"";"None";"580.09";"1";"4.70";"BDBM135259";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C2COCCC2O1";"IC50";"'='";"18.0";"nM";"7.75";"";"286278";"UO_0000065";"13.35";"0.26";"3.04";"6.24";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649907";"";"None";"552.04";"1";"3.92";"BDBM135261";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"131.0";"nM";"6.88";"";"286281";"UO_0000065";"12.47";"0.24";"2.96";"5.54";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649908";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CC(F)C[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"113.0";"nM";"6.95";"";"286283";"UO_0000065";"12.23";"0.24";"1.93";"6.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649909";"";"None";"564.09";"2";"5.46";"BDBM135267";"C[C@H]1CC[C@H](Cn2c(N3CCCOC4CCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"286286";"UO_0000065";"12.58";"0.24";"1.64";"6.17";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3933957";"";"None";"552.08";"2";"5.32";"BDBM135276";"CC1CN(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)[C@H](C)O1";"IC50";"'='";"1.0";"nM";"9.00";"";"286296";"UO_0000065";"16.30";"0.32";"3.68";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3933691";"";"None";"621.14";"1";"4.39";"BDBM135326";"C[C@H]1CN(C(=O)C2COC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286345";"UO_0000065";"13.52";"0.26";"4.01";"6.21";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649999";"";"None";"544.06";"2";"6.50";"BDBM135395";"CC(C)c1ccnc(-c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"286414";"UO_0000065";"15.44";"0.29";"1.90";"7.28";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3220090";"";"None";"594.52";"2";"7.95";"4e";"O=C1NC(=S)N(c2cccc(Cl)c2)C(=O)/C1=C/c1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1";"IC50";"'='";"163.0";"nM";"6.79";"";"";"UO_0000065";"11.42";"0.23";"-1.16";"12.49";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220098";"";"None";"512.36";"2";"5.32";"4n";"O=C1NC(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Br)cc3)c2-c2ccccc2)C(=O)N1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.16";"0.27";"1.42";"8.41";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220099";"";"None";"463.49";"0";"4.57";"4o";"COc1ccc(-n2c(-c3ccccc3)cc(C=C3C(=O)NC(=O)NC3=O)c2-c2ccccc2)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"12.34";"0.22";"1.15";"6.40";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220101";"";"None";"458.48";"0";"4.43";"4q";"N#Cc1ccc(-n2c(-c3ccccc3)cc(C=C3C(=O)NC(=O)NC3=O)c2-c2ccccc2)cc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"11.62";"0.21";"0.90";"5.12";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220103";"";"None";"478.46";"0";"4.47";"4s";"O=C1NC(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2)C(=O)N1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.26";"0.26";"2.35";"5.53";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3217780";"";"None";"494.53";"0";"4.63";"4t";"O=C1NC(=S)NC(=O)C1=Cc1cc(-c2ccccc2)n(-c2ccc([N+](=O)[O-])cc2)c1-c1ccccc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.69";"0.26";"2.14";"6.37";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220107";"";"None";"528.40";"2";"6.79";"7";"CC1(C)OC(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Br)cc3)c2-c2ccccc2)C(=O)O1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"9.03";"0.19";"-2.02";"8.29";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3663813";"";"None";"566.50";"1";"4.08";"BDBM60498";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'<'";"3000.0";"nM";"";"";"221948";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3233126";"";"None";"651.58";"2";"6.64";"12";"CC[C@@H](CN(c1ccccc1F)S(=O)(=O)C(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"14.62";"0.30";"2.88";"9.14";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233134";"";"None";"543.47";"1";"4.15";"19";"CC[C@@H](CS(=O)(=O)N(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.72";"0.31";"3.85";"7.68";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233138";"";"None";"570.54";"2";"5.72";"23";"CC(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"15.08";"0.32";"2.88";"8.52";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233140";"";"None";"568.52";"2";"5.47";"4, AM-8735";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"15.38";"0.32";"3.27";"8.66";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3704486";"";"None";"605.58";"1";"4.85";"BDBM170240";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CN2CCCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"2000.0";"nM";"";"";"314190";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3291436";"";"None";"458.56";"1";"7.56";"20c";"CCOC(=O)c1ccc(-c2c(C)[nH]c(-c3ccccc3)c2-c2ccccc2)nc1-c1ccccc1";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"13.55";"0.24";"-1.35";"11.30";"0";"CHEMBL3295827";"Inhibition of GST-tagged HDM2 (unknown origin) expressed in Escherichia coli BL21 cells assessed as p53 activation by measuring inhibition of His-p53 ubiquitination after 1 hr by fluorescence spectroscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286124";"1";"Scientific Literature";"Eur J Med Chem";"2014";"None";"";""
"CHEMBL3683134";"";"None";"576.18";"2";"6.98";"BDBM161875";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCCN(C)C3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"9.1";"nM";"8.04";"";"304981";"UO_0000065";"13.96";"0.27";"1.06";"17.77";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653213";"";"None";"531.98";"2";"6.06";"BDBM129778";"[C-]#[N+]c1ccc(C2c3c(nc(-c4cnc(NC)nc4OC)n3C(C)C)C(=O)N2c2ccc(F)c(Cl)c2)cc1";"IC50";"'='";"0.28";"nM";"9.55";"";"261509";"UO_0000065";"17.96";"0.34";"3.49";"10.67";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691779";"";"None";"545.00";"1";"3.82";"BDBM143676";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.097";"nM";"10.01";"";"279820";"UO_0000065";"18.37";"0.35";"6.19";"7.53";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657024";"";"None";"591.54";"2";"7.64";"BDBM129928";"COc1ccc(C(=O)NC(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.09";"nM";"10.05";"";"261659";"UO_0000065";"16.98";"0.33";"2.41";"13.14";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704506";"";"None";"536.48";"1";"4.77";"BDBM170262";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC(C)(C)O)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314212";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3890230";"";"None";"576.54";"2";"5.69";"BDBM119736";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(C)(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314283";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3932760";"";"None";"546.06";"1";"4.79";"BDBM119738";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314285";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3892878";"";"None";"544.52";"2";"5.16";"BDBM119741";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314288";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663812";"";"None";"592.52";"1";"4.00";"BDBM170323";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCc2ccsc2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314295";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663844";"";"None";"576.54";"2";"5.55";"BDBM170362";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H]2CC[C@@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314332";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663850";"";"None";"706.55";"2";"6.09";"BDBM170368";"CCOP(=O)(OCC)OC[C@@H](O)CCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1ccc(F)c(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314338";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663839";"";"None";"596.09";"1";"4.39";"BDBM170356";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2ccc(F)c(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314327";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663840";"";"None";"592.13";"1";"4.60";"BDBM170357";"CC(C)CC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'>'";"1000.0";"nM";"";"";"314328";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663841";"";"None";"610.12";"1";"4.74";"BDBM170358";"CC(C)CC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2ccc(F)c(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'>'";"3000.0";"nM";"";"";"314329";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653220";"";"None";"524.42";"2";"7.64";"53";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"9.58";"0.19";"-2.62";"10.60";"0";"CHEMBL4353002";"Inhibition of p53 derived Cy5-TFSDLWKLL peptide binding to human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL1369893";"";"None";"357.39";"0";"3.53";"BDBM47298";"CCC(=O)NC(c1cccs1)c1cc([N+](=O)[O-])c2cccnc2c1O";"IC50";"'='";"17000.0";"nM";"4.77";"";"198813";"UO_0000065";"13.35";"0.26";"1.24";"4.53";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3407568";"";"None";"705.74";"2";"7.20";"18";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N[C@H]2CC[C@@H](C(=O)O)CC2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.42";"nM";"9.38";"";"";"UO_0000065";"13.29";"0.27";"2.18";"7.76";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"1";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"1";"CHEMBL3413423";"Binding affinity to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407475";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3318762";"";"None";"593.57";"2";"5.78";"10";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)NC2CCC2)C2CC2)C1=O";"IC50";"'='";"0.086";"nM";"10.07";"";"";"UO_0000065";"16.96";"0.35";"4.29";"9.70";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3663851";"";"None";"597.53";"1";"4.45";"BDBM170369";"CN(C)C[C@@H](O)CCNC(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1ccc(F)c(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314339";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663854";"";"None";"634.58";"1";"3.14";"BDBM170372";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCN(C(=O)CO)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314342";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663873";"";"None";"575.56";"2";"5.34";"BDBM170396";"CN1CCC(CNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314364";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3675222";"";"None";"444.49";"0";"4.24";"BDBM111566";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccccc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"8300.0";"nM";"5.08";"";"232367";"UO_0000065";"11.43";"0.21";"0.84";"5.47";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675225";"";"None";"647.35";"2";"6.82";"BDBM111570";"O=C(O)CCC(=O)OCC1(COC2(c3ccc(Cl)cc3)c3c(Cl)cccc3C(=O)N2Cc2ccc(Br)cc2)CC1";"IC50";"'='";"102.0";"nM";"6.99";"";"232371";"UO_0000065";"10.80";"0.24";"0.17";"7.51";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3687249";"";"None";"596.60";"2";"7.51";"BDBM143369";"Cc1cc(Cl)ccc1C1c2c(nn(CC3CCN(C(=O)NC(C)C)CC3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.1";"nM";"8.68";"";"279517";"UO_0000065";"14.55";"0.29";"1.17";"12.31";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3109055";"";"None";"614.51";"2";"5.02";"7";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3nc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"12.95";"0.26";"2.94";"5.88";"0";"CHEMBL3110643";"Binding affinity to GST-tagged MDM2 (unknown origin) assessed as inhibition of interaction with biotinylated p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3108772";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"268636";"UO_0000065";"12.78";"0.25";"1.75";"6.27";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649822";"";"None";"604.09";"2";"6.03";"BDBM135148";"C[C@H]1CC[C@H](Cn2c(N3CCOCC3c3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"268660";"UO_0000065";"";"";"";"";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649826";"";"None";"550.11";"2";"6.33";"BDBM135155";"CC(C)(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268664";"UO_0000065";"15.49";"0.30";"2.19";"8.06";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647048";"";"None";"564.69";"2";"6.15";"BDBM135108";"Cc1cccc(-c2nc(-c3noc(=O)[nH]3)cc3nc(N4CCOC[C@H]4c4ccccc4)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"286127";"UO_0000065";"15.09";"0.28";"2.37";"8.35";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647050";"";"None";"585.11";"2";"6.50";"BDBM135110";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"286129";"UO_0000065";"13.75";"0.26";"1.55";"7.88";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649892";"";"None";"568.08";"1";"4.56";"BDBM135240";"COC[C@@H]1C[C@@H](OC)CN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286259";"UO_0000065";"15.00";"0.29";"3.96";"6.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649895";"";"None";"594.12";"2";"5.09";"BDBM135246";"CO[C@@H]1C[C@H](C2(OC)CC2)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"286265";"UO_0000065";"13.47";"0.26";"2.91";"6.44";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653329";"";"None";"552.64";"1";"4.64";"BDBM135448";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4ccnnc4)c32)CC1";"IC50";"'='";"72.0";"nM";"7.14";"";"286467";"UO_0000065";"12.92";"0.24";"2.50";"5.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653332";"";"None";"545.07";"1";"4.46";"BDBM135451";"CC(CS(C)(=O)=O)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"286470";"UO_0000065";"13.63";"0.27";"2.97";"5.44";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653337";"";"None";"558.68";"2";"5.36";"BDBM135456";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(OCC4CCC4)c32)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"286475";"UO_0000065";"13.30";"0.25";"2.07";"6.68";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663821";"";"None";"578.51";"1";"4.28";"BDBM60496";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2CCCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"221947";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3663835";"";"None";"596.09";"1";"4.39";"BDBM170352";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314323";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704515";"";"None";"533.48";"1";"4.31";"BDBM170277";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N2CCNCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314226";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"268867";"UO_0000065";"14.68";"0.28";"2.38";"6.60";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649861";"";"None";"566.11";"2";"5.57";"BDBM135197";"CO[C@@H]1C[C@@H](C(C)C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'<'";"1.0";"nM";"";"";"286216";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3982496";"";"None";"554.05";"1";"4.17";"BDBM148143";"CO[C@H]1COC[C@@H]1N(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1CC1CCC(C)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"286221";"UO_0000065";"13.69";"0.27";"3.42";"6.11";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649875";"";"None";"591.14";"2";"6.42";"BDBM135213";"Cc1nc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)cs1";"IC50";"'='";"1.0";"nM";"9.00";"";"286232";"UO_0000065";"15.22";"0.30";"2.58";"7.59";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3355429";"";"None";"546.47";"1";"4.81";"29D";"C[C@]1(O)C[C@@H](NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.09";"0.28";"2.89";"8.51";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3649859";"";"None";"572.09";"1";"3.94";"BDBM135195";"CC1CS(=O)(=O)CCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286214";"UO_0000065";"14.15";"0.28";"4.16";"5.79";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2398478";"";"None";"548.49";"1";"4.91";"8";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"11.1";"nM";"7.96";"";"";"UO_0000065";"14.50";"0.29";"3.04";"8.79";"0";"CHEMBL2401075";"Binding affinity to recombinant human His-tagged MDM2 (1 to 118 amino acids) using p53-based PMDM6-F as probe after 15 to 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396650";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3704494";"";"None";"575.56";"2";"5.48";"BDBM170250";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCN2CCCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"10000.0";"nM";"";"";"314200";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703354";"";"None";"946.72";"3";"6.67";"BDBM152985";"COc1cc(C(=O)OCOC(=O)OCCOCCOCCOCCOP(=O)(O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"26.5";"nM";"7.58";"";"293809";"UO_0000065";"8.00";"0.16";"0.91";"3.29";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703355";"";"None";"726.50";"2";"6.46";"BDBM152986";"COc1cc(C(=O)OCOP(=O)(O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.14";"nM";"8.29";"";"293810";"UO_0000065";"11.41";"0.24";"1.83";"4.96";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663843";"";"None";"669.62";"2";"5.29";"BDBM170360";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N2CCN(C(=O)C3CC3)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)N(C(=O)C1CC1)c1cc(Cl)c(F)cc12";"IC50";"'>'";"100000.0";"nM";"";"";"314331";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3799367";"";"None";"743.54";"2";"7.57";"20e";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2cccc(Br)n2)CC1";"IC50";"'='";"1863.0";"nM";"5.73";"";"";"UO_0000065";"7.71";"0.16";"-1.84";"6.75";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3663852";"";"None";"566.50";"1";"4.08";"BDBM170370";"CN(CC[C@H](O)CO)C(=O)[C@@H]1N[C@H](CC(C)(C)C)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"5000.0";"nM";"";"";"314340";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3675199";"";"None";"383.88";"0";"4.11";"BDBM111505";"CCCN1C(=O)c2ccccc2C1(O[C@H]1C=C[C@@H](O)C1)c1ccc(Cl)cc1";"IC50";"'='";"15100.0";"nM";"4.82";"";"232299";"UO_0000065";"12.56";"0.24";"0.71";"9.69";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675204";"";"None";"523.38";"2";"5.00";"BDBM111524";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Br)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"368.0";"nM";"6.43";"";"232321";"UO_0000065";"12.29";"0.26";"1.43";"6.93";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675212";"";"None";"412.80";"0";"4.24";"BDBM111534";"O=C1c2cc(F)ccc2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"5190.0";"nM";"5.29";"";"232331";"UO_0000065";"12.80";"0.25";"1.04";"6.32";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688145";"";"None";"378.36";"0";"3.58";"BDBM111567";"O=C1c2ccccc2C(O)(c2ccc(F)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"9460.0";"nM";"5.02";"";"232368";"UO_0000065";"13.28";"0.25";"1.44";"6.00";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3693983";"";"None";"559.47";"1";"4.13";"BDBM112768";"CC(=O)N1CC(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)C1";"IC50";"'<'";"100.0";"nM";"";"";"234043";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3986151";"";"None";"560.50";"2";"5.20";"BDBM112771";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234046";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3663872";"";"None";"561.53";"2";"5.09";"BDBM170395";"CN1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314363";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3924221";"";"None";"546.06";"1";"4.79";"BDBM119716";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"5000.0";"nM";"";"";"314246";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3260820";"";"None";"623.49";"2";"7.99";"15";"Nc1nnc(-c2nc(C3CCCCC3)n(-c3c(CC(=O)Nc4ccccc4)ccc(Cl)c3F)c2-c2ccc(F)c(Cl)c2)o1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.19";"0.26";"0.23";"7.35";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3693958";"";"None";"611.49";"1";"4.47";"BDBM112741";"O=C(NCCN1CCOCC1)[C@@H]1NC2(CCC(F)(F)CC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"5000.0";"nM";"";"";"234016";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3704511";"";"None";"593.55";"2";"5.62";"BDBM170271";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCN2CCCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314220";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663848";"";"None";"551.49";"1";"3.71";"BDBM170366";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CN)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314336";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663822";"";"None";"568.04";"1";"3.71";"BDBM170338";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]2(C(=O)Nc3cc(F)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'<'";"10000.0";"nM";"";"";"314352";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"1, AMG 232";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"12.89";"0.27";"0.95";"7.99";"0";"CHEMBL3412297";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 gene level after 7 hrs by qRT-PCR assay in presence of 10% human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3407573";"";"None";"677.69";"2";"6.42";"23";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)N[C@H]2C[C@@H](C(=O)O)C2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.83";"nM";"9.08";"";"";"UO_0000065";"13.40";"0.28";"2.66";"7.51";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"2";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"1";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3892878";"";"None";"544.52";"2";"5.16";"BDBM119741";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"256.02";"nM";"6.59";"";"246791";"UO_0000065";"12.11";"0.24";"1.43";"7.29";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665579";"";"None";"548.49";"1";"4.91";"BDBM119711";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"41.4";"nM";"7.38";"";"246802";"UO_0000065";"13.46";"0.27";"2.47";"8.16";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3125704";"";"None";"506.47";"2";"6.47";"4";"CC[C@@H](CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"62.4";"nM";"7.21";"";"";"UO_0000065";"14.23";"0.29";"0.73";"9.26";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125532";"";"None";"588.55";"2";"6.78";"30";"CC[C@@H](CS(=O)(=O)c1ccccc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"16.18";"0.33";"2.74";"10.38";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3819071";"";"None";"491.59";"0";"3.86";"4";"CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C)C(=O)OC";"IC50";"'='";"15.2";"nM";"7.82";"";"";"UO_0000065";"15.90";"0.30";"3.96";"6.66";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3649834";"";"None";"600.12";"2";"6.28";"BDBM135165";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(c2ccccc2)CO1";"IC50";"'='";"16.0";"nM";"7.80";"";"286187";"UO_0000065";"12.99";"0.25";"1.52";"6.78";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649869";"";"None";"534.00";"2";"6.20";"BDBM135205";"C[C@H]1CC[C@H](Cn2c(Nc3ccccc3F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286224";"UO_0000065";"16.85";"0.32";"2.80";"7.86";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649871";"";"None";"574.09";"2";"5.39";"BDBM135207";"Cn1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"286226";"UO_0000065";"14.20";"0.27";"2.76";"6.60";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286262";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3904045";"";"None";"586.04";"2";"5.32";"BDBM135252";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CCC(F)(F)[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286271";"UO_0000065";"15.36";"0.30";"3.68";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649924";"";"None";"538.05";"2";"5.10";"BDBM135286";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC[C@H]2C)nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"286306";"UO_0000065";"16.73";"0.32";"3.90";"7.83";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649970";"";"None";"559.07";"2";"6.44";"BDBM135351";"CCOC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286371";"UO_0000065";"15.02";"0.29";"1.96";"7.52";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649982";"";"None";"566.01";"2";"6.08";"BDBM135370";"CC(F)(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286390";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649983";"";"None";"566.01";"2";"6.08";"BDBM135372";"CC(F)(c1ccncc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286391";"UO_0000065";"14.84";"0.29";"2.32";"7.28";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649984";"";"None";"562.05";"2";"6.25";"BDBM135374";"Cc1cccnc1C(C)(F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"286393";"UO_0000065";"14.16";"0.27";"1.71";"6.90";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649996";"";"None";"511.03";"2";"5.46";"BDBM135392";"CCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286411";"UO_0000065";"16.09";"0.31";"2.76";"7.36";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649997";"";"None";"527.03";"1";"4.69";"BDBM135393";"COCC(COC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"286412";"UO_0000065";"15.36";"0.30";"3.41";"6.69";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3943959";"";"None";"574.13";"2";"6.73";"BDBM135416";"CCOC(=O)c1cc2nc(N3CCOC[C@H]3c3ccccc3)n(CC3CCC(C)CC3)c2c(-c2cncc(Cl)c2)n1";"IC50";"'='";"53.0";"nM";"7.28";"";"268925";"UO_0000065";"12.67";"0.24";"0.55";"8.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653337";"";"None";"558.68";"2";"5.36";"BDBM135456";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(OCC4CCC4)c32)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"268965";"UO_0000065";"13.30";"0.25";"2.07";"6.68";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL1688257";"";"None";"476.92";"0";"4.81";"BDBM50339352";"O=C1c2ccccc2C(O[C@H]2C=C[C@@H](O)C2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"232305";"UO_0000065";"12.27";"0.24";"1.04";"6.30";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649987";"";"None";"548.02";"2";"6.00";"BDBM135379";"CC(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268888";"UO_0000065";"15.32";"0.29";"2.40";"7.28";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4744920";"";"None";"1691.05";"None";"None";"12";"CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@H]1CCC(=O)NCCCC[C@@H](CN(CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)CN(CC(=O)N[C@@H](C)C(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)NC(=O)[C@H](C)NC(=O)CN(S(=O)(=O)c2ccc3ccccc3c2)C[C@H](Cc2ccc(O)cc2)NC1=O)S(C)(=O)=O)[C@@H](C)O";"IC50";"'='";"11700.0";"nM";"4.93";"";"";"UO_0000065";"2.92";"None";"None";"None";"0";"CHEMBL4704883";"Binding affinity to human recombinant MDM2 (1 to 150 residue) expressed in Escherichia coli using presence of FITC-labelled compound by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699617";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL3647046";"";"None";"586.10";"2";"5.89";"BDBM135106";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'<'";"1.0";"nM";"";"";"286125";"UO_0000065";"";"";"";"";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3647056";"";"None";"550.06";"2";"5.07";"BDBM135116";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"286135";"UO_0000065";"15.27";"0.29";"3.33";"7.31";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649845";"";"None";"538.05";"1";"4.93";"BDBM135179";"CC1OCCN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1C";"IC50";"'='";"25.0";"nM";"7.60";"";"286202";"UO_0000065";"14.13";"0.27";"2.67";"6.61";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649848";"";"None";"564.09";"2";"5.32";"BDBM135184";"C[C@H]1CC[C@H](Cn2c(N3CCCC4COCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"286203";"UO_0000065";"14.18";"0.27";"2.68";"6.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649853";"";"None";"575.07";"2";"5.95";"BDBM135189";"Cc1cc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)on1";"IC50";"'='";"2.0";"nM";"8.70";"";"286208";"UO_0000065";"15.13";"0.29";"2.75";"6.60";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3654191";"";"None";"579.11";"1";"4.76";"BDBM148148";"CC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"286319";"UO_0000065";"15.54";"0.30";"4.24";"7.14";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649950";"";"None";"608.15";"1";"4.90";"BDBM135319";"C[C@@H]1CN(C(=O)N(C)C)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286338";"UO_0000065";"14.80";"0.29";"4.10";"6.96";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4521951";"";"None";"1933.87";"None";"None";"PS4";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)CN(CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"2.87";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4214750";"";"None";"1806.01";"None";"None";"p53-TAD";"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(N)=O";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"2.97";"None";"None";"None";"0";"CHEMBL4185135";"Binding affinity to MDM2 (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4216340";"";"None";"1802.92";"None";"None";"D-MIPC-B16A";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4215007";"";"None";"1943.89";"None";"None";"D-MIPC-Z4a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"36500.0";"nM";"4.44";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4068667";"";"None";"461.56";"0";"4.27";"13";"CC(CC(=O)N[C@@H](Cc1ccc(OCCCNc2ccccn2)cc1)C(=O)O)c1ccccc1";"IC50";"'='";"141.5";"nM";"6.85";"";"";"UO_0000065";"14.84";"0.28";"2.58";"6.81";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3233122";"";"None";"631.58";"2";"6.26";"8";"CC[C@@H](CN(c1ccccc1)S(=O)(=O)C1CC1)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"14.40";"0.30";"2.84";"8.73";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233136";"";"None";"542.48";"2";"5.08";"21";"C[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.51";"0.35";"3.88";"8.87";"0";"CHEMBL3243058";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233136";"";"None";"542.48";"2";"5.08";"21";"C[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@H](CC(=O)O)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"15.04";"0.32";"3.08";"8.08";"0";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"25";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.43";"0.32";"2.44";"9.76";"1";"CHEMBL3243059";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"3";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"18.4";"nM";"7.74";"";"";"UO_0000065";"13.60";"0.29";"1.22";"8.43";"0";"CHEMBL3243052";"Binding affinity to MDM2 in human SJSA1 cells assessed as upregulation of p21 mRNA expression after 7 hrs by qRT-PCR analysis in absence of human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232857";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3693974";"";"None";"596.49";"2";"5.80";"41";"O=C(O)c1ccc(CNC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"9.9";"nM";"8.00";"";"";"UO_0000065";"13.42";"0.27";"2.20";"7.44";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693988";"";"None";"582.46";"2";"6.12";"40";"O=C(O)c1cccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)c1";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"13.83";"0.28";"1.94";"7.49";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4092120";"";"None";"588.51";"2";"5.54";"34";"O=C(N[C@H]1CC[C@@H](C(=O)O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"20.4";"nM";"7.69";"";"";"UO_0000065";"13.07";"0.26";"2.15";"7.15";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3693976";"";"None";"612.49";"2";"6.13";"44";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"13.60";"0.27";"2.20";"7.13";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4066543";"";"None";"558.44";"2";"6.49";"26";"Cc1oc([C@H]2[C@H](c3cccc(Cl)c3F)[C@]3(C(=O)Nc4cc(Cl)ccc43)C3(CCCCC3)N2C)nc1C(=O)O";"IC50";"'='";"30.9";"nM";"7.51";"";"";"UO_0000065";"13.45";"0.27";"1.02";"7.85";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3797694";"";"None";"689.66";"2";"6.68";"20i";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCC(Oc2ncccc2C#N)CC1";"IC50";"'='";"2399.0";"nM";"5.62";"";"";"UO_0000065";"8.15";"0.16";"-1.06";"5.17";"0";"CHEMBL3802428";"Binding affinity to human MDM2 assessed as inhibition of interaction with p53 by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797031";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.30";"0.24";"1.26";"8.57";"0";"CHEMBL3240507";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3236357";"";"None";"695.71";"2";"7.51";"4, AM-6761";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.37";"0.30";"2.49";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236363";"";"None";"567.58";"2";"5.92";"12";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"16.39";"0.34";"3.38";"9.54";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236637";"";"None";"613.65";"2";"7.69";"17";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccccn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"15.52";"0.32";"1.83";"14.14";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236656";"";"None";"637.67";"2";"7.89";"36";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nccs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"14.93";"0.32";"1.63";"14.14";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236659";"";"None";"703.75";"2";"7.86";"40";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C3(C(=O)O)CC3)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"13.78";"0.29";"1.84";"9.27";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236661";"";"None";"731.69";"2";"8.06";"42";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C(F)(F)C(=O)O)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"13.67";"0.29";"1.94";"9.56";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236662";"";"None";"679.64";"2";"7.05";"43";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)o2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.71";"0.30";"2.95";"8.49";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236664";"";"None";"660.66";"2";"6.64";"45";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(CC(=O)O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"14.68";"0.30";"3.06";"8.05";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3233049";"";"None";"659.63";"2";"6.72";"46";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)O[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"15.16";"0.31";"3.28";"8.78";"0";"CHEMBL3241171";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in serum free buffer incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236361";"";"None";"608.58";"2";"6.09";"10";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"14.33";"0.30";"2.63";"8.01";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236652";"";"None";"663.69";"2";"7.45";"32";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2nc(C(=O)O)cs2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"12.19";"0.26";"0.64";"7.73";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236659";"";"None";"703.75";"2";"7.86";"40";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ncc(C3(C(=O)O)CC3)s2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"12.27";"0.26";"0.78";"8.26";"0";"CHEMBL3241172";"Binding affinity to GST-thrombin-tagged human MDM2 (1 to 188) expressed in Escherichia coli assessed as inhibition of interaction with p53 in buffer containing 15% human serum incubated for 20 mins prior to p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3236356";"";"None";"657.66";"2";"7.38";"3, AM-1900";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(Cc2ccc(C(=O)O)cn2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"12.62";"0.26";"0.92";"7.93";"0";"CHEMBL3241501";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 expression";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232711";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3691750";"";"None";"569.45";"1";"4.87";"BDBM143591";"COc1ncc(-n2nc3c(c2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"111.31";"nM";"6.95";"";"279791";"UO_0000065";"12.21";"0.24";"2.08";"6.66";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683112";"";"None";"494.04";"1";"6.76";"BDBM161733";"CC[C@@H](C)Oc1cc2c(cc1OC)N(C)C(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"624.7";"nM";"6.20";"";"304958";"UO_0000065";"12.56";"0.24";"-0.56";"13.71";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683142";"";"None";"480.00";"1";"6.26";"BDBM161945";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)O)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"72.4";"nM";"7.14";"";"304991";"UO_0000065";"14.88";"0.29";"0.88";"12.10";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650062";"";"None";"486.05";"1";"5.94";"BDBM135932";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(C(C)(C)O)CC1)C(=O)C2";"IC50";"'='";"55.0";"nM";"7.26";"";"269510";"UO_0000065";"14.94";"0.29";"1.32";"12.30";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683166";"";"None";"576.14";"2";"6.09";"BDBM162096";"CNC(=O)[C@H]1CCCN1[C@@H](C)c1ccc(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"14.2";"nM";"7.85";"";"305019";"UO_0000065";"13.62";"0.26";"1.76";"11.04";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.76";"0.27";"2.11";"9.58";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4170132";"";"None";"504.55";"2";"1.19";"12";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCCc2ccc3ccccc3c2)c1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"12.75";"0.24";"5.24";"3.45";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL2386344";"";"None";"703.68";"2";"9.27";"2e";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCC(F)(F)F)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"10.88";"0.22";"-1.61";"15.83";"0";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3649832";"";"None";"510.04";"2";"5.43";"BDBM135163";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268672";"UO_0000065";"17.06";"0.33";"3.27";"9.32";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4068121";"";"None";"263.30";"0";"2.61";"3";"CN1CCc2cccc3c4c(cc1c23)C=CC(=O)C4=O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"21.91";"0.39";"3.16";"15.43";"0";"CHEMBL4017938";"Inhibition of biotin-labelled P4 peptide binding to MDM2 (25 to 109 residues) (unknown origin) by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL4095506";"";"None";"1494.67";"None";"None";"P4";"CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"52.4";"nM";"7.28";"";"";"UO_0000065";"4.87";"None";"None";"None";"0";"CHEMBL4017938";"Inhibition of biotin-labelled P4 peptide binding to MDM2 (25 to 109 residues) (unknown origin) by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"6";"Oc1ccccc1O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4017936";"Inhibition of biotin-labelled p53 binding to MDM2 (25 to 109 residues) (unknown origin) by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL416288";"(S)APOMORPHINE";"None";"267.33";"0";"2.85";"1b";"CN1CCc2cccc3c2[C@@H]1Cc1ccc(O)c(O)c1-3";"IC50";"'='";"175.0";"nM";"6.76";"";"";"UO_0000065";"25.28";"0.46";"3.91";"15.46";"0";"CHEMBL4017935";"Inhibition of biotin-labelled L-p53 binding to L-MDM2 (25 to 109 residues) (unknown origin) by FAM labeled P4 peptide based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3653231";"";"None";"552.46";"2";"6.61";"15a";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.08";"nM";"10.10";"";"";"UO_0000065";"18.28";"0.36";"3.49";"12.26";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3653186";"";"None";"522.44";"2";"6.60";"14";"COc1ncncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.26";"nM";"9.59";"";"";"UO_0000065";"18.35";"0.36";"2.99";"13.11";"0";"CHEMBL4267760";"Inhibition of Cy5-labeled p53 derived TFSDLWKLL peptide binding to C-terminal biotin-labelled human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265923";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL377524";"";"None";"637.30";"2";"6.58";"17";"O=C(O)CCCCN1C(=O)[C@H](c2ccc(Cl)cc2)N(Cc2ccc(Cl)cc2)C(=O)c2cc(I)ccc21";"IC50";"'='";"8220.0";"nM";"5.08";"";"";"UO_0000065";"7.98";"0.19";"-1.49";"6.53";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL210409";"";"None";"695.34";"2";"6.30";"15";"COC(=O)C(c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2820.0";"nM";"5.55";"";"";"UO_0000065";"7.98";"0.19";"-0.75";"5.33";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL207255";"";"None";"652.27";"2";"5.07";"4";"O=C(O)CCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"9.31";"0.22";"1.00";"5.24";"0";"CHEMBL854219";"Inhibition p53-HDM2 interaction by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL3703351";"";"None";"791.68";"2";"6.74";"BDBM152980";"COCCOCCNC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"40.8";"nM";"7.39";"";"293805";"UO_0000065";"9.33";"0.19";"0.65";"4.70";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703356";"";"None";"944.85";"3";"8.96";"BDBM152987";"COc1cc(C(=O)OC(C)OC(=O)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)C[C@@H]3OC(C)(C)O[C@H]23)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"26.7";"nM";"7.57";"";"293811";"UO_0000065";"8.02";"0.16";"-1.39";"4.38";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703359";"";"None";"960.75";"3";"7.06";"BDBM152990";"COc1cc(C(=O)OC(C)OC(=O)OCCOCCOCCOCCOP(=O)(O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.75";"nM";"8.32";"";"293814";"UO_0000065";"8.66";"0.18";"1.26";"3.61";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3219400";"";"None";"483.40";"1";"5.24";"96a";"COCCNC(=O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"62500.0";"nM";"4.20";"";"";"UO_0000065";"8.70";"0.17";"-1.04";"7.17";"0";"CHEMBL3222409";"Inhibition of Mdm2 in p53-deficient human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3657115";"";"None";"558.40";"2";"5.11";"BDBM130033";"COc1ncc(-c2nc3c(n2[C@H](C)CO)[C@@H](c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"40.95";"nM";"7.39";"";"261754";"UO_0000065";"13.23";"0.27";"2.28";"7.20";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3675213";"";"None";"409.27";"0";"4.71";"BDBM111536";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(O)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1620.0";"nM";"5.79";"";"232333";"UO_0000065";"14.15";"0.28";"1.08";"9.00";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3653311";"";"None";"615.98";"2";"5.45";"BDBM135429";"O=c1[nH]c(-c2cc3nc(N4CCO[C@@H]5CCC[C@H]54)n(Cc4ccc(C(F)(F)F)c(F)c4)c3c(-c3cncc(Cl)c3)n2)no1";"IC50";"'='";"28.0";"nM";"7.55";"";"268939";"UO_0000065";"12.26";"0.24";"2.10";"6.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3693965";"";"None";"491.39";"0";"3.29";"9";"CNC(=O)[C@@H]1NC2(CCN(C)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL1688297";"";"None";"434.92";"0";"4.38";"BDBM50339392";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccccn1";"IC50";"'='";"10600.0";"nM";"4.97";"";"232355";"UO_0000065";"11.44";"0.22";"0.59";"7.94";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649974";"";"None";"560.06";"2";"5.84";"BDBM135356";"CCOC(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268868";"UO_0000065";"15.53";"0.30";"2.86";"6.98";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4102205";"";"None";"581.48";"2";"5.52";"52";"NC(=O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"13.62";"0.27";"2.40";"6.99";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4085815";"";"None";"659.57";"2";"5.11";"49";"CS(=O)(=O)NC(=O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"12.27";"0.25";"2.98";"6.06";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4066694";"";"None";"612.49";"2";"6.13";"43";"COc1cc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"13.27";"0.26";"1.99";"6.96";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL2402737";"IDASANUTLIN";"3.0";"616.49";"2";"6.94";"RG7388";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.34";"0.27";"1.28";"7.38";"0";"CHEMBL4353483";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350988";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4084848";"";"None";"389.45";"0";"3.73";"4";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O";"IC50";"'='";"23.4";"nM";"7.63";"";"";"UO_0000065";"19.59";"0.36";"3.90";"8.81";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3687251";"";"None";"488.42";"1";"5.03";"BDBM143371";"Cc1cc(Cl)ccc1C1c2c(nn(CC(O)CO)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.2";"nM";"8.66";"";"279519";"UO_0000065";"17.73";"0.36";"3.63";"11.02";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3656998";"";"None";"514.99";"2";"6.86";"BDBM129902";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.38";"nM";"9.42";"";"261633";"UO_0000065";"18.29";"0.35";"2.56";"13.24";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3819001";"";"None";"538.65";"1";"4.02";"10";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)NC";"IC50";"'='";"9.8";"nM";"8.01";"";"";"UO_0000065";"14.87";"0.27";"3.99";"6.67";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3125531";"";"None";"568.52";"2";"5.12";"29";"CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"15.63";"0.33";"3.77";"8.80";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125525";"";"None";"552.52";"2";"5.89";"23";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"15.87";"0.33";"2.88";"9.56";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125524";"";"None";"540.51";"2";"5.74";"22";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"16.27";"0.34";"3.06";"9.59";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125699";"";"None";"512.46";"1";"4.96";"41";"C[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"17.65";"0.37";"4.09";"9.86";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125525";"";"None";"552.52";"2";"5.89";"23";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.55";"0.37";"3.81";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125526";"";"None";"554.54";"2";"6.13";"24";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"15.97";"0.34";"2.72";"9.65";"0";"CHEMBL3132469";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125529";"";"None";"566.55";"2";"6.28";"27";"CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"17.12";"0.36";"3.42";"10.57";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3649839";"";"None";"603.13";"2";"6.52";"BDBM135172";"CCc1noc(C)c1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"268681";"UO_0000065";"12.88";"0.25";"1.25";"5.90";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649881";"";"None";"582.11";"1";"4.95";"BDBM135220";"COC[C@@H]1CC[C@@H](COC)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268729";"UO_0000065";"14.94";"0.29";"3.75";"7.00";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3663810";"";"None";"552.47";"1";"3.74";"BDBM170321";"CC(C)CC[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"10000.0";"nM";"";"";"314293";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663813";"";"None";"566.50";"1";"4.08";"BDBM60498";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'>'";"3000.0";"nM";"";"";"314297";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663822";"";"None";"568.04";"1";"3.71";"BDBM170338";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]2(C(=O)Nc3cc(F)c(F)cc32)[C@H]1CC(C)(C)C";"IC50";"'>'";"3000.0";"nM";"";"";"314310";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649905";"";"None";"587.08";"2";"5.29";"BDBM135257";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286276";"UO_0000065";"15.33";"0.29";"3.71";"7.04";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704554";"";"None";"592.52";"1";"4.00";"BDBM170319";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCc2cccs2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"1000.0";"nM";"";"";"314291";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663811";"";"None";"536.43";"1";"3.11";"BDBM170322";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2CC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"10000.0";"nM";"";"";"314294";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704502";"";"None";"548.49";"1";"4.91";"BDBM170258";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314208";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704508";"";"None";"590.57";"1";"4.25";"BDBM170268";"CN1CCN(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"314217";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665585";"";"None";"532.03";"1";"4.40";"BDBM119717";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"5000.0";"nM";"";"";"314247";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4115330";"";"None";"574.52";"2";"5.45";"BDBM170298";"O=C(NC1CCC(O)CC1)[C@@H]1N[C@H](CC2CCCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"3000.0";"nM";"";"";"314256";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4109826";"";"None";"661.65";"2";"5.84";"BDBM170309";"CC(C)[C@H](N)C(=O)OC1CCC(NC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)CC1";"IC50";"'<'";"3000.0";"nM";"";"";"314267";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2396674";"";"None";"548.49";"1";"4.91";"BDBM119725";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314274";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665593";"";"None";"532.03";"1";"4.40";"BDBM119729";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314276";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3665596";"";"None";"530.50";"1";"4.77";"BDBM119732";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314279";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663819";"";"None";"606.55";"1";"4.34";"BDBM170331";"CN1[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1CCc1cccs1";"IC50";"'>'";"10000.0";"nM";"";"";"314303";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663820";"";"None";"576.45";"1";"3.53";"BDBM170332";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCc2ccco2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"5000.0";"nM";"";"";"314305";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663824";"";"None";"566.50";"1";"4.13";"BDBM170340";"CCC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314312";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663842";"";"None";"601.55";"1";"4.96";"BDBM170359";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N2CCN(C(=O)C3CC3)CC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'>'";"1000.0";"nM";"";"";"314330";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3819416";"";"None";"553.66";"1";"4.84";"3";"CCOC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12";"IC50";"'='";"11.65";"nM";"7.93";"";"";"UO_0000065";"14.33";"0.26";"3.09";"6.76";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3818934";"";"None";"491.59";"0";"3.86";"5";"CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"77.7";"nM";"7.11";"";"";"UO_0000065";"14.46";"0.27";"3.25";"6.06";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3819467";"";"None";"491.59";"0";"3.86";"7";"COC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C";"IC50";"'='";"154.6";"nM";"6.81";"";"";"UO_0000065";"13.85";"0.26";"2.95";"5.80";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"268630";"UO_0000065";"13.77";"0.27";"2.31";"6.76";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691792";"";"None";"586.46";"1";"4.75";"BDBM143727";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.155";"nM";"9.81";"";"279834";"UO_0000065";"16.73";"0.33";"5.06";"9.97";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3318755";"";"None";"553.51";"1";"4.86";"3";"CNS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"16.28";"0.34";"4.15";"8.68";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318775";"";"None";"583.58";"2";"5.84";"26";"CN(C)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"16.48";"0.35";"3.78";"10.13";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL383471";"";"None";"651.33";"2";"5.15";"6";"CN(C)CCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL426321";"";"None";"680.33";"2";"5.85";"5";"O=C(O)CCCCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853092";"Antiproliferative activity against wild type p53 expressing MCF7 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308403";"";""
"CHEMBL426321";"";"None";"680.33";"2";"5.85";"5";"O=C(O)CCCCNC(=O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL853093";"Antiproliferative activity against mutant p53 expressing MDA-MB-231 cells by BrdU proliferation assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147820";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3307960";"";""
"CHEMBL209201";"";"None";"664.37";"2";"6.22";"12c";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCN2CCOCC2)C(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"8.38";"0.20";"-0.65";"10.49";"0";"CHEMBL868168";"Displacement of p53 mimicking fluorescent peptide from Hdm2 by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148515";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";""
"CHEMBL4165669";"";"None";"454.49";"1";"0.56";"13";"C[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)c1cccc(NC(=N)N)c1)c1ccccc1";"IC50";"'='";"685.0";"nM";"6.16";"";"";"UO_0000065";"13.56";"0.26";"5.60";"3.31";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL5171791";"";"None";"673.26";"1";"2.35";"9";"CN1CCC(=O)NCCSCCS(=O)(=O)CCN(Cc2ccc(C#N)cc2)CC(=O)N[C@@H](Cc2cc3ccc(Cl)cc3[nH]2)C1=O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.24";"0.19";"3.87";"4.00";"0";"CHEMBL5111019";"Inhibition of MDM2 (unknown origin) by Fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108037";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3649932";"";"None";"605.14";"2";"5.15";"BDBM135300";"C[C@@H]1CN(C(=O)C2CC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268810";"UO_0000065";"14.87";"0.29";"3.85";"7.14";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647060";"";"None";"564.09";"2";"5.46";"BDBM135122";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4n[nH]c(=O)o4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"268631";"UO_0000065";"14.46";"0.28";"2.69";"7.09";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649817";"";"None";"538.05";"1";"4.93";"BDBM135142";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)CO1";"IC50";"'='";"20.0";"nM";"7.70";"";"268655";"UO_0000065";"14.31";"0.28";"2.77";"6.70";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2386346";"RO-5045337";"1.0";"727.80";"2";"7.75";"2g, RG7112";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"10.64";"0.22";"-0.01";"9.39";"1";"CHEMBL2389364";"Inhibition of N-terminal human recombinant MDM2 assessed as inhibition of protein interaction with p53 by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384945";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";""
"CHEMBL3649823";"";"None";"552.08";"2";"5.32";"BDBM135149";"COC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"961.0";"nM";"6.02";"";"268658";"UO_0000065";"10.90";"0.21";"0.70";"5.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649828";"";"None";"564.13";"2";"6.72";"BDBM135157";"CCC(C)(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268666";"UO_0000065";"15.42";"0.30";"1.98";"8.23";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3984635";"";"None";"538.05";"1";"4.93";"BDBM135166";"CO[C@H]1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"268675";"UO_0000065";"15.61";"0.30";"3.47";"7.31";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649855";"";"None";"576.06";"3";"5.35";"BDBM135191";"Cc1noc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"268700";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649880";"";"None";"565.08";"1";"4.42";"BDBM135219";"CCNC(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"144.0";"nM";"6.84";"";"268701";"UO_0000065";"12.11";"0.23";"2.42";"5.07";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649880";"";"None";"565.08";"1";"4.42";"BDBM135219";"CCNC(=O)[C@@H]1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"50.0";"nM";"7.30";"";"268728";"UO_0000065";"12.92";"0.25";"2.88";"5.41";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3407555";"";"None";"598.56";"2";"6.66";"4";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2F)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"13.69";"0.29";"1.53";"8.93";"0";"CHEMBL3412297";"Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 gene level after 7 hrs by qRT-PCR assay in presence of 10% human serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"CHEMBL3638229";"Serum";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"CHEMBL3308885";"";""
"CHEMBL3407559";"";"None";"729.72";"2";"7.78";"9";"COc1cc(C(=O)O)ccc1NC(=O)C[C@@]1(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)(C)C)C2CC2)C1=O";"IC50";"'='";"0.18";"nM";"9.74";"";"";"UO_0000065";"13.35";"0.27";"1.96";"7.49";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407557";"";"None";"699.70";"2";"7.78";"7";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)Nc2ccc(C(=O)O)cc2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.18";"nM";"9.74";"";"";"UO_0000065";"13.93";"0.28";"1.96";"8.06";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407554";"";"None";"598.56";"2";"6.66";"3";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)c(F)c1";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"16.71";"0.35";"3.34";"10.90";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"1, AMG 232";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"16.18";"0.34";"2.82";"10.03";"0";"CHEMBL3412296";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407575";"";"None";"747.71";"2";"7.92";"25, AM-7209";"COc1cc(NC(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)c(F)c3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"12.33";"0.25";"1.30";"7.09";"0";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3407558";"";"None";"729.72";"2";"7.78";"8";"COc1cc(NC(=O)C[C@@]2(C)C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N([C@H](CS(=O)(=O)C(C)(C)C)C3CC3)C2=O)ccc1C(=O)O";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"12.75";"0.26";"1.52";"7.15";"0";"CHEMBL3413418";"Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407331";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3649849";"";"None";"561.05";"1";"4.78";"BDBM135185";"C[C@H]1CC[C@H](Cn2c(N3CCCC3c3cnn[nH]3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"286204";"UO_0000065";"16.04";"0.31";"4.22";"6.11";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649872";"";"None";"576.06";"3";"5.35";"BDBM135208";"Cc1nc(C2CCCN2c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"286227";"UO_0000065";"15.62";"0.30";"3.65";"6.22";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649918";"";"None";"516.99";"2";"5.45";"BDBM135279";"C[C@H]1CC[C@H](Cn2c(Nc3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"286298";"UO_0000065";"14.77";"0.28";"2.19";"6.00";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649919";"";"None";"476.97";"1";"5.81";"BDBM135280";"C[C@H]1CC[C@H](Cn2c(Nc3ccccn3)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"286299";"UO_0000065";"15.51";"0.30";"1.59";"6.99";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649934";"";"None";"609.13";"2";"5.37";"BDBM135303";"CCOC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"286322";"UO_0000065";"14.28";"0.28";"3.33";"6.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704513";"";"None";"625.59";"1";"4.42";"BDBM170275";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCN(S(C)(=O)=O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"100.0";"nM";"";"";"314224";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704517";"";"None";"575.51";"1";"4.57";"BDBM170279";"CC(=O)N1CCN(C(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"10000.0";"nM";"";"";"314228";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704536";"";"None";"591.56";"1";"4.45";"BDBM170300";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CN(CC(C)(C)O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314258";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3906549";"";"None";"564.09";"2";"5.38";"BDBM135400";"Cc1c(-c2nc(=O)o[nH]2)nc(-c2cncc(Cl)c2)c2c1nc(N1CCO[C@H]3CCC[C@@H]31)n2C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268909";"UO_0000065";"15.42";"0.30";"3.32";"7.57";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3890287";"";"None";"593.13";"2";"5.14";"BDBM135433";"CN(C)c1ncc(Cl)cc1-c1nc(-c2nc(=O)o[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"268942";"UO_0000065";"14.67";"0.28";"3.56";"7.36";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665599";"";"None";"550.02";"1";"4.54";"BDBM119735";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1c2ccc(Cl)c1F";"IC50";"'='";"162.0";"nM";"6.79";"";"246836";"UO_0000065";"12.35";"0.24";"2.25";"7.51";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3890230";"";"None";"576.54";"2";"5.69";"BDBM119736";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(C)(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.0";"nM";"8.10";"";"246837";"UO_0000065";"14.04";"0.28";"2.41";"8.95";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3932760";"";"None";"546.06";"1";"4.79";"BDBM119738";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(F)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"272.83";"nM";"6.56";"";"246788";"UO_0000065";"12.02";"0.24";"1.77";"7.26";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653321";"";"None";"624.14";"3";"5.10";"BDBM135439";"COCCOc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@H]4CCC[C@@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"1.0";"nM";"9.00";"";"268948";"UO_0000065";"14.42";"0.28";"3.90";"6.75";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653296";"";"None";"556.50";"2";"8.19";"BDBM129864";"Cc1nc(-c2cccc(-c3nc4c(n3C(C)C)C(c3ccc(Cl)cc3)N(c3cc(Cl)ccc3C)C4=O)c2)c[nH]1";"IC50";"'='";"1.7";"nM";"8.77";"";"261594";"UO_0000065";"15.76";"0.31";"0.58";"13.13";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703320";"";"None";"730.64";"2";"7.94";"BDBM152945";"COc1cc(C(=O)OC(C)OC(=O)C(C)C)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"14.5";"nM";"7.84";"";"293768";"UO_0000065";"10.73";"0.21";"-0.10";"6.18";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703360";"";"None";"773.66";"2";"7.21";"BDBM152991";"COc1cc(C(=O)O[C@H](C)OC(=O)N2CCOCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"19.4";"nM";"7.71";"";"293774";"UO_0000065";"9.97";"0.20";"0.50";"5.54";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703334";"";"None";"938.85";"3";"7.61";"BDBM152959";"COCCOCCOCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.84";"nM";"8.23";"";"293783";"UO_0000065";"8.77";"0.18";"0.62";"4.52";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703338";"";"None";"761.61";"2";"6.55";"BDBM152963";"COc1cc(C(=O)OC(C)OC(=O)NCC(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.39";"nM";"8.36";"";"293787";"UO_0000065";"10.97";"0.22";"1.81";"4.75";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703341";"";"None";"999.89";"3";"9.72";"BDBM152966";"COc1cc(C(=O)OCOC(=O)N[C@@H](CCC(=O)OCc2ccccc2)C(=O)OCc2ccccc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"4.3";"nM";"8.37";"";"293790";"UO_0000065";"8.37";"0.16";"-1.35";"4.37";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703345";"";"None";"924.82";"3";"7.22";"BDBM152970";"COCCOCCOCCOCCOCCOC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"5.25";"nM";"8.28";"";"293794";"UO_0000065";"8.95";"0.18";"1.06";"4.55";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683122";"";"None";"553.15";"2";"7.67";"BDBM161813";"CCCN(c1ccc2c(c1)C(c1ccc(Cl)cc1)N(c1ccc(N(C)Cc3ccncc3)cc1)C(=O)C2)C(C)C";"IC50";"'='";"158.5";"nM";"6.80";"";"304968";"UO_0000065";"12.29";"0.23";"-0.87";"17.14";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4530683";"";"None";"1760.97";"None";"None";"p53";"CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@@H](C)O";"IC50";"'='";"4610.0";"nM";"5.34";"";"";"UO_0000065";"3.03";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4208067";"";"None";"1915.83";"None";"None";"D-MIPC-l10a";"CC(C)C[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@@H](C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C";"IC50";"'='";"21900.0";"nM";"4.66";"";"";"UO_0000065";"2.43";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3699943";"";"None";"773.71";"2";"8.61";"BDBM152940";"CCN(C(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1)C(C)C";"IC50";"'='";"29.6";"nM";"7.53";"";"293763";"UO_0000065";"9.73";"0.19";"-1.08";"5.79";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703331";"";"None";"787.69";"2";"7.65";"BDBM152956";"COc1cc(C(=O)OC(C)OC(=O)NC2CCOCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"11.7";"nM";"7.93";"";"293780";"UO_0000065";"10.07";"0.20";"0.28";"5.36";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4789298";"";"None";"1648.97";"None";"None";"15";"CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@H]1CCC(=O)NCCCC[C@@H](CN(CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)CN(CC(=O)N[C@@H](C)C(N)=O)S(C)(=O)=O)S(C)(=O)=O)NC(=O)[C@H](C)NC(=O)CN(S(=O)(=O)c2ccc3ccccc3c2)C[C@H](Cc2ccc(O)cc2)NC1=O)S(C)(=O)=O)[C@@H](C)O";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"3.06";"None";"None";"None";"0";"CHEMBL4704883";"Binding affinity to human recombinant MDM2 (1 to 150 residue) expressed in Escherichia coli using presence of FITC-labelled compound by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699617";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL3653327";"";"None";"552.64";"1";"4.64";"BDBM135446";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncnc4)c32)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"268955";"UO_0000065";"13.01";"0.24";"2.55";"5.62";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653329";"";"None";"552.64";"1";"4.64";"BDBM135448";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4ccnnc4)c32)CC1";"IC50";"'='";"72.0";"nM";"7.14";"";"268957";"UO_0000065";"12.92";"0.24";"2.50";"5.59";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653336";"";"None";"597.16";"2";"6.67";"BDBM135455";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(C4CC=CC(=O)N4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"70.0";"nM";"7.16";"";"268964";"UO_0000065";"11.98";"0.23";"0.48";"8.40";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3951933";"";"None";"564.05";"1";"4.93";"BDBM119722";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"169.0";"nM";"6.77";"";"246805";"UO_0000065";"12.01";"0.24";"1.84";"7.49";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3915391";"";"None";"568.48";"2";"5.24";"BDBM119746";"O=C(NC1CCC(O)CC1)[C@@H]1N[C@@H](c2ccccc2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"500.0";"nM";"";"";"246822";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3260809";"";"None";"409.27";"1";"6.21";"4";"O=C(O)c1nc(-c2ccccc2)n(-c2cccc(Cl)c2)c1-c1cccc(Cl)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"16.91";"0.34";"0.71";"12.56";"0";"CHEMBL3267322";"Inhibition of MDM2 (unknown origin) (2 to 188) assessed as inhibition of p53-MDM2 interaction by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3649846";"";"None";"550.06";"2";"5.08";"BDBM135180";"C[C@H]1CC[C@H](Cn2c(N3CCCC34CCOC4)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"286199";"UO_0000065";"14.95";"0.29";"3.14";"7.15";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3968776";"";"None";"595.10";"1";"4.98";"BDBM135308";"COC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"286327";"UO_0000065";"14.62";"0.28";"3.72";"6.43";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3966104";"";"None";"622.17";"2";"5.33";"BDBM135310";"CCCNC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"286329";"UO_0000065";"13.98";"0.27";"3.37";"6.30";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649964";"";"None";"525.05";"2";"6.19";"BDBM135339";"CCCOC(CC)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"286358";"UO_0000065";"16.23";"0.31";"2.33";"7.63";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704495";"";"None";"589.58";"2";"5.88";"BDBM170251";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCN2CCCCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"10000.0";"nM";"";"";"314201";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704491";"";"None";"575.56";"2";"5.48";"BDBM170247";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCCN2CCCC2)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314197";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3960238";"";"None";"580.50";"2";"5.44";"BDBM119739";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"309.08";"nM";"6.51";"";"246777";"UO_0000065";"11.21";"0.23";"1.07";"7.20";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665595";"";"None";"566.48";"2";"5.05";"BDBM119731";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"120.23";"nM";"6.92";"";"246783";"UO_0000065";"12.22";"0.25";"1.87";"7.65";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3924221";"";"None";"546.06";"1";"4.79";"BDBM119716";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'='";"176.0";"nM";"6.75";"";"246828";"UO_0000065";"12.37";"0.24";"1.96";"7.47";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687274";"";"None";"547.49";"2";"7.78";"BDBM143400";"Cc1cc(Cl)ccc1C1c2c(nn(C(=O)N(C)c3ccccc3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"21.1";"nM";"7.68";"";"279542";"UO_0000065";"14.02";"0.28";"-0.10";"13.13";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687270";"";"None";"515.49";"2";"6.33";"BDBM143396";"CCn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"4.1";"nM";"8.39";"";"279538";"UO_0000065";"16.27";"0.33";"2.06";"16.58";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653293";"";"None";"541.40";"2";"5.10";"BDBM129861";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cnc(O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"261591";"UO_0000065";"17.91";"0.36";"4.60";"8.40";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657012";"";"None";"581.48";"2";"7.04";"BDBM129916";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"261647";"UO_0000065";"17.13";"0.34";"2.92";"14.72";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3288451";"";"None";"761.16";"2";"5.30";"12";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)[C@@H]2CCO)CC1.Cl";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"10.51";"0.20";"2.32";"7.28";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL53";"APOMORPHINE";"4.0";"267.33";"0";"2.85";"1a";"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4017938";"Inhibition of biotin-labelled P4 peptide binding to MDM2 (25 to 109 residues) (unknown origin) by surface plasmon resonance method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3920895";"";"None";"564.05";"1";"4.93";"BDBM119740";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'='";"157.86";"nM";"6.80";"";"246778";"UO_0000065";"12.06";"0.24";"1.87";"7.52";"0";"CHEMBL3705137";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was optionally determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human MDM2 protein (residues 5-109) and PMDM6-F as follows: MDM2 protein was serially diluted with a step of 1.8 in a Costar 96-well, black, non binding surface reference 3686 plate, and the PMDM6-F peptide was added at 5 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin, 0.01% Triton X-100) and the anisotropy values were measured at equilibrium using a Fusion reader (Packard).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3219399";"";"None";"426.30";"1";"5.56";"95a";"O=C(O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'>'";"60000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3222409";"Inhibition of Mdm2 in p53-deficient human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3219401";"";"None";"590.56";"2";"5.32";"96b";"CN1CCN(CCNC(=O)[C@H]2c3ccccc3C(=O)N(Cc3ccc(Cl)cc3)[C@@H]2c2c[nH]c3cc(Cl)ccc23)CC1";"IC50";"'='";"11500.0";"nM";"4.94";"";"";"UO_0000065";"8.36";"0.16";"-0.38";"6.89";"0";"CHEMBL3222409";"Inhibition of Mdm2 in p53-deficient human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3703669";"";"None";"465.94";"1";"5.52";"BDBM156620";"COc1ccc(C(Nc2cc(C)c(Cl)cn2)c2ccc3cccnc3c2O)c(OC)c1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"298952";"UO_0000065";"10.73";"0.21";"-0.52";"5.83";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703673";"";"None";"500.38";"2";"6.18";"BDBM156635";"COc1ccc(C(Nc2nc(C)c(Cl)cc2Cl)c2ccc3cccnc3c2O)c(OC)c1OC";"IC50";"'='";"20000.0";"nM";"4.70";"";"298956";"UO_0000065";"9.39";"0.19";"-1.48";"5.48";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683105";"";"None";"509.05";"2";"5.76";"BDBM161694";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1CO";"IC50";"'='";"723.2";"nM";"6.14";"";"304950";"UO_0000065";"12.06";"0.23";"0.38";"9.87";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653297";"";"None";"540.02";"1";"3.50";"BDBM129865";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CN(C)C(=O)N(C)C2)C3=O)c(OC)n1";"IC50";"'='";"2.8";"nM";"8.55";"";"261595";"UO_0000065";"15.84";"0.31";"5.05";"8.07";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4107313";"";"None";"639.62";"1";"4.86";"BDBM170274";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(NS(C)(=O)=O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314222";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3986239";"";"None";"562.51";"2";"5.30";"BDBM119713";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"314223";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3704516";"";"None";"547.50";"1";"4.66";"BDBM170278";"CN1CCN(C(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"5000.0";"nM";"";"";"314227";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3951933";"";"None";"564.05";"1";"4.93";"BDBM119714";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"3000.0";"nM";"";"";"314252";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663821";"";"None";"578.51";"1";"4.28";"BDBM60496";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2CCCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"3000.0";"nM";"";"";"314306";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663821";"";"None";"578.51";"1";"4.28";"BDBM60496";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CC2CCCCC2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"314308";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663831";"";"None";"608.58";"2";"5.25";"BDBM170348";"CCCCC(C)(C)C[C@H]1N(C)[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"5000.0";"nM";"";"";"314319";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663834";"";"None";"612.55";"1";"4.91";"BDBM170351";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314322";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL53";"APOMORPHINE";"4.0";"267.33";"0";"2.85";"1a";"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3";"IC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"25.10";"0.46";"3.86";"15.35";"0";"CHEMBL4017941";"Inhibition of biotin-labelled D-p53 binding to D-MDM2 (25 to 109 residues) (unknown origin) by FAM labeled P4 peptide based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL3799447";"";"None";"591.66";"2";"7.86";"6e";"CC(C)Oc1ccc(C(=O)Nc2c(C(=O)O)nn(-c3ccc(Oc4ccccc4)cc3)c2-c2ccc(OC(C)C)cc2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.96";"0.16";"-2.56";"4.74";"0";"CHEMBL3801205";"Inhibition of MDM2 in human HCT116 p53+/+ cells assessed as growth inhibition";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797039";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308372";"";""
"CHEMBL3703324";"";"None";"773.66";"2";"7.21";"BDBM152949";"COc1cc(C(=O)OC(C)OC(=O)N2CCOCC2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"53.6";"nM";"7.27";"";"293772";"UO_0000065";"9.40";"0.19";"0.06";"5.22";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3355430";"";"None";"582.46";"2";"6.12";"31, MI-1061";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"14.35";"0.29";"2.24";"7.77";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3691723";"";"None";"591.54";"2";"7.31";"BDBM143512";"COc1ccc(CNC(C)=O)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.196";"nM";"9.71";"";"279768";"UO_0000065";"16.41";"0.32";"2.40";"12.70";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3650058";"";"None";"541.13";"2";"6.57";"BDBM135928";"CCCCN(C(C)=O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"257.0";"nM";"6.59";"";"269506";"UO_0000065";"12.18";"0.24";"0.02";"11.15";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691700";"";"None";"549.46";"2";"6.47";"BDBM143463";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)cc(C(N)=O)c1)C2=O";"IC50";"'='";"2.1";"nM";"8.68";"";"279595";"UO_0000065";"15.79";"0.31";"2.21";"9.59";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687247";"";"None";"568.51";"1";"4.98";"BDBM143364";"Cc1cc(Cl)ccc1C1c2c(nn(CC(=O)N3CCN(C)C(=O)C3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"3.0";"nM";"8.52";"";"279515";"UO_0000065";"14.99";"0.30";"3.54";"10.82";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657076";"";"None";"520.99";"2";"5.69";"BDBM129986";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(C)c1)C2=O";"IC50";"'='";"1.18";"nM";"8.93";"";"261713";"UO_0000065";"17.14";"0.33";"3.24";"12.87";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691752";"";"None";"554.44";"1";"4.61";"BDBM143598";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"279793";"UO_0000065";"17.83";"0.36";"5.28";"9.05";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4177354";"";"None";"530.59";"2";"1.63";"17";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(c2ccccc2)c2ccccc2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4162220";"";"None";"476.49";"1";"1.47";"11";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)Nc2cccc3ccccc23)c1";"IC50";"'='";"545.0";"nM";"6.26";"";"";"UO_0000065";"13.15";"0.24";"4.79";"3.36";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4208830";"";"None";"1927.89";"None";"None";"D-MIPC-t2a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](C)NC(=O)[C@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"11400.0";"nM";"4.94";"";"";"UO_0000065";"2.56";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL211045";"";"None";"581.50";"2";"5.89";"Nutlin";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.70";"0.21";"0.33";"7.45";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL4518146";"";"None";"2042.06";"None";"None";"PS11";"CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](Cc1ccccc1)CN(CC(=O)N[C@@H](CCC(=O)O)CN1CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)CN(S(C)(=O)=O)CC(=O)N[C@@H](CCCCN)CN(CC(=O)N[C@@H](CC(C)C)CN(CC(=O)N[C@@H](C)CN(CC(N)=O)S(C)(=O)=O)S(=O)(=O)CC(C)C)S(=O)(=O)CCCC/C=C/CCCCS1(=O)=O)S(C)(=O)=O)S(=O)(=O)c1ccc(Cl)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"2.80";"None";"None";"None";"0";"CHEMBL4325736";"Binding affinity to human MDM2 expressed in Escherichia coli expression system by using (FITC)-labeled p53 peptide based fluorescence polarization competitive assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321882";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL3938875";"";"None";"551.61";"2";"7.29";"BDBM135102";"Cc1c(C(=O)O)nc(N[C@@H](C)C2CCC2)c2c1nc(-c1cc(C(C)C)ccn1)n2Cc1ccc(C(F)(F)F)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"268611";"UO_0000065";"13.09";"0.25";"-0.07";"7.77";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3647055";"";"None";"564.09";"2";"5.46";"BDBM135115";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268624";"UO_0000065";"14.89";"0.29";"2.94";"7.31";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691780";"";"None";"573.41";"1";"4.70";"BDBM143677";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2F)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"1.089";"nM";"8.96";"";"279821";"UO_0000065";"15.63";"0.31";"4.26";"8.59";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649905";"";"None";"587.08";"2";"5.29";"BDBM135257";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccn3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268766";"UO_0000065";"15.33";"0.29";"3.71";"7.04";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649906";"";"None";"566.06";"1";"4.31";"BDBM135258";"C[C@H]1CC[C@H](Cn2c(N3CCOC4CCOCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"268767";"UO_0000065";"13.56";"0.26";"3.37";"6.18";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649907";"";"None";"552.04";"1";"3.92";"BDBM135261";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268770";"UO_0000065";"15.44";"0.30";"4.60";"6.86";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649907";"";"None";"552.04";"1";"3.92";"BDBM135261";"C[C@H]1CC[C@H](Cn2c(N3CCOC4COCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"131.0";"nM";"6.88";"";"268771";"UO_0000065";"12.47";"0.24";"2.96";"5.54";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3927923";"";"None";"568.05";"2";"5.02";"BDBM135263";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@H]4CC(F)C[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"48.0";"nM";"7.32";"";"268775";"UO_0000065";"12.88";"0.25";"2.30";"6.37";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649916";"";"None";"552.08";"2";"5.32";"BDBM135276";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)[C@@H](C)O1";"IC50";"'='";"1.0";"nM";"9.00";"";"268786";"UO_0000065";"16.30";"0.32";"3.68";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657098";"";"None";"569.45";"2";"5.00";"BDBM130015";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.417";"nM";"9.38";"";"261736";"UO_0000065";"16.47";"0.33";"4.38";"8.99";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649921";"";"None";"490.01";"1";"6.44";"BDBM135282";"CN(c1ccccc1)c1nc2cc(C(=O)O)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"86.0";"nM";"7.07";"";"268791";"UO_0000065";"14.42";"0.28";"0.63";"8.40";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3966472";"";"None";"538.05";"2";"5.10";"BDBM135286";"CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC[C@@H]2C)nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c21";"IC50";"'='";"1.0";"nM";"9.00";"";"268796";"UO_0000065";"16.73";"0.32";"3.90";"7.83";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649926";"";"None";"570.07";"2";"5.44";"BDBM135291";"CO[C@@H]1C[C@@H](CF)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C(C)[C@H]2CC[C@H](C)CC2)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"268800";"UO_0000065";"15.79";"0.31";"3.56";"7.83";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3965668";"";"None";"609.13";"2";"5.37";"BDBM135303";"CCOC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"268812";"UO_0000065";"14.28";"0.28";"3.33";"6.43";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3954453";"";"None";"593.13";"2";"5.15";"BDBM135305";"CCC(=O)N1C[C@H](C)N(c2nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268814";"UO_0000065";"14.37";"0.28";"3.37";"6.76";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649957";"";"None";"621.14";"1";"4.39";"BDBM135326";"C[C@@H]1CN(C(=O)C2COC2)C[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268835";"UO_0000065";"13.52";"0.26";"4.01";"6.21";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649958";"";"None";"609.13";"1";"4.39";"BDBM135327";"COCC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"10.0";"nM";"8.00";"";"268836";"UO_0000065";"13.13";"0.25";"3.61";"5.91";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649960";"";"None";"551.09";"2";"6.58";"BDBM135330";"CCOC(c1nc2cc(-c3n[nH]c(=O)o3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CCCC1";"IC50";"'='";"10.0";"nM";"8.00";"";"268840";"UO_0000065";"14.52";"0.28";"1.42";"7.16";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3703336";"";"None";"806.69";"3";"7.56";"BDBM152972";"COCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"7.13";"nM";"8.15";"";"293785";"UO_0000065";"10.10";"0.20";"0.59";"5.28";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653285";"";"None";"540.99";"2";"6.01";"BDBM129853";"COc1ncc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"1.93";"nM";"8.71";"";"261582";"UO_0000065";"16.11";"0.31";"2.70";"8.08";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3219402";"";"None";"410.30";"1";"6.05";"97";"O=C1C(O)=C(c2ccccc2)C(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"26200.0";"nM";"4.58";"";"";"UO_0000065";"11.17";"0.22";"-1.47";"11.30";"0";"CHEMBL3222409";"Inhibition of Mdm2 in p53-deficient human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3318766";"";"None";"607.60";"2";"6.13";"17";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCCC2)C2CC2)C1=O";"IC50";"'='";"0.64";"nM";"9.19";"";"";"UO_0000065";"15.13";"0.31";"3.06";"9.68";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318767";"";"None";"609.57";"1";"4.97";"18";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCOCC2)C2CC2)C1=O";"IC50";"'='";"0.096";"nM";"10.02";"";"";"UO_0000065";"16.43";"0.34";"5.05";"9.61";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318772";"";"None";"641.62";"2";"6.70";"23";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCc3ccccc32)C2CC2)C1=O";"IC50";"'='";"0.53";"nM";"9.28";"";"";"UO_0000065";"14.46";"0.29";"2.58";"9.76";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3318773";"";"None";"595.59";"2";"5.98";"24";"CC(C)[C@@H](CS(=O)(=O)N1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"15.99";"0.33";"3.54";"10.03";"0";"CHEMBL3370341";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay in presence of 15% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3288448";"";"None";"757.17";"2";"6.49";"9";"C=CC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ccccc2OCCOC)CC1.Cl";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"10.25";"0.20";"0.90";"8.75";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3649982";"";"None";"566.01";"2";"6.08";"BDBM135370";"CC(F)(c1ncccc1F)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"268879";"UO_0000065";"14.21";"0.27";"1.97";"6.97";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4166720";"";"None";"516.56";"2";"1.66";"18";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCc2cccc(-c3ccccc3)c2)c1";"IC50";"'='";"333.0";"nM";"6.48";"";"";"UO_0000065";"12.54";"0.23";"4.82";"3.47";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3639488";"";"None";"511.03";"2";"5.63";"BDBM135405";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C(C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"161.0";"nM";"6.79";"";"268914";"UO_0000065";"13.29";"0.26";"1.16";"6.08";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL2386346";"RO-5045337";"1.0";"727.80";"2";"7.75";"1; RG7112";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"10.64";"0.22";"-0.01";"9.39";"0";"CHEMBL5164639";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3703678";"";"None";"409.41";"1";"5.86";"BDBM47305";"Cc1cccc(NC(c2ccc(C(F)(F)F)cc2)c2ccc3cccnc3c2O)n1";"IC50";"'='";"4600.0";"nM";"5.34";"";"198816";"UO_0000065";"13.04";"0.24";"-0.52";"9.20";"0";"CHEMBL3705977";"AlphaScreen Assay: The following example describes an assay that measured the ability of compounds to inhibit the binding of p53 to MDM2 using the AlphaScreen assay technology (PerkinElmer). The following protocol is an adaptation of the method described by H. R. Lawrence et al. (Bioorg. Med. Chem. Lett. 19 (2009) 3756-3759). Recombinant, truncated, human, N-terminal GST-MDM2 (aa 1-150) was obtained from GeneScript. Wild-type, full length human N-terminal 6-his p53 was purchased from SignalChem.Resulting in a final reaction volume of 24 μl PBS, 0.1% Tween-20, and 10% glycerol, 30 ng of MDM2 was added, followed by the addition of 10 of compound diluted in 100% DMSO that provided a final DMSO concentration of 4%. 30 ng of p53 was then added, mixed, and incubated at room temperature for 1 hour. Glutathione donor beads and Nickel acceptor beads (0.5 μg each; PerkinElmer) were added under subdued lighting conditions to a final reaction volume of 30 μl/well in a 96 well, ½ volume Proxima plate.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638674";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4449512";"";"None";"774.72";"2";"6.07";"MG-277";"O=C1CCC(N2Cc3c(CCCCCNC(=O)[C@@H]4NC5(CCCCC5)[C@@]5(C(=O)Nc6cc(Cl)ccc65)[C@H]4c4cccc(Cl)c4F)cccc3C2=O)C(=O)N1";"IC50";"'='";"67.5";"nM";"7.17";"";"";"UO_0000065";"9.26";"0.18";"1.10";"5.25";"0";"CHEMBL4323192";"Displacement of PMDM6-F fluorescent probe from human recombinant His-tagged MDM2 (1 to 118 residues) after 15 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321819";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3220110";"";"None";"415.92";"1";"5.83";"10b";"OCC(=Cc1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1)CO";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"13.31";"0.25";"-0.29";"12.20";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3675210";"";"None";"429.26";"0";"4.75";"BDBM111554";"O=C1c2cccc(Cl)c2C(O)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"510.0";"nM";"6.29";"";"232356";"UO_0000065";"14.66";"0.30";"1.54";"7.52";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1688152";"";"None";"399.88";"1";"5.34";"BDBM111561";"O=C1c2ccccc2C(O)(c2ccc(Cl)cc2)N1Cc1cccc2ccccc12";"IC50";"'='";"96000.0";"nM";"4.02";"";"232363";"UO_0000065";"10.05";"0.19";"-1.32";"9.91";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3653259";"";"None";"541.41";"2";"6.03";"BDBM129826";"COc1cn(C)c(=O)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.31";"nM";"9.51";"";"261555";"UO_0000065";"17.56";"0.35";"3.48";"13.71";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691740";"";"None";"593.55";"2";"7.31";"BDBM143549";"COc1ccccc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"3.9";"nM";"8.41";"";"279624";"UO_0000065";"14.17";"0.28";"1.10";"14.05";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683152";"";"None";"618.26";"2";"8.07";"BDBM161964";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCC(N(C)C(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"305001";"UO_0000065";"12.39";"0.24";"-0.41";"16.92";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691745";"";"None";"568.47";"1";"4.62";"BDBM143574";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.103";"nM";"9.99";"";"279786";"UO_0000065";"17.57";"0.35";"5.37";"10.15";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"BDBM135342";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268851";"UO_0000065";"16.63";"0.32";"2.90";"7.79";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649817";"";"None";"538.05";"1";"4.93";"BDBM135142";"CC1CN(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)C(C)CO1";"IC50";"'='";"156.0";"nM";"6.81";"";"268651";"UO_0000065";"12.65";"0.24";"1.88";"5.92";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649819";"";"None";"536.08";"2";"5.94";"BDBM135144";"CC(C)C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268653";"UO_0000065";"16.79";"0.32";"3.06";"8.51";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3968578";"";"None";"522.05";"2";"5.69";"BDBM135145";"C[C@H]1CC[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"268654";"UO_0000065";"16.66";"0.32";"3.01";"8.23";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649821";"";"None";"521.97";"2";"6.20";"BDBM135147";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(C(=O)O)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268656";"UO_0000065";"17.24";"0.34";"2.80";"10.70";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4217924";"";"None";"1957.92";"None";"None";"D-MIPC";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"11500.0";"nM";"4.94";"";"";"UO_0000065";"2.52";"None";"None";"None";"0";"CHEMBL4185135";"Binding affinity to MDM2 (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4205527";"";"None";"1941.92";"None";"None";"D-MIPC-S15A";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"11800.0";"nM";"4.93";"";"";"UO_0000065";"2.54";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL4204416";"";"None";"1899.88";"None";"None";"D-MIPC-e8a";"CC(C)C[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(Br)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"2.69";"None";"None";"None";"0";"CHEMBL4185136";"Binding affinity to MDM2 (unknown origin) in assessed as reduction in MDM2 binding to Fl-p53-TAD after 30 mins by fluorescence polarization competition assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184127";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";""
"CHEMBL3653158";"";"None";"538.45";"2";"7.95";"52";"COc1ccc(F)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"12.57";"0.25";"-1.18";"14.29";"0";"CHEMBL4353002";"Inhibition of p53 derived Cy5-TFSDLWKLL peptide binding to human MDM2 (2 to 188 residues) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4514512";"";"None";"624.83";"2";"5.93";"46";"COc1cc2c(cc1OC(C)C)[C@H](c1ccccc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"14.56";"0.27";"3.17";"13.88";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3649985";"";"None";"548.02";"2";"5.94";"BDBM135376";"CC(F)(c1ccccn1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268885";"UO_0000065";"15.55";"0.30";"2.58";"7.39";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653325";"";"None";"579.11";"2";"5.12";"BDBM135444";"CNc1ncc(Cl)cc1-c1nc(-c2noc(=O)[nH]2)cc2nc(N3CCO[C@@H]4CCC[C@H]43)n(C[C@H]3CC[C@H](C)CC3)c12";"IC50";"'='";"2.0";"nM";"8.70";"";"268953";"UO_0000065";"15.02";"0.29";"3.58";"6.85";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649994";"";"None";"511.03";"2";"5.46";"BDBM135390";"CCOCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"268899";"UO_0000065";"15.84";"0.31";"2.64";"7.25";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3818299";"";"None";"538.65";"1";"4.02";"9";"CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"15.53";"0.29";"4.35";"6.96";"0";"CHEMBL3820275";"Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87MG ATCC";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817787";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307575";"";""
"CHEMBL4471701";"";"None";"1835.10";"None";"None";"Peptide 2";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCCOCCOCC(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"10.5";"nM";"7.98";"";"";"UO_0000065";"4.35";"None";"None";"None";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL4534075";"";"None";"2915.37";"None";"None";"Peptide 4";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=O)CC[C@@H]2NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccc4ccccc4c3)NC(=O)[C@@H](Cc3ccccc3)NC2=O)C(N)=O)[C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"11.9";"nM";"7.92";"";"";"UO_0000065";"2.72";"None";"None";"None";"0";"CHEMBL4379013";"Displacement of TMR-labelled PDI from human GST tagged MDM2 (1 to 139 residues) expressed in Escherichia coli BL21 (DE3) cells preincuabted for 1 hr with TMR-labelled PDI followed by compound addition and measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376831";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";""
"CHEMBL3693963";"";"None";"477.37";"0";"2.95";"8";"CNC(=O)[C@@H]1NC2(CCNCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4072857";"";"None";"614.54";"2";"6.07";"56";"O=C(NC12CCC(C(=O)O)(CC1)CC2)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"13.72";"0.27";"2.36";"7.84";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4083298";"";"None";"610.51";"2";"6.75";"54";"CC1(C)CCC2(CC1)N[C@@H](C(=O)Nc1ccc(C(=O)O)cc1)[C@H](c1cccc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"14.12";"0.28";"1.87";"8.02";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4077687";"";"None";"600.45";"2";"6.26";"45";"O=C(O)c1ccc(NC(=O)[C@@H]2NC3(CCCCC3)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)cc1F";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"13.56";"0.27";"1.88";"7.57";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL53";"APOMORPHINE";"4.0";"267.33";"0";"2.85";"1a";"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3";"IC50";"'='";"215.0";"nM";"6.67";"";"";"UO_0000065";"24.94";"0.46";"3.82";"15.26";"0";"CHEMBL4017935";"Inhibition of biotin-labelled L-p53 binding to L-MDM2 (25 to 109 residues) (unknown origin) by FAM labeled P4 peptide based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017461";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";""
"CHEMBL407632";"NUTLIN-2";"None";"686.45";"2";"5.89";"1";"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.98";"0.23";"0.96";"8.81";"1";"CHEMBL2400966";"Binding affinity to MDM2 (unknown origin) expressed in Escherichia coli BL21(DE3) after 30 mins by fluorescence polarization assay in presence of P4 peptide";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396572";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3703351";"";"None";"791.68";"2";"6.74";"BDBM152980";"COCCOCCNC(=O)OCOC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"4.63";"nM";"8.33";"";"293804";"UO_0000065";"10.53";"0.21";"1.59";"5.30";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3965113";"";"None";"619.17";"2";"5.54";"BDBM135325";"C[C@H]1CN(C(=O)C2(C)CC2)C[C@H](C)N1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"286344";"UO_0000065";"12.92";"0.25";"2.46";"6.35";"0";"CHEMBL3706331";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20. In the 1x assay buffer recombinant HDM2 protein, peptide and Lumi-4-Tb Cryptate-conjugate mouse.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638720";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4114738";"";"None";"572.51";"2";"5.37";"BDBM170299";"O=C(NC1CCC(O)CC1)[C@@H]1N[C@H](C=C2CCCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"5000.0";"nM";"";"";"314257";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663815";"";"None";"606.55";"1";"4.39";"BDBM170327";"O=C(NCC[C@H](O)CO)[C@@H]1N[C@H](CCCc2cccs2)[C@]2(C(=O)Nc3cc(Cl)c(F)cc32)[C@H]1c1cccc(Cl)c1";"IC50";"'>'";"1000.0";"nM";"";"";"314299";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663838";"";"None";"578.10";"1";"4.25";"BDBM170355";"CC(C)CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"314326";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663864";"";"None";"519.56";"1";"2.71";"BDBM170383";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(F)c2)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'>'";"5000.0";"nM";"";"";"314353";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3663870";"";"None";"618.63";"2";"5.03";"BDBM170391";"CCCN1CCN(CCNC(=O)[C@@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)c(F)cc43)[C@H]2c2cccc(Cl)c2)CC1";"IC50";"'<'";"3000.0";"nM";"";"";"314360";"UO_0000065";"";"";"";"";"0";"CHEMBL3705834";"Fluorescence-Polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide.The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-beta Ala-beta Ala-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) Garcia-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. The Kd value of PMDM6-F with the recombinant MDM2 protein was determined from the saturation curve. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 ug/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638529";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3703335";"";"None";"982.90";"3";"7.63";"BDBM152960";"COCCOCCOCCOCCOCCOCCOC(=O)OC(C)OC(=O)c1ccc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@](C#N)(c3ccc(Cl)cc3F)[C@H]2c2cccc(Cl)c2F)c(OC)c1";"IC50";"'='";"43.5";"nM";"7.36";"";"293784";"UO_0000065";"7.49";"0.15";"-0.27";"3.85";"0";"CHEMBL3706303";"Homogeneous Time-Resolved Fluorescence (HTRF) Assay: The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence) assay in which recombinant GST-tagged MDM2 binds to a peptide that resembles the MDM2-interacting region of p53 (Lane et al.). Binding of GST-MDM2 protein and p53-peptide (biotinylated on its N-terminal end) is registered by the FRET (fluorescence resonance energy transfer) between Europium (Eu)-labeled anti-GST antibody and streptavidin-conjugated Allophycocyanin (APC).Test is performed in black flat-bottom 384-well plates (Costar) in a total volume of 40 uL containing 90 nM biotinylate peptide, 160 ng/ml GST-MDM2, 20 nM streptavidin-APC (PerkinElmerWallac), 2 nM Eu-labeled anti-GST-antibody (PerkinElmerWallac), 0.02% bovine serum albumin (BSA), 1 mM dithiothreitol (DTT) and 20 mM Tris-borate saline (TBS) buffer as follows: Add 10 uL of GST-MDM2 (640 ng/ml working solution) in reaction buffer to each well.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638436";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3961782";"";"None";"562.51";"2";"5.30";"BDBM119726";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"13.3";"nM";"7.88";"";"246809";"UO_0000065";"14.00";"0.28";"2.58";"8.71";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3951933";"";"None";"564.05";"1";"4.93";"BDBM119714";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NC2CCC(O)CC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)c(F)cc12";"IC50";"'<'";"1000.0";"nM";"";"";"246815";"UO_0000065";"";"";"";"";"0";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3665585";"";"None";"532.03";"1";"4.40";"BDBM119717";"CC(C)(C)C[C@H]1N[C@@H](C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(F)ccc12";"IC50";"'<'";"5000.0";"nM";"";"";"246816";"UO_0000065";"";"";"";"";"1";"CHEMBL3705138";"Fluorescence-polarization Binding Assay: The binding affinity of the MDM2 inhibitors was determined using an optimized, sensitive and quantitative fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound (5-FAM-βAla-βAla-Phe-Met-Aib-pTyr-(6-Cl-LTrp)-Glu-Ac3c-Leu-Asn-NH2 (SEQ ID NO: 1)) (García-Echeverría et al., J. Med. Chem. 43: 3205-3208 (2000)). This tagged peptide is called PMDM6-F. MDM2 protein was serially double diluted in a Dynex 96-well, black, round-bottom plate, and the PMDM6-F peptide was added at 1 nM concentration. The assay was performed in the buffer: 100 mM potassium phosphate, pH 7.5; 100 μg/mL bovine gamma globulin; 0.02% sodium azide, 0.01% Triton X-100) and the polarization values were measured after 3 h of incubation using an ULTRA READER (Tecan U.S. Inc).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639230";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3355412";"";"None";"576.54";"2";"5.84";"14D";"CCCC1(CCC)N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"775.0";"nM";"6.11";"";"";"UO_0000065";"10.60";"0.21";"0.27";"6.76";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3355413";"";"None";"532.44";"1";"4.42";"15C";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCC2)[C@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"1719.0";"nM";"5.76";"";"";"UO_0000065";"10.83";"0.22";"1.34";"6.37";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3687271";"";"None";"525.48";"2";"6.30";"BDBM143397";"Cc1cc(Cl)ccc1C1c2c(nn(CCN3CCCC3=O)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"1.7";"nM";"8.77";"";"279539";"UO_0000065";"16.69";"0.33";"2.47";"15.01";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657081";"";"None";"527.37";"1";"3.26";"BDBM129998";"CC(C)n1c(-c2c[nH]c(=O)[nH]c2=O)nc2c1[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"17.24";"nM";"7.76";"";"261719";"UO_0000065";"14.72";"0.29";"4.50";"6.17";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657075";"";"None";"527.39";"2";"5.71";"BDBM129985";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"505.7";"nM";"6.30";"";"261712";"UO_0000065";"11.94";"0.24";"0.59";"6.35";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653276";"";"None";"554.05";"1";"3.94";"BDBM129844";"CNC(=O)N1CCC(N2C(=O)c3nc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"3.44";"nM";"8.46";"";"261573";"UO_0000065";"15.28";"0.30";"4.52";"7.38";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687260";"";"None";"515.44";"2";"7.02";"BDBM143383";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3cscn3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"8.8";"nM";"8.06";"";"279528";"UO_0000065";"15.63";"0.32";"1.04";"15.79";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4102803";"";"None";"389.45";"0";"3.73";"5";"O=C(CC(c1ccccc1)c1ccccc1)N[C@H](Cc1ccc(O)cc1)C(=O)O";"IC50";"'='";"9.6";"nM";"8.02";"";"";"UO_0000065";"20.59";"0.38";"4.29";"9.26";"0";"CHEMBL4019946";"Inhibition of MDM2 in human U87MG cells assessed as reduction in MDM2 interaction with p53 after 10 mins by quantitative sandwich immune-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4017523";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3653254";"";"None";"553.06";"1";"4.58";"BDBM129820";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](NC(C)=O)CC2)C3=O)c(OC)n1";"IC50";"'='";"11.8";"nM";"7.93";"";"261549";"UO_0000065";"14.34";"0.28";"3.35";"7.11";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687297";"";"None";"637.54";"2";"6.60";"BDBM143425";"COc1ccccc1-n1nc2c(c1C(C)C)C(CC(=O)N1CCOCC1)(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"7.1";"nM";"8.15";"";"279565";"UO_0000065";"12.78";"0.25";"1.55";"10.60";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653208";"";"None";"581.50";"2";"6.01";"BDBM129773";"COc1nc(NCCO)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"";"261504";"UO_0000065";"16.80";"0.33";"3.76";"9.27";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653241";"";"None";"554.41";"2";"6.28";"BDBM129806";"COc1ncc(-c2nc3c(n2C2CCC2)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"11.8";"nM";"7.93";"";"261536";"UO_0000065";"14.30";"0.28";"1.65";"9.63";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683181";"";"None";"507.03";"2";"6.01";"BDBM162209";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc([C@H](C)NC(C)=O)cc1)C(=O)C2";"IC50";"'='";"521.0";"nM";"6.28";"";"305039";"UO_0000065";"12.39";"0.24";"0.27";"9.26";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"23";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"29400.0";"nM";"4.53";"";"";"UO_0000065";"10.43";"0.21";"-0.36";"6.78";"0";"CHEMBL2351552";"Inhibition of MDM2 in human SJSA1 cells assessed as upregulation of p21 transcript level after 7 hrs by qRT-PCR analysis in presence of 10% serum";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308885";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"34";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"14.90";"0.30";"0.89";"11.19";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347377";"";"None";"434.32";"0";"4.89";"30";"O=C(O)C[C@@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"12.79";"0.26";"0.66";"8.31";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347376";"";"None";"434.32";"0";"4.89";"29";"O=C(O)C[C@H]1O[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"12.21";"0.25";"0.41";"7.93";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347391";"";"None";"448.35";"1";"5.28";"25";"O=C(O)CC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"15200.0";"nM";"4.82";"";"";"UO_0000065";"10.75";"0.22";"-0.46";"7.21";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347387";"";"None";"416.35";"1";"5.99";"21";"C=CC[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351554";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay in presence of 15% serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"32";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"16.47";"0.34";"1.57";"12.36";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347389";"";"None";"434.32";"0";"4.89";"23";"O=C(O)C[C@@H]1O[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"15.02";"0.31";"1.63";"9.76";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347383";"";"None";"530.42";"2";"6.64";"16";"CCC[C@H](C(=O)O)N1C(=O)[C@H](Cc2ccc(F)cc2)O[C@@H](c2ccc(Cl)cc2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"13.32";"0.27";"0.43";"10.57";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347399";"";"None";"515.25";"2";"6.09";"7";"CN1C(=O)[C@H](Cc2ccccc2)O[C@@H](c2ccc(Br)cc2)[C@H]1c1ccc(Br)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.06";"0.27";"-0.39";"19.29";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL2347395";"";"None";"453.37";"1";"6.93";"3";"COc1ccc([C@H]2CC(=O)C=C(c3ccc(Cl)cc3)[C@@H]2c2ccc(Cl)cc2)cc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2351555";"Inhibition of human recombinant GST-thrombin-MDM2 (1 to 188) expressed in Escherichia coli assessed as reduction of MDM2-p53 interaction incubated for 20 mins followed by p53 addition measured after 60 mins by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346599";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";""
"CHEMBL3656985";"";"None";"538.44";"2";"6.30";"BDBM129887";"COc1ncc(-c2nc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"15.8";"nM";"7.80";"";"261618";"UO_0000065";"14.49";"0.29";"1.50";"9.47";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691706";"";"None";"537.45";"2";"6.07";"BDBM143469";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.393";"nM";"9.41";"";"279757";"UO_0000065";"17.50";"0.35";"3.34";"13.56";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657072";"";"None";"527.39";"2";"5.71";"BDBM129982";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.2";"nM";"9.70";"";"261709";"UO_0000065";"18.39";"0.37";"3.99";"9.78";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657003";"";"None";"543.03";"2";"5.83";"BDBM129907";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(C#N)cc2C)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.33";"nM";"9.48";"";"261638";"UO_0000065";"17.46";"0.33";"3.65";"8.93";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653158";"";"None";"538.45";"2";"7.95";"BDBM129722";"COc1ccc(F)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.17";"nM";"9.77";"Potential transcription error";"261454";"UO_0000065";"";"";"";"";"1";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687227";"";"None";"509.41";"2";"6.95";"BDBM143334";"Cc1cc(Cl)ccc1C1c2c(nn(Cc3cccnc3)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"11.3";"nM";"7.95";"";"279494";"UO_0000065";"15.60";"0.31";"1.00";"15.58";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653221";"";"None";"555.42";"1";"4.69";"BDBM129786";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"3.58";"nM";"8.45";"";"261517";"UO_0000065";"15.21";"0.30";"3.76";"8.09";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650075";"";"None";"528.13";"2";"7.11";"BDBM135945";"CCCCC(C)(O)C1CCC(N2C(=O)Cc3cc(OC)c(OC(C)C)cc3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"6.3";"nM";"8.20";"";"269523";"UO_0000065";"15.53";"0.30";"1.09";"13.90";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653173";"";"None";"549.50";"2";"7.27";"BDBM129737";"COc1ccc(CN)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.09";"nM";"10.05";"";"261468";"UO_0000065";"18.28";"0.36";"2.78";"13.69";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653286";"";"None";"550.42";"2";"6.80";"BDBM129854";"COc1ncc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.65";"nM";"9.19";"";"261583";"UO_0000065";"16.69";"0.33";"2.39";"10.93";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653258";"";"None";"553.06";"1";"4.44";"BDBM129825";"CNC(=O)[C@H]1CC[C@H](N2C(=O)c3nc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"5.61";"nM";"8.25";"";"261554";"UO_0000065";"14.92";"0.29";"3.81";"7.40";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3288450";"";"None";"791.19";"1";"4.66";"11a, Diastereomer 1";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)[C@@H]2CC(O)CO)CC1.Cl";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"10.10";"0.20";"2.96";"6.10";"0";"CHEMBL3292645";"Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286134";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3687267";"";"None";"498.45";"1";"6.86";"BDBM143393";"Cc1cc(Cl)ccc1C1c2c(nn(CC3CCCO3)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.5";"nM";"8.60";"";"279535";"UO_0000065";"17.26";"0.35";"1.74";"18.16";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691789";"";"None";"562.99";"1";"3.96";"BDBM143715";"COc1nc(N(C)C)ncc1-n1nc2c(c1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.197";"nM";"9.71";"";"279831";"UO_0000065";"17.24";"0.33";"5.75";"7.30";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687306";"";"None";"458.39";"1";"5.67";"BDBM143435";"Cc1cc(Cl)ccc1C1c2c(nn(CCO)c2C(C)C)C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"2.6";"nM";"8.59";"";"279574";"UO_0000065";"18.73";"0.38";"2.92";"14.71";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3639906";"";"None";"563.98";"1";"4.59";"BDBM143692";"[C-]#[N+]c1ccc(C2c3c(nn(-c4cnc(OC)nc4OC)c3C(C)C)C(=O)N2c2cc(Cl)c(=O)n(C)c2)c(F)c1";"IC50";"'='";"4.058";"nM";"8.39";"";"279825";"UO_0000065";"14.88";"0.29";"3.80";"7.72";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687303";"";"None";"533.43";"2";"7.68";"BDBM143431";"Cc1cc(Cl)ccc1C1c2c(nn(-c3ccc(C#N)cc3C)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"3.2";"nM";"8.49";"";"279571";"UO_0000065";"15.92";"0.31";"0.81";"13.72";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657082";"";"None";"568.47";"1";"4.75";"BDBM129999";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"417.08";"nM";"6.38";"";"261720";"UO_0000065";"11.22";"0.22";"1.63";"6.48";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683118";"";"None";"465.98";"1";"6.21";"BDBM161755";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(OC)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"134.6";"nM";"6.87";"";"304964";"UO_0000065";"14.75";"0.28";"0.66";"14.31";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691741";"";"None";"555.42";"1";"4.56";"BDBM143550";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.53";"nM";"9.28";"";"279782";"UO_0000065";"16.70";"0.33";"4.72";"8.89";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691709";"";"None";"551.47";"2";"6.55";"BDBM143473";"CCn1cc(N2C(=O)c3nn(-c4ccccc4OC)c(C(C)C)c3C2c2ccc(Cl)cc2C)cc(Cl)c1=O";"IC50";"'='";"1.1";"nM";"8.96";"";"279604";"UO_0000065";"16.24";"0.32";"2.41";"12.92";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3683169";"";"None";"590.21";"2";"6.94";"BDBM162107";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(C(C)CN3CCC(N(C)C)CC3)cc1)C(=O)C2";"IC50";"'='";"21.5";"nM";"7.67";"";"305022";"UO_0000065";"12.99";"0.25";"0.73";"16.94";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653304";"";"None";"597.47";"2";"6.84";"BDBM129872";"CCOC(=O)Cc1cnc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"1.01";"nM";"9.00";"";"261602";"UO_0000065";"15.06";"0.30";"2.16";"10.39";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691748";"";"None";"541.40";"1";"4.55";"BDBM143584";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.232";"nM";"9.63";"";"279789";"UO_0000065";"17.80";"0.36";"5.08";"8.36";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687277";"";"None";"539.51";"2";"6.69";"BDBM143405";"CC(=O)N1CCCC1Cn1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.5";"nM";"8.82";"";"279545";"UO_0000065";"16.36";"0.33";"2.13";"15.10";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657119";"";"None";"585.45";"1";"4.32";"BDBM130037";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.414";"nM";"9.38";"";"261758";"UO_0000065";"16.03";"0.32";"5.06";"8.26";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657029";"";"None";"531.44";"2";"7.38";"BDBM129934";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"0.43";"nM";"9.37";"";"261664";"UO_0000065";"17.62";"0.35";"1.99";"13.16";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656981";"";"None";"554.44";"2";"5.15";"BDBM129883";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)cnc1O)C2=O";"IC50";"'='";"39.6";"nM";"7.40";"";"261613";"UO_0000065";"13.35";"0.27";"2.25";"6.76";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3687312";"";"None";"596.49";"2";"7.31";"BDBM143441";"COC(=O)CCC1(c2ccc(Cl)cc2)c2c(nn(-c3ccccc3OC)c2C(C)C)C(=O)N1c1ccc(F)c(Cl)c1";"IC50";"'='";"1.1";"nM";"8.96";"";"279580";"UO_0000065";"15.02";"0.30";"1.65";"12.16";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657097";"";"None";"569.45";"2";"5.18";"BDBM130014";"CCn1cc(Cl)cc(N2C(=O)c3nc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)c1=O";"IC50";"'='";"0.32";"nM";"9.49";"";"261735";"UO_0000065";"16.67";"0.33";"4.31";"9.10";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691735";"";"None";"462.35";"1";"5.50";"BDBM143544";"Cc1cc(Cl)ccc1[C@H]1c2c(nn(CCO)c2C(C)C)C(=O)N1c1cccc(Cl)c1F";"IC50";"'='";"2.6";"nM";"8.59";"";"279619";"UO_0000065";"18.57";"0.38";"3.09";"14.71";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657040";"";"None";"607.54";"2";"6.42";"BDBM129947";"COc1ccc(CNC(=O)CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.08";"nM";"10.10";"";"261677";"UO_0000065";"16.62";"0.33";"3.68";"10.44";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691742";"";"None";"569.45";"1";"4.87";"BDBM143554";"COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.348";"nM";"9.46";"";"279783";"UO_0000065";"16.61";"0.33";"4.59";"9.06";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691696";"";"None";"554.45";"2";"6.74";"BDBM143455";"COc1ccccc1-n1nc2c(c1C(C)C)C(CCO)(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"1.3";"nM";"8.89";"";"279591";"UO_0000065";"16.03";"0.32";"2.15";"13.15";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653253";"";"None";"540.02";"1";"4.78";"BDBM129819";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](C(=O)O)CC2)C3=O)c(OC)n1";"IC50";"'='";"15.1";"nM";"7.82";"";"261548";"UO_0000065";"14.48";"0.28";"3.04";"6.54";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683150";"";"None";"576.18";"2";"7.13";"BDBM161959";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N[C@H]3CC[C@H](N)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"106.0";"nM";"6.97";"";"304999";"UO_0000065";"12.11";"0.23";"-0.16";"9.08";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3691721";"";"None";"545.47";"2";"7.55";"BDBM143507";"COc1ccc(C#N)cc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.187";"nM";"9.73";"";"279766";"UO_0000065";"17.83";"0.35";"2.18";"13.67";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653249";"";"None";"564.45";"2";"7.10";"BDBM129814";"COc1cnc(CC#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.36";"nM";"9.44";"";"261544";"UO_0000065";"16.73";"0.33";"2.34";"11.24";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3656988";"";"None";"555.44";"2";"6.19";"BDBM129890";"COc1cnc(N(C)C)nc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.52";"nM";"9.28";"";"261621";"UO_0000065";"16.71";"0.33";"3.09";"12.16";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657091";"";"None";"577.02";"1";"4.11";"BDBM130008";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.152";"nM";"9.82";"";"261729";"UO_0000065";"17.02";"0.33";"5.71";"8.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657068";"";"None";"572.42";"2";"5.76";"BDBM129978";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)nc2c1C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"261705";"UO_0000065";"17.16";"0.34";"4.06";"10.72";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653215";"";"None";"593.51";"2";"5.87";"BDBM129780";"COc1nc(N2CC(C)(O)C2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.2";"nM";"9.70";"";"261511";"UO_0000065";"16.34";"0.32";"3.83";"10.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657125";"";"None";"598.49";"1";"4.38";"BDBM130043";"COC[C@@H](C)n1c(-c2cnc(N(C)C)nc2OC)nc2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"6.133";"nM";"8.21";"";"261764";"UO_0000065";"13.72";"0.27";"3.83";"7.63";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683110";"";"None";"480.01";"1";"6.73";"BDBM161723";"CC[C@@H](C)Oc1cc2c(cc1OC)NC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"1309.5";"nM";"5.88";"";"304956";"UO_0000065";"12.26";"0.24";"-0.85";"10.89";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657086";"";"None";"573.41";"1";"4.83";"BDBM130003";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.525";"nM";"9.28";"";"261724";"UO_0000065";"16.18";"0.32";"4.45";"8.89";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3657020";"";"None";"523.42";"2";"5.88";"BDBM129924";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"261655";"UO_0000065";"19.03";"0.38";"4.08";"10.04";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683154";"";"None";"590.16";"2";"6.43";"BDBM161966";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(C(C)N3CCN(C(C)=O)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"15.2";"nM";"7.82";"";"305003";"UO_0000065";"13.25";"0.25";"1.39";"12.55";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3657111";"";"None";"636.11";"1";"4.58";"BDBM130029";"COc1nc(N2CCS(=O)(=O)CC2)ncc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.631";"nM";"9.20";"";"261750";"UO_0000065";"14.46";"0.29";"4.62";"6.85";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3691769";"";"None";"530.98";"1";"3.80";"BDBM143657";"CNc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.661";"nM";"9.18";"";"279810";"UO_0000065";"17.29";"0.33";"5.38";"6.47";"0";"CHEMBL3707807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653171";"";"None";"619.55";"2";"6.63";"BDBM129735";"COc1ccc(C(=O)N2CC(O)C2)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.18";"nM";"9.74";"";"261466";"UO_0000065";"15.73";"0.31";"3.11";"11.09";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4060006";"";"None";"574.51";"2";"6.58";"27";"CN1[C@@H](c2nc(CC(=O)O)cs2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"12.5";"nM";"7.90";"";"";"UO_0000065";"13.76";"0.28";"1.32";"9.58";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4063804";"";"None";"560.48";"2";"6.65";"21";"CN1[C@@H](c2nc(C(=O)O)cs2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"14.08";"0.29";"1.24";"9.56";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4093145";"";"None";"566.53";"2";"5.26";"20";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)sc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"31.2";"nM";"7.51";"";"";"UO_0000065";"13.25";"0.28";"2.25";"8.30";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL4084744";"";"None";"561.49";"1";"4.60";"18";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3nc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"51.4";"nM";"7.29";"";"";"UO_0000065";"12.98";"0.26";"2.69";"7.05";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3355414";"";"None";"532.44";"1";"4.42";"13";"O=C(N[C@H]1CC[C@H](O)CC1)[C@@H]1NC2(CCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"149.0";"nM";"6.83";"";"";"UO_0000065";"12.82";"0.26";"2.41";"7.55";"0";"CHEMBL4011380";"Inhibition of FAM-tagged p53-based PMDM6-F peptide binding to human recombinant His-tagged MDM2 (1 to 118 residues) after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4007507";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";""
"CHEMBL3355425";"";"None";"550.46";"1";"3.64";"26D";"O=C(NCC[C@H](O)CO)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.67";"0.28";"3.88";"6.80";"0";"CHEMBL3380268";"Binding affinity to human His-tagged MDM2 (1 to 118 residues) using FAM tagged p53-based peptide by fluorescence prolarization based protein binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351696";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3125524";"";"None";"540.51";"2";"5.74";"22";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"17.62";"0.37";"3.78";"10.38";"0";"CHEMBL3132470";"Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124826";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";""
"CHEMBL3691772";"";"None";"555.42";"1";"4.56";"BDBM143669";"COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"279625";"UO_0000065";"16.48";"0.33";"4.59";"8.77";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL5204846";"";"None";"518.90";"1";"2.51";"RO-5963";"Cc1c(Cl)ccc2cc(/C=C3\NC(=O)N(C(C(=O)NC(CO)CO)c4ccc(F)c(F)c4)C3=O)[nH]c12";"IC50";"'='";"17.3";"nM";"7.76";"";"";"UO_0000065";"14.96";"0.29";"5.25";"5.76";"0";"CHEMBL5110385";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3683174";"";"None";"634.22";"2";"5.54";"BDBM162139";"CNC(=O)CN[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(OC(C)C)cc4[C@@H]3c3ccc(Cl)cc3)nc2)CC1";"IC50";"'='";"7.7";"nM";"8.11";"";"305029";"UO_0000065";"12.79";"0.25";"2.57";"8.45";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3653242";"";"None";"550.45";"2";"6.45";"BDBM129807";"COc1ncc(-c2nc3c(n2C2CCC2)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"4.6";"nM";"8.34";"";"261537";"UO_0000065";"15.15";"0.30";"1.89";"10.12";"0";"CHEMBL3705464";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639025";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683107";"";"None";"550.10";"2";"5.91";"BDBM161696";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1CNC(C)=O";"IC50";"'='";"16758.9";"nM";"4.78";"";"304952";"UO_0000065";"8.68";"0.17";"-1.13";"6.72";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL4539285";"";"None";"478.42";"1";"5.69";"50; AM-8553";"CC[C@H]([C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"18.73";"0.38";"3.27";"11.51";"0";"CHEMBL4352996";"Inhibition of p53 protein binding to MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350977";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL3220089";"";"None";"560.08";"2";"7.30";"4d";"O=C1NC(=S)N(c2ccccc2)C(=O)/C1=C/c1cc(-c2ccccc2)n(-c2ccc(Cl)cc2)c1-c1ccccc1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.85";"0.23";"-0.66";"12.22";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3220105";"";"None";"568.47";"2";"6.79";"4v";"CCN1C(=O)C(=Cc2cc(-c3ccccc3)n(-c3ccc(Br)cc3)c2-c2ccccc2)C(=O)N(CC)C1=O";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"10.64";"0.22";"-0.74";"9.66";"0";"CHEMBL3227586";"Inhibition of MDM2-p53 interaction (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3217694";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"AMG232";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.22";"0.34";"2.84";"10.05";"0";"CHEMBL4353483";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4350988";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";""
"CHEMBL4173588";"";"None";"454.49";"1";"0.56";"14";"C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)c1cccc(NC(=N)N)c1)c1ccccc1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"14.45";"0.27";"6.01";"3.52";"0";"CHEMBL4145046";"Displacement of p53 from MDM2 in human U87MG cells incubated for 10 mins by sandwich ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138308";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3675200";"";"None";"464.91";"0";"4.67";"BDBM111510";"O=C1c2ccccc2C(OC/C=C/CO)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"405.0";"nM";"6.39";"";"232307";"UO_0000065";"13.75";"0.26";"1.72";"6.88";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3675217";"";"None";"408.84";"0";"4.41";"BDBM111548";"Cc1ccc2c(c1)C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(O)c1ccc(Cl)cc1";"IC50";"'='";"1460.0";"nM";"5.84";"";"232345";"UO_0000065";"14.27";"0.27";"1.43";"6.97";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834377";"";"None";"557.83";"2";"5.66";"BDBM111552";"O=C1c2ccc(Br)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"902.0";"nM";"6.04";"";"232353";"UO_0000065";"10.84";"0.24";"0.38";"6.51";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL1834380";"";"None";"557.83";"2";"5.66";"BDBM111553";"O=C1c2cc(Br)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1030.0";"nM";"5.99";"";"232354";"UO_0000065";"10.73";"0.23";"0.33";"6.44";"0";"CHEMBL3705908";"ELISA Assay: Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived from the p53 binding site for MDM2 (QETFSDLWKLLP). IP3 has a higher affinity for MDM2 than the native peptide and has been used elsewhere to identify antagonists of the binding between MDM2 and p53 (Stoll et al 2001). Aliquots of MDM2 generated by in vitro translation are pre-incubated for 20 minutes at room temperature (i.e. 20-25C.) with test compounds and controls, before transfer into the IP3-coated 96-well plates. Following a further incubation period of 90 minutes at 4C., the plates are washed to remove unbound MDM2 and the residual bound MDM2 is detected using a primary monoclonal antibody (MDM2 Ab-1, clone IF2, Oncogene Research Products) and HRP-conjugated secondary antibody (Goat anti-mouse, Dako PO447).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639270";"37";"BindingDB Database";"";"2013";"None";"";""
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"BDBM135387";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268896";"UO_0000065";"16.01";"0.31";"2.89";"7.12";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650052";"";"None";"486.01";"0";"4.59";"BDBM135922";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(NC(N)=O)CC1)C(=O)C2";"IC50";"'='";"4408.0";"nM";"5.36";"";"269500";"UO_0000065";"11.02";"0.22";"0.77";"5.70";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3650053";"";"None";"500.04";"1";"4.93";"BDBM135923";"COc1cc2c(cc1OC(C)C)C(c1ccc(Cl)cc1)N(C1CCC(N(C)C(N)=O)CC1)C(=O)C2";"IC50";"'='";"372.0";"nM";"6.43";"";"269501";"UO_0000065";"12.86";"0.25";"1.50";"7.56";"0";"CHEMBL3706165";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638562";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3683101";"";"None";"551.09";"2";"6.02";"BDBM161686";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1NC(=O)NC";"IC50";"'='";"71187.8";"nM";"4.15";"";"304946";"UO_0000065";"7.53";"0.15";"-1.87";"4.99";"0";"CHEMBL3706352";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-Hdm2 and p53-Hdm4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, MDM2 protein (amino acids 2-188) and MDM4 protein (amino acids 2-185), tagged with a C-terminal Biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa 18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm. Disruption of the formation of the p53-MDM2 or p53-MDM4 complex due to an inhibitor molecule binding to the p53 binding site of MDM2 or MDM4 results in increased donor emission.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639156";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3687252";"";"None";"569.53";"2";"6.05";"BDBM143372";"CC(=O)N1CCC(O)(Cn2nc3c(c2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"279520";"UO_0000065";"14.94";"0.30";"2.46";"10.82";"0";"CHEMBL3706340";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, MA, USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638655";"37";"BindingDB Database";"";"2015";"None";"";""
"CHEMBL3693980";"";"None";"561.47";"1";"4.02";"BDBM112765";"CNC(=O)[C@@H]1NC2(CCCCC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cc(Cl)cnc1OC(C)(C)C(=O)O";"IC50";"'>'";"10000.0";"nM";"";"";"234040";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3918865";"";"None";"596.48";"2";"5.45";"BDBM112742";"O=C(NC1CCC(O)CC1)[C@@H]1NC2(CCC(F)(F)CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'<'";"100.0";"nM";"";"";"234017";"UO_0000065";"";"";"";"";"0";"CHEMBL3706032";"Binding Assay: The binding affinity of the MDM2 inhibitors disclosed herein was determined using a fluorescence polarization-based (FP-based) binding assay using a recombinant human His-tagged MDM2 protein (residues 1-118) and a fluorescently tagged p53-based peptide. The design of the fluorescence probe was based upon a previously reported high-affinity p53-based peptidomimetic compound called PMDM6-F (García-Echeverria et al., J. Med. Chem. 43: 3205-3208 (2000)).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638371";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3914761";"";"None";"550.06";"2";"5.07";"BDBM135432";"CCC1CCC(Cn2c(N3CCO[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"268941";"UO_0000065";"14.17";"0.27";"2.73";"6.78";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653326";"";"None";"602.10";"2";"5.19";"BDBM135445";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cc(Cl)c[nH]c4=O)c32)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"268954";"UO_0000065";"14.95";"0.29";"3.81";"6.67";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL5200711";"";"None";"2324.49";"None";"None";"[(127)I]SIB-VIP116";"CC(=O)NC(CCCCNC(=O)c1cccc([127I])c1)C(=O)NCCCCCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@]1(C)CCCCCC/C=C/CCC[C@@](C)(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O)[C@@H](C)O";"IC50";"'='";"48.5";"nM";"7.31";"";"";"UO_0000065";"3.15";"None";"None";"None";"0";"CHEMBL5147550";"Binding affinity to recombinant human MDM2 by using 5-FAM-PMDM6 by fluorescence polarization based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"BINDING AGENT"
"CHEMBL2402573";"";"None";"518.49";"1";"4.17";"RO5313109";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.52";"0.31";"3.88";"7.63";"0";"CHEMBL5164639";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL2386346";"RO-5045337";"1.0";"727.80";"2";"7.75";"33; RG7112";"CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"10.64";"0.22";"-0.01";"9.39";"1";"CHEMBL4620014";"Inhibition of MDM2 (unknown origin) by HTRF assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4619711";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";""
"CHEMBL5172740";"";"None";"553.66";"1";"4.84";"25";"CCOC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12";"IC50";"'='";"11.65";"nM";"7.93";"";"";"UO_0000065";"14.33";"0.26";"3.09";"6.76";"0";"CHEMBL5150964";"Inhibition of MDM2 (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149980";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR"
"CHEMBL5199785";"";"None";"488.57";"1";"5.19";"RS3594";"COc1cc(Cc2c(-c3ccn(S(=O)(=O)c4ccccc4)c3)[nH]c3ccccc23)cc(O)c1OC";"IC50";"'='";"10.6";"nM";"7.97";"";"";"UO_0000065";"16.32";"0.31";"2.78";"8.52";"0";"CHEMBL5110385";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5206050";"";"None";"552.46";"2";"6.55";"8";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N([C@@H](C)c2cccc(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.56";"0.29";"1.50";"9.77";"0";"CHEMBL5164639";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3952519";"";"None";"508.03";"2";"5.31";"BDBM135175";"C[C@H]1CCCN1c1nc2cc(-c3nc(=O)o[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"268684";"UO_0000065";"16.53";"0.32";"3.09";"7.94";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649854";"";"None";"589.10";"2";"6.26";"BDBM135190";"Cc1noc(C)c1C1CCCN1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"268699";"UO_0000065";"13.51";"0.26";"1.70";"6.04";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL4111957";"";"None";"565.08";"1";"3.88";"BDBM135234";"CC1CCC(Cn2c(N3CCO[C@@H]4CNCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"512.0";"nM";"6.29";"";"268743";"UO_0000065";"11.13";"0.21";"2.41";"4.95";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"268751";"UO_0000065";"14.74";"0.28";"3.07";"6.77";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649893";"";"None";"578.12";"2";"5.45";"BDBM135241";"C[C@H]1CC[C@H](Cn2c(N3CC(O)CC4CCCCC43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268753";"UO_0000065";"14.36";"0.28";"2.85";"6.59";"1";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3649940";"";"None";"623.16";"2";"5.76";"BDBM135309";"CC(C)OC(=O)N1C[C@@H](C)N(c2nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)[C@H](C)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"268818";"UO_0000065";"13.68";"0.26";"2.76";"6.30";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3963317";"";"None";"631.18";"2";"5.69";"BDBM135318";"C[C@H]1CC[C@H](Cn2c(N3CCN(C(=O)C4CCC4)[C@H]4CCC[C@@H]43)nc3cc(-c4nc(=O)o[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"268827";"UO_0000065";"13.15";"0.25";"2.61";"6.59";"0";"CHEMBL3706024";"FRET Assay: Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with residues 17 to 125 (containing p53 binding surface, Science (1994) 265, 346-355), with N-terminal His and Thioredoxin tag was generated in pET32a expression vector and expressed in E. coli strain BL21(DE3)Rosetta. Protein was purified using Ni-affinity chromatography, followed by size exclusion chromatography using Superdex 75 26/60 column. To assess inhibition of p53 binding to HDM2, a FITC labeled 8-mer peptide (SEQ ID NO:1: Ac-Phe-Arg-Dpr-Ac6c-(6-Br)Trp-Glu-Glu-Leu-NH2; Anal Biochem. 2004 Aug. 1; 331(1):138-46) with strong affinity towards the p53 binding pocket of HDM2 was used. The HDM2 assay buffer contained 1x Phosphate Buffered Saline (Invitrogen, Cat#14190), 0.01% BSA (Jackson ImmunoResearch, Cat#001-000-162), 0.01% Tween-20.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638835";"37";"BindingDB Database";"";"2014";"None";"";""
"CHEMBL3653256";"SIREMADLIN";"2.0";"555.42";"1";"4.69";"7; NVP-HDM201";"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"17.42";"0.35";"4.99";"9.27";"0";"CHEMBL5164642";"Inhibition of human MDM2 by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5169788";"";"None";"525.61";"1";"4.36";"26";"CC(C)C[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"12.74";"0.23";"2.33";"5.22";"0";"CHEMBL5150964";"Inhibition of MDM2 (unknown origin) by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149980";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR"
"CHEMBL5196857";"";"None";"605.51";"2";"7.44";"RG7388";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.58";"0.27";"0.78";"9.38";"0";"CHEMBL5164639";"Inhibition of MDM2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL5179024";"";"None";"610.74";"2";"5.57";"28";"CCOC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccc(N=C=S)cc12";"IC50";"'='";"6.81";"nM";"8.17";"";"";"UO_0000065";"13.37";"0.25";"2.60";"6.30";"0";"CHEMBL5150966";"Inhibition of MDM2 in human U-87 MG cells incubated for 15 mins";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5149980";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5171373";"";"None";"2324.49";"None";"None";"[*I]SIB-VIP116";"CC(=O)NC(CCCCNC(=O)c1cccc(I)c1)C(=O)NCCCCCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@]1(C)CCCCCC/C=C/CCC[C@@](C)(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O)[C@@H](C)O";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"3.53";"None";"None";"None";"0";"CHEMBL5147550";"Binding affinity to recombinant human MDM2 by using 5-FAM-PMDM6 by fluorescence polarization based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"BINDING AGENT"
"CHEMBL5199202";"";"None";"2094.49";"None";"None";"VIP116";"CC(=O)NC(CCCCN)C(=O)NCCCCCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@]1(C)CCCCCC/C=C/CCC[C@@](C)(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O)[C@@H](C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"4.08";"None";"None";"None";"0";"CHEMBL5147550";"Binding affinity to recombinant human MDM2 by using 5-FAM-PMDM6 by fluorescence polarization based assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL5023";"p53-binding protein Mdm-2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143669";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"BINDING AGENT"
